BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy12777
(697 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3P8G|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Benzamidine
pdb|3P8F|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Sfti-1
Length = 241
Score = 105 bits (263), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 60/146 (41%), Positives = 81/146 (55%), Gaps = 11/146 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED------VPPSD 444
+VGG A G+WPWQ+SL + H CGA+L + NW V+AAHC D P+
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQG---HICGASLISPNWLVSAAHCYIDDRGFRYSDPTQ 57
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPI 504
LG HD S P G QERR++ + SHP F+ TF+YD+ALL +P ++ + PI
Sbjct: 58 WTAFLGLHDQSQRSAP-GVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPI 116
Query: 505 CVPEDDTNF-VGTSAHVTGWGRLYEG 529
C+P+ F G + VTGWG G
Sbjct: 117 CLPDASHVFPAGKAIWVTGWGHTQYG 142
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 24/49 (48%), Positives = 31/49 (63%), Gaps = 3/49 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
+VGG A G+WPWQ+SL + H CGA+L + NW V+AAHC D
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQG---HICGASLISPNWLVSAAHCYID 46
>pdb|1EAW|A Chain A, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAW|C Chain C, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAX|A Chain A, Crystal Structure Of Mtsp1 (Matriptase)
pdb|2GV6|A Chain A, Crystal Structure Of Matriptase With Inhibitor Cj-730
pdb|2GV7|A Chain A, Structure Of Matriptase In Complex With Inhibitor Cj-672
Length = 241
Score = 105 bits (263), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 60/146 (41%), Positives = 81/146 (55%), Gaps = 11/146 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED------VPPSD 444
+VGG A G+WPWQ+SL + H CGA+L + NW V+AAHC D P+
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQG---HICGASLISPNWLVSAAHCYIDDRGFRYSDPTQ 57
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPI 504
LG HD S P G QERR++ + SHP F+ TF+YD+ALL +P ++ + PI
Sbjct: 58 WTAFLGLHDQSQRSAP-GVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPI 116
Query: 505 CVPEDDTNF-VGTSAHVTGWGRLYEG 529
C+P+ F G + VTGWG G
Sbjct: 117 CLPDASHVFPAGKAIWVTGWGHTQYG 142
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 24/49 (48%), Positives = 31/49 (63%), Gaps = 3/49 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
+VGG A G+WPWQ+SL + H CGA+L + NW V+AAHC D
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQG---HICGASLISPNWLVSAAHCYID 46
Score = 30.0 bits (66), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 14/46 (30%), Positives = 23/46 (50%), Gaps = 5/46 (10%)
Query: 643 VLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
+LQ+ + VIN + CE + + I +C G+ G DSC+
Sbjct: 148 ILQKGEIRVINQTTCENL-----LPQQITPRMMCVGFLSGGVDSCQ 188
>pdb|3BN9|B Chain B, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3BN9|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3NCL|A Chain A, Crystal Structure Of Mt-Sp1 Bound To Benzamidine
Phosphonate Inhibitor
pdb|3NPS|A Chain A, Crystal Structure Of Membrane-Type Serine Protease 1
(Mt-Sp1) In Complex With The Fab Inhibitor S4
pdb|3SO3|A Chain A, Structures Of Fab-Protease Complexes Reveal A Highly
Specific Non- Canonical Mechanism Of Inhibition
Length = 241
Score = 102 bits (254), Expect = 8e-22, Method: Compositional matrix adjust.
Identities = 59/146 (40%), Positives = 80/146 (54%), Gaps = 11/146 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED------VPPSD 444
+VGG A G+WPWQ+SL + H CGA+L + NW V+AAHC D P+
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQG---HICGASLISPNWLVSAAHCYIDDRGFRYSDPTQ 57
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPI 504
LG HD S P G QERR++ + SHP F+ TF+YD+ALL +P ++ + PI
Sbjct: 58 WTAFLGLHDQSQRSAP-GVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPI 116
Query: 505 CVPEDDTNF-VGTSAHVTGWGRLYEG 529
+P+ F G + VTGWG G
Sbjct: 117 SLPDASHVFPAGKAIWVTGWGHTQYG 142
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 24/49 (48%), Positives = 31/49 (63%), Gaps = 3/49 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
+VGG A G+WPWQ+SL + H CGA+L + NW V+AAHC D
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQG---HICGASLISPNWLVSAAHCYID 46
Score = 30.0 bits (66), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 14/46 (30%), Positives = 23/46 (50%), Gaps = 5/46 (10%)
Query: 643 VLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
+LQ+ + VIN + CE + + I +C G+ G DSC+
Sbjct: 148 ILQKGEIRVINQTTCENL-----LPQQITPRMMCVGFLSGGVDSCQ 188
>pdb|2CGA|A Chain A, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|2CGA|B Chain B, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|1ACB|E Chain E, Crystal And Molecular Structure Of The Bovine
Alpha-Chymotrypsin-Eglin C Complex At 2.0 Angstroms
Resolution
pdb|1CGI|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1CGJ|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1EX3|A Chain A, Crystal Structure Of Bovine Chymotrypsinogen A
(Tetragonal)
pdb|1GL1|A Chain A, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|B Chain B, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|C Chain C, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL0|E Chain E, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-D2v, An Inhibitor From The Insect Locusta
Migratoria
pdb|1K2I|1 Chain 1, Crystal Structure Of Gamma-Chymotrypsin In Complex With 7-
Hydroxycoumarin
pdb|1P2M|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2M|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OXG|A Chain A, Crystal Structure Of A Complex Formed Between Organic
Solvent Treated Bovine Alpha-Chymotrypsin And Its
Autocatalytically Produced Highly Potent 14-Residue
Peptide At 2.2 Resolution
pdb|1T7C|A Chain A, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T7C|C Chain C, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|A Chain A, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|C Chain C, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|A Chain A, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|C Chain C, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|A Chain A, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|C Chain C, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|A Chain A, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|C Chain C, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1CHG|A Chain A, Chymotrypsinogen,2.5 Angstroms Crystal Structure,
Comparison With Alpha-Chymotrypsin,And Implications For
Zymogen Activation
pdb|1GCD|A Chain A, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2Y6T|A Chain A, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|B Chain B, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|C Chain C, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|D Chain D, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|3T62|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|B Chain B, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|C Chain C, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
Length = 245
Score = 95.9 bits (237), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 52/137 (37%), Positives = 74/137 (54%), Gaps = 9/137 (6%)
Query: 389 SRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLR 448
SRIV GE+A G WPWQ+SL+ T H CG +L NENW VTAAHC V SD+++
Sbjct: 14 SRIVNGEEAVPGSWPWQVSLQD---KTGFHFCGGSLINENWVVTAAHC--GVTTSDVVVA 68
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
GE D + E Q+ ++ V + +++ T D+ LL+ F + +C+P
Sbjct: 69 -GEFDQGSSSEK--IQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS 125
Query: 509 DDTNF-VGTSAHVTGWG 524
+F GT+ TGWG
Sbjct: 126 ASDDFAAGTTCVTTGWG 142
Score = 63.2 bits (152), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 30/53 (56%), Positives = 35/53 (66%), Gaps = 3/53 (5%)
Query: 556 ILFPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
+L SRIV GE+A G WPWQ+SL+ T H CG +L NENW VTAAHC
Sbjct: 9 VLSGLSRIVNGEEAVPGSWPWQVSLQD---KTGFHFCGGSLINENWVVTAAHC 58
>pdb|2F91|A Chain A, 1.2a Resolution Structure Of A Crayfish Trypsin Complexed
With A Peptide Inhibitor, Sgti
Length = 237
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 54/142 (38%), Positives = 76/142 (53%), Gaps = 6/142 (4%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV--EDVP-PSDLLL 447
IVGG AT G++P+Q+S ++ H CGA+++NEN+A+TA HCV +D PS L +
Sbjct: 1 IVGGTDATLGEFPYQLSFQETFIGFSFHFCGASIYNENYAITAGHCVYGDDYENPSGLQI 60
Query: 448 RLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP 507
GE D+S E Q V + H FD + D++LL+ + F N+ PI +P
Sbjct: 61 VAGELDMSVNEGS--EQIITVSKIILHENFDYNLLDNDISLLKLSGSLTFNDNVAPIALP 118
Query: 508 EDDTNFVGTSAHVTGWGRLYEG 529
E G VTGWG EG
Sbjct: 119 EQGHTATG-DVIVTGWGTTSEG 139
Score = 58.5 bits (140), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 23/47 (48%), Positives = 34/47 (72%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IVGG AT G++P+Q+S ++ H CGA+++NEN+A+TA HCV
Sbjct: 1 IVGGTDATLGEFPYQLSFQETFIGFSFHFCGASIYNENYAITAGHCV 47
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 21/58 (36%), Positives = 31/58 (53%), Gaps = 4/58 (6%)
Query: 631 WKMALADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W G P VLQ+V+VP++++ C Y A + I + ICAG +G DSC+
Sbjct: 133 WGTTSEGGNTPDVLQKVTVPLVSDEDCRADYGA----DEILDSMICAGVPEGGKDSCQ 186
>pdb|1YM0|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component B: A Novel, Glycosylated Two-chained Trypsin
Length = 238
Score = 92.8 bits (229), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 46/139 (33%), Positives = 78/139 (56%), Gaps = 4/139 (2%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG +A ++PWQ+S+R+ +S+ H CG ++ N+ W V AAHC++ P+ + L +G
Sbjct: 1 IVGGIEARPYEFPWQVSVRR--KSSDSHFCGGSIINDRWVVCAAHCMQGEAPALVSLVVG 58
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EHD S Q V + + +DP T E D+++++ + F N+ PIC P+
Sbjct: 59 EHDSSAASTV--RQTHDVDSIFVNENYDPATLENDVSVIKTAVAITFDINVGPICAPDPA 116
Query: 511 TNFVGTSAHVTGWGRLYEG 529
++V + +GWG + G
Sbjct: 117 NDYVYRKSQCSGWGTINSG 135
Score = 47.8 bits (112), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 21/58 (36%), Positives = 38/58 (65%), Gaps = 2/58 (3%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWSQIIPII 620
IVGG +A ++PWQ+S+R+ +S+ H CG ++ N+ W V AAHC++ ++ ++
Sbjct: 1 IVGGIEARPYEFPWQVSVRR--KSSDSHFCGGSIINDRWVVCAAHCMQGEAPALVSLV 56
>pdb|2JET|B Chain B, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 128
Score = 90.9 bits (224), Expect = 2e-18, Method: Composition-based stats.
Identities = 51/133 (38%), Positives = 74/133 (55%), Gaps = 9/133 (6%)
Query: 394 GEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLGEHD 453
GE A G WPWQ+SL+ T H CG +L +E+W VTAAHC V SD+++ GE D
Sbjct: 1 GEDAIPGSWPWQVSLQD---KTGFHFCGGSLISEDWVVTAAHC--GVKTSDVVVA-GEFD 54
Query: 454 LSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDDTNF 513
++EE Q ++ V +P+F+ T D+ LL+ P +F + +C+P D +F
Sbjct: 55 QGSDEE--NIQVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAVCLPNVDDDF 112
Query: 514 -VGTSAHVTGWGR 525
GT TGWG+
Sbjct: 113 PPGTVCATTGWGK 125
Score = 53.9 bits (128), Expect = 3e-07, Method: Composition-based stats.
Identities = 23/43 (53%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 566 GEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
GE A G WPWQ+SL+ T H CG +L +E+W VTAAHC
Sbjct: 1 GEDAIPGSWPWQVSLQD---KTGFHFCGGSLISEDWVVTAAHC 40
>pdb|1KDQ|A Chain A, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 131
Score = 90.5 bits (223), Expect = 3e-18, Method: Composition-based stats.
Identities = 52/136 (38%), Positives = 75/136 (55%), Gaps = 9/136 (6%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IV GE A G WPWQ+SL+ T H CG +L +E+W VTAAHC V SD+++ G
Sbjct: 1 IVNGEDAIPGSWPWQVSLQD---KTGFHFCGGSLISEDWVVTAAHC--GVKTSDVVVA-G 54
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E D ++EE Q ++ V +P+F+ T D+ LL+ P +F + + +P D
Sbjct: 55 EFDQGSDEE--NIQVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAVSLPNVD 112
Query: 511 TNF-VGTSAHVTGWGR 525
+F GT TGWG+
Sbjct: 113 DDFPPGTVCATTGWGK 128
Score = 57.0 bits (136), Expect = 3e-08, Method: Composition-based stats.
Identities = 25/46 (54%), Positives = 30/46 (65%), Gaps = 3/46 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IV GE A G WPWQ+SL+ T H CG +L +E+W VTAAHC
Sbjct: 1 IVNGEDAIPGSWPWQVSLQD---KTGFHFCGGSLISEDWVVTAAHC 43
>pdb|1MTN|B Chain B, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|F Chain F, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|B Chain B, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|G Chain G, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|B Chain B, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|G Chain G, Bovine Chymotrypsin Complexed To Bpti
pdb|1AFQ|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|1VGC|B Chain B, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|B Chain B, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|B Chain B, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|B Chain B, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|B Chain B, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|B Chain B, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|C Chain C, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|D Chain D, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|B Chain B, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|F Chain F, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|B Chain B, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|F Chain F, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|F Chain F, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|F Chain F, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|F Chain F, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|F Chain F, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|F Chain F, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|F Chain F, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|F Chain F, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|B Chain B, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|F Chain F, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|B Chain B, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|F Chain F, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|B Chain B, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|F Chain F, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|F Chain F, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|B Chain B, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|B Chain B, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|B Chain B, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|B Chain B, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|B Chain B, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
pdb|3RU4|D Chain D, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 131
Score = 88.6 bits (218), Expect = 1e-17, Method: Composition-based stats.
Identities = 50/135 (37%), Positives = 72/135 (53%), Gaps = 9/135 (6%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IV GE+A G WPWQ+SL+ T H CG +L NENW VTAAHC V SD+++ G
Sbjct: 1 IVNGEEAVPGSWPWQVSLQD---KTGFHFCGGSLINENWVVTAAHC--GVTTSDVVVA-G 54
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E D + E Q+ ++ V + +++ T D+ LL+ F + +C+P
Sbjct: 55 EFDQGSSSEK--IQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSAS 112
Query: 511 TNF-VGTSAHVTGWG 524
+F GT+ TGWG
Sbjct: 113 DDFAAGTTCVTTGWG 127
Score = 61.6 bits (148), Expect = 1e-09, Method: Composition-based stats.
Identities = 27/46 (58%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IV GE+A G WPWQ+SL+ T H CG +L NENW VTAAHC
Sbjct: 1 IVNGEEAVPGSWPWQVSLQD---KTGFHFCGGSLINENWVVTAAHC 43
>pdb|1DLK|B Chain B, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
pdb|1DLK|D Chain D, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
Length = 230
Score = 88.2 bits (217), Expect = 1e-17, Method: Composition-based stats.
Identities = 50/135 (37%), Positives = 72/135 (53%), Gaps = 9/135 (6%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IV GE+A G WPWQ+SL+ T H CG +L NENW VTAAHC V SD+++ G
Sbjct: 1 IVNGEEAVPGSWPWQVSLQD---KTGFHFCGGSLINENWVVTAAHC--GVTTSDVVVA-G 54
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E D + E Q+ ++ V + +++ T D+ LL+ F + +C+P
Sbjct: 55 EFDQGSSSEK--IQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSAS 112
Query: 511 TNF-VGTSAHVTGWG 524
+F GT+ TGWG
Sbjct: 113 DDFAAGTTCVTTGWG 127
Score = 61.2 bits (147), Expect = 2e-09, Method: Composition-based stats.
Identities = 27/46 (58%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IV GE+A G WPWQ+SL+ T H CG +L NENW VTAAHC
Sbjct: 1 IVNGEEAVPGSWPWQVSLQD---KTGFHFCGGSLINENWVVTAAHC 43
>pdb|2WPH|S Chain S, Factor Ixa Superactive Triple Mutant
pdb|2WPJ|S Chain S, Factor Ixa Superactive Triple Mutant, Nacl-Soaked
pdb|2WPK|S Chain S, Factor Ixa Superactive Triple Mutant, Ethylene
Glycol-Soaked
pdb|2WPL|S Chain S, Factor Ixa Superactive Triple Mutant, Edta-Soaked
Length = 235
Score = 87.0 bits (214), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 53/146 (36%), Positives = 82/146 (56%), Gaps = 14/146 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
+VGGE A G++PWQ+ L + + CG ++ NE W VTAAHCVE + + G
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAF----CGGSIVNEKWIVTAAHCVE--TGVKITVVAG 54
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDP--RTFEYDLALLRFYEPVKFQPNIIPICVPE 508
EH++ EE + Q+R V + H F+ T+ +D+ALL EP+ + PIC+ +
Sbjct: 55 EHNI--EETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIAD 112
Query: 509 DD-TNFVGT--SAHVTGWGRLY-EGR 530
+ TN S +V+GWGR++ +GR
Sbjct: 113 KEYTNIFLKFGSGYVSGWGRVFHKGR 138
Score = 50.1 bits (118), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 23/48 (47%), Positives = 31/48 (64%), Gaps = 4/48 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVE 610
+VGGE A G++PWQ+ L + + CG ++ NE W VTAAHCVE
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAF----CGGSIVNEKWIVTAAHCVE 44
Score = 31.2 bits (69), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 18/58 (31%), Positives = 27/58 (46%), Gaps = 5/58 (8%)
Query: 631 WKMALADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W G VLQ + VP+++ + C R+ F I CAG+ +G DSC+
Sbjct: 130 WGRVFHKGRSALVLQYLRVPLVDRATC---LRSTKFT--ITNNMFCAGFHEGGRDSCQ 182
>pdb|2WPM|S Chain S, Factor Ixa Superactive Mutant, Egr-Cmk Inhibited
Length = 235
Score = 87.0 bits (214), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 53/146 (36%), Positives = 82/146 (56%), Gaps = 14/146 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
+VGGE A G++PWQ+ L + + CG ++ NE W VTAAHCVE + + G
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAF----CGGSIVNEKWIVTAAHCVE--TGVKITVVAG 54
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDP--RTFEYDLALLRFYEPVKFQPNIIPICVPE 508
EH++ EE + Q+R V + H F+ T+ +D+ALL EP+ + PIC+ +
Sbjct: 55 EHNI--EETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIAD 112
Query: 509 DD-TNFVGT--SAHVTGWGRLY-EGR 530
+ TN S +V+GWGR++ +GR
Sbjct: 113 KEYTNIFLKFGSGYVSGWGRVFHKGR 138
Score = 50.1 bits (118), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 23/48 (47%), Positives = 31/48 (64%), Gaps = 4/48 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVE 610
+VGGE A G++PWQ+ L + + CG ++ NE W VTAAHCVE
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAF----CGGSIVNEKWIVTAAHCVE 44
Score = 31.6 bits (70), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 18/58 (31%), Positives = 27/58 (46%), Gaps = 5/58 (8%)
Query: 631 WKMALADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W G VLQ + VP+++ + C R+ F I CAG+ +G DSC+
Sbjct: 130 WGRVFHKGRAALVLQYLRVPLVDRATC---LRSTKFT--ITNNMFCAGFHEGGRDSCQ 182
>pdb|2BQ6|B Chain B, Crystal Structure Of Factor Xa In Complex With 21
pdb|2BQ7|B Chain B, Crystal Structure Of Factor Xa In Complex With 43
pdb|2BQW|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound 45
Length = 249
Score = 86.7 bits (213), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 53/160 (33%), Positives = 84/160 (52%), Gaps = 17/160 (10%)
Query: 389 SRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLR 448
+RIVGG++ G+ PWQ L I CG + +E + +TAAHC+ +R
Sbjct: 14 TRIVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL--YQAKRFKVR 68
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
+G D +TE+E G V++V H +F T+++D+A+LR P+ F+ N+ P C+PE
Sbjct: 69 VG--DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE 126
Query: 509 DD----TNFVGTSAHVTGWGRLYEGRFRRSYGHPATRQEM 544
D T + V+G+GR +E G +TR +M
Sbjct: 127 RDWAESTLMTQKTGIVSGFGRTHE------KGRQSTRLKM 160
Score = 37.4 bits (85), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 19/49 (38%), Positives = 28/49 (57%), Gaps = 3/49 (6%)
Query: 561 SRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+RIVGG++ G+ PWQ L I CG + +E + +TAAHC+
Sbjct: 14 TRIVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL 59
>pdb|2WPI|S Chain S, Factor Ixa Superactive Double Mutant
Length = 235
Score = 85.9 bits (211), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 52/146 (35%), Positives = 82/146 (56%), Gaps = 14/146 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
+VGGE A G++PWQ+ L + + CG ++ NE W VTAAHCVE + + G
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAF----CGGSIVNEKWIVTAAHCVE--TGVKITVVAG 54
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDP--RTFEYDLALLRFYEPVKFQPNIIPICVPE 508
EH++ EE + Q+R V + H ++ T+ +D+ALL EP+ + PIC+ +
Sbjct: 55 EHNI--EETEHTEQKRNVIRIIPHHNYNAAINTYNHDIALLELDEPLVLNSYVTPICIAD 112
Query: 509 DD-TNFVGT--SAHVTGWGRLY-EGR 530
+ TN S +V+GWGR++ +GR
Sbjct: 113 KEYTNIFLKFGSGYVSGWGRVFHKGR 138
Score = 50.1 bits (118), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 23/48 (47%), Positives = 31/48 (64%), Gaps = 4/48 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVE 610
+VGGE A G++PWQ+ L + + CG ++ NE W VTAAHCVE
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAF----CGGSIVNEKWIVTAAHCVE 44
Score = 31.2 bits (69), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 18/58 (31%), Positives = 27/58 (46%), Gaps = 5/58 (8%)
Query: 631 WKMALADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W G VLQ + VP+++ + C R+ F I CAG+ +G DSC+
Sbjct: 130 WGRVFHKGRSALVLQYLRVPLVDRATC---LRSTKFT--ITNNMFCAGFHEGGRDSCQ 182
>pdb|1Z8G|A Chain A, Crystal Structure Of The Extracellular Region Of The
Transmembrane Serine Protease Hepsin With Covalently
Bound Preferred Substrate
Length = 372
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 57/154 (37%), Positives = 77/154 (50%), Gaps = 19/154 (12%)
Query: 381 CGRRLFPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDV 440
CGRR P RIVGG + G+WPWQ+SLR H CG +L + +W +TAAHC
Sbjct: 108 CGRRKLPVDRIVGGRDTSLGRWPWQVSLRY----DGAHLCGGSLLSGDWVLTAAHC---F 160
Query: 441 PPSDLLL---RLGEHDLSTEEEPYGYQERRVQIVASH----PQFDPRTFE--YDLALLRF 491
P + +L R+ ++ + P+G Q VQ V H P DP + E D+AL+
Sbjct: 161 PERNRVLSRWRVFAGAVA-QASPHGLQ-LGVQAVVYHGGYLPFRDPNSEENSNDIALVHL 218
Query: 492 YEPVKFQPNIIPICVPEDDTNFV-GTSAHVTGWG 524
P+ I P+C+P V G VTGWG
Sbjct: 219 SSPLPLTEYIQPVCLPAAGQALVDGKICTVTGWG 252
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 25/55 (45%), Positives = 32/55 (58%), Gaps = 4/55 (7%)
Query: 554 NRILFPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
R P RIVGG + G+WPWQ+SLR H CG +L + +W +TAAHC
Sbjct: 109 GRRKLPVDRIVGGRDTSLGRWPWQVSLRY----DGAHLCGGSLLSGDWVLTAAHC 159
Score = 35.0 bits (79), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 18/51 (35%), Positives = 26/51 (50%), Gaps = 3/51 (5%)
Query: 638 GPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
G VLQE VP+I+N +C A + I CAG+ +G D+C+
Sbjct: 258 GQQAGVLQEARVPIISNDVCNG---ADFYGNQIKPKMFCAGYPEGGIDACQ 305
>pdb|3T2N|A Chain A, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
pdb|3T2N|B Chain B, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
Length = 372
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 57/154 (37%), Positives = 77/154 (50%), Gaps = 19/154 (12%)
Query: 381 CGRRLFPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDV 440
CGRR P RIVGG + G+WPWQ+SLR H CG +L + +W +TAAHC
Sbjct: 108 CGRRKLPVDRIVGGRDTSLGRWPWQVSLRY----DGAHLCGGSLLSGDWVLTAAHC---F 160
Query: 441 PPSDLLL---RLGEHDLSTEEEPYGYQERRVQIVASH----PQFDPRTFE--YDLALLRF 491
P + +L R+ ++ + P+G Q VQ V H P DP + E D+AL+
Sbjct: 161 PERNRVLSRWRVFAGAVA-QASPHGLQ-LGVQAVVYHGGYLPFRDPNSEENSNDIALVHL 218
Query: 492 YEPVKFQPNIIPICVPEDDTNFV-GTSAHVTGWG 524
P+ I P+C+P V G VTGWG
Sbjct: 219 SSPLPLTEYIQPVCLPAAGQALVDGKICTVTGWG 252
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 25/55 (45%), Positives = 32/55 (58%), Gaps = 4/55 (7%)
Query: 554 NRILFPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
R P RIVGG + G+WPWQ+SLR H CG +L + +W +TAAHC
Sbjct: 109 GRRKLPVDRIVGGRDTSLGRWPWQVSLRY----DGAHLCGGSLLSGDWVLTAAHC 159
Score = 35.0 bits (79), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 18/51 (35%), Positives = 26/51 (50%), Gaps = 3/51 (5%)
Query: 638 GPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
G VLQE VP+I+N +C A + I CAG+ +G D+C+
Sbjct: 258 GQQAGVLQEARVPIISNDVCNG---ADFYGNQIKPKMFCAGYPEGGIDACQ 305
>pdb|3ELA|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia Mutant In Complex With Soluble Tissue Factor
Length = 254
Score = 84.7 bits (208), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 55/144 (38%), Positives = 78/144 (54%), Gaps = 13/144 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPP-SDLLLRL 449
IVGG+ G+ PWQ+ L + L CG L N W V+AAHC + + +L+ L
Sbjct: 1 IVGGKDCPKGECPWQVLL--LVNGAQL--CGGTLINTIWVVSAAHCFDKIKNWRNLIAVL 56
Query: 450 GEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPED 509
GEHDLS E Q RRV V + P T +D+ALLR ++PV +++P+C+PE
Sbjct: 57 GEHDLS--EHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPER 114
Query: 510 DTN-----FVGTSAHVTGWGRLYE 528
+ FV S V+GWG+L +
Sbjct: 115 TFSERTLAFVRFSL-VSGWGQLLD 137
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 22/60 (36%), Positives = 32/60 (53%), Gaps = 6/60 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDL--WSQIIPII 620
IVGG+ G+ PWQ+ L + L CG L N W V+AAHC + + W +I ++
Sbjct: 1 IVGGKDCPKGECPWQVLL--LVNGAQL--CGGTLINTIWVVSAAHCFDKIKNWRNLIAVL 56
Score = 38.5 bits (88), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 21/58 (36%), Positives = 27/58 (46%)
Query: 631 WKMALADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W L G VLQ ++VP + C R G +I E CAG+ GS DSC+
Sbjct: 132 WGQLLDRGATALVLQVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCK 189
>pdb|1DAN|H Chain H, Complex Of Active Site Inhibited Human Blood Coagulation
Factor Viia With Human Recombinant Soluble Tissue Factor
pdb|1QFK|H Chain H, Structure Of Human Factor Viia And Its Implications For
The Triggering Of Blood Coagulation
pdb|1CVW|H Chain H, Crystal Structure Of Active Site-inhibited Human
Coagulation Factor Viia (des-gla)
pdb|1FAK|H Chain H, Human Tissue Factor Complexed With Coagulation Factor Viia
Inhibited With A Bpti-Mutant
pdb|1DVA|H Chain H, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1DVA|I Chain I, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1JBU|H Chain H, Coagulation Factor Vii Zymogen (Egf2PROTEASE) IN COMPLEX
WITH Inhibitory Exosite Peptide A-183
pdb|1KLI|H Chain H, Cofactor-And Substrate-Assisted Activation Of Factor Viia
pdb|1KLJ|H Chain H, Crystal Structure Of Uninhibited Factor Viia
pdb|1J9C|H Chain H, Crystal Structure Of Tissue Factor-Factor Viia Complex
pdb|1W0Y|H Chain H, Tf7a_3771 Complex
pdb|1YGC|H Chain H, Short Factor Viia With A Small Molecule Inhibitor
pdb|1Z6J|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
Viia/tissue Factor/pyrazinone Inhibitor
pdb|1W2K|H Chain H, Tf7a_4380 Complex
pdb|1WQV|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Propylsulfonamide-D- Thr-Met-P-Aminobenzamidine
pdb|1W7X|H Chain H, Factor7- 413 Complex
pdb|1W8B|H Chain H, Factor7 - 413 Complex
pdb|1WSS|H Chain H, Human Factor Viia-Tissue Factor In Complex With Peprid
Mimetic Inhibitor That Has Two Charge Groups In P2 And
P4
pdb|1WTG|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Biphenylalanine-Gln-P-
Aminobenzamidine
pdb|1WUN|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Trp-Gln-P-Aminobenzamidine
pdb|1WV7|H Chain H, Human Factor Viia-tissue Factor Complexed With
Ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine
pdb|2B7D|H Chain H, Factor Viia Inhibitors: Chemical Optimization, Preclinical
Pharmacokinetics, Pharmacodynamics, And Efficacy In A
Baboon Thrombosis Model
pdb|2F9B|H Chain H, Discovery Of Novel Heterocyclic Factor Viia Inhibitors
pdb|2FLB|H Chain H, Discovery Of A Novel Hydroxy Pyrazole Based Factor Ixa
Inhibitor
pdb|2A2Q|H Chain H, Complex Of Active-Site Inhibited Human Coagulation Factor
Viia With Human Soluble Tissue Factor In The Presence Of
Ca2+, Mg2+, Na+, And Zn2+
pdb|2AER|H Chain H, Crystal Structure Of Benzamidine-Factor ViiaSOLUBLE TISSUE
Factor Complex.
pdb|2AEI|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
ViiaTISSUE FACTOR And
2-[[6-[3-(Aminoiminomethyl)phenoxy]-3,
5-Difluro-4-[(1-Methyl-3-
Phenylpropyl)amino]-2-Pyridinyl]oxy]-Benzoic Acid
pdb|2FIR|H Chain H, Crystal Structure Of Dfpr-ViiaSTF
pdb|2C4F|H Chain H, Crystal Structure Of Factor Vii.Stf Complexed With
Pd0297121
pdb|2FLR|H Chain H, Novel 5-azaindole Factor Viia Inhibitors
pdb|2B8O|H Chain H, Crystal Structure Of Glu-gly-arg-chloromethyl
Ketone-factor Viia/soluble Tissue Factor Complex
pdb|2PUQ|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia In Complex With Soluble Tissue Factor
pdb|2EC9|H Chain H, Crystal Structure Analysis Of Human Factor Viia , Souluble
Tissue Factor Complexed With Bcx-3607
pdb|2ZP0|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Benzylsulfonamide-D- Ile-Gln-P-Aminobenzamidine
pdb|2ZWL|H Chain H, Human Factor Viia-Tissue Factor Complexed With Highly
Selective Peptide Inhibitor
pdb|2ZZU|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-5-
(3-Carboxybenzyloxy)-Trp-Gln-P-Aminobenzamidine
pdb|3TH2|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH3|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH4|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|1O5D|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|2BZ6|H Chain H, Orally Available Factor7a Inhibitor
pdb|4ISI|H Chain H, Structure Of Factor Viia In Complex With The Inhibitor
(6s)-n-(4-
Carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,
8-diethyl-4-oxo-
4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide
Length = 254
Score = 84.3 bits (207), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 55/144 (38%), Positives = 78/144 (54%), Gaps = 13/144 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPP-SDLLLRL 449
IVGG+ G+ PWQ+ L + L CG L N W V+AAHC + + +L+ L
Sbjct: 1 IVGGKVCPKGECPWQVLLL--VNGAQL--CGGTLINTIWVVSAAHCFDKIKNWRNLIAVL 56
Query: 450 GEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPED 509
GEHDLS E Q RRV V + P T +D+ALLR ++PV +++P+C+PE
Sbjct: 57 GEHDLS--EHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPER 114
Query: 510 DTN-----FVGTSAHVTGWGRLYE 528
+ FV S V+GWG+L +
Sbjct: 115 TFSERTLAFVRFSL-VSGWGQLLD 137
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 22/60 (36%), Positives = 32/60 (53%), Gaps = 6/60 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDL--WSQIIPII 620
IVGG+ G+ PWQ+ L + L CG L N W V+AAHC + + W +I ++
Sbjct: 1 IVGGKVCPKGECPWQVLLL--VNGAQL--CGGTLINTIWVVSAAHCFDKIKNWRNLIAVL 56
Score = 33.5 bits (75), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 19/58 (32%), Positives = 25/58 (43%)
Query: 631 WKMALADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W L G L ++VP + C R G +I E CAG+ GS DSC+
Sbjct: 132 WGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCK 189
>pdb|1PYT|D Chain D, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 251
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 52/151 (34%), Positives = 77/151 (50%), Gaps = 7/151 (4%)
Query: 381 CGRRLFP---SSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 437
CG +F S+R+VGGE A WPWQISL+ +T+ H CG L N +TAAHC+
Sbjct: 1 CGAPIFQPNLSARVVGGEDAIPHSWPWQISLQYLRDNTWRHTCGGTLITPNHVLTAAHCI 60
Query: 438 EDVPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKF 497
+ + LG+++L E+E G V + H +++ D+AL++ E V+
Sbjct: 61 SNT--LTYRVALGKNNLEVEDEA-GSLYVGVDTIFVHEKWNSFLVRNDIALIKLAETVEL 117
Query: 498 QPNIIPICVPEDDTNF-VGTSAHVTGWGRLY 527
I C+P + + VTGWGRLY
Sbjct: 118 GDTIQVACLPSEGSLLPQDYPCFVTGWGRLY 148
Score = 56.2 bits (134), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 26/63 (41%), Positives = 38/63 (60%)
Query: 560 SSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWSQIIPI 619
S+R+VGGE A WPWQISL+ +T+ H CG L N +TAAHC+ + + + +
Sbjct: 11 SARVVGGEDAIPHSWPWQISLQYLRDNTWRHTCGGTLITPNHVLTAAHCISNTLTYRVAL 70
Query: 620 IQN 622
+N
Sbjct: 71 GKN 73
>pdb|1RFN|A Chain A, Human Coagulation Factor Ixa In Complex With P-Amino
Benzamidine
pdb|3LC3|A Chain A, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC3|C Chain C, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC5|A Chain A, Selective Benzothiophine Inhibitors Of Factor Ixa
Length = 235
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 51/146 (34%), Positives = 81/146 (55%), Gaps = 14/146 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
+VGGE A G++PWQ+ L + + CG ++ NE W VTAAHCVE + + G
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAF----CGGSIVNEKWIVTAAHCVE--TGVKITVVAG 54
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDP--RTFEYDLALLRFYEPVKFQPNIIPICVPE 508
EH++ EE + Q+R V + H ++ + +D+ALL EP+ + PIC+ +
Sbjct: 55 EHNI--EETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIAD 112
Query: 509 DD-TNFVGT--SAHVTGWGRLY-EGR 530
+ TN S +V+GWGR++ +GR
Sbjct: 113 KEYTNIFLKFGSGYVSGWGRVFHKGR 138
Score = 50.1 bits (118), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 23/48 (47%), Positives = 31/48 (64%), Gaps = 4/48 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVE 610
+VGGE A G++PWQ+ L + + CG ++ NE W VTAAHCVE
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAF----CGGSIVNEKWIVTAAHCVE 44
Score = 30.4 bits (67), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 18/58 (31%), Positives = 27/58 (46%), Gaps = 5/58 (8%)
Query: 631 WKMALADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W G VLQ + VP+++ + C R+ F I CAG+ +G DSC+
Sbjct: 130 WGRVFHKGRSALVLQYLRVPLVDRATC---LRSTKFT--IYNNMFCAGFHEGGRDSCQ 182
>pdb|1MQ5|A Chain A, Crystal Structure Of
3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)
Amino]carbonyl]phenyl]-4-[(4-methyl-1-
piperazinyl)methyl]-2- Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1MQ6|A Chain A, Crystal Structure Of
3-Chloro-N-[4-Chloro-2-[[(5-Chloro-2-Pyridinyl)
Amino]carbonyl]-6-Methoxyphenyl]-4-[[(4,
5-Dihydro-2-Oxazolyl)
Methylamino]methyl]-2-Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1V3X|A Chain A, Factor Xa In Complex With The Inhibitor
1-[6-Methyl-4,5,6,7-
Tetrahydrothiazolo(5,4-C)pyridin-2-Yl] Carbonyl-2-
Carbamoyl-4-(6-Chloronaphth-2-Ylsulphonyl)piperazine
pdb|1WU1|A Chain A, Factor Xa In Complex With The Inhibitor
4-[(5-Chloroindol-2-Yl)
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl)
Pyrimidin-2- Yl]carbonyl]piperazine
pdb|2D1J|A Chain A, Factor Xa In Complex With The Inhibitor 2-[[4-[(5-
Chloroindol-2-Yl)sulfonyl]piperazin-1-Yl]
Carbonyl]thieno[3,2-B]pyridine N-Oxide
pdb|2H9E|H Chain H, Crystal Structure Of FxaSELECTIDENAPC2 TERNARY COMPLEX
pdb|2P3U|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-N-(4-Chloro-2-{[(5-Chloropyridin-2-Yl)
Amino]carbonyl}-6-Methoxyphenyl)-4-[(1-Methyl-1h-
Imidazol- 2-Yl)methyl]thiophene-2-Carboxamide {pfizer
320663}
pdb|2P3T|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-4-(2-Methylamino-Imidazol-1-Ylmethyl)-Thiophene-
2- Carboxylic Acid [4-Chloro-2-(5-Chloro-Pyridin-2-
Ylcarbamoyl)-6-Methoxy-Phenyl]-Amide
pdb|2EI6|A Chain A, Factor Xa In Complex With The Inhibitor (-)-Cis-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI7|A Chain A, Factor Xa In Complex With The Inhibitor Trans-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI8|A Chain A, Factor Xa In Complex With The Inhibitor (1s,2r,4s)-N1-[(5-
Chloroindol-2-Yl)carbonyl]-4-(N,N-Dimethylcarbamoyl)-N2-
[(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,
4-C]pyridin-2-Yl) Carbonyl]-1,2-Cyclohexanediamine
pdb|3IIT|A Chain A, Factor Xa In Complex With A Cis-1,2-Diaminocyclohexane
Derivative
pdb|3Q3K|A Chain A, Factor Xa In Complex With A Phenylenediamine Derivative
pdb|3TK5|A Chain A, Factor Xa In Complex With D102-4380
pdb|3TK6|A Chain A, Factor Xa In Complex With D46-5241
Length = 233
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 52/158 (32%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG++ G+ PWQ L I CG + +E + +TAAHC+ +R+G
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL--YQAKRFKVRVG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
D +TE+E G V++V H +F T+++D+A+LR P+ F+ N+ P C+PE D
Sbjct: 56 --DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 511 ----TNFVGTSAHVTGWGRLYEGRFRRSYGHPATRQEM 544
T + V+G+GR +E G +TR +M
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHE------KGRQSTRLKM 145
Score = 34.3 bits (77), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 26/47 (55%), Gaps = 3/47 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IVGG++ G+ PWQ L I CG + +E + +TAAHC+
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL 44
>pdb|1XKA|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|D Chain D, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1G2L|A Chain A, Factor Xa Inhibitor Complex
pdb|1G2M|A Chain A, Factor Xa Inhibitor Complex
pdb|1IOE|A Chain A, Human Coagulation Factor Xa In Complex With M55532
pdb|1IQE|A Chain A, Human Coagulation Factor Xa In Complex With M55590
pdb|1IQF|A Chain A, Human Coagulation Factor Xa In Complex With M55165
pdb|1IQG|A Chain A, Human Coagulation Factor Xa In Complex With M55159
pdb|1IQH|A Chain A, Human Coagulation Factor Xa In Complex With M55143
pdb|1IQI|A Chain A, Human Coagulation Factor Xa In Complex With M55125
pdb|1IQJ|A Chain A, Human Coagulation Factor Xa In Complex With M55124
pdb|1IQK|A Chain A, Human Coagulation Factor Xa In Complex With M55113
pdb|1IQL|A Chain A, Human Coagulation Factor Xa In Complex With M54476
pdb|1IQM|A Chain A, Human Coagulation Factor Xa In Complex With M54471
pdb|1IQN|A Chain A, Human Coagulation Factor Xa In Complex With M55192
pdb|2P3F|H Chain H, Crystal Structure Of The Factor XaNAP5 COMPLEX
Length = 235
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 52/158 (32%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG++ G+ PWQ L I CG + +E + +TAAHC+ +R+G
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL--YQAKRFKVRVG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
D +TE+E G V++V H +F T+++D+A+LR P+ F+ N+ P C+PE D
Sbjct: 56 --DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 511 ----TNFVGTSAHVTGWGRLYEGRFRRSYGHPATRQEM 544
T + V+G+GR +E G +TR +M
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHE------KGRQSTRLKM 145
Score = 34.3 bits (77), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 26/47 (55%), Gaps = 3/47 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IVGG++ G+ PWQ L I CG + +E + +TAAHC+
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL 44
>pdb|1FJS|A Chain A, Crystal Structure Of The Inhibitor Zk-807834 (Ci-1031)
Complexed With Factor Xa
pdb|1Z6E|A Chain A, Factor Xa In Complex With The Inhibitor
1-(3'-Amino-1,2-Benzisoxazol-
5'-Yl)-N-(4-(2'-((Dimethylamino)methyl)-1h-Imidazol-1-
Yl)-2-
Fluorophenyl)-3-(Trifluoromethyl)-1h-Pyrazole-5-
Carboxamide (Razaxaban; Dpc906; Bms-561389)
pdb|2BMG|B Chain B, Crystal Structure Of Factor Xa In Complex With 50
pdb|2FZZ|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-Amino-1,2-
Benzisoxazol-5-Yl)-6-(2'-(((3r)-3-Hydroxy-1-
Pyrrolidinyl)
Methyl)-4-Biphenylyl)-3-(Trifluoromethyl)-1,4,5,6-
Tetrahydro-7h-Pyrazolo[3,4-C]pyridin-7-One
pdb|2G00|A Chain A, Factor Xa In Complex With The Inhibitor 3-(6-(2'-
((Dimethylamino)methyl)-4-Biphenylyl)-7-Oxo-3-
(Trifluoromethyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3,4-
C]pyridin-1-Yl)benzamide
pdb|2P93|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-(2-(4-(2-
Oxopyridin-1(2h)-Yl)benzamido)ethyl)thiophene-2-
Carboxamide
pdb|2P94|A Chain A, Factor Xa In Complex With The Inhibitor
3-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido)cyclohexyl)-1h-
Indole-6-Carboxamide
pdb|2P95|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido) Cyclopentyl)
Thiophene-2-Carboxamide
pdb|2PR3|A Chain A, Factor Xa Inhibitor
pdb|2Q1J|A Chain A, The Discovery Of Glycine And Related Amino Acid-Based
Factor Xa Inhibitors
pdb|2P16|A Chain A, Factor Xa In Complex With The Inhibitor Apixaban (Bms-
562247) Aka 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1-
Piperidinyl)phenyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3, 4-
C]pyridine-3-Carboxamide
pdb|2RA0|A Chain A, X-Ray Structure Of Fxa In Complex With 7-Fluoroindazole
pdb|2PHB|A Chain A, An Orally Efficacious Factor Xa Inhibitor
pdb|3CEN|A Chain A, Factor Xa In Complex With The Inhibitor
N-(2-(((5-Chloro-2- Pyridinyl)
Amino)sulfonyl)phenyl)-4-(2-Oxo-1(2h)-
Pyridinyl)benzamide
pdb|3CS7|A Chain A, Factor Xa In Complex With The Inhibitor
1-(4-Methoxyphenyl)-
6-(4-(1-(Pyrrolidin-1-Ylmethyl)cyclopropyl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|2W26|A Chain A, Factor Xa In Complex With Bay59-7939
pdb|2W3I|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-disubstituted
Pyrrolidine-1,2-dicarboxamide Inhibitor 2
pdb|2W3K|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-Disubstituted
Pyrrolidine-1,2-Dicarboxamide Inhibitor 1
pdb|3FFG|A Chain A, Factor Xa In Complex With The Inhibitor (R)-6-(2'-((3-
Hydroxypyrrolidin-1-Yl)methyl)biphenyl-4-Yl)-1-(3-(5-
Oxo-4, 5-Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|3KQB|A Chain A, Factor Xa In Complex With The Inhibitor N-(3-Fluoro-2'-
(Methylsulfonyl)biphenyl-4-Yl)-1-(3-(5-Oxo-4,
5-Dihydro-1h-
Triazol-3-Yl)phenyl)-3-(Trifluoromethyl)-1h-
Pyrazole-5-Car
pdb|3KQC|A Chain A, Factor Xa In Complex With The Inhibitor 6-(2'-
(Methylsulfon Biphenyl-4-Yl)-1-(3-(5-Oxo-4,5-Dihydro-1h-
1,2,4-Triazol-3- Phenyl)-3-(Trifluoromethyl)-5,6-
Dihydro-1h-Pyrazolo[3,4-C] 7(4h)-One
pdb|3KQD|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-(5-Oxo-4,5-
Dih 2,4-Triazol-3-Yl)phenyl)-6-(2'-(Pyrrolidin-1-
Ylmethyl)biph Yl)-3-(Trifluoromethyl)-5,6-Dihydro-
1h-Pyrazolo[3,4-C]pyri One
pdb|3KQE|A Chain A, Factor Xa In Complex With The Inhibitor 3-Methyl-1-(3-(5-
Ox Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-6-(2'-
(Pyrrolidin-1- Biphenyl-4-Yl)-5,6-Dihydro-1h-
Pyrazolo[3,4-C]pyridin-7(4h)
pdb|3LIW|A Chain A, Factor Xa In Complex With
(R)-2-(1-Adamantylcarbamoylamino)-
3-(3-Carbamidoyl-Phenyl)-N-Phenethyl-Propionic Acid
Amide
pdb|3M36|A Chain A, Factor Xa In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3M37|A Chain A, Factor Xa In Complex With The Inhibitor 1-[2-(Aminomethyl)
Phenyl]-N-(3-Fluoro-2'-Sulfamoylbiphenyl-4-Yl)-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc602)
Length = 234
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 52/158 (32%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG++ G+ PWQ L I CG + +E + +TAAHC+ +R+G
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL--YQAKRFKVRVG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
D +TE+E G V++V H +F T+++D+A+LR P+ F+ N+ P C+PE D
Sbjct: 56 --DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 511 ----TNFVGTSAHVTGWGRLYEGRFRRSYGHPATRQEM 544
T + V+G+GR +E G +TR +M
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHE------KGRQSTRLKM 145
Score = 34.3 bits (77), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 26/47 (55%), Gaps = 3/47 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IVGG++ G+ PWQ L I CG + +E + +TAAHC+
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL 44
>pdb|2Y5F|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5G|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5H|A Chain A, Factor Xa - Cation Inhibitor Complex
Length = 234
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 52/158 (32%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG++ G+ PWQ L I CG + +E + +TAAHC+ +R+G
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL--YQAKRFKVRVG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
D +TE+E G V++V H +F T+++D+A+LR P+ F+ N+ P C+PE D
Sbjct: 56 --DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 511 ----TNFVGTSAHVTGWGRLYEGRFRRSYGHPATRQEM 544
T + V+G+GR +E G +TR +M
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHE------KGEQSTRLKM 145
Score = 34.3 bits (77), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 26/47 (55%), Gaps = 3/47 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IVGG++ G+ PWQ L I CG + +E + +TAAHC+
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL 44
>pdb|3KCG|H Chain H, Crystal Structure Of The Antithrombin-Factor Ixa-
Pentasaccharide Complex
Length = 235
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 51/146 (34%), Positives = 81/146 (55%), Gaps = 14/146 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
+VGGE A G++PWQ+ L + + CG ++ NE W VTAAHCVE + + G
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAF----CGGSIVNEKWIVTAAHCVE--TGVKITVVAG 54
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDP--RTFEYDLALLRFYEPVKFQPNIIPICVPE 508
EH++ EE + Q+R V + H ++ + +D+ALL EP+ + PIC+ +
Sbjct: 55 EHNI--EETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIAD 112
Query: 509 DD-TNFVGT--SAHVTGWGRLY-EGR 530
+ TN S +V+GWGR++ +GR
Sbjct: 113 KEYTNIFLKFGSGYVSGWGRVFHKGR 138
Score = 50.1 bits (118), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 23/48 (47%), Positives = 31/48 (64%), Gaps = 4/48 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVE 610
+VGGE A G++PWQ+ L + + CG ++ NE W VTAAHCVE
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAF----CGGSIVNEKWIVTAAHCVE 44
Score = 30.8 bits (68), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 19/61 (31%), Positives = 28/61 (45%), Gaps = 5/61 (8%)
Query: 631 WKMALADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCEEH 690
W G VLQ + VP+++ + C R+ F I CAG+ +G DSC+
Sbjct: 130 WGRVFHKGRSALVLQYLRVPLVDRATC---LRSTKFT--IYNNMFCAGFHEGGRDSCQGD 184
Query: 691 A 691
A
Sbjct: 185 A 185
>pdb|1HCG|A Chain A, Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms
Resolution
pdb|3KL6|A Chain A, Discovery Of Tetrahydropyrimidin-2(1h)-One Derivative
Tak-44 Potent, Selective And Orally Active Factor Xa
Inhibitor
pdb|2XBW|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBX|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBY|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC0|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC4|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC5|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 83.6 bits (205), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 52/158 (32%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG++ G+ PWQ L I CG + +E + +TAAHC+ +R+G
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL--YQAKRFKVRVG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
D +TE+E G V++V H +F T+++D+A+LR P+ F+ N+ P C+PE D
Sbjct: 56 --DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 511 ----TNFVGTSAHVTGWGRLYEGRFRRSYGHPATRQEM 544
T + V+G+GR +E G +TR +M
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHE------KGRQSTRLKM 145
Score = 34.3 bits (77), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 26/47 (55%), Gaps = 3/47 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IVGG++ G+ PWQ L I CG + +E + +TAAHC+
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL 44
>pdb|2BOK|A Chain A, Factor Xa- Cation
pdb|2JKH|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2VVC|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVC|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVU|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVV|A Chain A, Aminopyrrolidine-Related Triazole Factor Xa Inhibitor
pdb|2VWL|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWN|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWO|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2XBV|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 83.6 bits (205), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 52/158 (32%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG++ G+ PWQ L I CG + +E + +TAAHC+ +R+G
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL--YQAKRFKVRVG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
D +TE+E G V++V H +F T+++D+A+LR P+ F+ N+ P C+PE D
Sbjct: 56 --DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 511 ----TNFVGTSAHVTGWGRLYEGRFRRSYGHPATRQEM 544
T + V+G+GR +E G +TR +M
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHE------KGEQSTRLKM 145
Score = 34.3 bits (77), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 26/47 (55%), Gaps = 3/47 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IVGG++ G+ PWQ L I CG + +E + +TAAHC+
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL 44
>pdb|2GD4|H Chain H, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
pdb|2GD4|B Chain B, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
Length = 241
Score = 83.6 bits (205), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 52/158 (32%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG++ G+ PWQ L I CG + +E + +TAAHC+ +R+G
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL--YQAKRFKVRVG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
D +TE+E G V++V H +F T+++D+A+LR P+ F+ N+ P C+PE D
Sbjct: 56 --DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 511 ----TNFVGTSAHVTGWGRLYEGRFRRSYGHPATRQEM 544
T + V+G+GR +E G +TR +M
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHE------KGRQSTRLKM 145
Score = 34.3 bits (77), Expect = 0.24, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 26/47 (55%), Gaps = 3/47 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IVGG++ G+ PWQ L I CG + +E + +TAAHC+
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL 44
>pdb|3ENS|B Chain B, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3ENS|D Chain D, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3HPT|B Chain B, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3HPT|D Chain D, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3K9X|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3K9X|D Chain D, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3SW2|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
6-Chloro-N-((3s)-
2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,
5-Methanopyrido[1,2-
A][1,5]diazocin-3(2h,4h,
8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- Sulfonamide
Length = 238
Score = 83.6 bits (205), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 52/158 (32%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG++ G+ PWQ L I CG + +E + +TAAHC+ +R+G
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL--YQAKRFKVRVG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
D +TE+E G V++V H +F T+++D+A+LR P+ F+ N+ P C+PE D
Sbjct: 56 --DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 511 ----TNFVGTSAHVTGWGRLYEGRFRRSYGHPATRQEM 544
T + V+G+GR +E G +TR +M
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHE------KGRQSTRLKM 145
Score = 34.3 bits (77), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 26/47 (55%), Gaps = 3/47 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IVGG++ G+ PWQ L I CG + +E + +TAAHC+
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL 44
>pdb|1PFX|C Chain C, Porcine Factor Ixa
pdb|1X7A|C Chain C, Porcine Factor Ixa Complexed To 1-{3-[amino(Imino)
Methyl]phenyl}-N-[4-(1h-Benzimidazol-1-Yl)-2-
Fluorophenyl]-
3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide
Length = 235
Score = 83.2 bits (204), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 52/142 (36%), Positives = 76/142 (53%), Gaps = 13/142 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGGE A G++PWQ+ L I + CG ++ NE W VTAAHC+E P + + G
Sbjct: 1 IVGGENAKPGQFPWQVLLNGKIDAF----CGGSIINEKWVVTAAHCIE--PGVKITVVAG 54
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEY--DLALLRFYEPVKFQPNIIPICVPE 508
E++ TEE Q R V H ++ +Y D+ALL EP+ + PIC+ +
Sbjct: 55 EYN--TEETEPTEQRRNVIRAIPHHSYNATVNKYSHDIALLELDEPLTLNSYVTPICIAD 112
Query: 509 DD-TNFVGT--SAHVTGWGRLY 527
+ TN S +V+GWGR++
Sbjct: 113 KEYTNIFLKFGSGYVSGWGRVF 134
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 24/48 (50%), Positives = 31/48 (64%), Gaps = 4/48 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVE 610
IVGGE A G++PWQ+ L I + CG ++ NE W VTAAHC+E
Sbjct: 1 IVGGENAKPGQFPWQVLLNGKIDAF----CGGSIINEKWVVTAAHCIE 44
Score = 30.8 bits (68), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 17/58 (29%), Positives = 28/58 (48%), Gaps = 5/58 (8%)
Query: 631 WKMALADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W G ++LQ + VP+++ + C R+ F I CAG+ +G DSC+
Sbjct: 130 WGRVFNRGRSATILQYLKVPLVDRATC---LRSTKFT--IYSNMFCAGFHEGGKDSCQ 182
>pdb|1EZQ|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr128515
pdb|1F0R|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208815
pdb|1F0S|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208707
pdb|1KSN|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Fxv673
pdb|1NFU|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr132747
pdb|1NFW|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr209685
pdb|1NFX|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208944
pdb|1NFY|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr200095
pdb|1LPG|B Chain B, Crystal Structure Of Fxa In Complex With 79.
pdb|1LPK|B Chain B, Crystal Structure Of Fxa In Complex With 125.
pdb|1LPZ|B Chain B, Crystal Structure Of Fxa In Complex With 41.
pdb|1LQD|B Chain B, Crystal Structure Of Fxa In Complex With 45.
pdb|1P0S|H Chain H, Crystal Structure Of Blood Coagulation Factor Xa In
Complex With Ecotin M84r
pdb|2BOH|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound
"1"
pdb|2CJI|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J2U|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J34|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J38|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J4I|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J94|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J95|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2UWL|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWO|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWP|A Chain A, Factor Xa Inhibitor Complex
pdb|2VH0|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Biaryl Pyrrolidin-2-Ones Incorporating Basic
Heterocyclic Motifs
pdb|2VH6|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Biaryl P4 Motifs
pdb|2WYG|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2WYJ|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2Y7X|A Chain A, The Discovery Of Potent And Long-Acting Oral Factor Xa
Inhibitors With Tetrahydroisoquinoline And Benzazepine
P4 Motifs
pdb|2Y7Z|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y80|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y81|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y82|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|4A7I|B Chain B, Factor Xa In Complex With A Potent 2-Amino-Ethane
Sulfonamide Inhibitor
Length = 254
Score = 83.2 bits (204), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 52/158 (32%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG++ G+ PWQ L I CG + +E + +TAAHC+ +R+G
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL--YQAKRFKVRVG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
D +TE+E G V++V H +F T+++D+A+LR P+ F+ N+ P C+PE D
Sbjct: 56 --DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 511 ----TNFVGTSAHVTGWGRLYEGRFRRSYGHPATRQEM 544
T + V+G+GR +E G +TR +M
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHE------KGRQSTRLKM 145
Score = 34.3 bits (77), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 26/47 (55%), Gaps = 3/47 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IVGG++ G+ PWQ L I CG + +E + +TAAHC+
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL 44
>pdb|1C5M|D Chain D, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
Length = 255
Score = 83.2 bits (204), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 52/158 (32%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG++ G+ PWQ L I CG + +E + +TAAHC+ +R+G
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCLYQA--KRFKVRVG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
D +TE+E G V++V H +F T+++D+A+LR P+ F+ N+ P C+PE D
Sbjct: 56 --DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 511 ----TNFVGTSAHVTGWGRLYEGRFRRSYGHPATRQEM 544
T + V+G+GR +E G +TR +M
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHE------KGRQSTRLKM 145
Score = 34.3 bits (77), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 26/47 (55%), Gaps = 3/47 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IVGG++ G+ PWQ L I CG + +E + +TAAHC+
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL 44
>pdb|1KIG|H Chain H, Bovine Factor Xa
Length = 241
Score = 82.8 bits (203), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 48/146 (32%), Positives = 75/146 (51%), Gaps = 12/146 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG G+ PWQ L + CG + NE + +TAAHC+ +R+G
Sbjct: 1 IVGGRDCAEGECPWQALLVNEENEGF---CGGTILNEFYVLTAAHCLHQA--KRFTVRVG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
D +TE+E V++ H +F T+++D+A+LR P++F+ N+ P C+PE D
Sbjct: 56 --DRNTEQEEGNEMAHEVEMTVKHSRFVKETYDFDIAVLRLKTPIRFRRNVAPACLPEKD 113
Query: 511 ----TNFVGTSAHVTGWGRLYE-GRF 531
T + V+G+GR +E GR
Sbjct: 114 WAEATLMTQKTGIVSGFGRTHEKGRL 139
Score = 35.4 bits (80), Expect = 0.094, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 24/47 (51%), Gaps = 3/47 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IVGG G+ PWQ L + CG + NE + +TAAHC+
Sbjct: 1 IVGGRDCAEGECPWQALLVNEENEGF---CGGTILNEFYVLTAAHCL 44
>pdb|1MD8|A Chain A, Monomeric Structure Of The Active Catalytic Domain Of
Complement Protease C1r
Length = 329
Score = 82.8 bits (203), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 54/171 (31%), Positives = 88/171 (51%), Gaps = 17/171 (9%)
Query: 368 ESQGINMSNYKEVCGRRLFP---SSRIVGGEKATFGKWPWQISLRQWIRSTYLH-KCGAA 423
E +G + VCG+ + P RI+GG+KA G +PWQ+ T +H + G A
Sbjct: 64 EQKGEKIPRCLPVCGKPVNPVEQRQRIIGGQKAKMGNFPWQVF-------TNIHGRGGGA 116
Query: 424 LFNENWAVTAAHCV-----EDVPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFD 478
L + W +TAAH + E + L + LG ++ + + RRV + + Q +
Sbjct: 117 LLGDRWILTAAHTLYPKEHEAQSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDE 176
Query: 479 PRTFEYDLALLRFYEPVKFQPNIIPICVPEDDTNF-VGTSAHVTGWGRLYE 528
FE D+ALL V PN++PIC+P++DT + +G +V+G+G + E
Sbjct: 177 SYNFEGDIALLELENSVTLGPNLLPICLPDNDTFYDLGLMGYVSGFGVMEE 227
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 20/50 (40%), Positives = 29/50 (58%), Gaps = 8/50 (16%)
Query: 561 SRIVGGEKATFGKWPWQISLRQWIRSTYLH-KCGAALFNENWAVTAAHCV 609
RI+GG+KA G +PWQ+ T +H + G AL + W +TAAH +
Sbjct: 88 QRIIGGQKAKMGNFPWQV-------FTNIHGRGGGALLGDRWILTAAHTL 130
>pdb|4H4F|A Chain A, Crystal Structure Of Human Chymotrypsin C (ctrc) Bound To
Inhibitor Eglin C From Hirudo Medicinalis
Length = 249
Score = 82.8 bits (203), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 4/138 (2%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
+VGGE A WPWQISL+ T+ H CG L N+ +TAAHC+ + + +G
Sbjct: 1 VVGGEDARPHSWPWQISLQYLKNDTWRHTCGGTLIASNFVLTAAHCISNT--RTYRVAVG 58
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
+++L E+E G V + H +++ D+AL++ E V+ I C+PE D
Sbjct: 59 KNNLEVEDEE-GSLFVGVDTIHVHKRWNALLLRNDIALIKLAEHVELSDTIQVACLPEKD 117
Query: 511 TNF-VGTSAHVTGWGRLY 527
+ +VTGWGRL+
Sbjct: 118 SLLPKDYPCYVTGWGRLW 135
Score = 53.1 bits (126), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 24/60 (40%), Positives = 35/60 (58%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWSQIIPIIQN 622
+VGGE A WPWQISL+ T+ H CG L N+ +TAAHC+ + + + + +N
Sbjct: 1 VVGGEDARPHSWPWQISLQYLKNDTWRHTCGGTLIASNFVLTAAHCISNTRTYRVAVGKN 60
>pdb|1MH0|A Chain A, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1MH0|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
Length = 287
Score = 82.8 bits (203), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 14/154 (9%)
Query: 386 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------ED 439
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++
Sbjct: 26 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKN 83
Query: 440 VPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQ 498
+DLL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F
Sbjct: 84 FTENDLLVRIGKHS-RTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 142
Query: 499 PNIIPICVPEDDTNF----VGTSAHVTGWGRLYE 528
I P+C+P+ +T G VTGWG L E
Sbjct: 143 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKE 176
Score = 43.1 bits (100), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 30/52 (57%), Gaps = 2/52 (3%)
Query: 558 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 26 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 75
>pdb|1MD7|A Chain A, Monomeric Structure Of The Zymogen Of Complement Protease
C1r
Length = 328
Score = 82.4 bits (202), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 54/171 (31%), Positives = 88/171 (51%), Gaps = 17/171 (9%)
Query: 368 ESQGINMSNYKEVCGRRLFP---SSRIVGGEKATFGKWPWQISLRQWIRSTYLH-KCGAA 423
E +G + VCG+ + P RI+GG+KA G +PWQ+ T +H + G A
Sbjct: 64 EQKGEKIPRCLPVCGKPVNPVEQRQRIIGGQKAKMGNFPWQVF-------TNIHGRGGGA 116
Query: 424 LFNENWAVTAAHCV-----EDVPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFD 478
L + W +TAAH + E + L + LG ++ + + RRV + + Q +
Sbjct: 117 LLGDRWILTAAHTLYPKEHEAQSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDE 176
Query: 479 PRTFEYDLALLRFYEPVKFQPNIIPICVPEDDTNF-VGTSAHVTGWGRLYE 528
FE D+ALL V PN++PIC+P++DT + +G +V+G+G + E
Sbjct: 177 SYNFEGDIALLELENSVTLGPNLLPICLPDNDTFYDLGLMGYVSGFGVMEE 227
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 20/50 (40%), Positives = 29/50 (58%), Gaps = 8/50 (16%)
Query: 561 SRIVGGEKATFGKWPWQISLRQWIRSTYLH-KCGAALFNENWAVTAAHCV 609
RI+GG+KA G +PWQ+ T +H + G AL + W +TAAH +
Sbjct: 88 QRIIGGQKAKMGNFPWQV-------FTNIHGRGGGALLGDRWILTAAHTL 130
>pdb|1BRU|P Chain P, Structure Of Porcine Pancreatic Elastase Complexed With
The Elastase Inhibitor Gr143783
Length = 241
Score = 82.4 bits (202), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 50/142 (35%), Positives = 70/142 (49%), Gaps = 13/142 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
+VGGE A WPWQ+SL+ + H CG L +++W +TAAHC+ ++ LG
Sbjct: 1 VVGGEDARPNSWPWQVSLQYDSSGQWRHTCGGTLVDQSWVLTAAHCISSSRTYRVV--LG 58
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFE--YDLALLRFYEPVKFQPNIIPICVPE 508
H LST E G +V + H ++ D+ALL+ PV I C+P
Sbjct: 59 RHSLSTNEP--GSLAVKVSKLVVHQDWNSNQLSNGNDIALLKLASPVSLTDKIQLGCLPA 116
Query: 509 DDT----NFVGTSAHVTGWGRL 526
T N+V +VTGWGRL
Sbjct: 117 AGTILPNNYV---CYVTGWGRL 135
Score = 52.8 bits (125), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 21/48 (43%), Positives = 30/48 (62%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVE 610
+VGGE A WPWQ+SL+ + H CG L +++W +TAAHC+
Sbjct: 1 VVGGEDARPNSWPWQVSLQYDSSGQWRHTCGGTLVDQSWVLTAAHCIS 48
>pdb|1D6W|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electrophilic Inhibitors Having Cyclohexyl Moieties
At P1
pdb|1G37|A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed With
Bch-10556 And Exosite-directed Peptide
Length = 287
Score = 82.0 bits (201), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 14/154 (9%)
Query: 386 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------ED 439
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++
Sbjct: 26 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKN 83
Query: 440 VPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQ 498
+DLL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F
Sbjct: 84 FTENDLLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 142
Query: 499 PNIIPICVPEDDTNF----VGTSAHVTGWGRLYE 528
I P+C+P+ +T G VTGWG L E
Sbjct: 143 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKE 176
Score = 43.1 bits (100), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 30/52 (57%), Gaps = 2/52 (3%)
Query: 558 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 26 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 75
>pdb|1EOJ|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
pdb|1EOL|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
Length = 289
Score = 82.0 bits (201), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 14/154 (9%)
Query: 386 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------ED 439
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++
Sbjct: 28 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKN 85
Query: 440 VPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQ 498
+DLL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F
Sbjct: 86 FTENDLLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 144
Query: 499 PNIIPICVPEDDTNF----VGTSAHVTGWGRLYE 528
I P+C+P+ +T G VTGWG L E
Sbjct: 145 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKE 178
Score = 42.7 bits (99), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 30/52 (57%), Gaps = 2/52 (3%)
Query: 558 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 28 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 77
>pdb|1NM6|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
At 1.8a
pdb|1NT1|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
pdb|1TA2|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 1
pdb|1TA6|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 14b
pdb|1SL3|A Chain A, Crystal Structue Of Thrombin In Complex With A Potent P1
Heterocycle- Aryl Based Inhibitor
pdb|1Z71|A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex
Structure
pdb|1ZRB|A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b
pdb|1ZGI|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 21
pdb|1ZGV|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 2
pdb|3C1K|A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 15
Length = 287
Score = 82.0 bits (201), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 14/154 (9%)
Query: 386 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------ED 439
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++
Sbjct: 25 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKN 82
Query: 440 VPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQ 498
+DLL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F
Sbjct: 83 FTENDLLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 141
Query: 499 PNIIPICVPEDDTNF----VGTSAHVTGWGRLYE 528
I P+C+P+ +T G VTGWG L E
Sbjct: 142 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKE 175
Score = 43.1 bits (100), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 30/52 (57%), Gaps = 2/52 (3%)
Query: 558 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 25 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 74
>pdb|1D9I|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electophilic Inhibitors Having Cyclohexyl Moieties
At P1
Length = 288
Score = 82.0 bits (201), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 14/154 (9%)
Query: 386 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------ED 439
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++
Sbjct: 26 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKN 83
Query: 440 VPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQ 498
+DLL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F
Sbjct: 84 FTENDLLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 142
Query: 499 PNIIPICVPEDDTNF----VGTSAHVTGWGRLYE 528
I P+C+P+ +T G VTGWG L E
Sbjct: 143 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKE 176
Score = 42.7 bits (99), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 30/52 (57%), Gaps = 2/52 (3%)
Query: 558 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 26 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 75
>pdb|2BDY|A Chain A, Thrombin In Complex With Inhibitor
Length = 289
Score = 82.0 bits (201), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 14/154 (9%)
Query: 386 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------ED 439
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++
Sbjct: 26 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKN 83
Query: 440 VPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQ 498
+DLL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F
Sbjct: 84 FTENDLLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 142
Query: 499 PNIIPICVPEDDTNF----VGTSAHVTGWGRLYE 528
I P+C+P+ +T G VTGWG L E
Sbjct: 143 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKE 176
Score = 43.1 bits (100), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 30/52 (57%), Gaps = 2/52 (3%)
Query: 558 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 26 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 75
>pdb|1NU9|A Chain A, Staphylocoagulase-prethrombin-2 Complex
pdb|1NU9|D Chain D, Staphylocoagulase-prethrombin-2 Complex
Length = 291
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 14/154 (9%)
Query: 386 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------ED 439
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++
Sbjct: 28 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKN 85
Query: 440 VPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQ 498
+DLL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F
Sbjct: 86 FTENDLLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 144
Query: 499 PNIIPICVPEDDTNF----VGTSAHVTGWGRLYE 528
I P+C+P+ +T G VTGWG L E
Sbjct: 145 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKE 178
Score = 43.1 bits (100), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 30/52 (57%), Gaps = 2/52 (3%)
Query: 558 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 28 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 77
>pdb|1HAG|E Chain E, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1DOJ|A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex
At 1.7 A
pdb|1XM1|A Chain A, Nonbasic Thrombin Inhibitor Complex
Length = 295
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 14/154 (9%)
Query: 386 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------ED 439
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++
Sbjct: 32 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKN 89
Query: 440 VPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQ 498
+DLL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F
Sbjct: 90 FTENDLLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 148
Query: 499 PNIIPICVPEDDTNF----VGTSAHVTGWGRLYE 528
I P+C+P+ +T G VTGWG L E
Sbjct: 149 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKE 182
Score = 43.1 bits (100), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 30/52 (57%), Gaps = 2/52 (3%)
Query: 558 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 32 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 81
>pdb|3SQE|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The
Alternative Form
pdb|3SQH|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The The
Open Form
Length = 290
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 14/154 (9%)
Query: 386 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------ED 439
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++
Sbjct: 27 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKN 84
Query: 440 VPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQ 498
+DLL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F
Sbjct: 85 FTENDLLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 143
Query: 499 PNIIPICVPEDDTNF----VGTSAHVTGWGRLYE 528
I P+C+P+ +T G VTGWG L E
Sbjct: 144 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKE 177
Score = 43.1 bits (100), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 30/52 (57%), Gaps = 2/52 (3%)
Query: 558 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 27 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 76
>pdb|1AUT|C Chain C, Human Activated Protein C
Length = 250
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 16/154 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
++ G+ G PWQ+ L + S CGA L + +W +TAAHC+++ LL+RLG
Sbjct: 1 LIDGKMTRRGDSPWQVVL---LDSKKKLACGAVLIHPSWVLTAAHCMDE--SKKLLVRLG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP--- 507
E+DL E+ + ++ V HP + T + D+ALL +P I+PIC+P
Sbjct: 56 EYDLRRWEK--WELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSG 113
Query: 508 --EDDTNFVGTSAHVTGWG----RLYEGRFRRSY 535
E + N G VTGWG R E + R++
Sbjct: 114 LAERELNQAGQETLVTGWGYHSSREKEAKRNRTF 147
Score = 37.7 bits (86), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 17/49 (34%), Positives = 28/49 (57%), Gaps = 3/49 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
++ G+ G PWQ+ L + S CGA L + +W +TAAHC+++
Sbjct: 1 LIDGKMTRRGDSPWQVVL---LDSKKKLACGAVLIHPSWVLTAAHCMDE 46
>pdb|3F6U|H Chain H, Crystal Structure Of Human Activated Protein C (Apc)
Complexed With Ppack
Length = 240
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 16/154 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
++ G+ G PWQ+ L + S CGA L + +W +TAAHC+++ LL+RLG
Sbjct: 1 LIDGKMTRRGDSPWQVVL---LDSKKKLACGAVLIHPSWVLTAAHCMDE--SKKLLVRLG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP--- 507
E+DL E+ + ++ V HP + T + D+ALL +P I+PIC+P
Sbjct: 56 EYDLRRWEK--WELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSG 113
Query: 508 --EDDTNFVGTSAHVTGWG----RLYEGRFRRSY 535
E + N G VTGWG R E + R++
Sbjct: 114 LAERELNQAGQETLVTGWGYHSSREKEAKRNRTF 147
Score = 37.7 bits (86), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 17/49 (34%), Positives = 28/49 (57%), Gaps = 3/49 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
++ G+ G PWQ+ L + S CGA L + +W +TAAHC+++
Sbjct: 1 LIDGKMTRRGDSPWQVVL---LDSKKKLACGAVLIHPSWVLTAAHCMDE 46
>pdb|3K65|B Chain B, Crystal Structure Of Prethombin-2FRAGMENT-2 Complex
Length = 308
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 14/154 (9%)
Query: 386 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------ED 439
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++
Sbjct: 45 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKN 102
Query: 440 VPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQ 498
+DLL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F
Sbjct: 103 FTENDLLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 161
Query: 499 PNIIPICVPEDDTNF----VGTSAHVTGWGRLYE 528
I P+C+P+ +T G VTGWG L E
Sbjct: 162 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKE 195
Score = 42.7 bits (99), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 30/52 (57%), Gaps = 2/52 (3%)
Query: 558 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 45 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 94
>pdb|1JWT|A Chain A, Crystal Structure Of Thrombin In Complex With A Novel
Bicyclic Lactam Inhibitor
Length = 305
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 14/154 (9%)
Query: 386 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------ED 439
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++
Sbjct: 32 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKN 89
Query: 440 VPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQ 498
+DLL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F
Sbjct: 90 FTENDLLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 148
Query: 499 PNIIPICVPEDDTNF----VGTSAHVTGWGRLYE 528
I P+C+P+ +T G VTGWG L E
Sbjct: 149 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKE 182
Score = 43.1 bits (100), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 30/52 (57%), Gaps = 2/52 (3%)
Query: 558 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 32 YIDGRIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 81
>pdb|1H8I|H Chain H, X-Ray Crystal Structure Of Human Alpha-Thrombin With A
Tripeptide Phosphonate Inhibitor
Length = 253
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 53/163 (32%), Positives = 86/163 (52%), Gaps = 19/163 (11%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYEGRFRRSYGHPATRQ 542
+C+P+ +T G VTGWG L E ++G P+ Q
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE-----TWGQPSVLQ 155
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1DM4|B Chain B, Ser195ala Mutant Of Human Thrombin Complexed With
Fibrinopeptide A (7- 16)
pdb|1JMO|H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a
Thrombin Complex
Length = 260
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 51/150 (34%), Positives = 81/150 (54%), Gaps = 14/150 (9%)
Query: 390 RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPS 443
RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +
Sbjct: 1 RIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEN 58
Query: 444 DLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNII 502
DLL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I
Sbjct: 59 DLLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 117
Query: 503 PICVPEDDTNF----VGTSAHVTGWGRLYE 528
P+C+P+ +T G VTGWG L E
Sbjct: 118 PVCLPDRETAASLLQAGYKGRVTGWGNLKE 147
Score = 42.4 bits (98), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 21/48 (43%), Positives = 29/48 (60%), Gaps = 2/48 (4%)
Query: 562 RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 RIVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 46
>pdb|3NXP|A Chain A, Crystal Structure Of Human Prethrombin-1
Length = 424
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 14/154 (9%)
Query: 386 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------ED 439
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++
Sbjct: 161 YIDGRIVEGSDAEIGMSPWQVML--FRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKN 218
Query: 440 VPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQ 498
+DLL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F
Sbjct: 219 FTENDLLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 277
Query: 499 PNIIPICVPEDDTNF----VGTSAHVTGWGRLYE 528
I P+C+P+ +T G VTGWG L E
Sbjct: 278 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKE 311
Score = 42.7 bits (99), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 30/52 (57%), Gaps = 2/52 (3%)
Query: 558 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+ RIV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 161 YIDGRIVEGSDAEIGMSPWQVML--FRKSPQELLCGASLISDRWVLTAAHCL 210
>pdb|2F83|A Chain A, Crystal Structure At 2.9 Angstroms Resolution Of Human
Plasma Coagulation Factor Xi Zymogen
Length = 625
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 13/163 (7%)
Query: 367 IESQGINMSNYKEVCGRRLFPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFN 426
I + + C ++ P RIVGG + G+WPWQ++L T H CG ++
Sbjct: 366 ISGYTLRLCKMDNECTTKIKP--RIVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIG 422
Query: 427 ENWAVTAAHCVEDVPPSDLLLR----LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTF 482
W +TAAHC V +L L + ++ + +G QE + H Q+
Sbjct: 423 NQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQE-----IIIHDQYKMAES 477
Query: 483 EYDLALLRFYEPVKFQPNIIPICVP-EDDTNFVGTSAHVTGWG 524
YD+ALL+ V + + PIC+P + D N + T VTGWG
Sbjct: 478 GYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWG 520
Score = 49.7 bits (117), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 21/47 (44%), Positives = 28/47 (59%), Gaps = 1/47 (2%)
Query: 562 RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
RIVGG + G+WPWQ++L T H CG ++ W +TAAHC
Sbjct: 387 RIVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHC 432
Score = 37.4 bits (85), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 17/58 (29%), Positives = 28/58 (48%), Gaps = 4/58 (6%)
Query: 631 WKMALADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W + + LQ+ +P++ N C+ YR I ICAG+R+G D+C+
Sbjct: 519 WGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRG----HKITHKMICAGYREGGKDACK 572
>pdb|1FAX|A Chain A, Coagulation Factor Xa Inhibitor Complex
Length = 254
Score = 81.3 bits (199), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 50/158 (31%), Positives = 81/158 (51%), Gaps = 17/158 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG++ G+ PWQ L I CG + +E + +TAAHC+ +R+G
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCLYQA--KRFKVRVG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
+ + + EE E V++V H +F T+++D+A+LR P+ F+ N+ P C+PE D
Sbjct: 56 DRNTAAEEGGEAVHE--VEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 511 ----TNFVGTSAHVTGWGRLYEGRFRRSYGHPATRQEM 544
T + V+G+GR +E G +TR +M
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHE------KGRQSTRLKM 145
Score = 34.3 bits (77), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 26/47 (55%), Gaps = 3/47 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IVGG++ G+ PWQ L I CG + +E + +TAAHC+
Sbjct: 1 IVGGQECKDGECPWQALL---INEENEGFCGGTILSEFYILTAAHCL 44
>pdb|1GPZ|A Chain A, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
pdb|1GPZ|B Chain B, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
Length = 399
Score = 80.9 bits (198), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 53/171 (30%), Positives = 88/171 (51%), Gaps = 17/171 (9%)
Query: 368 ESQGINMSNYKEVCGRRLFP---SSRIVGGEKATFGKWPWQISLRQWIRSTYLH-KCGAA 423
E +G + VCG+ + P +I+GG+KA G +PWQ+ T +H + G A
Sbjct: 132 EQKGEKIPRCLPVCGKPVNPVEQRQQIIGGQKAKMGNFPWQVF-------TNIHGRGGGA 184
Query: 424 LFNENWAVTAAHCV-----EDVPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFD 478
L + W +TAAH + E + L + LG ++ + + RRV + + Q +
Sbjct: 185 LLGDRWILTAAHTLYPKEHEAQSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDE 244
Query: 479 PRTFEYDLALLRFYEPVKFQPNIIPICVPEDDTNF-VGTSAHVTGWGRLYE 528
FE D+ALL V PN++PIC+P++DT + +G +V+G+G + E
Sbjct: 245 SYNFEGDIALLELENSVTLGPNLLPICLPDNDTFYDLGLMGYVSGFGVMEE 295
Score = 39.3 bits (90), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 19/50 (38%), Positives = 29/50 (58%), Gaps = 8/50 (16%)
Query: 561 SRIVGGEKATFGKWPWQISLRQWIRSTYLH-KCGAALFNENWAVTAAHCV 609
+I+GG+KA G +PWQ+ T +H + G AL + W +TAAH +
Sbjct: 156 QQIIGGQKAKMGNFPWQV-------FTNIHGRGGGALLGDRWILTAAHTL 198
>pdb|2A0Q|B Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride
pdb|2A0Q|D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride
Length = 257
Score = 80.5 bits (197), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1SFQ|B Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SFQ|E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SG8|B Chain B, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SG8|E Chain E, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SGI|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SGI|E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SHH|B Chain B, Slow Form Of Thrombin Bound With Ppack
pdb|1SHH|E Chain E, Slow Form Of Thrombin Bound With Ppack
pdb|2HWL|B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|2HWL|D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|3BV9|B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19
Length = 259
Score = 80.5 bits (197), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|2OD3|B Chain B, Human Thrombin Chimera With Human Residues 184a, 186,
186a, 186b, 186c And 222 Replaced By Murine Thrombin
Equivalents
Length = 259
Score = 80.1 bits (196), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1BHX|B Chain B, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|B Chain B, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
pdb|2PKS|B Chain B, Thrombin In Complex With Inhibitor
pdb|3PO1|B Chain B, Thrombin In Complex With Benzothiazole Guanidine
Length = 147
Score = 80.1 bits (196), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1TQ0|B Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ0|D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ7|B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant
W215aE217A Bound To Ppack
Length = 257
Score = 80.1 bits (196), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|3R3G|B Chain B, Structure Of Human Thrombin With Residues 145-150 Of
Murine Thrombin
Length = 259
Score = 80.1 bits (196), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLRE 146
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1H8D|H Chain H, X-Ray Structure Of The Human Alpha-Thrombin Complex With A
Tripeptide Phosphonate Inhibitor
Length = 260
Score = 79.7 bits (195), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 53/163 (32%), Positives = 84/163 (51%), Gaps = 20/163 (12%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYEGRFRRSYGHPATRQ 542
+C+P+ +T G VTGWG L E G P+ Q
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKET------GQPSVLQ 154
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1B7X|B Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D-
Phe-Pro-Arg-Chloromethylketone
Length = 259
Score = 79.7 bits (195), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1QUR|H Chain H, Human Alpha-Thrombin In Complex With Bivalent,
Benzamidine-Based Synthetic Inhibitor
pdb|1D3D|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzothiophene Inhibitor 4
pdb|1EB1|H Chain H, Complex Structure Of Human Thrombin With N-Methyl-Arginine
Inhibitor
pdb|1GHV|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1YPE|H Chain H, Thrombin Inhibitor Complex
pdb|1YPG|H Chain H, Thrombin Inhibitor Complex
pdb|1YPJ|H Chain H, Thrombin Inhibitor Complex
pdb|1YPK|H Chain H, Thrombin Inhibitor Complex
pdb|1YPL|H Chain H, X-Ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1008
pdb|1YPM|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1014
pdb|2ANM|H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor
With Human Thrombin And A C-Terminal Hirudin Derived
Exo-Sit Inhibitor
pdb|2CF9|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|1GHX|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GHY|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2CF8|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|2CN0|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Inhibitor
pdb|3BIU|H Chain H, Human Thrombin-In Complex With Ub-Thr10
pdb|3BIV|H Chain H, Human Thrombin-In Complex With Ub-Thr11
pdb|2V3H|H Chain H, Thrombin With 3-Cycle No F
pdb|2V3O|H Chain H, Thrombin With 3-Cycle With F
pdb|4AX9|H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240
pdb|4AYV|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AYY|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AZ2|B Chain B, Human Thrombin - Inhibitor Complex
pdb|1GHW|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-centered Short Hydrogen Bonding Network At The
Active Site
Length = 257
Score = 79.7 bits (195), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|3EE0|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN
Thrombin (Space Group P2(1)2(1)2(1))
pdb|3HKJ|B Chain B, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
pdb|3HKJ|E Chain E, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
Length = 259
Score = 79.7 bits (195), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1Z8I|B Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound To
Ppack
Length = 259
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1TWX|B Chain B, Crystal Structure Of The Thrombin Mutant D221aD222K
Length = 259
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.0 bits (92), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1ABI|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1ABJ|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1DWB|H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-directed Inhibitors
pdb|1DWC|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWD|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWE|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1FPH|H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural
Basis For Its Specificity
pdb|1HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha-
Thrombin
pdb|1IHS|H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1IHT|H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1PPB|H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human
Alpha-Thrombin: Interaction With D-Phe-Pro-Arg
Chloromethylketone And Significance Of The
Tyr-Pro-Pro-Trp Insertion Segment
pdb|1THR|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1THS|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1TMB|H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin
By The Macrocyclic Peptide Cyclotheonamide A
pdb|2HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of
Alpha-Thrombin
pdb|2HPP|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin
pdb|2HPQ|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-thrombin
pdb|3HTC|H Chain H, The Structure Of A Complex Of Recombinant Hirudin And
Human Alpha-Thrombin
pdb|4HTC|H Chain H, The Refined Structure Of The Hirudin-Thrombin Complex
pdb|1HUT|H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer
Single-Stranded Dna Aptamer
pdb|1NRN|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRO|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRP|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRQ|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRR|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRS|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1TMT|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1TMU|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1HLT|H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HLT|K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HAH|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1HAI|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|3HAT|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1FPC|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1HBT|H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium
Methyl Ketone Containing Bivalent Inhibitor
pdb|1HDT|H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed
With Human Alpha-Thrombin
pdb|1HAO|H Chain H, Complex Of Human Alpha-thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of
Dna)
pdb|1HAP|H Chain H, Complex Of Human Alpha-Thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of
Dna)
pdb|1AHT|H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed With
Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms
Resolution
pdb|1DIT|H Chain H, Complex Of A Divalent Inhibitor With Thrombin
pdb|1TOM|H Chain H, Alpha-Thrombin Complexed With Hirugen
pdb|1HXF|H Chain H, Human Thrombin Complex With Hirudin Variant
pdb|1BMM|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-4-[(Aminoiminomethyl)
Amino]-N-[[1-[3-Hydroxy-2-[(2-
Naphthalenylsulfonyl)amino]-1-
Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide
(Bms-186282)
pdb|1BMN|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-1-(Aminoiminomethyl)-
N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-
Pyrrolidinyl]methyl]-3- Piperidenecarboxamide
(Bms-189090)
pdb|1UMA|H Chain H, Alpha-Thrombin (Hirugen) Complexed With
Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine
pdb|1LHD|H Chain H, Human Alpha-thrombin Complexed With
Ac-(d)phe-pro-borolys-oh
pdb|1LHE|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N-
Butyl-Amidino-Glycine-Oh
pdb|1LHF|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-
Homolys-Oh
pdb|1LHG|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-
Boroornithine-Oh
pdb|1LHC|H Chain H, Human Alpha-Thrombin Complexed With
Ac-(D)phe-Pro-Boroarg-Oh
pdb|1AD8|H Chain H, Complex Of Thrombin With And Inhibitor Containing A Novel
P1 Moiety
pdb|1AI8|H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Borompg
pdb|1AIX|H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Boroval
pdb|1AE8|H Chain H, Human Alpha-Thrombin Inhibition By
Eoc-D-Phe-Pro-Azalys-Onp
pdb|1AFE|H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp
pdb|1UVS|H Chain H, Bovine Thrombin--Bm51.1011 Complex
pdb|5GDS|H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure
Of Human Alpha-Thrombin:hirunorm V Complex
pdb|1AY6|H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based
Macrocyclic Tripeptide Motif
pdb|1A46|H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic
Inhibitor
pdb|1A4W|H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing
Inhibitors: Probes Of The S1' Binding Site
pdb|1A5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1B5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1TBZ|H Chain H, Human Thrombin With Active Site N-Methyl-D
Phenylalanyl-N-[5-
(Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl]
Butyl]-L- Prolinamide Trifluroacetate And
Exosite-Hirugen
pdb|1A2C|H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-A From A
Blue-Green Alga
pdb|1A61|H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing
Inhibitor
pdb|1A3B|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog1
pdb|1A3E|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog2
pdb|1AWF|H Chain H, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|B Chain B, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|D Chain D, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1BCU|H Chain H, Alpha-Thrombin Complexed With Hirugen And Proflavin
pdb|8KME|2 Chain 2, Crystal Structure Of Human Alpha-thrombin Inhibited With
Sel2770.
pdb|1BA8|B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes
pdb|1BB0|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1CA8|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|4THN|H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv
Complex Reveals A Novel Specificity Site Recognition
Mode.
pdb|1QBV|H Chain H, Crystal Structure Of Thrombin Complexed With An
Guanidine-Mimetic Inhibitor
pdb|1D4P|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
5- Amidinoindole-4-benzylpiperidine Inhibitor
pdb|7KME|H Chain H, Crystal Structure Of Human Alpha-Thrombin Inhibited With
Sel2711.
pdb|1QHR|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ1|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ6|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ7|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1D3P|B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex With
Benzo[b]thiophene Inhibitor 3
pdb|1D3Q|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 2
pdb|1D3T|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 1
pdb|1C4U|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4V|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4Y|2 Chain 2, Selective Non-Electrophilic Thrombin Inhibitors
pdb|1DE7|H Chain H, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1DE7|K Chain K, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1G30|B Chain B, Thrombin Inhibitor Complex
pdb|1G32|B Chain B, Thrombin Inhibitor Complex
pdb|1KTS|B Chain B, Thrombin Inhibitor Complex
pdb|1KTT|B Chain B, Thrombin Inhibitor Complex
pdb|1K21|H Chain H, Human Thrombin-Inhibitor Complex
pdb|1K22|H Chain H, Human Thrombin-inhibitor Complex
pdb|1NY2|2 Chain 2, Human Alpha Thrombin Inhibited By Rppgf And Hirugen
pdb|1O2G|H Chain H, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1OYT|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Fluorinated Inhibitor
pdb|1NO9|H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating
Novel P1 Binding Functions: Molecular And X-Ray
Crystallographic Studies.
pdb|1OOK|B Chain B, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Human Alpha-thrombin
pdb|1P8V|C Chain C, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Alpha-thrombin At 2.6a
pdb|1NU7|B Chain B, Staphylocoagulase-Thrombin Complex
pdb|1NU7|F Chain F, Staphylocoagulase-Thrombin Complex
pdb|1NZQ|H Chain H, D-Phe-Pro-Arg-Type Thrombin Inhibitor
pdb|1O0D|H Chain H, Human Thrombin Complexed With A D-Phe-Pro-Arg-Type
Inhibitor And A C- Terminal Hirudin Derived Exo-Site
Inhibitor
pdb|1MU6|B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622
pdb|1MU8|B Chain B, Thrombin-Hirugen_l-378,650
pdb|1MUE|B Chain B, Thrombin-Hirugen-L405,426
pdb|1SR5|C Chain C, Antithrombin-Anhydrothrombin-Heparin Ternary Complex
Structure
pdb|1O5G|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1XMN|B Chain B, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|D Chain D, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|F Chain F, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|H Chain H, Crystal Structure Of Thrombin Bound To Heparin
pdb|1WAY|B Chain B, Active Site Thrombin Inhibitors
pdb|1T4U|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|1T4V|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|2AFQ|B Chain B, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2AFQ|D Chain D, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2A45|B Chain B, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|2A45|E Chain E, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|1W7G|H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues
54-65) And L- Arginine Template Inhibitor Cs107
pdb|2FES|H Chain H, Orally Active Thrombin Inhibitors
pdb|2C8W|B Chain B, Thrombin Inhibitors
pdb|2C8X|B Chain B, Thrombin Inhibitors
pdb|2C8Y|B Chain B, Thrombin Inhibitors
pdb|2C8Z|B Chain B, Thrombin Inhibitors
pdb|2C90|B Chain B, Thrombin Inhibitors
pdb|2C93|B Chain B, Thrombin Inhibitors
pdb|2FEQ|H Chain H, Orally Active Thrombin Inhibitors
pdb|2BVS|H Chain H, Human Thrombin Complexed With Fragment-Based Small
Molecules Occupying The S1 Pocket
pdb|2BVX|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-P2-Linker
pdb|2BXT|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2BXU|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2A2X|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
Inh12
pdb|2ANK|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
And An Exosite Decapeptide
pdb|2GDE|H Chain H, Thrombin In Complex With Inhibitor
pdb|2H9T|H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex With
Suramin
pdb|2JH0|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH5|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH6|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|1C1U|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1V|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1W|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5L|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5N|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5O|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1HXE|H Chain H, Serine Protease
pdb|2UUF|B Chain B, Thrombin-Hirugen Binary Complex At 1.26a Resolution
pdb|2UUJ|B Chain B, Thrombin-Hirugen-Gw473178 Ternary Complex At 1.32a
Resolution
pdb|2UUK|B Chain B, Thrombin-Hirugen-Gw420128 Ternary Complex At 1.39a
Resolution
pdb|3BF6|H Chain H, Thrombin:suramin Complex
pdb|2R2M|B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin
Inhibitors
pdb|3EGK|H Chain H, Knoble Inhibitor
pdb|2ZC9|H Chain H, Thrombin In Complex With Inhibitor
pdb|2ZDA|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZDV|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZF0|H Chain H, Exploring Thrombin S1 Pocket
pdb|3E6P|H Chain H, Crystal Structure Of Human Meizothrombin Desf1
pdb|2ZFF|H Chain H, Exploring Thrombin S1-Pocket
pdb|2ZFP|H Chain H, Thrombin Inibition
pdb|2ZGB|H Chain H, Thrombin Inhibition
pdb|2ZGX|H Chain H, Thrombin Inhibition
pdb|2ZFQ|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZFR|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHQ|H Chain H, Thrombin Inhibition
pdb|2ZI2|H Chain H, Thrombin Inhibition
pdb|2ZIQ|H Chain H, Thrombin Inhibition
pdb|2ZG0|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHE|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHF|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHW|H Chain H, Exploring Thrombin S3 Pocket
pdb|3C27|B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin
Inhibitors
pdb|2ZNK|H Chain H, Thrombin Inhibition
pdb|2ZO3|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3D49|H Chain H, Thrombin Inhibition
pdb|3DA9|B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor
pdb|3DHK|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3DT0|H Chain H, Understanding Thrombin Inhibition
pdb|3DUX|H Chain H, Understanding Thrombin Inhibition
pdb|3EQ0|H Chain H, Thrombin Inhibitor
pdb|3F68|H Chain H, Thrombin Inhibition
pdb|3PMH|B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib
Interaction With Two Distinct Alpha-Thrombin Sites
pdb|3P6Z|B Chain B, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P6Z|H Chain H, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3LDX|H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A
Thrombin Inhibitor With An Oxyguanidine P1 Motif
pdb|3P70|B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3TU7|H Chain H, Human Alpha-Thrombin Complexed With
N-(Methylsulfonyl)-D-Phenylalanyl-
N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide
(Bms-189664)
pdb|3QLP|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And A Modified Thrombin Binding Aptamer (Mtba)
pdb|3P17|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3B23|B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights
Of A Novel Mechanism Of Inhibition And Design Of Tunable
Thrombin Inhibitors
pdb|3QTO|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QTV|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QX5|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QWC|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3U69|H Chain H, Unliganded Wild-Type Human Thrombin
pdb|3U8T|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Cys
pdb|3RLW|H Chain H, Human Thrombin In Complex With Mi328
pdb|3RLY|H Chain H, Human Thrombin In Complex With Mi329
pdb|3RM0|H Chain H, Human Thrombin In Complex With Mi354
pdb|3RM2|H Chain H, Human Thrombin In Complex With Mi003
pdb|3RML|H Chain H, Human Thrombin In Complex With Mi331
pdb|3RMM|H Chain H, Human Thrombin In Complex With Mi332
pdb|3RMN|H Chain H, Human Thrombin In Complex With Mi341
pdb|3RMO|H Chain H, Human Thrombin In Complex With Mi004
pdb|3U8O|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-D-Thr
pdb|3U8R|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Ile
pdb|3SHA|H Chain H, Human Thrombin In Complex With Ubthr97
pdb|3SHC|H Chain H, Human Thrombin In Complex With Ubthr101
pdb|3SI3|H Chain H, Human Thrombin In Complex With Ubthr103
pdb|3SI4|H Chain H, Human Thrombin In Complex With Ubthr104
pdb|3SV2|H Chain H, Human Thrombin In Complex With Ubthr105
pdb|4E7R|H Chain H, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4E7R|G Chain G, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4DIH|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Sodium Ions
pdb|4DII|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Potassium Ions
pdb|3T5F|H Chain H, Human Thrombin In Complex With Mi340
pdb|3UTU|H Chain H, High Affinity Inhibitor Of Human Thrombin
pdb|3U98|H Chain H, Human Thrombin In Complex With Mi001
pdb|3U9A|H Chain H, Human Thrombin In Complex With Mi330
pdb|4E05|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|4E06|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|3UWJ|H Chain H, Human Thrombin In Complex With Mi353
pdb|4BAH|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAK|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAM|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAN|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAO|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAQ|B Chain B, Thrombin In Complex With Inhibitor
Length = 259
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1WBG|B Chain B, Active Site Thrombin Inhibitors
Length = 259
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1BTH|H Chain H, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
pdb|1BTH|K Chain K, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 259
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1RD3|B Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
pdb|1RD3|D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
Length = 259
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1GJ5|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190ALA190 PROTEASE, Structure-Based Drug Design
pdb|1SB1|H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating P1
4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain
Mimetics
pdb|2PW8|H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin
pdb|3DD2|H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human
Thrombin
pdb|1GJ4|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190/ala190 Protease, Structure-based Drug Design
Length = 258
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|2THF|B Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound To
D-phe-pro-arg- Chloromethylketone
Length = 259
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1JOU|B Chain B, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|D Chain D, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|F Chain F, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1TB6|H Chain H, 2.5a Crystal Structure Of The
Antithrombin-Thrombin-Heparin Ternary Complex
pdb|2B5T|B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|2B5T|D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|3B9F|H Chain H, 1.6 A Structure Of The Pci-Thrombin-Heparin Complex
pdb|3GIS|B Chain B, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|D Chain D, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|F Chain F, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3LU9|B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|3LU9|E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|4DT7|B Chain B, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DT7|D Chain D, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DY7|B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
pdb|4DY7|E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
Length = 259
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1Z8J|B Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound To
Ppack
Length = 259
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|2PGB|B Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a
pdb|2PGQ|B Chain B, Human Thrombin Mutant C191a-C220a In Complex With The
Inhibitor Ppack
Length = 259
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|2BVR|H Chain H, Human Thrombin Complexed With Fragment-based Small
Molecules Occupying The S1 Pocket
Length = 252
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 53/163 (32%), Positives = 84/163 (51%), Gaps = 20/163 (12%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYEGRFRRSYGHPATRQ 542
+C+P+ +T G VTGWG L E G P+ Q
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKEK------GQPSVLQ 154
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1THP|B Chain B, Structure Of Human Alpha-Thrombin Y225p Mutant Bound To
D-Phe-Pro-Arg- Chloromethylketone
pdb|3S7H|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|D Chain D, Structure Of Thrombin Mutant Y225p In The E Form
Length = 259
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1VZQ|H Chain H, Complex Of Thrombin With Designed Inhibitor 7165
Length = 250
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 49/149 (32%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H + E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHSRTAYERNI-EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1DX5|M Chain M, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|N Chain N, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|O Chain O, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|P Chain P, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1E0F|D Chain D, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|F Chain F, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|E Chain E, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
Length = 259
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 52/150 (34%), Positives = 80/150 (53%), Gaps = 16/150 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPP-------S 443
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ PP +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLL-YPPWDKNFIEN 57
Query: 444 DLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNII 502
DLL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I
Sbjct: 58 DLLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 503 PICVPEDDTNF----VGTSAHVTGWGRLYE 528
P+C+P+ +T G VTGWG L E
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|2XXL|A Chain A, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
pdb|2XXL|B Chain B, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
Length = 408
Score = 79.3 bits (194), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 62/189 (32%), Positives = 90/189 (47%), Gaps = 23/189 (12%)
Query: 360 FIDESNEIESQGINMSNYKEV---CGRRLFPSSRIVGGEKATFGKWPWQISLR--QWIRS 414
F S I+ MS +K+ CG F S R+ G + PW LR Q+ S
Sbjct: 87 FCCPSANIQHNSKVMSLFKDENFDCGN--FLSQRVSNGYEVKLSSRPWMALLRYQQFGES 144
Query: 415 TYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLGEHDLSTEEE--PYGYQERRVQIVA 472
+L CG A+ +E + +TAAHCV + +RLGEH +STEE+ G +++ V
Sbjct: 145 RFL--CGGAMISERYILTAAHCVHGLQNDLYEIRLGEHRISTEEDCRQQGRKKKCAPPVV 202
Query: 473 S--------HPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD----TNFVGTSAHV 520
+ H ++D R +D+ALL+ V FQ +I PIC+P D ++ V
Sbjct: 203 NVGIEKHLIHEKYDARHIMHDIALLKLNRSVPFQKHIKPICLPITDELKEKAEQISTYFV 262
Query: 521 TGWGRLYEG 529
TGWG G
Sbjct: 263 TGWGTTENG 271
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 23/64 (35%), Positives = 33/64 (51%), Gaps = 4/64 (6%)
Query: 558 FPSSRIVGGEKATFGKWPWQISLR--QWIRSTYLHKCGAALFNENWAVTAAHCVEDLWSQ 615
F S R+ G + PW LR Q+ S +L CG A+ +E + +TAAHCV L +
Sbjct: 114 FLSQRVSNGYEVKLSSRPWMALLRYQQFGESRFL--CGGAMISERYILTAAHCVHGLQND 171
Query: 616 IIPI 619
+ I
Sbjct: 172 LYEI 175
>pdb|1ZHM|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Coagulation Factor Xia In Complex With Benzamidine
(s434a- T475a-k437 Mutant)
Length = 238
Score = 79.0 bits (193), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 46/139 (33%), Positives = 69/139 (49%), Gaps = 11/139 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLR-- 448
IVGG + G+WPWQ++L T H CG ++ W +TAAHC V +L
Sbjct: 1 IVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYS 59
Query: 449 --LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICV 506
L + +++ + +G QE + H Q+ YD+ALL+ V + + PIC+
Sbjct: 60 GILNQAEIAEDTSFFGVQE-----IIIHDQYKMAESGYDIALLKLETTVNYADSQRPICL 114
Query: 507 P-EDDTNFVGTSAHVTGWG 524
P + D N + T VTGWG
Sbjct: 115 PSKGDRNVIYTDCWVTGWG 133
Score = 47.0 bits (110), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 27/46 (58%), Gaps = 1/46 (2%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG + G+WPWQ++L T H CG ++ W +TAAHC
Sbjct: 1 IVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHC 45
Score = 38.1 bits (87), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 16/49 (32%), Positives = 27/49 (55%), Gaps = 4/49 (8%)
Query: 640 LPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
+ + LQ+ +P++ N C+ YR I ICAG+R+G D+C+
Sbjct: 141 IQNTLQKAKIPLVTNEECQKRYRG----HKITHKMICAGYREGGKDACK 185
>pdb|2ANY|A Chain A, Expression, Crystallization And The Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 79.0 bits (193), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 45/138 (32%), Positives = 79/138 (57%), Gaps = 9/138 (6%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLL-LRL 449
IVGG ++++G+WPWQ+SL Q + H CG +L W +TAAHC + +P D+ +
Sbjct: 1 IVGGTESSWGEWPWQVSL-QVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYS 59
Query: 450 GEHDLS--TEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP 507
G +LS T++ P+ +++ + H + +D+AL++ P+++ PI +P
Sbjct: 60 GILELSDITKDTPF----SQIKEIIIHQNYKVSEGNHDIALIKLQAPLEYTEFQKPISLP 115
Query: 508 -EDDTNFVGTSAHVTGWG 524
+ DT+ + T+ VTGWG
Sbjct: 116 SKGDTSTIYTNCWVTGWG 133
Score = 65.9 bits (159), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 49/190 (25%), Positives = 80/190 (42%), Gaps = 69/190 (36%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC-----VEDLW---- 613
IVGG ++++G+WPWQ+SL Q + H CG +L W +TAAHC ++D+W
Sbjct: 1 IVGGTESSWGEWPWQVSL-QVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYS 59
Query: 614 --------------SQIIPII--QNCRRRESNL--------------------------- 630
SQI II QN + E N
Sbjct: 60 GILELSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLEYTEFQKPISLPSKGD 119
Query: 631 ------------WKMALADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAG 678
W + G + ++LQ+V++P++ N C+ Y+ I + +CAG
Sbjct: 120 TSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDY----KITQRMVCAG 175
Query: 679 WRKGSFDSCE 688
+++G D+C+
Sbjct: 176 YKEGGKDACK 185
>pdb|3JZ1|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E:na+
Form
pdb|3JZ2|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E Form
pdb|3QGN|B Chain B, The Allosteric E-E Equilibrium Is A Key Property Of The
Trypsin Fold
Length = 259
Score = 79.0 bits (193), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGPLKE 146
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1XX9|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
pdb|1XX9|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
Length = 238
Score = 79.0 bits (193), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 46/139 (33%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLR-- 448
IVGG + G+WPWQ++L T H CG ++ W +TAAHC V +L
Sbjct: 1 IVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYS 59
Query: 449 --LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICV 506
L + ++ + +G QE + H Q+ YD+ALL+ V + + PIC+
Sbjct: 60 GILNQSEIKEDTSFFGVQE-----IIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICL 114
Query: 507 P-EDDTNFVGTSAHVTGWG 524
P + D N + T VTGWG
Sbjct: 115 PSKGDRNVIYTDCWVTGWG 133
Score = 47.0 bits (110), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 27/46 (58%), Gaps = 1/46 (2%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG + G+WPWQ++L T H CG ++ W +TAAHC
Sbjct: 1 IVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHC 45
Score = 38.1 bits (87), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 16/49 (32%), Positives = 27/49 (55%), Gaps = 4/49 (8%)
Query: 640 LPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
+ + LQ+ +P++ N C+ YR I ICAG+R+G D+C+
Sbjct: 141 IQNTLQKAKIPLVTNEECQKRYRG----HKITHKMICAGYREGGKDACK 185
>pdb|4IGD|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-1
Length = 406
Score = 79.0 bits (193), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 67/216 (31%), Positives = 93/216 (43%), Gaps = 42/216 (19%)
Query: 380 VCG-----RRLFPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAA 434
VCG R+L ++I G A G PW L + CG +L +W VTAA
Sbjct: 142 VCGLPKFSRKLM--AQIFNGRPAQKGTTPWIAMLSHLNGQPF---CGGSLLGSSWIVTAA 196
Query: 435 HCV------ED--------VPPSDLLLRLGEH-DLSTEEEPYGYQERRVQIVASHPQFDP 479
HC+ ED + PSD + LG+H L ++E Q V+ HPQ+DP
Sbjct: 197 HCLHQSLDPEDPTLRDSDLLSPSDFKIILGKHWRLRSDENE---QHLGVKHTTLHPQYDP 253
Query: 480 RTFEYDLALLRFYEPVKFQPNIIPICVPEDDTNFVGTSAHVTGWGRLYEGRFRRSYGHPA 539
TFE D+AL+ E ++PIC+PE G V+GWG+ + RF P
Sbjct: 254 NTFENDVALVELLESPVLNAFVMPICLPEGPQQ-EGAMVIVSGWGKQFLQRF------PE 306
Query: 540 TRQEM-------ATCWNHFLGNRILFPSSRIVGGEK 568
T E+ +TC + + I GEK
Sbjct: 307 TLMEIEIPIVDHSTCQKAYAPLKKKVTRDMICAGEK 342
Score = 37.0 bits (84), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 15/48 (31%), Positives = 27/48 (56%), Gaps = 2/48 (4%)
Query: 640 LPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSC 687
P L E+ +P++++S C+ Y A + + ICAG ++G D+C
Sbjct: 304 FPETLMEIEIPIVDHSTCQKAY--APLKKKVTRDMICAGEKEGGKDAC 349
Score = 33.9 bits (76), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 20/76 (26%), Positives = 32/76 (42%), Gaps = 3/76 (3%)
Query: 561 SRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWSQIIPII 620
++I G A G PW L + CG +L +W VTAAHC+ P +
Sbjct: 154 AQIFNGRPAQKGTTPWIAMLSHLNGQPF---CGGSLLGSSWIVTAAHCLHQSLDPEDPTL 210
Query: 621 QNCRRRESNLWKMALA 636
++ + +K+ L
Sbjct: 211 RDSDLLSPSDFKIILG 226
>pdb|2ZEB|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
Length = 243
Score = 79.0 bits (193), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 50/140 (35%), Positives = 71/140 (50%), Gaps = 11/140 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTY-LHKCGAALFNENWAVTAAHCVEDVPPSDLLLRL 449
IVGG++A KWPWQ+SLR + Y +H CG +L + W +TAAHCV LR
Sbjct: 1 IVGGQEAPRSKWPWQVSLR--VHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALR- 57
Query: 450 GEHDLSTEEEPYGYQERRVQI--VASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP 507
+ E+ YQ++ + + + HPQF D+ALL EPVK ++ + +P
Sbjct: 58 ----VQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLP 113
Query: 508 EDDTNF-VGTSAHVTGWGRL 526
F G VTGWG +
Sbjct: 114 PASETFPPGMPCWVTGWGDV 133
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 25/48 (52%), Positives = 33/48 (68%), Gaps = 3/48 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTY-LHKCGAALFNENWAVTAAHCV 609
IVGG++A KWPWQ+SLR + Y +H CG +L + W +TAAHCV
Sbjct: 1 IVGGQEAPRSKWPWQVSLR--VHGPYWMHFCGGSLIHPQWVLTAAHCV 46
Score = 29.6 bits (65), Expect = 5.2, Method: Compositional matrix adjust.
Identities = 15/54 (27%), Positives = 27/54 (50%), Gaps = 6/54 (11%)
Query: 639 PLPSVLQEVSVPVINNSLCETMYRAAGF----IEHIPEIFICAGWRKGSFDSCE 688
P P L++V VP++ N +C+ Y + + + + +CAG DSC+
Sbjct: 140 PPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAG--NTRRDSCQ 191
>pdb|1A0L|A Chain A, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|B Chain B, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|C Chain C, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|D Chain D, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
Length = 244
Score = 78.6 bits (192), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 53/138 (38%), Positives = 72/138 (52%), Gaps = 11/138 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTY-LHKCGAALFNENWAVTAAHCV-EDVPP-SDLLL 447
IVGG++A KWPWQ+SLR + Y +H CG +L + W +TAAHCV DV + L +
Sbjct: 1 IVGGQEAPRSKWPWQVSLR--VHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRV 58
Query: 448 RLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP 507
+L E L ++ Q V + HPQF D+ALL EPVK ++ + +P
Sbjct: 59 QLREQHLYYQD-----QLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLP 113
Query: 508 EDDTNF-VGTSAHVTGWG 524
F G VTGWG
Sbjct: 114 PASETFPPGMPCWVTGWG 131
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 25/48 (52%), Positives = 33/48 (68%), Gaps = 3/48 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTY-LHKCGAALFNENWAVTAAHCV 609
IVGG++A KWPWQ+SLR + Y +H CG +L + W +TAAHCV
Sbjct: 1 IVGGQEAPRSKWPWQVSLR--VHGPYWMHFCGGSLIHPQWVLTAAHCV 46
Score = 30.0 bits (66), Expect = 5.1, Method: Compositional matrix adjust.
Identities = 15/54 (27%), Positives = 27/54 (50%), Gaps = 6/54 (11%)
Query: 639 PLPSVLQEVSVPVINNSLCETMYRAAGF----IEHIPEIFICAGWRKGSFDSCE 688
P P L++V VP++ N +C+ Y + + + + +CAG DSC+
Sbjct: 140 PPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAG--NTRRDSCQ 191
>pdb|2BM2|A Chain A, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|B Chain B, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|C Chain C, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|D Chain D, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2FWW|A Chain A, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|B Chain B, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|C Chain C, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|D Chain D, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FXR|A Chain A, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|B Chain B, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|C Chain C, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|D Chain D, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FPZ|A Chain A, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|B Chain B, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|C Chain C, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|D Chain D, Human Tryptase With 2-Amino Benzimidazole
pdb|2FS8|A Chain A, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|B Chain B, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|C Chain C, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|D Chain D, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS9|A Chain A, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|B Chain B, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|C Chain C, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|D Chain D, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2GDD|A Chain A, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|B Chain B, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|C Chain C, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|D Chain D, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2ZA5|A Chain A, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|B Chain B, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|C Chain C, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|D Chain D, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|4A6L|A Chain A, Beta-Tryptase Inhibitor
pdb|4A6L|B Chain B, Beta-Tryptase Inhibitor
pdb|4A6L|C Chain C, Beta-Tryptase Inhibitor
pdb|4A6L|D Chain D, Beta-Tryptase Inhibitor
pdb|3V7T|A Chain A, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|B Chain B, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|C Chain C, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|D Chain D, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
Length = 245
Score = 78.6 bits (192), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 49/138 (35%), Positives = 70/138 (50%), Gaps = 11/138 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTY-LHKCGAALFNENWAVTAAHCVEDVPPSDLLLRL 449
IVGG++A KWPWQ+SLR + Y +H CG +L + W +TAAHCV + L
Sbjct: 1 IVGGQEAPRSKWPWQVSLR--VHGPYWMHFCGGSLIHPQWVLTAAHCV-----GPDVKDL 53
Query: 450 GEHDLSTEEEPYGYQERRVQI--VASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP 507
+ E+ YQ++ + + + HPQF D+ALL EPVK ++ + +P
Sbjct: 54 AALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLP 113
Query: 508 EDDTNF-VGTSAHVTGWG 524
F G VTGWG
Sbjct: 114 PASETFPPGMPCWVTGWG 131
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 25/48 (52%), Positives = 33/48 (68%), Gaps = 3/48 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTY-LHKCGAALFNENWAVTAAHCV 609
IVGG++A KWPWQ+SLR + Y +H CG +L + W +TAAHCV
Sbjct: 1 IVGGQEAPRSKWPWQVSLR--VHGPYWMHFCGGSLIHPQWVLTAAHCV 46
Score = 29.6 bits (65), Expect = 5.2, Method: Compositional matrix adjust.
Identities = 15/54 (27%), Positives = 27/54 (50%), Gaps = 6/54 (11%)
Query: 639 PLPSVLQEVSVPVINNSLCETMYRAAGF----IEHIPEIFICAGWRKGSFDSCE 688
P P L++V VP++ N +C+ Y + + + + +CAG DSC+
Sbjct: 140 PPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAG--NTRRDSCQ 191
>pdb|1ZHP|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine (S434a-T475a-K505
Mutant)
Length = 238
Score = 78.6 bits (192), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 46/139 (33%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLR-- 448
IVGG + G+WPWQ++L T H CG ++ W +TAAHC V +L
Sbjct: 1 IVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYS 59
Query: 449 --LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICV 506
L + ++ + +G QE + H Q+ YD+ALL+ V + + PIC+
Sbjct: 60 GILNQAEIKEDTSFFGVQE-----IIIHDQYKMAESGYDIALLKLETTVNYADSQRPICL 114
Query: 507 P-EDDTNFVGTSAHVTGWG 524
P + D N + T VTGWG
Sbjct: 115 PSKGDRNVIYTDCWVTGWG 133
Score = 47.0 bits (110), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 27/46 (58%), Gaps = 1/46 (2%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG + G+WPWQ++L T H CG ++ W +TAAHC
Sbjct: 1 IVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHC 45
Score = 38.5 bits (88), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 19/55 (34%), Positives = 30/55 (54%), Gaps = 5/55 (9%)
Query: 634 ALADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
AL D + + LQ+ +P++ N C+ YR I ICAG+R+G D+C+
Sbjct: 136 ALRD-KIQNTLQKAKIPLVTNEECQKRYRG----HKITHKMICAGYREGGKDACK 185
>pdb|1XXD|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXD|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXF|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
pdb|1XXF|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
Length = 238
Score = 78.6 bits (192), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 46/139 (33%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLR-- 448
IVGG + G+WPWQ++L T H CG ++ W +TAAHC V +L
Sbjct: 1 IVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYS 59
Query: 449 --LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICV 506
L + ++ + +G QE + H Q+ YD+ALL+ V + + PIC+
Sbjct: 60 GILNQAEIKEDTSFFGVQE-----IIIHDQYKMAESGYDIALLKLETTVNYADSQRPICL 114
Query: 507 P-EDDTNFVGTSAHVTGWG 524
P + D N + T VTGWG
Sbjct: 115 PSKGDRNVIYTDCWVTGWG 133
Score = 47.0 bits (110), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 27/46 (58%), Gaps = 1/46 (2%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG + G+WPWQ++L T H CG ++ W +TAAHC
Sbjct: 1 IVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHC 45
Score = 38.1 bits (87), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 16/49 (32%), Positives = 27/49 (55%), Gaps = 4/49 (8%)
Query: 640 LPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
+ + LQ+ +P++ N C+ YR I ICAG+R+G D+C+
Sbjct: 141 IQNTLQKAKIPLVTNEECQKRYRG----HKITHKMICAGYREGGKDACK 185
>pdb|2ANW|A Chain A, Expression, Crystallization And Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 78.6 bits (192), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 45/138 (32%), Positives = 77/138 (55%), Gaps = 9/138 (6%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLL-LRL 449
IVGG +++G+WPWQ+SL Q + H CG +L W +TAAHC + +P D+ +
Sbjct: 1 IVGGTNSSWGEWPWQVSL-QVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYS 59
Query: 450 GEHDLS--TEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP 507
G +LS T++ P+ +++ + H + +D+AL++ P+ + PI +P
Sbjct: 60 GILNLSDITKDTPF----SQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPISLP 115
Query: 508 -EDDTNFVGTSAHVTGWG 524
+ DT+ + T+ VTGWG
Sbjct: 116 SKGDTSTIYTNCWVTGWG 133
Score = 65.5 bits (158), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 49/190 (25%), Positives = 79/190 (41%), Gaps = 69/190 (36%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC-----VEDLW---- 613
IVGG +++G+WPWQ+SL Q + H CG +L W +TAAHC ++D+W
Sbjct: 1 IVGGTNSSWGEWPWQVSL-QVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYS 59
Query: 614 --------------SQIIPII--QNCRRRESNL--------------------------- 630
SQI II QN + E N
Sbjct: 60 GILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPISLPSKGD 119
Query: 631 ------------WKMALADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAG 678
W + G + ++LQ+V++P++ N C+ Y+ I + +CAG
Sbjct: 120 TSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDY----KITQRMVCAG 175
Query: 679 WRKGSFDSCE 688
+++G D+C+
Sbjct: 176 YKEGGKDACK 185
>pdb|3GIC|B Chain B, Structure Of Thrombin Mutant Delta(146-149e) In The Free
Form
Length = 250
Score = 78.6 bits (192), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 49/147 (33%), Positives = 79/147 (53%), Gaps = 14/147 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRL 526
+C+P+ +T G VTGWG L
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNL 144
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|3EDX|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|D Chain D, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|F Chain F, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3HK3|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(ONE Molecule In The Asymmetric Unit)
pdb|3HK6|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HK6|D Chain D, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HKI|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
pdb|3HKI|E Chain E, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
Length = 258
Score = 78.6 bits (192), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 51/149 (34%), Positives = 79/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGWDAEKGIAPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+ALL+ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ T G VTGWG L E
Sbjct: 118 VCLPDKQTVTSLLRAGYKGRVTGWGNLRE 146
Score = 38.1 bits (87), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGWDAEKGIAPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCI 45
>pdb|2PUX|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par3
pdb|2PV9|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par4
Length = 258
Score = 78.6 bits (192), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 51/149 (34%), Positives = 79/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGWDAEKGIAPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+ALL+ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ T G VTGWG L E
Sbjct: 118 VCLPDKQTVTSLLRAGYKGRVTGWGNLRE 146
Score = 38.1 bits (87), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGWDAEKGIAPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCI 45
>pdb|1VR1|H Chain H, Specifity For Plasminogen Activator Inhibitor-1
Length = 261
Score = 78.6 bits (192), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 50/151 (33%), Positives = 80/151 (52%), Gaps = 14/151 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHK--CGAALFNENWAVTAAHCV------EDVPP 442
IV G A G PWQ+ L R + + CGA+L ++ W +TAAHC+ ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFAKHRRSPGERFLCGASLISDRWVLTAAHCLLYPPWDKNFTE 60
Query: 443 SDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNI 501
+DLL+R+G+H T E + ++ + HP+++ R + D+AL++ +PV F I
Sbjct: 61 NDLLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYI 119
Query: 502 IPICVPEDDTNF----VGTSAHVTGWGRLYE 528
P+C+P+ +T G VTGWG L E
Sbjct: 120 HPVCLPDRETAASLLQAGYKGRVTGWGNLKE 150
Score = 38.9 bits (89), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 20/49 (40%), Positives = 28/49 (57%), Gaps = 2/49 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHK--CGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L R + + CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFAKHRRSPGERFLCGASLISDRWVLTAAHCL 49
>pdb|1ELT|A Chain A, Structure Of Native Pancreatic Elastase From North
Atlantic Salmon At 1.61 Angstroms Resolution
Length = 236
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 45/140 (32%), Positives = 65/140 (46%), Gaps = 3/140 (2%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
+VGG A WPWQISL+ S+Y H CG +L + W +TAAHCV+ ++ LG
Sbjct: 1 VVGGRVAQPNSWPWQISLQYKSGSSYYHTCGGSLIRQGWVMTAAHCVDSARTWRVV--LG 58
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH+L+T E + S D YD+ALLR + +P +
Sbjct: 59 EHNLNTNEGKEQIMTVNSVFIHSGWNSDDVAGGYDIALLRLNTQASLNSAVQLAALPPSN 118
Query: 511 TNFVGTS-AHVTGWGRLYEG 529
+ ++TGWG+ G
Sbjct: 119 QILPNNNPCYITGWGKTSTG 138
Score = 57.0 bits (136), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 24/49 (48%), Positives = 31/49 (63%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
+VGG A WPWQISL+ S+Y H CG +L + W +TAAHCV+
Sbjct: 1 VVGGRVAQPNSWPWQISLQYKSGSSYYHTCGGSLIRQGWVMTAAHCVDS 49
>pdb|2OCV|B Chain B, Structural Basis Of Na+ Activation Mimicry In Murine
Thrombin
Length = 259
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 51/149 (34%), Positives = 79/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGWDAEKGIAPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + D+ALL+ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ T G VTGWG L E
Sbjct: 118 VCLPDKQTVTSLLRAGYKGRVTGWGNLRE 146
Score = 38.1 bits (87), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGWDAEKGIAPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCI 45
>pdb|2GP9|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A Self-
Inhibited Conformation
pdb|3BEI|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A
Self_inhibited Conformation
pdb|3BEF|B Chain B, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3BEF|E Chain E, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3QDZ|B Chain B, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4.
pdb|3QDZ|D Chain D, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4
Length = 259
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 49/149 (32%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPR-TFEYDLALLRFYEPVKFQPNIIP 503
LL+R+G+H T E + ++ + HP+++ R + ++AL++ +PV F I P
Sbjct: 59 LLVRIGKHS-RTRYERNIEKISMLEKIYIHPRYNWRENLDRNIALMKLKKPVAFSDYIHP 117
Query: 504 ICVPEDDTNF----VGTSAHVTGWGRLYE 528
+C+P+ +T G VTGWG L E
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKE 146
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1EAI|A Chain A, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1EAI|B Chain B, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1C1M|A Chain A, Porcine Elastase Under Xenon Pressure (8 Bar)
pdb|1HV7|A Chain A, Porcine Pancreatic Elastase Complexed With Gw311616a
pdb|1FZZ|A Chain A, The Crystal Structure Of The Complex Of Non-Peptidic
Inhibitor Ono-6818 And Porcine Pancreatic Elastase.
pdb|1GWA|A Chain A, Triiodide Derivative Of Porcine Pancreas Elastase
pdb|1L0Z|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Dry Paraffin
Oil
pdb|1L1G|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Glycerol
pdb|1LKA|A Chain A, Porcine Pancreatic ElastaseCA-Complex
pdb|1LKB|A Chain A, Porcine Pancreatic Elastase/na-complex
pdb|1MMJ|N Chain N, Porcine Pancreatic Elastase Complexed With A Potent
Peptidyl Inhibitor, Fr136706
pdb|1MCV|A Chain A, Crystal Structure Analysis Of A Hybrid Squash Inhibitor In
Complex With Porcine Pancreatic Elastase
pdb|1UO6|A Chain A, Porcine Pancreatic ElastaseXE-Complex
pdb|1UVO|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(crystal A)
pdb|1UVP|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(Crystal B)
pdb|2A7C|A Chain A, On The Routine Use Of Soft X-rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2A7J|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2BLO|A Chain A, Elastase Before A High Dose X-Ray "burn"
pdb|2BLQ|A Chain A, Elastase After A High Dose X-Ray "burn"
pdb|2D26|C Chain C, Active Site Distortion Is Sufficient For Proteinase
Inhibit Second Crystal Structure Of Covalent
Serpin-Proteinase Complex
pdb|2CV3|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With A Macroclyclic Peptide Inhibitor
pdb|2DE8|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With A
Unique Conformation Induced By Tris
pdb|2DE9|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With Tris After Soaking A Tris-Free Solution
pdb|2G4T|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastase (na)
pdb|2G4U|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastaase
(ca)
pdb|2OQU|A Chain A, High Pressure Cryocooling Of Capillary Sample
Cryoprotection And Diffraction Phasing At Long
Wavelengths
pdb|1QNJ|A Chain A, The Structure Of Native Porcine Pancreatic Elastase At
Atomic Resolution (1.1 A)
pdb|2IOT|A Chain A, Clavulanic Acid Bound To Elastase
pdb|2V0B|A Chain A, Sad Structure Solution Porcine Pancreatic Elastase From A
Selenate Derivative
pdb|2V35|A Chain A, Porcine Pancreatic Elastase In Complex With Inhibitor Jm54
pdb|3HGP|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By High
Resolution Crystallography
pdb|3HGN|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By Neutron
Crystallography
pdb|3UOU|A Chain A, Crystal Structure Of The Kunitz-Type Protease Inhibitor
Shpi-1 Lys13leu Mutant In Complex With Pancreatic
Elastase
Length = 240
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 49/139 (35%), Positives = 70/139 (50%), Gaps = 11/139 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLR-- 448
+VGG +A WP QISL+ S++ H CG L +NW +TAAHCV+ +L R
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVD----RELTFRVV 56
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQF--DPRTFEYDLALLRFYEPVKFQPNIIPICV 506
+GEH+L+ + Y VQ + HP + D YD+ALLR + V + +
Sbjct: 57 VGEHNLNQNDGTEQYVG--VQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVL 114
Query: 507 PEDDTNFVGTS-AHVTGWG 524
P T S ++TGWG
Sbjct: 115 PRAGTILANNSPCYITGWG 133
Score = 53.1 bits (126), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 23/48 (47%), Positives = 31/48 (64%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVE 610
+VGG +A WP QISL+ S++ H CG L +NW +TAAHCV+
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVD 48
>pdb|3DFJ|A Chain A, Crystal Structure Of Human Prostasin
pdb|3DFL|A Chain A, Crystal Structure Of Human Prostasin Complexed To 4-
Guanidinobenzoic Acid
Length = 263
Score = 77.4 bits (189), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 48/144 (33%), Positives = 73/144 (50%), Gaps = 20/144 (13%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTY--LHKCGAALFNENWAVTAAHCVEDVPPSD---- 444
I GG A G+WPWQ+S+ TY +H CG +L +E W ++AAHC PS+
Sbjct: 1 ITGGSSAVAGQWPWQVSI------TYEGVHVCGGSLVSEQWVLSAAHCF----PSEHHKE 50
Query: 445 -LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIP 503
++LG H L + E + ++ + HP + + D+ALL+ P+ F I P
Sbjct: 51 AYEVKLGAHQLDSYSE--DAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRP 108
Query: 504 ICVPEDDTNFV-GTSAHVTGWGRL 526
I +P + +F G VTGWG +
Sbjct: 109 ISLPAANASFPNGLHCTVTGWGHV 132
Score = 49.3 bits (116), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 22/48 (45%), Positives = 30/48 (62%), Gaps = 8/48 (16%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTY--LHKCGAALFNENWAVTAAHC 608
I GG A G+WPWQ+S+ TY +H CG +L +E W ++AAHC
Sbjct: 1 ITGGSSAVAGQWPWQVSI------TYEGVHVCGGSLVSEQWVLSAAHC 42
Score = 35.8 bits (81), Expect = 0.085, Method: Compositional matrix adjust.
Identities = 26/114 (22%), Positives = 43/114 (37%), Gaps = 25/114 (21%)
Query: 578 ISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWSQIIPIIQNCRRRESNLWKMALAD 637
I+ ++IR L A+ N HC W + P +
Sbjct: 100 ITFSRYIRPISLPAANASFPN------GLHCTVTGWGHVAPSVSLLT------------- 140
Query: 638 GPLPSVLQEVSVPVINNSLCETMYRAAGFIEH---IPEIFICAGWRKGSFDSCE 688
P LQ++ VP+I+ C +Y E + E +CAG+ +G D+C+
Sbjct: 141 ---PKPLQQLEVPLISRETCNALYNIDAKPEEPHFVQEDMVCAGYVEGGKDACQ 191
>pdb|2EST|E Chain E, Crystallographic Study Of The Binding Of A Trifluoroacetyl
Dipeptide Anilide Inhibitor With Elastase
pdb|4EST|E Chain E, Crystal Structure Of The Covalent Complex Formed By A
Peptidyl Alpha, Alpha-Difluoro-Beta-Keto Amide With
Porcine Pancreatic Elastase At 1.78-Angstroms Resolution
pdb|5EST|E Chain E, Crystallographic Analysis Of The Inhibition Of Porcine
Pancreatic Elastase By A Peptidyl Boronic Acid:
Structure Of A Reaction Intermediate
pdb|7EST|E Chain E, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|8EST|E Chain E, Reaction Of Porcine Pancreatic Elastase With 7-substituted
3-alkoxy-4-chloroisocoumarins: Design Of Potent
Inhibitors Using The Crystal Structure Of The Complex
Formed With 4- Chloro-3-ethoxy-7-guanidino-isocoumarin
pdb|1ELA|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELC|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELB|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELD|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1ELE|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1NES|E Chain E, Structure Of The Product Complex Of Acetyl-ala-pro-ala
With Porcine Pancreatic Elastase At 1.65 Angstroms
Resolution
pdb|1BMA|A Chain A, Benzyl Methyl Aminimide Inhibitor Complexed To Porcine
Pancreatic Elastase
pdb|1FLE|E Chain E, Crystal Structure Of Elafin Complexed With Porcine
Pancreatic Elastase
pdb|1B0E|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With Mdl
101,146
pdb|1QGF|A Chain A, Porcine Pancreatic Elastase Complexed With (3r, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One
pdb|1QIX|B Chain B, Porcine Pancreatic Elastase Complexed With Human
Beta-casomorphin-7
pdb|1QR3|E Chain E, Structure Of Porcine Pancreatic Elastase In Complex With
Fr901277, A Novel Macrocyclic Inhibitor Of Elastases At
1.6 Angstrom Resolution
pdb|1E34|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2- One Soaked In Ph 9 Buffer For One Minute
pdb|1E35|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One Soaked In Ph 9 Buffer For Two
Minutes
pdb|1E36|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One
pdb|1E37|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 1 Minute
pdb|1E38|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 2 Minutes
pdb|1HAZ|B Chain B, Snapshots Of Serine Protease Catalysis: (c) Acyl-enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-casomorphin-7 Jumped To Ph 9 For 1 Minute
pdb|1H9L|B Chain B, Porcine Pancreatic Elastase Complexed With
Acetyl-Val-Glu-Pro-Ile-Cooh
pdb|1OKX|A Chain A, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|1OKX|B Chain B, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|2FO9|A Chain A, Structure Of Porcine Pancreatic Elastase In 95% Acetone
pdb|2FOA|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010 %
BENZENE
pdb|2FOB|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010
CYCLOHEXANE
pdb|2FOC|A Chain A, Structure Of Porcine Pancreatic Elastase In 55%
Dimethylformamide
pdb|2FOD|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Ethanol
pdb|2FOE|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Hexane
pdb|2FOF|A Chain A, Structure Of Porcine Pancreatic Elastase In 80%
Isopropanol
pdb|2FOG|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2FOH|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2BD4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin- 7 And Lys-Ser At Ph 5.0
pdb|2BD5|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Lys- Ser At Ph 5 And Immersed In
Ph 9 Buffer For 30 Seconds
pdb|2BD9|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 28 Seconds (2nd Ph Jump)
pdb|2BDC|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile At
Ph 5.0
pdb|2H1U|A Chain A, Porcine Pancreatic Elastase Complexed With Metpheleuglu At
Ph 5.0
pdb|1BTU|A Chain A, Porcine Pancreatic Elastase Complexed With (3s, 4r)-1-
Toluenesulphonyl-3-Ethyl-Azetidin-2-One-4-Carboxylic
Acid
pdb|1EAS|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 3.
Design, Synthesis, X-Ray Crystallographic Analysis, And
Structure-Activity Relationships For A Series Of Orally
Active 3-Amino-6-Phenylpyridin- 2-One Trifluoromethyl
Ketones
pdb|1EAT|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 5.
Design, Synthesis, And X-Ray Crystallography Of A Series
Of Orally Active 5- Amino-Pyrimidin-6-One-Containing
Trifluoromethylketones
pdb|1EAU|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 6.
Design Of A Potent, Intratracheally Active,
Pyridone-Based Trifluoromethyl Ketone
pdb|1ELF|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ELG|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ESA|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|1EST|A Chain A, The Atomic Structure Of Crystalline Porcine Pancreatic
Elastase At 2.5 Angstroms Resolution. Comparisons With
The Structure Of Alpha- Chymotrypsin
pdb|1INC|A Chain A, Crystal Structures Of The Complex Of Porcine Pancreatic
Elastase With Two Valine-Derived Benzoxazinone
Inhibitors
pdb|1JIM|A Chain A, Stereospecific Reaction Of 3-Methoxy-4-Chloro-7-
Aminoisocoumarin With Crystalline Porcine Pancreatic
Elastase
pdb|1LVY|A Chain A, Porcine Elastase
pdb|3EST|A Chain A, Structure Of Native Porcine Pancreatic Elastase At 1.65
Angstroms Resolution
pdb|6EST|A Chain A, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|9EST|A Chain A, Structural Study Of Porcine Pancreatic Elastase Complexed
With 7- Amino-3-(2-Bromoethoxy)-4-Chloroisocoumarin As A
Nonreactivatable Doubly Covalent Enzyme-Inhibitor
Complex
pdb|1GVK|B Chain B, Porcine Pancreatic Elastase Acyl Enzyme At 0.95 A
Resolution
pdb|3E3T|A Chain A, Structure Of Porcine Pancreatic Elastase With The Magic
Triangle I3c
pdb|3MNB|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. First Stage Of
Radiation Damage
pdb|3MNC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Second Stage Of
Radiation Damage
pdb|3MNS|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Third Stage Of
Radiation Damage
pdb|3MNX|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fourth Stage Of
Radiation Damage
pdb|3MO3|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fifth Stage Of
Radiation Damage
pdb|3MO6|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Sixth Stage Of
Radiation Damage
pdb|3MO9|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Seventh Stage Of
Radiation Damage
pdb|3MOC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Eighth Stage Of
Radiation Damage
pdb|3MTY|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. First Step Of Radiation
Damage
pdb|3MU0|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU1|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3MU4|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. First Step Of Radiation
Damage
pdb|3MU5|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU8|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3ODD|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Second Step Of Radiation
Damage
pdb|3ODF|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Second Step Of Radiation
Damage
pdb|2BB4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Asp- Phe At Ph 5.0
pdb|2BD2|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0
pdb|2BD3|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Lys- Ala-nh2 At Ph 5.0
pdb|2BD7|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
pdb|2BD8|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 30 Seconds
pdb|2BDA|A Chain A, Porcine Pancreatic Elastase Complexed With N-Acetyl-Npi
And Ala-Ala At Ph 5.0
pdb|2BDB|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile And
Ala-ala At Ph 5.0
pdb|1ESB|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|4GVU|A Chain A, Lyngbyastatin 7-porcine Pancreatic Elastase Co-crystal
Structure
Length = 240
Score = 77.0 bits (188), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 49/139 (35%), Positives = 69/139 (49%), Gaps = 11/139 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLR-- 448
+VGG +A WP QISL+ S++ H CG L +NW +TAAHCV+ +L R
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDR----ELTFRVV 56
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQF--DPRTFEYDLALLRFYEPVKFQPNIIPICV 506
+GEH+L+ Y VQ + HP + D YD+ALLR + V + +
Sbjct: 57 VGEHNLNQNNGTEQYVG--VQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVL 114
Query: 507 PEDDTNFVGTS-AHVTGWG 524
P T S ++TGWG
Sbjct: 115 PRAGTILANNSPCYITGWG 133
Score = 53.1 bits (126), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 23/48 (47%), Positives = 31/48 (64%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVE 610
+VGG +A WP QISL+ S++ H CG L +NW +TAAHCV+
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVD 48
>pdb|2QY0|B Chain B, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
pdb|2QY0|D Chain D, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
Length = 242
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 47/145 (32%), Positives = 77/145 (53%), Gaps = 14/145 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLH-KCGAALFNENWAVTAAHCV-----EDVPPSD 444
I+GG+KA G +PWQ+ T +H + G AL + W +TAAH + E +
Sbjct: 1 IIGGQKAKMGNFPWQVF-------TNIHGRGGGALLGDRWILTAAHTLYPKEHEAQSNAS 53
Query: 445 LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPI 504
L + LG ++ + + RRV + + Q + FE D+ALL V PN++PI
Sbjct: 54 LDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPI 113
Query: 505 CVPEDDTNF-VGTSAHVTGWGRLYE 528
C+P++DT + +G +V+G+G + E
Sbjct: 114 CLPDNDTFYDLGLMGYVSGFGVMEE 138
Score = 38.9 bits (89), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 19/48 (39%), Positives = 28/48 (58%), Gaps = 8/48 (16%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLH-KCGAALFNENWAVTAAHCV 609
I+GG+KA G +PWQ+ T +H + G AL + W +TAAH +
Sbjct: 1 IIGGQKAKMGNFPWQV-------FTNIHGRGGGALLGDRWILTAAHTL 41
>pdb|2F9O|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9P|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
Length = 245
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 53/138 (38%), Positives = 71/138 (51%), Gaps = 11/138 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTY-LHKCGAALFNENWAVTAAHCV-EDVPP-SDLLL 447
IVGG++A KWPWQ+SLR +R Y +H CG +L + W +TAAHCV DV + L +
Sbjct: 1 IVGGQEAPRSKWPWQVSLR--VRDRYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLATLRV 58
Query: 448 RLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP 507
+L E L ++ Q V + HPQF D+ALL EPV + + +P
Sbjct: 59 QLREQHLYYQD-----QLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLP 113
Query: 508 EDDTNF-VGTSAHVTGWG 524
F G VTGWG
Sbjct: 114 PASETFPPGMPCWVTGWG 131
Score = 57.0 bits (136), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 26/48 (54%), Positives = 34/48 (70%), Gaps = 3/48 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTY-LHKCGAALFNENWAVTAAHCV 609
IVGG++A KWPWQ+SLR +R Y +H CG +L + W +TAAHCV
Sbjct: 1 IVGGQEAPRSKWPWQVSLR--VRDRYWMHFCGGSLIHPQWVLTAAHCV 46
Score = 30.8 bits (68), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 16/54 (29%), Positives = 27/54 (50%), Gaps = 6/54 (11%)
Query: 639 PLPSVLQEVSVPVINNSLCETMYRAAGF----IEHIPEIFICAGWRKGSFDSCE 688
P P L++V VP++ N +C+ Y + + I + +CAG DSC+
Sbjct: 140 PPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAG--NSQRDSCK 191
>pdb|3GYL|B Chain B, Structure Of Prostasin At 1.3 Angstroms Resolution In
Complex With A Calcium Ion.
pdb|3GYM|A Chain A, Structure Of Prostasin In Complex With Aprotinin
pdb|3GYM|B Chain B, Structure Of Prostasin In Complex With Aprotinin
Length = 261
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 48/144 (33%), Positives = 72/144 (50%), Gaps = 20/144 (13%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTY--LHKCGAALFNENWAVTAAHCVEDVPPSD---- 444
I GG A G+WPWQ+S+ TY +H CG +L +E W ++AAHC PS+
Sbjct: 1 ITGGSSAVAGQWPWQVSI------TYEGVHVCGGSLVSEQWVLSAAHCF----PSEHHKE 50
Query: 445 -LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIP 503
++LG H L + E + ++ + HP + + D+ALL+ P+ F I P
Sbjct: 51 AYEVKLGAHQLDSYSE--DAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRP 108
Query: 504 ICVPEDDTNFV-GTSAHVTGWGRL 526
I +P +F G VTGWG +
Sbjct: 109 ISLPAAQASFPNGLHCTVTGWGHV 132
Score = 49.7 bits (117), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 22/48 (45%), Positives = 30/48 (62%), Gaps = 8/48 (16%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTY--LHKCGAALFNENWAVTAAHC 608
I GG A G+WPWQ+S+ TY +H CG +L +E W ++AAHC
Sbjct: 1 ITGGSSAVAGQWPWQVSI------TYEGVHVCGGSLVSEQWVLSAAHC 42
Score = 36.2 bits (82), Expect = 0.068, Method: Compositional matrix adjust.
Identities = 26/114 (22%), Positives = 44/114 (38%), Gaps = 25/114 (21%)
Query: 578 ISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWSQIIPIIQNCRRRESNLWKMALAD 637
I+ ++IR L A+ N HC W + P +
Sbjct: 100 ITFSRYIRPISLPAAQASFPN------GLHCTVTGWGHVAPSVSLLT------------- 140
Query: 638 GPLPSVLQEVSVPVINNSLCETMYRAAGFIEH---IPEIFICAGWRKGSFDSCE 688
P LQ++ VP+I+ C ++Y E + E +CAG+ +G D+C+
Sbjct: 141 ---PKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQEDMVCAGYVEGGKDACQ 191
>pdb|3E0P|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With A
Covalent Benzoxazole Inhibitor
pdb|3E16|B Chain B, X-Ray Structure Of Human Prostasin In Complex With
Benzoxazole Warhead Peptidomimic, Lysine In P3
pdb|3E1X|B Chain B, The Crystal Structure Of Apo Prostasin At 1.7 Angstroms
Resolution
pdb|3FVF|B Chain B, The Crystal Structure Of Prostasin Complexed With Camostat
At 1.6 Angstroms Resolution
pdb|3E0N|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With
Dffr- Chloromethyl Ketone Inhibitor
Length = 271
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 48/144 (33%), Positives = 72/144 (50%), Gaps = 20/144 (13%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTY--LHKCGAALFNENWAVTAAHCVEDVPPSD---- 444
I GG A G+WPWQ+S+ TY +H CG +L +E W ++AAHC PS+
Sbjct: 1 ITGGSSAVAGQWPWQVSI------TYEGVHVCGGSLVSEQWVLSAAHCF----PSEHHKE 50
Query: 445 -LLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIP 503
++LG H L + E + ++ + HP + + D+ALL+ P+ F I P
Sbjct: 51 AYEVKLGAHQLDSYSE--DAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRP 108
Query: 504 ICVPEDDTNFV-GTSAHVTGWGRL 526
I +P +F G VTGWG +
Sbjct: 109 ISLPAAQASFPNGLHCTVTGWGHV 132
Score = 49.7 bits (117), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 22/48 (45%), Positives = 30/48 (62%), Gaps = 8/48 (16%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTY--LHKCGAALFNENWAVTAAHC 608
I GG A G+WPWQ+S+ TY +H CG +L +E W ++AAHC
Sbjct: 1 ITGGSSAVAGQWPWQVSI------TYEGVHVCGGSLVSEQWVLSAAHC 42
Score = 36.2 bits (82), Expect = 0.068, Method: Compositional matrix adjust.
Identities = 26/114 (22%), Positives = 44/114 (38%), Gaps = 25/114 (21%)
Query: 578 ISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWSQIIPIIQNCRRRESNLWKMALAD 637
I+ ++IR L A+ N HC W + P +
Sbjct: 100 ITFSRYIRPISLPAAQASFPN------GLHCTVTGWGHVAPSVSLLT------------- 140
Query: 638 GPLPSVLQEVSVPVINNSLCETMYRAAGFIEH---IPEIFICAGWRKGSFDSCE 688
P LQ++ VP+I+ C ++Y E + E +CAG+ +G D+C+
Sbjct: 141 ---PKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQEDMVCAGYVEGGKDACQ 191
>pdb|2F9N|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
Length = 245
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 53/138 (38%), Positives = 71/138 (51%), Gaps = 11/138 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTY-LHKCGAALFNENWAVTAAHCV-EDVPP-SDLLL 447
IVGG++A KWPWQ+SLR +R Y +H CG +L + W +TAAHCV DV + L +
Sbjct: 1 IVGGQEAPRSKWPWQVSLR--VRDRYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLATLRV 58
Query: 448 RLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP 507
+L E L ++ Q V + HPQF D+ALL EPV + + +P
Sbjct: 59 QLREQHLYYQD-----QLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLP 113
Query: 508 EDDTNF-VGTSAHVTGWG 524
F G VTGWG
Sbjct: 114 PASETFPPGMPCWVTGWG 131
Score = 57.0 bits (136), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 26/48 (54%), Positives = 34/48 (70%), Gaps = 3/48 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTY-LHKCGAALFNENWAVTAAHCV 609
IVGG++A KWPWQ+SLR +R Y +H CG +L + W +TAAHCV
Sbjct: 1 IVGGQEAPRSKWPWQVSLR--VRDRYWMHFCGGSLIHPQWVLTAAHCV 46
Score = 31.2 bits (69), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 16/54 (29%), Positives = 27/54 (50%), Gaps = 6/54 (11%)
Query: 639 PLPSVLQEVSVPVINNSLCETMYRAAGF----IEHIPEIFICAGWRKGSFDSCE 688
P P L++V VP++ N +C+ Y + + I + +CAG DSC+
Sbjct: 140 PPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAG--NSQRDSCQ 191
>pdb|1CO7|E Chain E, R117h Mutant Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
Length = 245
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 45/136 (33%), Positives = 68/136 (50%), Gaps = 12/136 (8%)
Query: 390 RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRL 449
+IVGG P+Q+SL S Y H CG +L N+ W V+AAHC + S + +RL
Sbjct: 22 KIVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHCYK----SRIQVRL 72
Query: 450 GEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPED 509
GEH+++ E Q + HP FD +T D+ L++ PVK ++ + +P
Sbjct: 73 GEHNINVLEG--NEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNAHVATVALPS- 129
Query: 510 DTNFVGTSAHVTGWGR 525
GT ++GWG
Sbjct: 130 SCAPAGTQCLISGWGN 145
Score = 43.5 bits (101), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 24/61 (39%), Positives = 32/61 (52%), Gaps = 8/61 (13%)
Query: 551 FLGNRILFP---SSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAH 607
+G + FP +IVGG P+Q+SL S Y H CG +L N+ W V+AAH
Sbjct: 8 LVGAAVAFPVDDDDKIVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAH 62
Query: 608 C 608
C
Sbjct: 63 C 63
Score = 29.6 bits (65), Expect = 6.3, Method: Compositional matrix adjust.
Identities = 14/48 (29%), Positives = 24/48 (50%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
P +LQ + P++ + CE Y I + +C G+ +G DSC+
Sbjct: 154 PDLLQCLDAPLLPQADCEASYPG-----KITDNMVCVGFLEGGKDSCQ 196
>pdb|1LTO|A Chain A, Human Alpha1-Tryptase
pdb|1LTO|B Chain B, Human Alpha1-Tryptase
pdb|1LTO|C Chain C, Human Alpha1-Tryptase
pdb|1LTO|D Chain D, Human Alpha1-Tryptase
Length = 245
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 52/140 (37%), Positives = 72/140 (51%), Gaps = 15/140 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTY-LHKCGAALFNENWAVTAAHC----VEDVPPSDL 445
IVGG++A KWPWQ+SLR +R Y +H CG +L + W +TAAHC V+D+ + L
Sbjct: 1 IVGGQEAPRSKWPWQVSLR--VRDRYWMHFCGGSLIHPQWVLTAAHCLGPDVKDL--ATL 56
Query: 446 LLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPIC 505
++L E L ++ Q V + HPQF D+ALL EPV + +
Sbjct: 57 RVQLREQHLYYQD-----QLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVM 111
Query: 506 VPEDDTNF-VGTSAHVTGWG 524
+P F G VTGWG
Sbjct: 112 LPPASETFPPGMPCWVTGWG 131
Score = 55.8 bits (133), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 25/48 (52%), Positives = 34/48 (70%), Gaps = 3/48 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTY-LHKCGAALFNENWAVTAAHCV 609
IVGG++A KWPWQ+SLR +R Y +H CG +L + W +TAAHC+
Sbjct: 1 IVGGQEAPRSKWPWQVSLR--VRDRYWMHFCGGSLIHPQWVLTAAHCL 46
Score = 30.8 bits (68), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 16/54 (29%), Positives = 27/54 (50%), Gaps = 6/54 (11%)
Query: 639 PLPSVLQEVSVPVINNSLCETMYRAAGF----IEHIPEIFICAGWRKGSFDSCE 688
P P L++V VP++ N +C+ Y + + I + +CAG DSC+
Sbjct: 140 PPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAG--NSQRDSCK 191
>pdb|2B9L|A Chain A, Crystal Structure Of Prophenoloxidase Activating Factor-Ii
From The Beetle Holotrichia Diomphalia
Length = 394
Score = 76.6 bits (187), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 47/160 (29%), Positives = 80/160 (50%), Gaps = 13/160 (8%)
Query: 396 KATFGKWPWQISLRQWIRSTYLHK-------CGAALFNENWAVTAAHCVEDVPPS--DLL 446
+A +G++PW +++ +++ + CG +L + +T AHCV + +
Sbjct: 136 EAEYGEFPWMVAV---LKANVIPGSGEEQLVCGGSLIAPSVVLTGAHCVNSYQSNLDAIK 192
Query: 447 LRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICV 506
+R GE D TE+E YQER+++ V H F+P+T D+ALL P+ NI IC+
Sbjct: 193 IRAGEWDTLTEKERLPYQERKIRQVIIHSNFNPKTVVNDVALLLLDRPLVQADNIGTICL 252
Query: 507 PEDDTNFVGTSAHVTGWGRLYEGRFRRSYGHPATRQEMAT 546
P+ F T +GWG+ G R Y + + ++ T
Sbjct: 253 PQQSQIFDSTECFASGWGKKEFGS-RHRYSNILKKIQLPT 291
>pdb|1MKW|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
Length = 308
Score = 76.6 bits (187), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 53/163 (32%), Positives = 82/163 (50%), Gaps = 31/163 (19%)
Query: 383 RRLFPS---SRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 439
+ LF S RIV G+ A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 39 KELFESYIEGRIVEGQDAEVGLSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLL- 95
Query: 440 VPP-------SDLLLRLGEHDLSTEEEPYGYQERRVQIVAS------HPQFD-PRTFEYD 485
PP DLL+R+G+H + ER+V+ ++ HP+++ + D
Sbjct: 96 YPPWDKNFTVDDLLVRIGKHSRTR-------YERKVEKISMLDKIYIHPRYNWKENLDRD 148
Query: 486 LALLRFYEPVKFQPNIIPICVPEDDTN----FVGTSAHVTGWG 524
+ALL+ P++ I P+C+P+ T G VTGWG
Sbjct: 149 IALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWG 191
Score = 42.7 bits (99), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 31/52 (59%), Gaps = 2/52 (3%)
Query: 558 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+ RIV G+ A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 45 YIEGRIVEGQDAEVGLSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 94
Score = 32.0 bits (71), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 22/67 (32%), Positives = 36/67 (53%), Gaps = 11/67 (16%)
Query: 625 RRESNLWKMALADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGS- 683
RRE+ W ++A+ PSVLQ V++P++ +C+ R I + CAG++ G
Sbjct: 193 RRET--WTTSVAE-VQPSVLQVVNLPLVERPVCKASTRI-----RITDNMFCAGYKPGEG 244
Query: 684 --FDSCE 688
D+CE
Sbjct: 245 KRGDACE 251
>pdb|3TGJ|E Chain E, S195a Trypsinogen Complexed With Bovine Pancreatic Trypsin
Inhibitor (Bpti)
Length = 233
Score = 76.3 bits (186), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 45/136 (33%), Positives = 67/136 (49%), Gaps = 12/136 (8%)
Query: 390 RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRL 449
+IVGG P+Q+SL S Y H CG +L N+ W V+AAHC + S + +RL
Sbjct: 10 KIVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHCYK----SRIQVRL 60
Query: 450 GEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPED 509
GEH+++ E Q + HP FD +T D+ L++ PVK + + +P
Sbjct: 61 GEHNINVLEG--NEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS- 117
Query: 510 DTNFVGTSAHVTGWGR 525
GT ++GWG
Sbjct: 118 SCAPAGTQCLISGWGN 133
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 21/47 (44%), Positives = 27/47 (57%), Gaps = 5/47 (10%)
Query: 562 RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
+IVGG P+Q+SL S Y H CG +L N+ W V+AAHC
Sbjct: 10 KIVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHC 51
Score = 30.4 bits (67), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 15/51 (29%), Positives = 25/51 (49%), Gaps = 5/51 (9%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCEEHA 691
P +LQ + P++ + CE Y I + +C G+ +G DSC+ A
Sbjct: 142 PDLLQCLDAPLLPQADCEASYPG-----KITDNMVCVGFLEGGKDSCQGDA 187
>pdb|1HAX|B Chain B, Snapshots Of Serine Protease Catalysis: (A) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 At Ph 5
pdb|1HAY|B Chain B, Snapshots Of Serine Protease Catalysis: (B) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 10 Seconds
pdb|1HB0|B Chain B, Snapshots Of Serine Protease Catalysis: (D) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 2 Minutes
Length = 240
Score = 75.9 bits (185), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 49/139 (35%), Positives = 69/139 (49%), Gaps = 11/139 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLR-- 448
+VGG +A WP QISL+ S++ H CG L +NW +TAAHCV+ +L R
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDR----ELTFRVV 56
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQF--DPRTFEYDLALLRFYEPVKFQPNIIPICV 506
+GEH+L+ Y VQ + HP + D YD+ALLR + V + +
Sbjct: 57 VGEHNLNQNNGTEQYVG--VQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVL 114
Query: 507 PEDDTNFVGTS-AHVTGWG 524
P T S ++TGWG
Sbjct: 115 PRAGTILRNNSPCYITGWG 133
Score = 53.1 bits (126), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 23/48 (47%), Positives = 31/48 (64%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVE 610
+VGG +A WP QISL+ S++ H CG L +NW +TAAHCV+
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVD 48
>pdb|1ZPZ|A Chain A, Factor Xi Catalytic Domain Complexed With N-((R)-1-(4-
Bromophenyl)ethyl)urea-Asn-Val-Arg-Alpha-Ketothiazole
pdb|1ZRK|A Chain A, Factor Xi Complexed With 3-Hydroxypropyl 3-(7-
Amidinonaphthalene-1-Carboxamido)benzenesulfonate
pdb|1ZSL|A Chain A, Factor Xi Complexed With A Pyrimidinone Inhibitor
Length = 238
Score = 75.5 bits (184), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 45/139 (32%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLR-- 448
IVGG + G+WPWQ++L T H CG ++ W +TAAHC V +L
Sbjct: 1 IVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYS 59
Query: 449 --LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICV 506
L + +++ + +G QE + H Q+ YD+ALL+ V + + PI +
Sbjct: 60 GILNQSEIAEDTSFFGVQE-----IIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISL 114
Query: 507 P-EDDTNFVGTSAHVTGWG 524
P + D N + T VTGWG
Sbjct: 115 PSKGDRNVIYTDCWVTGWG 133
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 27/46 (58%), Gaps = 1/46 (2%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG + G+WPWQ++L T H CG ++ W +TAAHC
Sbjct: 1 IVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHC 45
Score = 38.1 bits (87), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 16/49 (32%), Positives = 27/49 (55%), Gaps = 4/49 (8%)
Query: 640 LPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
+ + LQ+ +P++ N C+ YR I ICAG+R+G D+C+
Sbjct: 141 IQNTLQKAKIPLVTNEECQKRYRG----HKITHKMICAGYREGGKDACK 185
>pdb|3GOV|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-1
pdb|4DJZ|B Chain B, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
pdb|4DJZ|D Chain D, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 251
Score = 75.5 bits (184), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 60/200 (30%), Positives = 83/200 (41%), Gaps = 35/200 (17%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED----------- 439
I G A G PW L + CG +L +W VTAAHC+
Sbjct: 1 IFNGRPAQKGTTPWIAMLSHLNGQPF---CGGSLLGSSWIVTAAHCLHQSLDPKDPTLRD 57
Query: 440 ---VPPSDLLLRLGEH-DLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPV 495
+ PSD + LG+H L ++E Q V+ HPQ+DP TFE D+AL+ E
Sbjct: 58 SDLLSPSDFKIILGKHWRLRSDEN---EQHLGVKHTTLHPQYDPNTFENDVALVELLESP 114
Query: 496 KFQPNIIPICVPEDDTNFVGTSAHVTGWGRLYEGRFRRSYGHPATRQEM-------ATCW 548
++PIC+PE G V+GWG+ + RF P T E+ +TC
Sbjct: 115 VLNAFVMPICLPEGPQQ-EGAMVIVSGWGKQFLQRF------PETLMEIEIPIVDHSTCQ 167
Query: 549 NHFLGNRILFPSSRIVGGEK 568
+ + I GEK
Sbjct: 168 KAYAPLKKKVTRDMICAGEK 187
Score = 37.4 bits (85), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 15/48 (31%), Positives = 27/48 (56%), Gaps = 2/48 (4%)
Query: 640 LPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSC 687
P L E+ +P++++S C+ Y A + + ICAG ++G D+C
Sbjct: 149 FPETLMEIEIPIVDHSTCQKAY--APLKKKVTRDMICAGEKEGGKDAC 194
Score = 33.1 bits (74), Expect = 0.56, Method: Compositional matrix adjust.
Identities = 20/74 (27%), Positives = 30/74 (40%), Gaps = 3/74 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWSQIIPIIQN 622
I G A G PW L + CG +L +W VTAAHC+ P +++
Sbjct: 1 IFNGRPAQKGTTPWIAMLSHLNGQPF---CGGSLLGSSWIVTAAHCLHQSLDPKDPTLRD 57
Query: 623 CRRRESNLWKMALA 636
+ +K+ L
Sbjct: 58 SDLLSPSDFKIILG 71
>pdb|1ZLR|A Chain A, Factor Xi Catalytic Domain Complexed With
2-Guanidino-1-(4-(4,4,5,5-
Tetramethyl-1,3,2-Dioxaborolan-2-Yl)phenyl)ethyl
Nicotinate
Length = 237
Score = 75.5 bits (184), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 45/139 (32%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLR-- 448
IVGG + G+WPWQ++L T H CG ++ W +TAAHC V +L
Sbjct: 1 IVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYS 59
Query: 449 --LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICV 506
L + +++ + +G QE + H Q+ YD+ALL+ V + + PI +
Sbjct: 60 GILNQAEIAEDTSFFGVQE-----IIIHDQYKMAESGYDIALLKLETTVNYADSQRPISL 114
Query: 507 P-EDDTNFVGTSAHVTGWG 524
P + D N + T VTGWG
Sbjct: 115 PSKGDRNVIYTDCWVTGWG 133
Score = 47.0 bits (110), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 27/46 (58%), Gaps = 1/46 (2%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG + G+WPWQ++L T H CG ++ W +TAAHC
Sbjct: 1 IVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHC 45
Score = 38.1 bits (87), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 16/49 (32%), Positives = 27/49 (55%), Gaps = 4/49 (8%)
Query: 640 LPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
+ + LQ+ +P++ N C+ YR I ICAG+R+G D+C+
Sbjct: 141 IQNTLQKAKIPLVTNEECQKRYRG----HKITHKMICAGYREGGKDACK 185
>pdb|1ZHR|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine
(S434a-T475a-C482s-K437a Mutant)
pdb|1ZPB|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 4-Methyl-Pentanoic Acid {1-[4-
Guanidino-1-(Thiazole-2-Carbonyl)-Butylcarbamoyl]-2-
Methyl- Propyl}-Amide
pdb|1ZPC|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
2-[2-(3-Chloro-Phenyl)-2-Hydroxy-
Acetylamino]-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]- 3-Methyl-Butyramide
pdb|2FDA|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Coagulation Factor Xia In Complex With
Alpha-Ketothiazole Arginine Derived Ligand
pdb|1ZMJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With 4-(Guanidinomethyl)-Phenylboronic Acid
pdb|1ZML|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With (R)-1-(4-(4-(Hydroxymethyl)-1,3,2-
Dioxaborolan-2-Yl)phenethyl)guanidine
pdb|1ZMN|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
(R)-1-(4-(4-(Hydroxymethyl)-1,3,
2-Dioxaborolan-2-Yl)phenyl)guanidine
pdb|1ZOM|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With A Peptidomimetic Inhibitor
pdb|1ZSJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
N-(7-Carbamimidoyl-Naphthalen-1-
Yl)-3-Hydroxy-2-Methyl-Benzamide
pdb|1ZSK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
6-Carbamimidoyl-4-(3-Hydroxy-2-
Methyl-Benzoylamino)-Naphthalene-2-Carboxylic Acid
Methyl Ester
pdb|1ZTJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Benzylamino-2-
Methylsulfanyl-6-Oxo-6h-Pyrimidin-1-Yl)-N-[4-Guanidino-
1- (Thiazole-2-Carbonyl)-Butyl]-Acetamide
pdb|1ZTK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Amino-6-Oxo-2-M-Tolyl-6h-
Pyrimidin-1-Yl)-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]-Acetamide
pdb|1ZTL|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With N-[4-Guanidino-1-(Thiazole-2-
Carbonyl)-Butyl]-2-{6-Oxo-5-[(Quinolin-8-Ylmethyl)-
Amino]- 2-M-Tolyl-6h-Pyrimidin-1-Yl}-Acetamide
Length = 238
Score = 75.5 bits (184), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 45/139 (32%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLR-- 448
IVGG + G+WPWQ++L T H CG ++ W +TAAHC V +L
Sbjct: 1 IVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYS 59
Query: 449 --LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICV 506
L + +++ + +G QE + H Q+ YD+ALL+ V + + PI +
Sbjct: 60 GILNQAEIAEDTSFFGVQE-----IIIHDQYKMAESGYDIALLKLETTVNYADSQRPISL 114
Query: 507 P-EDDTNFVGTSAHVTGWG 524
P + D N + T VTGWG
Sbjct: 115 PSKGDRNVIYTDCWVTGWG 133
Score = 47.0 bits (110), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 27/46 (58%), Gaps = 1/46 (2%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG + G+WPWQ++L T H CG ++ W +TAAHC
Sbjct: 1 IVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHC 45
Score = 38.1 bits (87), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 16/49 (32%), Positives = 27/49 (55%), Gaps = 4/49 (8%)
Query: 640 LPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
+ + LQ+ +P++ N C+ YR I ICAG+R+G D+C+
Sbjct: 141 IQNTLQKAKIPLVTNEECQKRYRG----HKITHKMICAGYREGGKDACK 185
>pdb|3SOR|A Chain A, Factor Xia In Complex With A Clorophenyl-tetrazole
Inhibitor
pdb|3SOS|A Chain A, Benzothiazinone Inhibitor In Complex With Fxia
Length = 238
Score = 75.1 bits (183), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 45/139 (32%), Positives = 67/139 (48%), Gaps = 11/139 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLR-- 448
IVGG + G+WPWQ++L T H CG ++ W +TAAHC V +L
Sbjct: 1 IVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYS 59
Query: 449 --LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICV 506
L + ++ + +G QE + H Q+ YD+ALL+ V + + PI +
Sbjct: 60 GILNQSEIKEDTSFFGVQE-----IIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISL 114
Query: 507 P-EDDTNFVGTSAHVTGWG 524
P + D N + T VTGWG
Sbjct: 115 PSKGDRNVIYTDCWVTGWG 133
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 27/46 (58%), Gaps = 1/46 (2%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG + G+WPWQ++L T H CG ++ W +TAAHC
Sbjct: 1 IVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHC 45
Score = 38.1 bits (87), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 16/49 (32%), Positives = 27/49 (55%), Gaps = 4/49 (8%)
Query: 640 LPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
+ + LQ+ +P++ N C+ YR I ICAG+R+G D+C+
Sbjct: 141 IQNTLQKAKIPLVTNEECQKRYRG----HKITHKMICAGYREGGKDACK 185
>pdb|1F7Z|A Chain A, Rat Trypsinogen K15a Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 233
Score = 75.1 bits (183), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 45/135 (33%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC + S + +RLG
Sbjct: 11 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHCYK----SRIQVRLG 61
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH+++ E Q + HP FD +T D+ L++ PVK + + +P
Sbjct: 62 EHNINVLEG--NEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS-S 118
Query: 511 TNFVGTSAHVTGWGR 525
GT ++GWG
Sbjct: 119 CAPAGTQCLISGWGN 133
Score = 39.7 bits (91), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 21/46 (45%), Positives = 26/46 (56%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC
Sbjct: 11 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHC 51
Score = 29.6 bits (65), Expect = 6.1, Method: Compositional matrix adjust.
Identities = 14/48 (29%), Positives = 24/48 (50%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
P +LQ + P++ + CE Y I + +C G+ +G DSC+
Sbjct: 142 PDLLQCLDAPLLPQADCEASYPG-----KITDNMVCVGFLEGGKDSCQ 184
>pdb|1ZJD|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Kunitz Protease Inhibitor
Domain Of Protease Nexin Ii
Length = 237
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 45/139 (32%), Positives = 67/139 (48%), Gaps = 11/139 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLR-- 448
IVGG + G+WPWQ++L T H CG ++ W +TAAHC V +L
Sbjct: 1 IVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYS 59
Query: 449 --LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICV 506
L + ++ + +G QE + H Q+ YD+ALL+ V + + PI +
Sbjct: 60 GILNQAEIKEDTSFFGVQE-----IIIHDQYKMAESGYDIALLKLETTVNYADSQRPISL 114
Query: 507 P-EDDTNFVGTSAHVTGWG 524
P + D N + T VTGWG
Sbjct: 115 PSKGDRNVIYTDCWVTGWG 133
Score = 47.0 bits (110), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 27/46 (58%), Gaps = 1/46 (2%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG + G+WPWQ++L T H CG ++ W +TAAHC
Sbjct: 1 IVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHC 45
Score = 38.1 bits (87), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 16/49 (32%), Positives = 27/49 (55%), Gaps = 4/49 (8%)
Query: 640 LPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
+ + LQ+ +P++ N C+ YR I ICAG+R+G D+C+
Sbjct: 141 IQNTLQKAKIPLVTNEECQKRYRG----HKITHKMICAGYREGGKDACK 185
>pdb|1BBR|H Chain H, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|H Chain H, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|F Chain F, Thrombin:hirudin 51-65 Complex
pdb|1YCP|K Chain K, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 150
Score = 74.7 bits (182), Expect = 1e-13, Method: Composition-based stats.
Identities = 50/156 (32%), Positives = 78/156 (50%), Gaps = 28/156 (17%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPP-------S 443
IV G+ A G PWQ+ L + +S CGA+L ++ W +TAAHC+ PP
Sbjct: 1 IVEGQDAEVGLSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLL-YPPWDKNFTVD 57
Query: 444 DLLLRLGEHDLSTEEEPYGYQERRVQIVAS------HPQFD-PRTFEYDLALLRFYEPVK 496
DLL+R+G+H + ER+V+ ++ HP+++ + D+ALL+ P++
Sbjct: 58 DLLVRIGKHSRTR-------YERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIE 110
Query: 497 FQPNIIPICVPEDDTN----FVGTSAHVTGWGRLYE 528
I P+C+P+ T G VTGWG E
Sbjct: 111 LSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRE 146
Score = 41.2 bits (95), Expect = 0.002, Method: Composition-based stats.
Identities = 20/47 (42%), Positives = 29/47 (61%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G+ A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGQDAEVGLSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1SLW|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Nickel- Bound
Length = 223
Score = 74.7 bits (182), Expect = 2e-13, Method: Composition-based stats.
Identities = 46/134 (34%), Positives = 66/134 (49%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH+++ E Q + HP FD +T D+ L++ PVK + I +P
Sbjct: 52 EHNINVLEG--NEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATIALPSSC 109
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 110 AP-AGTQCLISGWG 122
Score = 40.0 bits (92), Expect = 0.004, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 26/46 (56%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHC 41
Score = 29.6 bits (65), Expect = 6.0, Method: Composition-based stats.
Identities = 17/59 (28%), Positives = 28/59 (47%), Gaps = 6/59 (10%)
Query: 631 WKMALADG-PLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W L+ G P +LQ + P++ + CE Y I + +C G+ +G DSC+
Sbjct: 121 WGHTLSSGVNHPDLLQCLDAPLLPQADCEASYPGK-----ITDNMVCVGFLEGGKDSCQ 174
>pdb|1ID5|H Chain H, Crystal Structure Of Bovine Thrombin Complex With Protease
Inhibitor Ecotin
Length = 256
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/152 (32%), Positives = 77/152 (50%), Gaps = 28/152 (18%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPP-------S 443
IV G+ A G PWQ+ L + +S CGA+L ++ W +TAAHC+ PP
Sbjct: 1 IVEGQDAEVGLSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLL-YPPWDKNFTVD 57
Query: 444 DLLLRLGEHDLSTEEEPYGYQERRVQIVAS------HPQFD-PRTFEYDLALLRFYEPVK 496
DLL+R+G+H + ER+V+ ++ HP+++ + D+ALL+ P++
Sbjct: 58 DLLVRIGKHSRTR-------YERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIE 110
Query: 497 FQPNIIPICVPEDDTN----FVGTSAHVTGWG 524
I P+C+P+ T G VTGWG
Sbjct: 111 LSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWG 142
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 29/47 (61%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G+ A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGQDAEVGLSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
Score = 31.6 bits (70), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 22/67 (32%), Positives = 36/67 (53%), Gaps = 11/67 (16%)
Query: 625 RRESNLWKMALADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGS- 683
RRE+ W ++A+ PSVLQ V++P++ +C+ R I + CAG++ G
Sbjct: 144 RRET--WTTSVAEVQ-PSVLQVVNLPLVERPVCKASTRI-----RITDNMFCAGYKPGEG 195
Query: 684 --FDSCE 688
D+CE
Sbjct: 196 KRGDACE 202
>pdb|1ANC|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Lys
Length = 223
Score = 73.9 bits (180), Expect = 2e-13, Method: Composition-based stats.
Identities = 45/134 (33%), Positives = 66/134 (49%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH+++ E Q + HP FD +T D+ L++ PVK + + +P
Sbjct: 52 EHNINVLEG--NEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 110 AP-AGTQCLISGWG 122
Score = 40.4 bits (93), Expect = 0.004, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 26/46 (56%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHC 41
Score = 29.3 bits (64), Expect = 7.2, Method: Composition-based stats.
Identities = 17/59 (28%), Positives = 28/59 (47%), Gaps = 6/59 (10%)
Query: 631 WKMALADG-PLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W L+ G P +LQ + P++ + CE Y I + +C G+ +G DSC+
Sbjct: 121 WGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGK-----ITDNMVCVGFLEGGKDSCQ 174
>pdb|1K9O|E Chain E, Crystal Structure Of Michaelis Serpin-Trypsin Complex
pdb|1YKT|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLC|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLD|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|3FP7|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Cleaved At The
Scissile Bond (Lys15-Ala16) Determined To The 1.46 A
Resolution Limit
pdb|3FP8|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Determined To The
1.46 A Resolution Limit
Length = 223
Score = 73.9 bits (180), Expect = 2e-13, Method: Composition-based stats.
Identities = 45/134 (33%), Positives = 66/134 (49%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH+++ E Q + HP FD +T D+ L++ PVK + + +P
Sbjct: 52 EHNINVLEG--NEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 110 AP-AGTQCLISGWG 122
Score = 40.4 bits (93), Expect = 0.004, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 26/46 (56%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHC 41
Score = 29.6 bits (65), Expect = 5.9, Method: Composition-based stats.
Identities = 18/62 (29%), Positives = 29/62 (46%), Gaps = 6/62 (9%)
Query: 631 WKMALADG-PLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCEE 689
W L+ G P +LQ + P++ + CE Y I + +C G+ +G DSC+
Sbjct: 121 WGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGK-----ITDNMVCVGFLEGGKDSCQG 175
Query: 690 HA 691
A
Sbjct: 176 DA 177
>pdb|1BBR|K Chain K, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1BBR|N Chain N, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1ETR|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETS|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETT|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1HRT|H Chain H, The Structure Of A Complex Of Bovine Alpha-Thrombin And
Recombinant Hirudin At 2.8 Angstroms Resolution
pdb|1TBR|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBR|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1UCY|K Chain K, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1UCY|N Chain N, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|H Chain H, Thrombin:hirudin 51-65 Complex
pdb|1MKW|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1TOC|B Chain B, Structure Of Serine Proteinase
pdb|1TOC|D Chain D, Structure Of Serine Proteinase
pdb|1TOC|F Chain F, Structure Of Serine Proteinase
pdb|1TOC|H Chain H, Structure Of Serine Proteinase
pdb|1UVT|H Chain H, Bovine Thrombin--Bm14.1248 Complex
pdb|1UVU|H Chain H, Bovine Thrombin--Bm12.1700 Complex
pdb|1YCP|H Chain H, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
pdb|1A0H|B Chain B, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1A0H|E Chain E, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1AVG|H Chain H, Thrombin Inhibitor From Triatoma Pallidipennis
pdb|2A1D|B Chain B, Staphylocoagulase Bound To Bovine Thrombin
pdb|2A1D|F Chain F, Staphylocoagulase Bound To Bovine Thrombin
pdb|2ODY|B Chain B, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|2ODY|D Chain D, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|3PMA|B Chain B, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMA|D Chain D, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMB|B Chain B, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
pdb|3PMB|D Chain D, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
Length = 259
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/152 (32%), Positives = 77/152 (50%), Gaps = 28/152 (18%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPP-------S 443
IV G+ A G PWQ+ L + +S CGA+L ++ W +TAAHC+ PP
Sbjct: 1 IVEGQDAEVGLSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLL-YPPWDKNFTVD 57
Query: 444 DLLLRLGEHDLSTEEEPYGYQERRVQIVAS------HPQFD-PRTFEYDLALLRFYEPVK 496
DLL+R+G+H + ER+V+ ++ HP+++ + D+ALL+ P++
Sbjct: 58 DLLVRIGKHSRTR-------YERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIE 110
Query: 497 FQPNIIPICVPEDDTN----FVGTSAHVTGWG 524
I P+C+P+ T G VTGWG
Sbjct: 111 LSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWG 142
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 29/47 (61%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G+ A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGQDAEVGLSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
Score = 31.6 bits (70), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 22/67 (32%), Positives = 36/67 (53%), Gaps = 11/67 (16%)
Query: 625 RRESNLWKMALADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGS- 683
RRE+ W ++A+ PSVLQ V++P++ +C+ R I + CAG++ G
Sbjct: 144 RRET--WTTSVAEVQ-PSVLQVVNLPLVERPVCKASTRI-----RITDNMFCAGYKPGEG 195
Query: 684 --FDSCE 688
D+CE
Sbjct: 196 KRGDACE 202
>pdb|3TGI|E Chain E, Wild-Type Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
pdb|1ANE|A Chain A, Anionic Trypsin Wild Type
pdb|3FP6|E Chain E, Anionic Trypsin In Complex With Bovine Pancreatic Trypsin
Inhibitor (Bpti) Determined To The 1.49 A Resolution
Limit
Length = 223
Score = 73.9 bits (180), Expect = 3e-13, Method: Composition-based stats.
Identities = 45/134 (33%), Positives = 66/134 (49%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH+++ E Q + HP FD +T D+ L++ PVK + + +P
Sbjct: 52 EHNINVLEG--NEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 110 AP-AGTQCLISGWG 122
Score = 40.0 bits (92), Expect = 0.004, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 26/46 (56%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHC 41
Score = 29.3 bits (64), Expect = 7.2, Method: Composition-based stats.
Identities = 17/59 (28%), Positives = 28/59 (47%), Gaps = 6/59 (10%)
Query: 631 WKMALADG-PLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W L+ G P +LQ + P++ + CE Y I + +C G+ +G DSC+
Sbjct: 121 WGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGK-----ITDNMVCVGFLEGGKDSCQ 174
>pdb|1BRB|E Chain E, Crystal Structures Of Rat Anionic Trypsin Complexed With
The Protein Inhibitors Appi And Bpti
pdb|1BRC|E Chain E, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
pdb|1BRA|A Chain A, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
Length = 223
Score = 73.9 bits (180), Expect = 3e-13, Method: Composition-based stats.
Identities = 45/134 (33%), Positives = 66/134 (49%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH+++ E Q + HP FD +T D+ L++ PVK + + +P
Sbjct: 52 EHNINVLEG--NEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 110 AP-AGTQCLISGWG 122
Score = 40.0 bits (92), Expect = 0.004, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 26/46 (56%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHC 41
>pdb|1SLX|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Zinc-Bound
pdb|1SLV|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Copper- Bound
pdb|1SLU|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin
Length = 223
Score = 73.9 bits (180), Expect = 3e-13, Method: Composition-based stats.
Identities = 45/134 (33%), Positives = 66/134 (49%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH+++ E Q + HP FD +T D+ L++ PVK + + +P
Sbjct: 52 EHNINVLEG--NEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 110 AP-AGTQCLISGWG 122
Score = 40.0 bits (92), Expect = 0.004, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 26/46 (56%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHC 41
Score = 29.6 bits (65), Expect = 6.0, Method: Composition-based stats.
Identities = 17/59 (28%), Positives = 28/59 (47%), Gaps = 6/59 (10%)
Query: 631 WKMALADG-PLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W L+ G P +LQ + P++ + CE Y I + +C G+ +G DSC+
Sbjct: 121 WGHTLSSGVNHPDLLQCLDAPLLPQADCEASYPGK-----ITDNMVCVGFLEGGKDSCQ 174
>pdb|1ANB|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Glu
Length = 223
Score = 73.9 bits (180), Expect = 3e-13, Method: Composition-based stats.
Identities = 45/134 (33%), Positives = 66/134 (49%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH+++ E Q + HP FD +T D+ L++ PVK + + +P
Sbjct: 52 EHNINVLEG--NEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 110 AP-AGTQCLISGWG 122
Score = 40.0 bits (92), Expect = 0.004, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 26/46 (56%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHC 41
Score = 29.3 bits (64), Expect = 7.4, Method: Composition-based stats.
Identities = 17/59 (28%), Positives = 28/59 (47%), Gaps = 6/59 (10%)
Query: 631 WKMALADG-PLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W L+ G P +LQ + P++ + CE Y I + +C G+ +G DSC+
Sbjct: 121 WGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGK-----ITDNMVCVGFLEGGKDSCQ 174
>pdb|1DPO|A Chain A, Structure Of Rat Trypsin
Length = 223
Score = 73.9 bits (180), Expect = 3e-13, Method: Composition-based stats.
Identities = 45/134 (33%), Positives = 66/134 (49%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH+++ E Q + HP FD +T D+ L++ PVK + + +P
Sbjct: 52 EHNINVLEG--NEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 110 AP-AGTQCLISGWG 122
Score = 40.0 bits (92), Expect = 0.004, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 26/46 (56%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHC 41
Score = 29.3 bits (64), Expect = 7.4, Method: Composition-based stats.
Identities = 17/59 (28%), Positives = 28/59 (47%), Gaps = 6/59 (10%)
Query: 631 WKMALADG-PLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W L+ G P +LQ + P++ + CE Y I + +C G+ +G DSC+
Sbjct: 121 WGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGK-----ITDNMVCVGFLEGGKDSCQ 174
>pdb|1AND|A Chain A, Anionic Trypsin Mutant With Arg 96 Replaced By His
Length = 223
Score = 73.9 bits (180), Expect = 3e-13, Method: Composition-based stats.
Identities = 45/134 (33%), Positives = 66/134 (49%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH+++ E Q + HP FD +T D+ L++ PVK + + +P
Sbjct: 52 EHNINVLEG--NEQFVNAAKIIKHPNFDHKTLNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 110 AP-AGTQCLISGWG 122
Score = 40.0 bits (92), Expect = 0.004, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 26/46 (56%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHC 41
Score = 29.3 bits (64), Expect = 7.4, Method: Composition-based stats.
Identities = 17/59 (28%), Positives = 28/59 (47%), Gaps = 6/59 (10%)
Query: 631 WKMALADG-PLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W L+ G P +LQ + P++ + CE Y I + +C G+ +G DSC+
Sbjct: 121 WGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGK-----ITDNMVCVGFLEGGKDSCQ 174
>pdb|1EKB|B Chain B, The Serine Protease Domain Of Enteropeptidase Bound To
Inhibitor Val- Asp-asp-asp-asp-lys-chloromethane
Length = 235
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 47/143 (32%), Positives = 71/143 (49%), Gaps = 9/143 (6%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV--EDVPPSDLLLR 448
IVGG + G WPW ++L CGA+L + +W V+AAHCV ++ PS
Sbjct: 1 IVGGSDSREGAWPWVVALY----FDDQQVCGASLVSRDWLVSAAHCVYGRNMEPSKWKAV 56
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
LG H S P + R + + +P ++ R D+A++ V + I PIC+PE
Sbjct: 57 LGLHMASNLTSPQ-IETRLIDQIVINPHYNKRRKNNDIAMMHLEMKVNYTDYIQPICLPE 115
Query: 509 DDTNF-VGTSAHVTGWGRL-YEG 529
++ F G + GWG L Y+G
Sbjct: 116 ENQVFPPGRICSIAGWGALIYQG 138
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 27/47 (57%), Gaps = 4/47 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IVGG + G WPW ++L CGA+L + +W V+AAHCV
Sbjct: 1 IVGGSDSREGAWPWVVALY----FDDQQVCGASLVSRDWLVSAAHCV 43
Score = 38.1 bits (87), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 18/58 (31%), Positives = 28/58 (48%), Gaps = 4/58 (6%)
Query: 631 WKMALADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W + G VLQE VP+++N C+ E++ +CAG+ G DSC+
Sbjct: 131 WGALIYQGSTADVLQEADVPLLSNEKCQQQMPEYNITENM----VCAGYEAGGVDSCQ 184
>pdb|1AMH|A Chain A, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
pdb|1AMH|B Chain B, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
Length = 223
Score = 73.9 bits (180), Expect = 3e-13, Method: Composition-based stats.
Identities = 45/134 (33%), Positives = 66/134 (49%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH+++ E Q + HP FD +T D+ L++ PVK + + +P
Sbjct: 52 EHNINVLEG--NEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 110 AP-AGTQCLISGWG 122
Score = 40.0 bits (92), Expect = 0.004, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 26/46 (56%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHC 41
>pdb|1J15|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J16|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J17|T Chain T, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99175190RT
Length = 223
Score = 73.9 bits (180), Expect = 3e-13, Method: Composition-based stats.
Identities = 45/134 (33%), Positives = 66/134 (49%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH+++ E Q + HP FD T+ D+ L++ PVK + + +P
Sbjct: 52 EHNINVLEG--NEQFVNAAKIIKHPNFDRETYNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 110 AP-AGTQCLISGWG 122
Score = 40.0 bits (92), Expect = 0.004, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 26/46 (56%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHC 41
>pdb|1QL9|A Chain A, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99rt
pdb|1J14|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99rt
Length = 223
Score = 73.9 bits (180), Expect = 3e-13, Method: Composition-based stats.
Identities = 45/134 (33%), Positives = 66/134 (49%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH+++ E Q + HP FD T+ D+ L++ PVK + + +P
Sbjct: 52 EHNINVLEG--NEQFVNAAKIIKHPNFDRETYNNDIMLIKLSSPVKLNARVATVALPSSC 109
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 110 AP-AGTQCLISGWG 122
Score = 40.0 bits (92), Expect = 0.004, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 26/46 (56%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHC 41
Score = 29.3 bits (64), Expect = 7.9, Method: Composition-based stats.
Identities = 17/59 (28%), Positives = 28/59 (47%), Gaps = 6/59 (10%)
Query: 631 WKMALADG-PLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W L+ G P +LQ + P++ + CE Y I + +C G+ +G DSC+
Sbjct: 121 WGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGK-----ITDNMVCVGFLEGGKDSCQ 174
>pdb|1FDP|A Chain A, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|B Chain B, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|C Chain C, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|D Chain D, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
Length = 235
Score = 73.6 bits (179), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 49/153 (32%), Positives = 68/153 (44%), Gaps = 8/153 (5%)
Query: 387 PSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLL 446
P RI+GG +A P+ S ++ H CG L E W ++AAHC+ED +
Sbjct: 4 PRGRILGGREAEAHARPYMAS----VQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQ 59
Query: 447 LRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICV 506
+ LG H LS E + V HP P T ++DL LL+ E P + P+
Sbjct: 60 VLLGAHSLSQPEPSKRLYD--VLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPW 117
Query: 507 PEDDTNFV-GTSAHVTGWGRL-YEGRFRRSYGH 537
D + GT V GWG + + GR S H
Sbjct: 118 QRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQH 150
Score = 42.4 bits (98), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 20/53 (37%), Positives = 28/53 (52%), Gaps = 4/53 (7%)
Query: 559 PSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
P RI+GG +A P+ S ++ H CG L E W ++AAHC+ED
Sbjct: 4 PRGRILGGREAEAHARPYMAS----VQLNGAHLCGGVLVAEQWVLSAAHCLED 52
>pdb|3BG8|A Chain A, Crystal Structure Of Factor Xia In Complex With
Clavatadine A
Length = 238
Score = 73.6 bits (179), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 44/139 (31%), Positives = 67/139 (48%), Gaps = 11/139 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLR-- 448
IVGG + G+WPWQ++L T H CG ++ W +TAAHC V +L
Sbjct: 1 IVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYS 59
Query: 449 --LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICV 506
L + ++ + +G QE + H Q+ YD+ALL+ V + + PI +
Sbjct: 60 GILNQSEIKEDTSFFGVQE-----IIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISL 114
Query: 507 P-EDDTNFVGTSAHVTGWG 524
P + + N + T VTGWG
Sbjct: 115 PSKGERNVIYTDCWVTGWG 133
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 27/46 (58%), Gaps = 1/46 (2%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG + G+WPWQ++L T H CG ++ W +TAAHC
Sbjct: 1 IVGGTASVRGEWPWQVTLHT-TSPTQRHLCGGSIIGNQWILTAAHC 45
Score = 38.1 bits (87), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 16/49 (32%), Positives = 27/49 (55%), Gaps = 4/49 (8%)
Query: 640 LPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
+ + LQ+ +P++ N C+ YR I ICAG+R+G D+C+
Sbjct: 141 IQNTLQKAKIPLVTNEECQKRYRG----HKITHKMICAGYREGGKDACK 185
>pdb|1BUI|A Chain A, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
pdb|1BUI|B Chain B, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
Length = 250
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 49/138 (35%), Positives = 64/138 (46%), Gaps = 13/138 (9%)
Query: 389 SRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVP-PSDLLL 447
R+VGG A WPWQ+SLR +H CG L + W +TAAHC+E P PS +
Sbjct: 19 GRVVGGCVAHPHSWPWQVSLRTRFG---MHFCGGTLISPEWVLTAAHCLEKSPRPSSYKV 75
Query: 448 RLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP 507
LG H EP+ QE V + P D+ALL+ P +IP C+P
Sbjct: 76 ILGAHQ-EVNLEPH-VQEIEVSRLFLEPT------RKDIALLKLSSPAVITDKVIPACLP 127
Query: 508 EDDTNFVG-TSAHVTGWG 524
+ T +TGWG
Sbjct: 128 SPNYVVADRTECFITGWG 145
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 23/51 (45%), Positives = 29/51 (56%), Gaps = 3/51 (5%)
Query: 561 SRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
R+VGG A WPWQ+SLR +H CG L + W +TAAHC+E
Sbjct: 19 GRVVGGCVAHPHSWPWQVSLRTRFG---MHFCGGTLISPEWVLTAAHCLEK 66
>pdb|1BML|A Chain A, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
pdb|1BML|B Chain B, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
Length = 250
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 49/138 (35%), Positives = 64/138 (46%), Gaps = 13/138 (9%)
Query: 389 SRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVP-PSDLLL 447
R+VGG A WPWQ+SLR +H CG L + W +TAAHC+E P PS +
Sbjct: 19 GRVVGGCVAHPHSWPWQVSLRTRFG---MHFCGGTLISPEWVLTAAHCLEKSPRPSSYKV 75
Query: 448 RLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP 507
LG H EP+ QE V + P D+ALL+ P +IP C+P
Sbjct: 76 ILGAHQ-EVNLEPH-VQEIEVSRLFLEPT------RKDIALLKLSSPAVITDKVIPACLP 127
Query: 508 EDDTNFVG-TSAHVTGWG 524
+ T +TGWG
Sbjct: 128 SPNYVVADRTECFITGWG 145
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 23/51 (45%), Positives = 29/51 (56%), Gaps = 3/51 (5%)
Query: 561 SRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
R+VGG A WPWQ+SLR +H CG L + W +TAAHC+E
Sbjct: 19 GRVVGGCVAHPHSWPWQVSLRTRFG---MHFCGGTLISPEWVLTAAHCLEK 66
Score = 28.9 bits (63), Expect = 9.6, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 24/50 (48%), Gaps = 3/50 (6%)
Query: 642 SVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCEEHA 691
+L+E +PVI N +C G ++ +CAG G DSC+ A
Sbjct: 154 GLLKEAQLPVIENKVCNRYEFLNGRVQSTE---LCAGHLAGGTDSCQGDA 200
>pdb|3UIR|A Chain A, Crystal Structure Of The Plasmin-Textilinin-1 Complex
pdb|3UIR|B Chain B, Crystal Structure Of The Plasmin-Textilinin-1 Complex
Length = 247
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 49/138 (35%), Positives = 64/138 (46%), Gaps = 13/138 (9%)
Query: 389 SRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVP-PSDLLL 447
R+VGG A WPWQ+SLR +H CG L + W +TAAHC+E P PS +
Sbjct: 16 GRVVGGCVAHPHSWPWQVSLRTRFG---MHFCGGTLISPEWVLTAAHCLEKSPRPSSYKV 72
Query: 448 RLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP 507
LG H EP+ QE V + P D+ALL+ P +IP C+P
Sbjct: 73 ILGAHQ-EVNLEPH-VQEIEVSRLFLEPT------RKDIALLKLSSPAVITDKVIPACLP 124
Query: 508 EDDTNFVG-TSAHVTGWG 524
+ T +TGWG
Sbjct: 125 SPNYVVADRTECFITGWG 142
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 23/51 (45%), Positives = 29/51 (56%), Gaps = 3/51 (5%)
Query: 561 SRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
R+VGG A WPWQ+SLR +H CG L + W +TAAHC+E
Sbjct: 16 GRVVGGCVAHPHSWPWQVSLRTRFG---MHFCGGTLISPEWVLTAAHCLEK 63
>pdb|1DDJ|A Chain A, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|B Chain B, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|C Chain C, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|D Chain D, Crystal Structure Of Human Plasminogen Catalytic Domain
Length = 247
Score = 72.8 bits (177), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 49/138 (35%), Positives = 64/138 (46%), Gaps = 13/138 (9%)
Query: 389 SRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVP-PSDLLL 447
R+VGG A WPWQ+SLR +H CG L + W +TAAHC+E P PS +
Sbjct: 16 GRVVGGCVAHPHSWPWQVSLRTRFG---MHFCGGTLISPEWVLTAAHCLEKSPRPSSYKV 72
Query: 448 RLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP 507
LG H EP+ QE V + P D+ALL+ P +IP C+P
Sbjct: 73 ILGAHQ-EVNLEPH-VQEIEVSRLFLEPT------RKDIALLKLSSPAVITDKVIPACLP 124
Query: 508 EDDTNFVG-TSAHVTGWG 524
+ T +TGWG
Sbjct: 125 SPNYVVADRTECFITGWG 142
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 23/51 (45%), Positives = 29/51 (56%), Gaps = 3/51 (5%)
Query: 561 SRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
R+VGG A WPWQ+SLR +H CG L + W +TAAHC+E
Sbjct: 16 GRVVGGCVAHPHSWPWQVSLRTRFG---MHFCGGTLISPEWVLTAAHCLEK 63
Score = 28.9 bits (63), Expect = 9.3, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 24/50 (48%), Gaps = 3/50 (6%)
Query: 642 SVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCEEHA 691
+L+E +PVI N +C G ++ +CAG G DSC+ A
Sbjct: 151 GLLKEAQLPVIENKVCNRYEFLNGRVQSTE---LCAGHLAGGTDSCQGDA 197
>pdb|1L4D|A Chain A, Crystal Structure Of Microplasminogen-streptokinase Alpha
Domain Complex
Length = 249
Score = 72.8 bits (177), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 49/138 (35%), Positives = 64/138 (46%), Gaps = 13/138 (9%)
Query: 389 SRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVP-PSDLLL 447
R+VGG A WPWQ+SLR +H CG L + W +TAAHC+E P PS +
Sbjct: 18 GRVVGGCVAHPHSWPWQVSLRTRFG---MHFCGGTLISPEWVLTAAHCLEKSPRPSSYKV 74
Query: 448 RLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP 507
LG H EP+ QE V + P D+ALL+ P +IP C+P
Sbjct: 75 ILGAHQ-EVNLEPH-VQEIEVSRLFLEPT------RKDIALLKLSSPAVITDKVIPACLP 126
Query: 508 EDDTNFVG-TSAHVTGWG 524
+ T +TGWG
Sbjct: 127 SPNYVVADRTECFITGWG 144
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 23/51 (45%), Positives = 29/51 (56%), Gaps = 3/51 (5%)
Query: 561 SRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
R+VGG A WPWQ+SLR +H CG L + W +TAAHC+E
Sbjct: 18 GRVVGGCVAHPHSWPWQVSLRTRFG---MHFCGGTLISPEWVLTAAHCLEK 65
Score = 28.9 bits (63), Expect = 9.2, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 24/50 (48%), Gaps = 3/50 (6%)
Query: 642 SVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCEEHA 691
+L+E +PVI N +C G ++ +CAG G DSC+ A
Sbjct: 153 GLLKEAQLPVIENKVCNRYEFLNGRVQSTE---LCAGHLAGGTDSCQGDA 199
>pdb|1L4Z|A Chain A, X-Ray Crystal Structure Of The Complex Of Microplasminogen
With Alpha Domain Of Streptokinase In The Presence
Cadmium Ions
Length = 248
Score = 72.8 bits (177), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 49/138 (35%), Positives = 64/138 (46%), Gaps = 13/138 (9%)
Query: 389 SRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVP-PSDLLL 447
R+VGG A WPWQ+SLR +H CG L + W +TAAHC+E P PS +
Sbjct: 17 GRVVGGCVAHPHSWPWQVSLRTRFG---MHFCGGTLISPEWVLTAAHCLEKSPRPSSYKV 73
Query: 448 RLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP 507
LG H EP+ QE V + P D+ALL+ P +IP C+P
Sbjct: 74 ILGAHQ-EVNLEPH-VQEIEVSRLFLEPT------RKDIALLKLSSPAVITDKVIPACLP 125
Query: 508 EDDTNFVG-TSAHVTGWG 524
+ T +TGWG
Sbjct: 126 SPNYVVADRTECFITGWG 143
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 23/51 (45%), Positives = 29/51 (56%), Gaps = 3/51 (5%)
Query: 561 SRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
R+VGG A WPWQ+SLR +H CG L + W +TAAHC+E
Sbjct: 17 GRVVGGCVAHPHSWPWQVSLRTRFG---MHFCGGTLISPEWVLTAAHCLEK 64
Score = 28.9 bits (63), Expect = 9.5, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 24/50 (48%), Gaps = 3/50 (6%)
Query: 642 SVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCEEHA 691
+L+E +PVI N +C G ++ +CAG G DSC+ A
Sbjct: 152 GLLKEAQLPVIENKVCNRYEFLNGRVQSTE---LCAGHLAGGTDSCQGDA 198
>pdb|1FXY|A Chain A, Coagulation Factor Xa-Trypsin Chimera Inhibited With
D-Phe-Pro-Arg- Chloromethylketone
Length = 228
Score = 72.8 bits (177), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 44/134 (32%), Positives = 68/134 (50%), Gaps = 8/134 (5%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG G+ PWQ L I CG + +E + +TAAHC+ +R+G
Sbjct: 1 IVGGYNCKDGEVPWQALL---INEENEGFCGGTILSEFYILTAAHCLYQA--KRFKVRVG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
D +TE+E G V++V H +F T+++D+A+LR P+ F+ N+ P +P
Sbjct: 56 --DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPASLPTAP 113
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 114 PA-TGTKCLISGWG 126
Score = 32.0 bits (71), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 24/47 (51%), Gaps = 3/47 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IVGG G+ PWQ L I CG + +E + +TAAHC+
Sbjct: 1 IVGGYNCKDGEVPWQALL---INEENEGFCGGTILSEFYILTAAHCL 44
Score = 28.9 bits (63), Expect = 9.4, Method: Compositional matrix adjust.
Identities = 15/48 (31%), Positives = 22/48 (45%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
P LQ + PV++ + CE Y I C G+ +G DSC+
Sbjct: 136 PDELQCLDAPVLSQAKCEASYPG-----KITSNMFCVGFLEGGKDSCQ 178
>pdb|4DUR|A Chain A, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUR|B Chain B, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUU|A Chain A, The X-Ray Crystal Structure Of Full-Length Type I Human
Plasminogen
pdb|4A5T|S Chain S, Structural Basis For The Conformational Modulation
Length = 791
Score = 72.8 bits (177), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 53/146 (36%), Positives = 69/146 (47%), Gaps = 18/146 (12%)
Query: 390 RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVP-PSDLLLR 448
R+VGG A WPWQ+SLR +H CG L + W +TAAHC+E P PS +
Sbjct: 561 RVVGGCVAHPHSWPWQVSLRTRFG---MHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVI 617
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
LG H EP+ QE V + P D+ALL+ P +IP C+P
Sbjct: 618 LGAHQ-EVNLEPH-VQEIEVSRLFLEPT------RKDIALLKLSSPAVITDKVIPACLP- 668
Query: 509 DDTNFV---GTSAHVTGWGRLYEGRF 531
N+V T +TGWG +G F
Sbjct: 669 -SPNYVVADRTECFITGWGET-QGTF 692
Score = 49.3 bits (116), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 3/49 (6%)
Query: 562 RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVE 610
R+VGG A WPWQ+SLR +H CG L + W +TAAHC+E
Sbjct: 561 RVVGGCVAHPHSWPWQVSLRTRFG---MHFCGGTLISPEWVLTAAHCLE 606
Score = 29.3 bits (64), Expect = 8.4, Method: Compositional matrix adjust.
Identities = 15/46 (32%), Positives = 23/46 (50%), Gaps = 3/46 (6%)
Query: 643 VLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
+L+E +PVI N +C G ++ +CAG G DSC+
Sbjct: 696 LLKEAQLPVIENKVCNRYEFLNGRVQ---STELCAGHLAGGTDSCQ 738
>pdb|1EQ9|A Chain A, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
pdb|1EQ9|B Chain B, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
Length = 222
Score = 72.8 bits (177), Expect = 7e-13, Method: Composition-based stats.
Identities = 43/135 (31%), Positives = 72/135 (53%), Gaps = 10/135 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLL-LRL 449
IVGG+ A GK+P+Q+SLR + H+CGA++ + N +TAAHCV+ + + L + +
Sbjct: 1 IVGGKDAPVGKYPYQVSLRL----SGSHRCGASILDNNNVLTAAHCVDGLSNLNRLKVHV 56
Query: 450 GEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPED 509
G + LS + Y ++ V + +D D+AL+ P+KF + PI + +
Sbjct: 57 GTNYLSESGDVYDVEDAVV-----NKNYDDFLLRNDVALVHLTNPIKFNDLVQPIKLSTN 111
Query: 510 DTNFVGTSAHVTGWG 524
D + +TGWG
Sbjct: 112 DEDLESNPCTLTGWG 126
Score = 52.0 bits (123), Expect = 1e-06, Method: Composition-based stats.
Identities = 24/50 (48%), Positives = 35/50 (70%), Gaps = 4/50 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDL 612
IVGG+ A GK+P+Q+SLR + H+CGA++ + N +TAAHCV+ L
Sbjct: 1 IVGGKDAPVGKYPYQVSLRL----SGSHRCGASILDNNNVLTAAHCVDGL 46
>pdb|1QRZ|A Chain A, Catalytic Domain Of Plasminogen
pdb|1QRZ|B Chain B, Catalytic Domain Of Plasminogen
pdb|1QRZ|C Chain C, Catalytic Domain Of Plasminogen
pdb|1QRZ|D Chain D, Catalytic Domain Of Plasminogen
Length = 246
Score = 72.0 bits (175), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 49/138 (35%), Positives = 63/138 (45%), Gaps = 13/138 (9%)
Query: 389 SRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVP-PSDLLL 447
R+VGG A WPWQ+SLR H CG L + W +TAAHC+E P PS +
Sbjct: 15 GRVVGGCVAHPHSWPWQVSLRTRFGQ---HFCGGTLISPEWVLTAAHCLEKSPRPSSYKV 71
Query: 448 RLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP 507
LG H EP+ QE V + P D+ALL+ P +IP C+P
Sbjct: 72 ILGAHQ-EVNLEPH-VQEIEVSRLFLEPT------RKDIALLKLSSPAVITDKVIPACLP 123
Query: 508 EDDTNFVG-TSAHVTGWG 524
+ T +TGWG
Sbjct: 124 SPNYMVADRTECFITGWG 141
Score = 47.8 bits (112), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 23/51 (45%), Positives = 28/51 (54%), Gaps = 3/51 (5%)
Query: 561 SRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
R+VGG A WPWQ+SLR H CG L + W +TAAHC+E
Sbjct: 15 GRVVGGCVAHPHSWPWQVSLRTRFGQ---HFCGGTLISPEWVLTAAHCLEK 62
>pdb|1TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|1TRM|B Chain B, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|2TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
Length = 223
Score = 72.0 bits (175), Expect = 1e-12, Method: Composition-based stats.
Identities = 44/134 (32%), Positives = 66/134 (49%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH+++ E Q + HP FD +T ++ L++ PVK + + +P
Sbjct: 52 EHNINVLEG--NEQFVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALPSSC 109
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 110 AP-AGTQCLISGWG 122
Score = 40.0 bits (92), Expect = 0.004, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 26/46 (56%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHC 41
Score = 29.3 bits (64), Expect = 7.6, Method: Composition-based stats.
Identities = 17/59 (28%), Positives = 28/59 (47%), Gaps = 6/59 (10%)
Query: 631 WKMALADG-PLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W L+ G P +LQ + P++ + CE Y I + +C G+ +G DSC+
Sbjct: 121 WGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGK-----ITDNMVCVGFLEGGKDSCQ 174
>pdb|1EZS|C Chain C, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZS|D Chain D, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZU|C Chain C, Ecotin Y69f, D70p Bound To D102n Trypsin
pdb|1EZU|D Chain D, Ecotin Y69f, D70p Bound To D102n Trypsin
Length = 223
Score = 71.6 bits (174), Expect = 1e-12, Method: Composition-based stats.
Identities = 44/134 (32%), Positives = 66/134 (49%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH+++ E Q + HP FD +T ++ L++ PVK + + +P
Sbjct: 52 EHNINVLEG--DEQFVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALPSSC 109
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 110 AP-AGTQCLISGWG 122
Score = 40.0 bits (92), Expect = 0.004, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 26/46 (56%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N+ W V+AAHC
Sbjct: 1 IVGGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHC 41
Score = 29.3 bits (64), Expect = 7.2, Method: Composition-based stats.
Identities = 17/59 (28%), Positives = 28/59 (47%), Gaps = 6/59 (10%)
Query: 631 WKMALADG-PLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W L+ G P +LQ + P++ + CE Y I + +C G+ +G DSC+
Sbjct: 121 WGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGK-----ITDNMVCVGFLEGGKDSCQ 174
>pdb|1AKS|A Chain A, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
pdb|1UHB|A Chain A, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 125
Score = 71.2 bits (173), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL ++ H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCAANSIPYQVSL-----NSGSHFCGGSLINSQWVVSAAHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH++ E Q + +HP F+ T + D+ L++ P + + +P
Sbjct: 52 EHNIDVLEG--NEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR-S 108
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 109 CAAAGTECLISGWG 122
Score = 38.9 bits (89), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 19/46 (41%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL ++ H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCAANSIPYQVSL-----NSGSHFCGGSLINSQWVVSAAHC 41
>pdb|1RJX|B Chain B, Human Plasminogen Catalytic Domain, K698m Mutant
Length = 247
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 48/136 (35%), Positives = 63/136 (46%), Gaps = 13/136 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVP-PSDLLLRL 449
+VGG A WPWQ+SLR +H CG L + W +TAAHC+E P PS + L
Sbjct: 18 VVGGCVAYPHSWPWQVSLRTRFG---MHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVIL 74
Query: 450 GEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPED 509
G H EP+ QE V + P D+ALL+ P +IP C+P
Sbjct: 75 GAHQ-EVNLEPH-VQEIEVSRLFLEPT------RKDIALLKLSSPAVITDKVIPACLPSP 126
Query: 510 DTNFVG-TSAHVTGWG 524
+ T +TGWG
Sbjct: 127 NYVVADRTECFITGWG 142
Score = 46.6 bits (109), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 22/49 (44%), Positives = 28/49 (57%), Gaps = 3/49 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
+VGG A WPWQ+SLR +H CG L + W +TAAHC+E
Sbjct: 18 VVGGCVAYPHSWPWQVSLRTRFG---MHFCGGTLISPEWVLTAAHCLEK 63
>pdb|1O5E|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5F|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1P57|B Chain B, Extracellular Domain Of Human Hepsin
Length = 255
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 49/141 (34%), Positives = 68/141 (48%), Gaps = 13/141 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG + G+WPWQ+SLR H CG +L + +W +TAAHC + R+
Sbjct: 1 IVGGRDTSLGRWPWQVSLRY----DGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWRVF 56
Query: 451 EHDLSTEEEPYGYQERRVQIVASH----PQFDPRTFE--YDLALLRFYEPVKFQPNIIPI 504
++ + P+G Q VQ V H P DP + E D+AL+ P+ I P+
Sbjct: 57 AGAVA-QASPHGLQ-LGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPV 114
Query: 505 CVPEDDTNFV-GTSAHVTGWG 524
C+P V G VTGWG
Sbjct: 115 CLPAAGQALVDGKICTVTGWG 135
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 22/46 (47%), Positives = 29/46 (63%), Gaps = 4/46 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG + G+WPWQ+SLR H CG +L + +W +TAAHC
Sbjct: 1 IVGGRDTSLGRWPWQVSLRY----DGAHLCGGSLLSGDWVLTAAHC 42
Score = 34.7 bits (78), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 18/51 (35%), Positives = 26/51 (50%), Gaps = 3/51 (5%)
Query: 638 GPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
G VLQE VP+I+N +C A + I CAG+ +G D+C+
Sbjct: 141 GQQAGVLQEARVPIISNDVCNG---ADFYGNQIKPKMFCAGYPEGGIDACQ 188
>pdb|1F5R|A Chain A, Rat Trypsinogen Mutant Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 231
Score = 70.9 bits (172), Expect = 2e-12, Method: Composition-based stats.
Identities = 43/132 (32%), Positives = 64/132 (48%), Gaps = 12/132 (9%)
Query: 393 GGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLGEH 452
GG P+Q+SL S Y H CG +L N+ W V+AAHC + S + +RLGEH
Sbjct: 11 GGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHCYK----SRIQVRLGEH 61
Query: 453 DLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDDTN 512
+++ E Q + HP FD +T D+ L++ PVK + + +P
Sbjct: 62 NINVLEG--NEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAP 119
Query: 513 FVGTSAHVTGWG 524
GT ++GWG
Sbjct: 120 -AGTQCLISGWG 130
Score = 37.0 bits (84), Expect = 0.035, Method: Composition-based stats.
Identities = 19/44 (43%), Positives = 24/44 (54%), Gaps = 5/44 (11%)
Query: 565 GGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
GG P+Q+SL S Y H CG +L N+ W V+AAHC
Sbjct: 11 GGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHC 49
>pdb|1FY8|E Chain E, Crystal Structure Of The Deltaile16val17 Rat Anionic
Trypsinogen-Bpti Complex
Length = 231
Score = 70.9 bits (172), Expect = 2e-12, Method: Composition-based stats.
Identities = 43/132 (32%), Positives = 64/132 (48%), Gaps = 12/132 (9%)
Query: 393 GGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLGEH 452
GG P+Q+SL S Y H CG +L N+ W V+AAHC + S + +RLGEH
Sbjct: 11 GGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHCYK----SRIQVRLGEH 61
Query: 453 DLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDDTN 512
+++ E Q + HP FD +T D+ L++ PVK + + +P
Sbjct: 62 NINVLEG--NEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAP 119
Query: 513 FVGTSAHVTGWG 524
GT ++GWG
Sbjct: 120 -AGTQCLISGWG 130
Score = 37.0 bits (84), Expect = 0.036, Method: Composition-based stats.
Identities = 19/44 (43%), Positives = 24/44 (54%), Gaps = 5/44 (11%)
Query: 565 GGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
GG P+Q+SL S Y H CG +L N+ W V+AAHC
Sbjct: 11 GGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHC 49
Score = 29.3 bits (64), Expect = 7.4, Method: Composition-based stats.
Identities = 17/59 (28%), Positives = 28/59 (47%), Gaps = 6/59 (10%)
Query: 631 WKMALADG-PLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W L+ G P +LQ + P++ + CE Y I + +C G+ +G DSC+
Sbjct: 129 WGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGK-----ITDNMVCVGFLEGGKDSCQ 182
>pdb|3TGK|E Chain E, Trypsinogen Mutant D194n And Deletion Of Ile 16-Val 17
Complexed With Bovine Pancreatic Trypsin Inhibitor
(Bpti)
Length = 231
Score = 70.9 bits (172), Expect = 3e-12, Method: Composition-based stats.
Identities = 43/132 (32%), Positives = 64/132 (48%), Gaps = 12/132 (9%)
Query: 393 GGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLGEH 452
GG P+Q+SL S Y H CG +L N+ W V+AAHC + S + +RLGEH
Sbjct: 11 GGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHCYK----SRIQVRLGEH 61
Query: 453 DLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDDTN 512
+++ E Q + HP FD +T D+ L++ PVK + + +P
Sbjct: 62 NINVLEG--NEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAP 119
Query: 513 FVGTSAHVTGWG 524
GT ++GWG
Sbjct: 120 -AGTQCLISGWG 130
Score = 37.0 bits (84), Expect = 0.037, Method: Composition-based stats.
Identities = 19/44 (43%), Positives = 24/44 (54%), Gaps = 5/44 (11%)
Query: 565 GGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
GG P+Q+SL S Y H CG +L N+ W V+AAHC
Sbjct: 11 GGYTCQENSVPYQVSLN----SGY-HFCGGSLINDQWVVSAAHC 49
Score = 29.3 bits (64), Expect = 7.7, Method: Composition-based stats.
Identities = 17/59 (28%), Positives = 28/59 (47%), Gaps = 6/59 (10%)
Query: 631 WKMALADG-PLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W L+ G P +LQ + P++ + CE Y I + +C G+ +G DSC+
Sbjct: 129 WGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGK-----ITDNMVCVGFLEGGKDSCQ 182
>pdb|1UTJ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTK|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTL|M Chain M, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTM|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
Length = 242
Score = 70.5 bits (171), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 45/138 (32%), Positives = 68/138 (49%), Gaps = 16/138 (11%)
Query: 390 RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRL 449
+IVGG + P Q+SL S Y H CG +L NENW V+AAHC + S + +RL
Sbjct: 20 KIVGGYECKPYSQPHQVSLN----SGY-HFCGGSLVNENWVVSAAHCYK----SRVEVRL 70
Query: 450 GEHDLSTEE--EPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP 507
GEH++ E E + R ++ HP + + D+ L++ +P + P+ +P
Sbjct: 71 GEHNIKVTEGSEQFISSSRVIR----HPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALP 126
Query: 508 EDDTNFVGTSAHVTGWGR 525
GT V+GWG
Sbjct: 127 TSCAP-AGTMCTVSGWGN 143
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 24/58 (41%), Positives = 30/58 (51%), Gaps = 5/58 (8%)
Query: 551 FLGNRILFPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
+G +IVGG + P Q+SL S Y H CG +L NENW V+AAHC
Sbjct: 9 LIGAAFATEDDKIVGGYECKPYSQPHQVSLN----SGY-HFCGGSLVNENWVVSAAHC 61
>pdb|1FIZ|A Chain A, Three Dimensional Structure Of Beta-Acrosin From Boar
Spermatozoa
Length = 263
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 8/152 (5%)
Query: 391 IVGGEKATFGKWPWQISLRQWI--RSTYLHKCGAALFNENWAVTAAHCVEDVPP-SDLLL 447
+VGG A G WPW +SL+ ++ + H CG L N +W +TAAHC ++ +D L
Sbjct: 1 VVGGMSAEPGAWPWMVSLQIFMYHNNRRYHTCGGILLNSHWVLTAAHCFKNKKKVTDWRL 60
Query: 448 RLGEHDL---STEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPI 504
G +++ S + QER V+ + H ++ D+AL++ PV P I P
Sbjct: 61 IFGANEVVWGSNKPVKPPLQERFVEEIIIHEKYVSGLEINDIALIKITPPVPCGPFIGPG 120
Query: 505 CVPEDDTN--FVGTSAHVTGWGRLYEGRFRRS 534
C+P+ + VTGWG L E R S
Sbjct: 121 CLPQFKAGPPRAPQTCWVTGWGYLKEKGPRTS 152
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 21/51 (41%), Positives = 31/51 (60%), Gaps = 2/51 (3%)
Query: 563 IVGGEKATFGKWPWQISLRQWI--RSTYLHKCGAALFNENWAVTAAHCVED 611
+VGG A G WPW +SL+ ++ + H CG L N +W +TAAHC ++
Sbjct: 1 VVGGMSAEPGAWPWMVSLQIFMYHNNRRYHTCGGILLNSHWVLTAAHCFKN 51
Score = 29.3 bits (64), Expect = 7.5, Method: Compositional matrix adjust.
Identities = 19/59 (32%), Positives = 27/59 (45%), Gaps = 4/59 (6%)
Query: 631 WKMALADGPLPS-VLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
W GP S LQE V +I+ LC + G I +CAG+ +G D+C+
Sbjct: 141 WGYLKEKGPRTSPTLQEARVALIDLELCNSTRWYNGRIR---STNVCAGYPRGKIDTCQ 196
>pdb|4DGJ|A Chain A, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|B Chain B, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|C Chain C, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|D Chain D, Structure Of A Human Enteropeptidase Light Chain Variant
Length = 235
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 47/143 (32%), Positives = 71/143 (49%), Gaps = 9/143 (6%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV--EDVPPSDLLLR 448
IVGG A G WPW + L R CGA+L + +W V+AAHCV ++ PS
Sbjct: 1 IVGGSDAKEGAWPWVVGLYYDDRLL----CGASLVSSDWLVSAAHCVYGRNLEPSKWTAI 56
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
LG H S P R + + +P ++ R + D+A++ V + I PI +PE
Sbjct: 57 LGLHMKSNLTSPQTV-PRLIDEIVINPHYNRRRKDNDIAMMHLEFKVNYTDYIQPISLPE 115
Query: 509 DDTNF-VGTSAHVTGWGR-LYEG 529
++ F G + + GWG +Y+G
Sbjct: 116 ENQVFPPGRNCSIAGWGTVVYQG 138
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 22/47 (46%), Positives = 27/47 (57%), Gaps = 4/47 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IVGG A G WPW + L R CGA+L + +W V+AAHCV
Sbjct: 1 IVGGSDAKEGAWPWVVGLYYDDRLL----CGASLVSSDWLVSAAHCV 43
>pdb|1DST|A Chain A, Mutant Of Factor D With Enhanced Catalytic Activity
Length = 228
Score = 69.3 bits (168), Expect = 7e-12, Method: Composition-based stats.
Identities = 48/151 (31%), Positives = 72/151 (47%), Gaps = 12/151 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG +A P+ S ++ H CG L E W ++AAHC+ED + + LG
Sbjct: 1 ILGGREAEAHARPYMAS----VQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVAS--HPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
H LS + EP +R ++ + HP + P T ++DL LL+ E P + P+
Sbjct: 57 AHSLS-QPEP---SKRLYDVLRAVPHPDYQPDTIDHDLLLLQLSEKATLGPAVRPLPWQR 112
Query: 509 DDTNFV-GTSAHVTGWGRL-YEGRFRRSYGH 537
D + GT V GWG + + GR S H
Sbjct: 113 VDRDVAPGTLCDVAGWGIVNHAGRRPDSLQH 143
Score = 37.4 bits (85), Expect = 0.025, Method: Composition-based stats.
Identities = 18/49 (36%), Positives = 26/49 (53%), Gaps = 4/49 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GG +A P+ S ++ H CG L E W ++AAHC+ED
Sbjct: 1 ILGGREAEAHARPYMAS----VQLNGAHLCGGVLVAEQWVLSAAHCLED 45
>pdb|1FIW|A Chain A, Three-Dimensional Structure Of Beta-Acrosin From Ram
Spermatozoa
Length = 290
Score = 69.3 bits (168), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 47/152 (30%), Positives = 71/152 (46%), Gaps = 8/152 (5%)
Query: 391 IVGGEKATFGKWPWQISLR--QWIRSTYLHKCGAALFNENWAVTAAHCVE-DVPPSDLLL 447
I+GG+ A G WPW +SL+ + + H CG +L N W +TAAHC +D L
Sbjct: 1 IIGGQDAAHGAWPWMVSLQIFTYHNNRRYHVCGGSLLNSQWLLTAAHCFRIKKKVTDWRL 60
Query: 448 RLGEHDL---STEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPI 504
G ++ + + QER V+ + H ++ + D+AL++ PV I P
Sbjct: 61 IFGAKEVEWGTNKPVKPPLQERYVEKIIIHEKYSASSEANDIALMKITPPVTCGHFIGPG 120
Query: 505 CVPEDDTN--FVGTSAHVTGWGRLYEGRFRRS 534
C+P+ V + V GWG L E R S
Sbjct: 121 CLPQFRAGPPRVPQTCWVAGWGFLQENARRTS 152
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 21/48 (43%), Positives = 29/48 (60%), Gaps = 2/48 (4%)
Query: 563 IVGGEKATFGKWPWQISLR--QWIRSTYLHKCGAALFNENWAVTAAHC 608
I+GG+ A G WPW +SL+ + + H CG +L N W +TAAHC
Sbjct: 1 IIGGQDAAHGAWPWMVSLQIFTYHNNRRYHVCGGSLLNSQWLLTAAHC 48
>pdb|2ZPR|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
pdb|2ZPR|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
Length = 222
Score = 68.9 bits (167), Expect = 9e-12, Method: Composition-based stats.
Identities = 46/136 (33%), Positives = 66/136 (48%), Gaps = 16/136 (11%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG + P Q+SL S Y H CG +L NENW V+AAHC + S + +RLG
Sbjct: 1 IVGGYECKAYSQPHQVSLN----SGY-HFCGGSLVNENWVVSAAHCYK----SRVAVRLG 51
Query: 451 EHDLSTEE--EPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
EH++ E E + R V HP + + D+ L++ +P + P+ +P
Sbjct: 52 EHNIKVTEGSEQFISSSR----VIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPS 107
Query: 509 DDTNFVGTSAHVTGWG 524
GT V+GWG
Sbjct: 108 SCAP-AGTMCTVSGWG 122
Score = 41.6 bits (96), Expect = 0.002, Method: Composition-based stats.
Identities = 23/46 (50%), Positives = 27/46 (58%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG + P Q+SL S Y H CG +L NENW V+AAHC
Sbjct: 1 IVGGYECKAYSQPHQVSLN----SGY-HFCGGSLVNENWVVSAAHC 41
>pdb|1SGF|G Chain G, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|Z Chain Z, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 237
Score = 68.9 bits (167), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 47/153 (30%), Positives = 75/153 (49%), Gaps = 22/153 (14%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG K PW +++ ++ + YL CG L + NW +TAAHC +D + + LG
Sbjct: 1 IVGGFKCEKNSQPWHVAVYRYTQ--YL--CGGVLLDPNWVLTAAHCYDD----NYKVWLG 52
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDP-------RTFEY----DLALLRFYEPVKFQP 499
+++L +E Q R V HP F+ R EY DL LLR +P
Sbjct: 53 KNNLFKDEP--SAQHRFVSKAIPHPGFNMSLMRKHIRFLEYDYSNDLMLLRLSKPADITD 110
Query: 500 NIIPICVPEDDTNFVGTSAHVTGWGRLYEGRFR 532
+ PI +P ++ +G++ +GWG + +F+
Sbjct: 111 TVKPITLPTEEPK-LGSTCLASGWGSITPTKFQ 142
Score = 42.4 bits (98), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 20/49 (40%), Positives = 29/49 (59%), Gaps = 4/49 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
IVGG K PW +++ ++ + YL CG L + NW +TAAHC +D
Sbjct: 1 IVGGFKCEKNSQPWHVAVYRYTQ--YL--CGGVLLDPNWVLTAAHCYDD 45
>pdb|4AN7|A Chain A, Kunitz Type Trypsin Inhibitor Complex With Porcine Trypsin
Length = 231
Score = 68.9 bits (167), Expect = 9e-12, Method: Composition-based stats.
Identities = 42/142 (29%), Positives = 67/142 (47%), Gaps = 15/142 (10%)
Query: 386 FPSS---RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPP 442
FP+ +IVGG P+Q+SL ++ H CG +L N W V+AAHC +
Sbjct: 1 FPTDDDDKIVGGYTCAANSIPYQVSL-----NSGSHFCGGSLINSQWVVSAAHCYK---- 51
Query: 443 SDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNII 502
S + +RLGEH++ E Q + +HP F+ T + D+ L++ P +
Sbjct: 52 SRIQVRLGEHNIDVLEG--NEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVA 109
Query: 503 PICVPEDDTNFVGTSAHVTGWG 524
+ +P GT ++GWG
Sbjct: 110 TVSLPR-SCAAAGTECLISGWG 130
Score = 40.8 bits (94), Expect = 0.002, Method: Composition-based stats.
Identities = 21/54 (38%), Positives = 29/54 (53%), Gaps = 8/54 (14%)
Query: 558 FPSS---RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
FP+ +IVGG P+Q+SL ++ H CG +L N W V+AAHC
Sbjct: 1 FPTDDDDKIVGGYTCAANSIPYQVSL-----NSGSHFCGGSLINSQWVVSAAHC 49
Score = 33.5 bits (75), Expect = 0.41, Method: Composition-based stats.
Identities = 17/48 (35%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
PS+LQ + PV+++S C++ Y I IC G+ +G DSC+
Sbjct: 140 PSLLQCLKAPVLSDSSCKSSYPG-----QITGNMICVGFLEGGKDSCQ 182
>pdb|2ZPQ|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
pdb|2ZPQ|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
Length = 222
Score = 68.2 bits (165), Expect = 1e-11, Method: Composition-based stats.
Identities = 46/136 (33%), Positives = 66/136 (48%), Gaps = 16/136 (11%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG + P Q+SL S Y H CG +L NENW V+AAHC + S + +RLG
Sbjct: 1 IVGGYECKAYSQPHQVSLN----SGY-HFCGGSLVNENWVVSAAHCYK----SRVEVRLG 51
Query: 451 EHDLSTEE--EPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
EH++ E E + R V HP + + D+ L++ +P + P+ +P
Sbjct: 52 EHNIKVTEGSEQFISSSR----VIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPS 107
Query: 509 DDTNFVGTSAHVTGWG 524
GT V+GWG
Sbjct: 108 SCAP-AGTMCTVSGWG 122
Score = 41.6 bits (96), Expect = 0.002, Method: Composition-based stats.
Identities = 23/46 (50%), Positives = 27/46 (58%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG + P Q+SL S Y H CG +L NENW V+AAHC
Sbjct: 1 IVGGYECKAYSQPHQVSLN----SGY-HFCGGSLVNENWVVSAAHC 41
>pdb|1BIT|A Chain A, The Crystal Structure Of Anionic Salmon Trypsin In A
Second Crystal Form
Length = 237
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 44/138 (31%), Positives = 67/138 (48%), Gaps = 16/138 (11%)
Query: 390 RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRL 449
+IVGG + Q+SL S Y H CG +L NENW V+AAHC + S + +RL
Sbjct: 15 KIVGGYECKAYSQAHQVSLN----SGY-HFCGGSLVNENWVVSAAHCYK----SRVEVRL 65
Query: 450 GEHDLSTEE--EPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP 507
GEH++ E E + R ++ HP + + D+ L++ +P + P+ +P
Sbjct: 66 GEHNIKVTEGSEQFISSSRVIR----HPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALP 121
Query: 508 EDDTNFVGTSAHVTGWGR 525
GT V+GWG
Sbjct: 122 TSCAP-AGTMCTVSGWGN 138
Score = 39.3 bits (90), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 23/58 (39%), Positives = 29/58 (50%), Gaps = 5/58 (8%)
Query: 551 FLGNRILFPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
+G +IVGG + Q+SL S Y H CG +L NENW V+AAHC
Sbjct: 4 LIGAAFATEDDKIVGGYECKAYSQAHQVSLN----SGY-HFCGGSLVNENWVVSAAHC 56
>pdb|1ZZZ|A Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
Length = 237
Score = 67.8 bits (164), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 41/136 (30%), Positives = 63/136 (46%), Gaps = 12/136 (8%)
Query: 390 RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRL 449
+IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RL
Sbjct: 14 KIVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRL 64
Query: 450 GEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPED 509
GE +++ E + IV HP ++ T D+ L++ + I +P
Sbjct: 65 GEDNINVVEGNEQFISASKSIV--HPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTS 122
Query: 510 DTNFVGTSAHVTGWGR 525
+ GT ++GWG
Sbjct: 123 CAS-AGTQCLISGWGN 137
Score = 43.5 bits (101), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 25/60 (41%), Positives = 31/60 (51%), Gaps = 8/60 (13%)
Query: 552 LGNRILFP---SSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
LG + FP +IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 LGAAVAFPVDDDDKIVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 55
Score = 32.7 bits (73), Expect = 0.64, Method: Compositional matrix adjust.
Identities = 15/48 (31%), Positives = 26/48 (54%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
P VL+ + P++++S C++ Y I CAG+ +G DSC+
Sbjct: 146 PDVLKCLKAPILSDSSCKSAYPG-----QITSNMFCAGYLEGGKDSCQ 188
>pdb|1F0T|A Chain A, Bovine Trypsin Complexed With Rpr131247
pdb|1F0U|A Chain A, Bovine Trypsin Complexed With Rpr128515
pdb|1EZX|C Chain C, Crystal Structure Of A Serpin:protease Complex
pdb|1LQE|A Chain A, Crystal Structure Of Trypsin In Complex With 79.
pdb|1UTN|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTO|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-ray Structures And Association Constant Measurements
pdb|1UTP|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTQ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|2BY5|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY6|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY7|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY8|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY9|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BYA|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
Length = 243
Score = 67.8 bits (164), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 41/136 (30%), Positives = 63/136 (46%), Gaps = 12/136 (8%)
Query: 390 RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRL 449
+IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RL
Sbjct: 20 KIVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRL 70
Query: 450 GEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPED 509
GE +++ E + IV HP ++ T D+ L++ + I +P
Sbjct: 71 GEDNINVVEGNEQFISASKSIV--HPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTS 128
Query: 510 DTNFVGTSAHVTGWGR 525
+ GT ++GWG
Sbjct: 129 CAS-AGTQCLISGWGN 143
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 25/61 (40%), Positives = 31/61 (50%), Gaps = 8/61 (13%)
Query: 551 FLGNRILFP---SSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAH 607
LG + FP +IVGG P+Q+SL S Y H CG +L N W V+AAH
Sbjct: 6 LLGAAVAFPVDDDDKIVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAH 60
Query: 608 C 608
C
Sbjct: 61 C 61
Score = 32.7 bits (73), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 15/48 (31%), Positives = 26/48 (54%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
P VL+ + P++++S C++ Y I CAG+ +G DSC+
Sbjct: 152 PDVLKCLKAPILSDSSCKSAYPG-----QITSNMFCAGYLEGGKDSCQ 194
>pdb|1HJ8|A Chain A, 1.00 Aa Trypsin From Atlantic Salmon
Length = 222
Score = 67.8 bits (164), Expect = 2e-11, Method: Composition-based stats.
Identities = 46/136 (33%), Positives = 66/136 (48%), Gaps = 16/136 (11%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG + P Q+SL S Y H CG +L NENW V+AAHC + S + +RLG
Sbjct: 1 IVGGYECKAYSQPHQVSLN----SGY-HFCGGSLVNENWVVSAAHCYK----SRVEVRLG 51
Query: 451 EHDLSTEE--EPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
EH++ E E + R V HP + + D+ L++ +P + P+ +P
Sbjct: 52 EHNIKVTEGSEQFISSSR----VIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPT 107
Query: 509 DDTNFVGTSAHVTGWG 524
GT V+GWG
Sbjct: 108 SCAP-AGTMCTVSGWG 122
Score = 41.2 bits (95), Expect = 0.002, Method: Composition-based stats.
Identities = 23/46 (50%), Positives = 27/46 (58%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG + P Q+SL S Y H CG +L NENW V+AAHC
Sbjct: 1 IVGGYECKAYSQPHQVSLN----SGY-HFCGGSLVNENWVVSAAHC 41
>pdb|1OPH|B Chain B, Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And
S195a Trypsin
Length = 243
Score = 67.8 bits (164), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 41/136 (30%), Positives = 63/136 (46%), Gaps = 12/136 (8%)
Query: 390 RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRL 449
+IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RL
Sbjct: 20 KIVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRL 70
Query: 450 GEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPED 509
GE +++ E + IV HP ++ T D+ L++ + I +P
Sbjct: 71 GEDNINVVEGNEQFISASKSIV--HPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTS 128
Query: 510 DTNFVGTSAHVTGWGR 525
+ GT ++GWG
Sbjct: 129 CAS-AGTQCLISGWGN 143
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 25/61 (40%), Positives = 31/61 (50%), Gaps = 8/61 (13%)
Query: 551 FLGNRILFP---SSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAH 607
LG + FP +IVGG P+Q+SL S Y H CG +L N W V+AAH
Sbjct: 6 LLGAAVAFPVDDDDKIVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAH 60
Query: 608 C 608
C
Sbjct: 61 C 61
Score = 33.9 bits (76), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 16/51 (31%), Positives = 27/51 (52%), Gaps = 5/51 (9%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCEEHA 691
P VL+ + P++++S C++ Y I CAG+ +G DSC+ A
Sbjct: 152 PDVLKCLKAPILSDSSCKSAYPG-----QITSNMFCAGYLEGGKDSCQGDA 197
>pdb|2XWA|A Chain A, Crystal Structure Of Complement Factor D Mutant R202a
pdb|2XWA|B Chain B, Crystal Structure Of Complement Factor D Mutant R202a
Length = 228
Score = 67.8 bits (164), Expect = 2e-11, Method: Composition-based stats.
Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG +A P+ S ++ H CG L E W ++AAHC+ED + + LG
Sbjct: 1 ILGGREAEAHARPYMAS----VQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVAS--HPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
H LS + EP +R ++ + HP P T ++DL LL+ E P + P+
Sbjct: 57 AHSLS-QPEP---SKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQR 112
Query: 509 DDTNFV-GTSAHVTGWGRL-YEGRFRRSYGH 537
D + GT V GWG + + GR S H
Sbjct: 113 VDRDVAPGTLCDVAGWGIVNHAGRRPDSLQH 143
Score = 37.7 bits (86), Expect = 0.022, Method: Composition-based stats.
Identities = 18/49 (36%), Positives = 26/49 (53%), Gaps = 4/49 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GG +A P+ S ++ H CG L E W ++AAHC+ED
Sbjct: 1 ILGGREAEAHARPYMAS----VQLNGAHLCGGVLVAEQWVLSAAHCLED 45
>pdb|2XW9|A Chain A, Crystal Structure Of Complement Factor D Mutant S183a
pdb|2XWB|I Chain I, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|J Chain J, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 228
Score = 67.8 bits (164), Expect = 2e-11, Method: Composition-based stats.
Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG +A P+ S ++ H CG L E W ++AAHC+ED + + LG
Sbjct: 1 ILGGREAEAHARPYMAS----VQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVAS--HPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
H LS + EP +R ++ + HP P T ++DL LL+ E P + P+
Sbjct: 57 AHSLS-QPEP---SKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQR 112
Query: 509 DDTNFV-GTSAHVTGWGRL-YEGRFRRSYGH 537
D + GT V GWG + + GR S H
Sbjct: 113 VDRDVAPGTLCDVAGWGIVNHAGRRPDSLQH 143
Score = 37.7 bits (86), Expect = 0.022, Method: Composition-based stats.
Identities = 18/49 (36%), Positives = 26/49 (53%), Gaps = 4/49 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GG +A P+ S ++ H CG L E W ++AAHC+ED
Sbjct: 1 ILGGREAEAHARPYMAS----VQLNGAHLCGGVLVAEQWVLSAAHCLED 45
>pdb|1DSU|A Chain A, Human Factor D, Complement Activating Enzyme
pdb|1DSU|B Chain B, Human Factor D, Complement Activating Enzyme
pdb|1DFP|A Chain A, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DFP|B Chain B, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DIC|A Chain A, Structure Of 3,4-Dichloroisocoumarin-Inhibited Factor D
pdb|1BIO|A Chain A, Human Complement Factor D In Complex With Isatoic
Anhydride Inhibitor
pdb|1HFD|A Chain A, Human Complement Factor D In A P21 Crystal Form
pdb|4D9R|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9R|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 67.4 bits (163), Expect = 2e-11, Method: Composition-based stats.
Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG +A P+ S ++ H CG L E W ++AAHC+ED + + LG
Sbjct: 1 ILGGREAEAHARPYMAS----VQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVAS--HPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
H LS + EP +R ++ + HP P T ++DL LL+ E P + P+
Sbjct: 57 AHSLS-QPEP---SKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQR 112
Query: 509 DDTNFV-GTSAHVTGWGRL-YEGRFRRSYGH 537
D + GT V GWG + + GR S H
Sbjct: 113 VDRDVAPGTLCDVAGWGIVNHAGRRPDSLQH 143
Score = 37.7 bits (86), Expect = 0.022, Method: Composition-based stats.
Identities = 18/49 (36%), Positives = 26/49 (53%), Gaps = 4/49 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GG +A P+ S ++ H CG L E W ++AAHC+ED
Sbjct: 1 ILGGREAEAHARPYMAS----VQLNGAHLCGGVLVAEQWVLSAAHCLED 45
>pdb|2OQ5|A Chain A, Crystal Structure Of Desc1, A New Member Of The Type Ii
Transmembrane Serine Proteinases Family
Length = 232
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 44/147 (29%), Positives = 71/147 (48%), Gaps = 12/147 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVP-PSDLLLRL 449
IVGG + G+WPWQ SL QW S H+CGA L N W V+AAHC P+
Sbjct: 1 IVGGTEVEEGEWPWQASL-QWDGS---HRCGATLINATWLVSAAHCFTTYKNPARWTASF 56
Query: 450 GEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPED 509
G ++ +R ++ + H ++ + +YD++L PV + + +C+P+
Sbjct: 57 GVTIKPSK------MKRGLRRIIVHEKYKHPSHDYDISLAELSSPVPYTNAVHRVCLPDA 110
Query: 510 DTNFV-GTSAHVTGWGRLYEGRFRRSY 535
F G VTG+G L + +++
Sbjct: 111 SYEFQPGDVMFVTGFGALKNDGYSQNH 137
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 26/46 (56%), Positives = 30/46 (65%), Gaps = 4/46 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG + G+WPWQ SL QW S H+CGA L N W V+AAHC
Sbjct: 1 IVGGTEVEEGEWPWQASL-QWDGS---HRCGATLINATWLVSAAHC 42
>pdb|3MYW|A Chain A, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
pdb|3MYW|B Chain B, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
Length = 223
Score = 67.4 bits (163), Expect = 3e-11, Method: Composition-based stats.
Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL ++ H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCAANSVPYQVSL-----NSGSHFCGGSLINSQWVVSAAHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH++ E Q + +HP F+ T + D+ L++ P + + +P
Sbjct: 52 EHNIDVLEG--NEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR-S 108
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 109 CAAAGTECLISGWG 122
Score = 39.3 bits (90), Expect = 0.007, Method: Composition-based stats.
Identities = 19/46 (41%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL ++ H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCAANSVPYQVSL-----NSGSHFCGGSLINSQWVVSAAHC 41
Score = 33.9 bits (76), Expect = 0.36, Method: Composition-based stats.
Identities = 17/48 (35%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
PS+LQ + PV+++S C++ Y I IC G+ +G DSC+
Sbjct: 132 PSLLQCLKAPVLSDSSCKSAYPG-----QITGNMICVGFLEGGKDSCQ 174
>pdb|1MCT|A Chain A, The Refined 1.6 Angstroms Resolution Crystal Structure Of
The Complex Formed Between Porcine Beta-trypsin And
Mcti-a, A Trypsin Inhibitor Of Squash Family
pdb|1QQU|A Chain A, Crystal Structure Of Porcine Beta Trypsin With Bound
Acetate Ion
pdb|1FMG|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.04%
Polydocanol
pdb|1FN6|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.1%
Polydocanol
pdb|1FNI|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01%
Polydocanol
Length = 223
Score = 67.4 bits (163), Expect = 3e-11, Method: Composition-based stats.
Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL ++ H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCAANSIPYQVSL-----NSGSHFCGGSLINSQWVVSAAHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH++ E Q + +HP F+ T + D+ L++ P + + +P
Sbjct: 52 EHNIDVLEG--NEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR-S 108
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 109 CAAAGTECLISGWG 122
Score = 39.3 bits (90), Expect = 0.007, Method: Composition-based stats.
Identities = 19/46 (41%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL ++ H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCAANSIPYQVSL-----NSGSHFCGGSLINSQWVVSAAHC 41
Score = 35.4 bits (80), Expect = 0.11, Method: Composition-based stats.
Identities = 18/48 (37%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
PS+LQ + PV++NS C++ Y I IC G+ +G DSC+
Sbjct: 132 PSLLQCLKAPVLSNSSCKSSYPG-----QITGNMICVGFLQGGKDSCQ 174
>pdb|1TFX|A Chain A, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1TFX|B Chain B, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1LDT|T Chain T, Complex Of Leech-Derived Tryptase Inhibitor With Porcine
Trypsin
pdb|1AVW|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Orthorhombic Crystal Form
pdb|1AVX|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Tetragonal Crystal Form
pdb|1EJA|A Chain A, Structure Of Porcine Trypsin Complexed With Bdellastasin,
An Antistasin-Type Inhibitor
pdb|1S5S|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S6F|A Chain A, Porcine Trypsin Covalent Complex With Borate And
Guanidine- 3 Inhibitor
pdb|1S6H|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S81|A Chain A, Porcine Trypsin With No Inhibitor Bound
pdb|1S82|A Chain A, Porcine Trypsin Complexed With Borate And Ethylene Glycol
pdb|1S83|A Chain A, Porcine Trypsin Complexed With 4-amino Propanol
pdb|1S84|A Chain A, Porcine Trypsin Covalent Complex With 4-Amino Butanol,
Borate And Ethylene Glycol
pdb|1S85|A Chain A, Porcine Trypsin Complexed With P-Hydroxymethyl Benzamidine
And Borate
pdb|1H9I|E Chain E, Complex Of Eeti-Ii Mutant With Porcine Trypsin
pdb|1V6D|A Chain A, The Crystal Structure Of The Trypsin Complex With
Synthetic Heterochiral Peptide
pdb|1TX6|A Chain A, Trypsin:bbi Complex
pdb|1TX6|B Chain B, Trypsin:bbi Complex
pdb|1TX6|C Chain C, Trypsin:bbi Complex
pdb|1TX6|D Chain D, Trypsin:bbi Complex
pdb|1Z7K|A Chain A, Crystal Structure Of Trypsin- Ovomucoid Turkey Egg White
Inhibitor Complex
pdb|1YF4|A Chain A, Crystal Structure Of Trypsin-Vasopressin Complex
Length = 223
Score = 67.4 bits (163), Expect = 3e-11, Method: Composition-based stats.
Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL ++ H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCAANSIPYQVSL-----NSGSHFCGGSLINSQWVVSAAHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH++ E Q + +HP F+ T + D+ L++ P + + +P
Sbjct: 52 EHNIDVLEG--NEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR-S 108
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 109 CAAAGTECLISGWG 122
Score = 39.3 bits (90), Expect = 0.007, Method: Composition-based stats.
Identities = 19/46 (41%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL ++ H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCAANSIPYQVSL-----NSGSHFCGGSLINSQWVVSAAHC 41
Score = 33.5 bits (75), Expect = 0.44, Method: Composition-based stats.
Identities = 17/48 (35%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
PS+LQ + PV+++S C++ Y I IC G+ +G DSC+
Sbjct: 132 PSLLQCLKAPVLSDSSCKSSYPG-----QITGNMICVGFLEGGKDSCQ 174
>pdb|1AN1|E Chain E, Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX
pdb|1C9P|A Chain A, Complex Of Bdellastasin With Porcine Trypsin
Length = 223
Score = 67.0 bits (162), Expect = 3e-11, Method: Composition-based stats.
Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL ++ H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCAANSIPYQVSL-----NSGSHFCGGSLINSQWVVSAAHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH++ E Q + +HP F+ T + D+ L++ P + + +P
Sbjct: 52 EHNIDVLEG--NEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLXSRVATVSLPR-S 108
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 109 CAAAGTECLISGWG 122
Score = 39.3 bits (90), Expect = 0.007, Method: Composition-based stats.
Identities = 19/46 (41%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL ++ H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCAANSIPYQVSL-----NSGSHFCGGSLINSQWVVSAAHC 41
Score = 33.5 bits (75), Expect = 0.42, Method: Composition-based stats.
Identities = 17/48 (35%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
PS+LQ + PV+++S C++ Y I IC G+ +G DSC+
Sbjct: 132 PSLLQCLKAPVLSDSSCKSSYPG-----QITGNMICVGFLEGGKDSCQ 174
>pdb|2ZPS|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 3 From Chum
Salmon
Length = 222
Score = 67.0 bits (162), Expect = 3e-11, Method: Composition-based stats.
Identities = 45/136 (33%), Positives = 66/136 (48%), Gaps = 16/136 (11%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG + P Q+SL S Y H CG +L NENW V+AAHC + + + +RLG
Sbjct: 1 IVGGYECKAYSQPHQVSLN----SGY-HFCGGSLVNENWVVSAAHCYK----TRVEVRLG 51
Query: 451 EHDLSTEE--EPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
EH++ E E + R V HP + + D+ L++ +P + P+ +P
Sbjct: 52 EHNIKVTEGSEQFISSSR----VIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPS 107
Query: 509 DDTNFVGTSAHVTGWG 524
GT V+GWG
Sbjct: 108 SCAP-AGTMCTVSGWG 122
Score = 41.6 bits (96), Expect = 0.002, Method: Composition-based stats.
Identities = 23/46 (50%), Positives = 27/46 (58%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG + P Q+SL S Y H CG +L NENW V+AAHC
Sbjct: 1 IVGGYECKAYSQPHQVSLN----SGY-HFCGGSLVNENWVVSAAHC 41
>pdb|1BZX|E Chain E, The Crystal Structure Of Anionic Salmon Trypsin In Complex
With Bovine Pancreatic Trypsin Inhibitor
pdb|2STA|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (Cucurbita Maxima Trypsin Inhibitor I)
pdb|2STB|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (cucurbita Pepo Trypsin Inhibitor Ii)
Length = 222
Score = 67.0 bits (162), Expect = 3e-11, Method: Composition-based stats.
Identities = 46/136 (33%), Positives = 66/136 (48%), Gaps = 16/136 (11%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG + P Q+SL S Y H CG +L NENW V+AAHC + S + +RLG
Sbjct: 1 IVGGYECKPYSQPHQVSLN----SGY-HFCGGSLVNENWVVSAAHCYK----SRVEVRLG 51
Query: 451 EHDLSTEE--EPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
EH++ E E + R V HP + + D+ L++ +P + P+ +P
Sbjct: 52 EHNIKVTEGSEQFISSSR----VIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPT 107
Query: 509 DDTNFVGTSAHVTGWG 524
GT V+GWG
Sbjct: 108 SCAP-AGTMCTVSGWG 122
Score = 40.8 bits (94), Expect = 0.003, Method: Composition-based stats.
Identities = 23/46 (50%), Positives = 27/46 (58%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG + P Q+SL S Y H CG +L NENW V+AAHC
Sbjct: 1 IVGGYECKPYSQPHQVSLN----SGY-HFCGGSLVNENWVVSAAHC 41
>pdb|1TRN|A Chain A, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
pdb|1TRN|B Chain B, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
Length = 224
Score = 66.6 bits (161), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 43/134 (32%), Positives = 62/134 (46%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L NE W V+A HC + S + +RLG
Sbjct: 1 IVGGYNCEENSVPYQVSLN----SGY-HFCGGSLINEQWVVSAGHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH++ E Q + HPQ+D +T D+ L++ + I +P
Sbjct: 52 EHNIEVLEG--NEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAP 109
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 110 P-ATGTKCLISGWG 122
Score = 38.9 bits (89), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L NE W V+A HC
Sbjct: 1 IVGGYNCEENSVPYQVSLN----SGY-HFCGGSLINEQWVVSAGHC 41
>pdb|1ELV|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Complement C1s Protease
Length = 333
Score = 66.2 bits (160), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 54/174 (31%), Positives = 76/174 (43%), Gaps = 29/174 (16%)
Query: 368 ESQGINMSNYKEVCGRRLFP---SSRIVGGEKATFGKWPWQISLRQ-WIRSTYLHKCGAA 423
E G + VCG P RI+GG A +PWQ+ W G A
Sbjct: 57 EVLGPELPKCVPVCGVPREPFEEKQRIIGGSDADIKNFPWQVFFDNPW--------AGGA 108
Query: 424 LFNENWAVTAAHCVEDVPPSDLLL--------RLGEHDLSTEEEPYGYQERRVQIVASHP 475
L NE W +TAAH VE + + RL + + T E + + ++ V
Sbjct: 109 LINEYWVLTAAHVVEGNREPTMYVGSTSVQTSRLAKSKMLTPEHVFIHPGWKLLAVPEG- 167
Query: 476 QFDPRT-FEYDLALLRFYEPVKFQPNIIPICVP--EDDTNFV-GTSAHVTGWGR 525
RT F+ D+AL+R +PVK P + PIC+P D N + G ++GWGR
Sbjct: 168 ----RTNFDNDIALVRLKDPVKMGPTVSPICLPGTSSDYNLMDGDLGLISGWGR 217
Score = 38.9 bits (89), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 21/50 (42%), Positives = 25/50 (50%), Gaps = 9/50 (18%)
Query: 562 RIVGGEKATFGKWPWQISLRQ-WIRSTYLHKCGAALFNENWAVTAAHCVE 610
RI+GG A +PWQ+ W G AL NE W +TAAH VE
Sbjct: 82 RIIGGSDADIKNFPWQVFFDNPW--------AGGALINEYWVLTAAHVVE 123
>pdb|1PYT|C Chain C, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 253
Score = 65.9 bits (159), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 13/150 (8%)
Query: 387 PSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLL 446
PSSR+V GE A W WQ+SL+ + H CG +L +W VTA HC+ ++
Sbjct: 8 PSSRVVNGEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCISTSRTYQVV 67
Query: 447 LRLGEHDLSTEEEPYGYQERRVQIVAS----HPQFDPRTFE--YDLALLRFYEPVKFQPN 500
LGE+D S + E+ + I A HP ++ D+AL++ +
Sbjct: 68 --LGEYDRSVLQG----SEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDK 121
Query: 501 I-IPICVPEDDTNFVGTSAHVTGWGRLYEG 529
+ + P D +++GWGRLY G
Sbjct: 122 VQLANLPPAGDILPNEAPCYISGWGRLYTG 151
Score = 53.9 bits (128), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 23/52 (44%), Positives = 30/52 (57%)
Query: 559 PSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVE 610
PSSR+V GE A W WQ+SL+ + H CG +L +W VTA HC+
Sbjct: 8 PSSRVVNGEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCIS 59
>pdb|2A31|A Chain A, Trypsin In Complex With Borate
pdb|2A32|A Chain A, Trypsin In Complex With Benzene Boronic Acid
Length = 223
Score = 65.5 bits (158), Expect = 1e-10, Method: Composition-based stats.
Identities = 39/133 (29%), Positives = 62/133 (46%), Gaps = 12/133 (9%)
Query: 392 VGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLGE 451
VGG P+Q+SL ++ H CG +L N W V+AAHC + S + +RLGE
Sbjct: 2 VGGYTCAANSIPYQVSL-----NSGSHFCGGSLINSQWVVSAAHCYK----SRIQVRLGE 52
Query: 452 HDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDDT 511
H++ E Q + +HP F+ T + D+ L++ P + + +P
Sbjct: 53 HNIDVLEG--NEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR-SC 109
Query: 512 NFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 110 AAAGTECLISGWG 122
Score = 37.7 bits (86), Expect = 0.022, Method: Composition-based stats.
Identities = 18/45 (40%), Positives = 24/45 (53%), Gaps = 5/45 (11%)
Query: 564 VGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
VGG P+Q+SL ++ H CG +L N W V+AAHC
Sbjct: 2 VGGYTCAANSIPYQVSL-----NSGSHFCGGSLINSQWVVSAAHC 41
Score = 33.1 bits (74), Expect = 0.47, Method: Composition-based stats.
Identities = 17/48 (35%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
PS+LQ + PV+++S C++ Y I IC G+ +G DSC+
Sbjct: 132 PSLLQCLKAPVLSDSSCKSSYPG-----QITGNMICVGFLEGGKDSCQ 174
>pdb|2RA3|A Chain A, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
pdb|2RA3|B Chain B, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
Length = 224
Score = 65.5 bits (158), Expect = 1e-10, Method: Composition-based stats.
Identities = 43/134 (32%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L NE W V+A HC + S + +RLG
Sbjct: 1 IVGGYNCEENSVPYQVSLN----SGY-HFCGGSLINEQWVVSAGHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH++ E Q + HPQ+D +T D+ L++ ++ I +P
Sbjct: 52 EHNIEVLEG--NEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINAHVSTISLPTAP 109
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 110 PA-TGTKCLISGWG 122
Score = 40.0 bits (92), Expect = 0.004, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L NE W V+A HC
Sbjct: 1 IVGGYNCEENSVPYQVSLN----SGY-HFCGGSLINEQWVVSAGHC 41
>pdb|4D9Q|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9Q|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 65.5 bits (158), Expect = 1e-10, Method: Composition-based stats.
Identities = 44/137 (32%), Positives = 65/137 (47%), Gaps = 11/137 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG +A P+ S ++ H CG L E W ++AAHC+ED + + LG
Sbjct: 1 ILGGREAEAHARPYMAS----VQVNGEHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVAS--HPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
H LS + EP +R ++ + HP P T ++DL LL+ E P + P+
Sbjct: 57 AHSLS-QPEP---SKRLYDVLRAVPHPDSRPDTIDHDLLLLQLSEKATLGPAVRPLPWQR 112
Query: 509 DDTNF-VGTSAHVTGWG 524
D + GT V GWG
Sbjct: 113 VDRDVEPGTLCDVAGWG 129
Score = 37.4 bits (85), Expect = 0.029, Method: Composition-based stats.
Identities = 18/49 (36%), Positives = 26/49 (53%), Gaps = 4/49 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GG +A P+ S ++ H CG L E W ++AAHC+ED
Sbjct: 1 ILGGREAEAHARPYMAS----VQVNGEHLCGGVLVAEQWVLSAAHCLED 45
>pdb|1L2E|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor
pdb|1LO6|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor At 1.56 A Resolution
Length = 223
Score = 65.5 bits (158), Expect = 1e-10, Method: Composition-based stats.
Identities = 41/128 (32%), Positives = 64/128 (50%), Gaps = 11/128 (8%)
Query: 420 CGAALFNENWAVTAAHCVEDVPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDP 479
CG L + W +TAAHC + +L + LG+H+L E ++ V HP +D
Sbjct: 26 CGGVLIHPLWVLTAAHCKK----PNLQVFLGKHNLRQRES--SQEQSSVVRAVIHPDYDA 79
Query: 480 RTFEYDLALLRFYEPVKFQPNIIPICVPEDDTNFVGTSAHVTGWGRLYEGRF----RRSY 535
+ + D+ LLR P K I P+ + E D + TS H+ GWG+ +G F + +Y
Sbjct: 80 ASHDQDIMLLRLARPAKLSELIQPLPL-ERDCSANTTSCHILGWGKTADGDFPDTIQCAY 138
Query: 536 GHPATRQE 543
H +R+E
Sbjct: 139 IHLVSREE 146
Score = 29.3 bits (64), Expect = 8.8, Method: Composition-based stats.
Identities = 19/77 (24%), Positives = 34/77 (44%), Gaps = 8/77 (10%)
Query: 615 QIIPIIQNCRRRESNLWKMA---LADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIP 671
Q +P+ ++C ++ + ADG P +Q + +++ CE Y I
Sbjct: 102 QPLPLERDCSANTTSCHILGWGKTADGDFPDTIQCAYIHLVSREECEHAYPG-----QIT 156
Query: 672 EIFICAGWRKGSFDSCE 688
+ +CAG K DSC+
Sbjct: 157 QNMLCAGDEKYGKDSCQ 173
>pdb|2OLG|A Chain A, Crystal Structure Of The Serine Protease Domain Of
Prophenoloxidase Activating Factor-I In A Zymogen Form
Length = 278
Score = 65.5 bits (158), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 381 CGRRLFPSSRIVGGEKATFGKWPWQISLRQWIRSTYLH-KCGAALFNENWAVTAAHCVED 439
CG ++ + +I+ G+ ++PW + S + CG +L N + VTAAHCV
Sbjct: 14 CGYQV-EADKILNGDDTVPEEFPWTAMIGYKNSSNFEQFACGGSLINNRYIVTAAHCVAG 72
Query: 440 ----VPPSDLLLRLGEHDLSTEEEPYGYQ---------ERRVQIVASHPQF--DPRTFEY 484
V + +RLGE + +T+ + YG + ++ HP + + +
Sbjct: 73 RVLRVVGALNKVRLGEWNTATDPDCYGAVRVCVPDKPIDLGIEETIQHPDYVDGSKDRYH 132
Query: 485 DLALLRFYEPVKFQPNIIPICVPEDDTNF-VGTSAHVTGWGRLYEGRF---RRSYGHPAT 540
D+AL+R V+F I P+C+P+ + VG V GWGR G++ ++ P
Sbjct: 133 DIALIRLNRQVEFTNYIRPVCLPQPNEEVQVGQRLTVVGWGRTETGQYSTIKQKLAVPVV 192
Query: 541 RQEMATCWNHFLGNRILFPSSRI-VGGEKA 569
E C F + SS++ GGEKA
Sbjct: 193 HAEQ--CAKTFGAAGVRVRSSQLCAGGEKA 220
Score = 34.3 bits (77), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 33/71 (46%), Gaps = 1/71 (1%)
Query: 560 SSRIVGGEKATFGKWPWQISLRQWIRSTYLH-KCGAALFNENWAVTAAHCVEDLWSQIIP 618
+ +I+ G+ ++PW + S + CG +L N + VTAAHCV +++
Sbjct: 20 ADKILNGDDTVPEEFPWTAMIGYKNSSNFEQFACGGSLINNRYIVTAAHCVAGRVLRVVG 79
Query: 619 IIQNCRRRESN 629
+ R E N
Sbjct: 80 ALNKVRLGEWN 90
>pdb|1M9U|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|B Chain B, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|C Chain C, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
Length = 241
Score = 65.1 bits (157), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 42/138 (30%), Positives = 74/138 (53%), Gaps = 7/138 (5%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
++GG A+ G++PWQ+S +Q ++ H CGA+L + A++A+HCV+ V P+++ + G
Sbjct: 1 VIGGTNASPGEFPWQLS-QQRQSGSWSHSCGASLLSSTSALSASHCVDGVLPNNIRVIAG 59
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEY--DLALLRFYEPVKFQPNIIPICVPE 508
L + + G Q V H + T Y D+A+L + NI +P
Sbjct: 60 ---LWQQSDTSGTQTANVDSYTMHENYGAGTASYSNDIAILHLATSISLGGNIQAAVLPA 116
Query: 509 DDTN-FVGTSAHVTGWGR 525
++ N + GT+ ++GWGR
Sbjct: 117 NNNNDYAGTTCVISGWGR 134
Score = 35.0 bits (79), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 44/76 (57%), Gaps = 8/76 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWSQIIPIIQN 622
++GG A+ G++PWQ+S +Q ++ H CGA+L + A++A+HCV+ ++ N
Sbjct: 1 VIGGTNASPGEFPWQLS-QQRQSGSWSHSCGASLLSSTSALSASHCVDG-------VLPN 52
Query: 623 CRRRESNLWKMALADG 638
R + LW+ + G
Sbjct: 53 NIRVIAGLWQQSDTSG 68
>pdb|1MBQ|A Chain A, Anionic Trypsin From Pacific Chum Salmon
Length = 220
Score = 65.1 bits (157), Expect = 1e-10, Method: Composition-based stats.
Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 16/136 (11%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG + P Q+SL S Y H CG +L NENW V+AAHC + S + +RLG
Sbjct: 1 IVGGYECKAYSQPHQVSLN----SGY-HFCGGSLVNENWVVSAAHCYK----SRVEVRLG 51
Query: 451 EHDLSTEE--EPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
EH++ E E + R V HP + + D+ L++ + + P+ +P
Sbjct: 52 EHNIKVTEGSEQFISSSR----VIRHPNYSSYNIDNDIMLIKLSKSATLNTYVQPVALPS 107
Query: 509 DDTNFVGTSAHVTGWG 524
GT V+GWG
Sbjct: 108 SCAP-AGTMCTVSGWG 122
Score = 41.6 bits (96), Expect = 0.002, Method: Composition-based stats.
Identities = 23/46 (50%), Positives = 27/46 (58%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG + P Q+SL S Y H CG +L NENW V+AAHC
Sbjct: 1 IVGGYECKAYSQPHQVSLN----SGY-HFCGGSLVNENWVVSAAHC 41
>pdb|2TBS|A Chain A, Cold-Adaption Of Enzymes: Structural Comparison Between
Salmon And Bovine Trypsins
Length = 222
Score = 64.7 bits (156), Expect = 1e-10, Method: Composition-based stats.
Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 16/136 (11%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG + Q+SL S Y H CG +L NENW V+AAHC + S + +RLG
Sbjct: 1 IVGGYECKAYSQAHQVSLN----SGY-HFCGGSLVNENWVVSAAHCYK----SRVEVRLG 51
Query: 451 EHDLSTEE--EPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
EH++ E E + R V HP + + D+ L++ +P + P+ +P
Sbjct: 52 EHNIKVTEGSEQFISSSR----VIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPT 107
Query: 509 DDTNFVGTSAHVTGWG 524
GT V+GWG
Sbjct: 108 SCAP-AGTMCTVSGWG 122
Score = 38.1 bits (87), Expect = 0.015, Method: Composition-based stats.
Identities = 22/46 (47%), Positives = 26/46 (56%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG + Q+SL S Y H CG +L NENW V+AAHC
Sbjct: 1 IVGGYECKAYSQAHQVSLN----SGY-HFCGGSLVNENWVVSAAHC 41
>pdb|3S9A|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Closed-Form)
pdb|3S9B|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V (Open-Form)
pdb|3S9C|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V In Complex
With The Fragment (Residues 1533-1546) Of Human Factor V
pdb|3SBK|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Ppack-Bound Form)
Length = 234
Score = 64.3 bits (155), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/136 (27%), Positives = 66/136 (48%), Gaps = 8/136 (5%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
+VGG++ + P+ ++L ST C AL N W +TAAHC ++ ++LG
Sbjct: 1 VVGGDECNINEHPFLVALYTSASSTI--HCAGALINREWVLTAAHCDR----RNIRIKLG 54
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H + E + R + + +F P + D+ L+R PV + +I P+ +P
Sbjct: 55 MHSKNIRNEDEQIRVPRGKYFCLNTKF-PNGLDKDIMLIRLRRPVTYSTHIAPVSLPS-R 112
Query: 511 TNFVGTSAHVTGWGRL 526
+ VG+ + GWG++
Sbjct: 113 SRGVGSRCRIMGWGKI 128
Score = 36.6 bits (83), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 17/46 (36%), Positives = 25/46 (54%), Gaps = 2/46 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
+VGG++ + P+ ++L ST C AL N W +TAAHC
Sbjct: 1 VVGGDECNINEHPFLVALYTSASSTI--HCAGALINREWVLTAAHC 44
>pdb|4DG4|A Chain A, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|B Chain B, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|D Chain D, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|G Chain G, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
Length = 224
Score = 63.9 bits (154), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 41/134 (30%), Positives = 64/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L +E W V+AAHC + + + +RLG
Sbjct: 1 IVGGYTCEENSLPYQVSLN----SGY-HFCGGSLISEQWVVSAAHCYK----TRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH++ E Q + HP+++ T + D+ L++ P + I +P
Sbjct: 52 EHNIKVLEG--NEQFINAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPTAP 109
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 110 P-AAGTECLISGWG 122
Score = 38.1 bits (87), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 21/46 (45%), Positives = 26/46 (56%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L +E W V+AAHC
Sbjct: 1 IVGGYTCEENSLPYQVSLN----SGY-HFCGGSLISEQWVVSAAHC 41
>pdb|2R9P|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|B Chain B, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|C Chain C, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|D Chain D, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|3L33|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L3T|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3P92|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17G)
pdb|3P95|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17D)
Length = 224
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL ++ H CG +L +E W V+AAHC + + + +RLG
Sbjct: 1 IVGGYTCEENSLPYQVSL-----NSGSHFCGGSLISEQWVVSAAHCYK----TRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH++ E Q + HP+++ T + D+ L++ P + I +P
Sbjct: 52 EHNIKVLEG--NEQFINAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPTAP 109
Query: 511 TNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 110 P-AAGTECLISGWG 122
Score = 37.7 bits (86), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 19/46 (41%), Positives = 26/46 (56%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL ++ H CG +L +E W V+AAHC
Sbjct: 1 IVGGYTCEENSLPYQVSL-----NSGSHFCGGSLISEQWVVSAAHC 41
>pdb|1H4W|A Chain A, Structure Of Human Trypsin Iv (Brain Trypsin)
Length = 224
Score = 63.5 bits (153), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 41/136 (30%), Positives = 69/136 (50%), Gaps = 16/136 (11%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL ++ H CG +L +E W V+AAHC + + + +RLG
Sbjct: 1 IVGGYTCEENSLPYQVSL-----NSGSHFCGGSLISEQWVVSAAHCYK----TRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQE--RRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
EH++ E G ++ V+I+ HP+++ T + D+ L++ P + I +P
Sbjct: 52 EHNIKVLE---GNEQFINAVKII-RHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPT 107
Query: 509 DDTNFVGTSAHVTGWG 524
GT ++GWG
Sbjct: 108 APP-AAGTECLISGWG 122
Score = 37.7 bits (86), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 19/46 (41%), Positives = 26/46 (56%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL ++ H CG +L +E W V+AAHC
Sbjct: 1 IVGGYTCEENSLPYQVSL-----NSGSHFCGGSLISEQWVVSAAHC 41
>pdb|1HYL|A Chain A, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|1HYL|B Chain B, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|2HLC|A Chain A, Hl Collagenase Structure At 1.7a Resolution
pdb|2HLC|B Chain B, Hl Collagenase Structure At 1.7a Resolution
Length = 230
Score = 63.5 bits (153), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 45/138 (32%), Positives = 70/138 (50%), Gaps = 11/138 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+ G +A G +P+Q L ++ CG +L + W +TAAHCV D +++ LG
Sbjct: 1 IINGYEAYTGLFPYQAGLDITLQDQRRVWCGGSLIDNKWILTAAHCVHDA--VSVVVYLG 58
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP--- 507
+ E E ER + SH F+P T+ D+AL++ V++ NI PI +P
Sbjct: 59 SA-VQYEGEAVVNSER----IISHSMFNPDTYLNDVALIKI-PHVEYTDNIQPIRLPSGE 112
Query: 508 EDDTNFVGTSAHVTGWGR 525
E + F A V+GWG+
Sbjct: 113 ELNNKFENIWATVSGWGQ 130
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 19/55 (34%), Positives = 30/55 (54%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWSQII 617
I+ G +A G +P+Q L ++ CG +L + W +TAAHCV D S ++
Sbjct: 1 IINGYEAYTGLFPYQAGLDITLQDQRRVWCGGSLIDNKWILTAAHCVHDAVSVVV 55
>pdb|3PLK|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 63.2 bits (152), Expect = 5e-10, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLLNSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T+ D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.7 bits (91), Expect = 0.006, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLLNSQWVVSAAHC 41
>pdb|1A0J|A Chain A, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|B Chain B, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|C Chain C, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|D Chain D, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species
Length = 223
Score = 63.2 bits (152), Expect = 5e-10, Method: Composition-based stats.
Identities = 41/136 (30%), Positives = 70/136 (51%), Gaps = 12/136 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG + +Q SL+ S Y H CG +L + W V+AAHC + S + +RLG
Sbjct: 1 IVGGYECRKNSASYQASLQ----SGY-HFCGGSLISSTWVVSAAHCYK----SRIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH+++ E + + V+++ HP ++ R + D+ L++ +P + + +P
Sbjct: 52 EHNIAVNEGTEQFID-SVKVIM-HPSYNSRNLDNDIMLIKLSKPASLNSYVSTVALPSSC 109
Query: 511 TNFVGTSAHVTGWGRL 526
+ GT V+GWG L
Sbjct: 110 AS-SGTRCLVSGWGNL 124
Score = 33.1 bits (74), Expect = 0.55, Method: Composition-based stats.
Identities = 19/46 (41%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG + +Q SL+ S Y H CG +L + W V+AAHC
Sbjct: 1 IVGGYECRKNSASYQASLQ----SGY-HFCGGSLISSTWVVSAAHC 41
Score = 29.6 bits (65), Expect = 5.4, Method: Composition-based stats.
Identities = 14/48 (29%), Positives = 25/48 (52%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
P L+ + +P++++S C + Y I CAG+ +G DSC+
Sbjct: 132 PDTLRCLDLPILSSSSCNSAYPG-----QITSNMFCAGFMEGGKDSCQ 174
>pdb|4B1T|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
pdb|4B1T|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
Length = 223
Score = 63.2 bits (152), Expect = 5e-10, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T+ D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.007, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
>pdb|4B2A|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
pdb|4B2A|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
Length = 223
Score = 63.2 bits (152), Expect = 5e-10, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T+ D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.007, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
>pdb|1V2N|T Chain T, Potent Factor Xa Inhibitor In Complex With Bovine Trypsin
Variant X(99175190)BT
Length = 223
Score = 62.8 bits (151), Expect = 6e-10, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T+ D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.007, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
>pdb|4B2C|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
pdb|4B2C|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
Length = 223
Score = 62.8 bits (151), Expect = 6e-10, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T+ D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.007, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
>pdb|3PMJ|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLB|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLP|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PM3|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 62.8 bits (151), Expect = 6e-10, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T+ D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.007, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
>pdb|3UNS|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UOP|A Chain A, Bovine Trypsin Variant X(triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UQO|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 62.8 bits (151), Expect = 6e-10, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T+ D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.008, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
>pdb|3UWI|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|B Chain B, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|C Chain C, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|D Chain D, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|E Chain E, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|F Chain F, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|G Chain G, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|H Chain H, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|I Chain I, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|J Chain J, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|K Chain K, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|L Chain L, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|M Chain M, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|N Chain N, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|O Chain O, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|P Chain P, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V12|A Chain A, Bovine Trypsin Variant X(tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V13|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 62.8 bits (151), Expect = 6e-10, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T+ D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.008, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
>pdb|3UNQ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UPE|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|B Chain B, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 62.8 bits (151), Expect = 6e-10, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T+ D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.008, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
>pdb|1V2K|T Chain T, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin Variant X(Triple.Glu)bt.D2
pdb|1V2L|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.D1
pdb|1V2M|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.A1
Length = 223
Score = 62.8 bits (151), Expect = 6e-10, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T+ D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.008, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
>pdb|4B2B|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
pdb|4B2B|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
Length = 223
Score = 62.8 bits (151), Expect = 6e-10, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T+ D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.008, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
>pdb|3PWB|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PWC|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PYH|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3Q00|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Comlex
With Small Molecule Inhibitor
Length = 223
Score = 62.8 bits (151), Expect = 6e-10, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T+ D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.008, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
>pdb|3UQV|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 62.8 bits (151), Expect = 6e-10, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T+ D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.008, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
>pdb|4F4O|C Chain C, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|F Chain F, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|I Chain I, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|L Chain L, Structure Of The Haptoglobin-Haemoglobin Complex
Length = 347
Score = 62.8 bits (151), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 53/198 (26%), Positives = 81/198 (40%), Gaps = 30/198 (15%)
Query: 371 GINMSNYKEVCGRRLFPSS---RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNE 427
G + + VCG+ P RI+GG G +PWQ + S + GA L NE
Sbjct: 80 GEKLPECEAVCGKPKNPVDQVQRIMGGSLDAKGSFPWQAKMI----SHHNLTSGATLINE 135
Query: 428 NWAVTAAHCVEDVPPSDLLLRLGEH------DLSTEEEPYGYQERRVQIVASHPQFDPRT 481
W +T A LRLG D++ Y +++ V+I F P
Sbjct: 136 QWLLTTAKN----------LRLGHKNDTKAKDIAPTLRLYVGKKQEVEI--EKVIFHPDN 183
Query: 482 FEYDLALLRFYEPVKFQPNIIPICVPEDDTNFVGTSAHVTGWGRLYEGRFRRSYGH---P 538
D+ L++ + V ++PIC+P D VG +V+GWGR F + P
Sbjct: 184 STVDIGLIKLKQKVPVNERVMPICLPSKDYVNVGLVGYVSGWGRNANLNFTEHLKYVMLP 243
Query: 539 ATRQEMATCWNHFLGNRI 556
QE C ++ G+ +
Sbjct: 244 VADQE--KCVQYYEGSTV 259
Score = 31.2 bits (69), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 17/45 (37%), Positives = 22/45 (48%), Gaps = 4/45 (8%)
Query: 562 RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAA 606
RI+GG G +PWQ + S + GA L NE W +T A
Sbjct: 102 RIMGGSLDAKGSFPWQAKM----ISHHNLTSGATLINEQWLLTTA 142
>pdb|1TGS|Z Chain Z, Three-Dimensional Structure Of The Complex Between
Pancreatic Secretory Inhibitor (Kazal Type) And
Trypsinogen At 1.8 Angstroms Resolution. Structure
Solution, Crystallographic Refinement And Preliminary
Structural Interpretation
pdb|2TGP|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2TPI|Z Chain Z, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3TPI|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|4TPI|Z Chain Z, The Refined 2.2-angstroms (0.22-nm) X-ray Crystal
Structure Of The Ternary Complex Formed By Bovine
Trypsinogen, Valine-valine And The Arg15 Analogue Of
Bovine Pancreatic Trypsin Inhibitor
pdb|1BTZ|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTX|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTW|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTP|A Chain A, Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4-
(Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-
N- Allylglycine Methanesulfonate To Bovine Trypsin,
Revealed By The Crystal Structure Of The Complex
pdb|1BTY|A Chain A, Crystal Structure Of Beta-Trypsin In Complex With
Benzamidine
pdb|1TGB|A Chain A, Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms
Resolution. Ii. Crystallographic Refinement, Refined
Crystal Structure And Comparison With Bovine Trypsin
pdb|1TGC|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TGN|A Chain A, Structure Of Bovine Trypsinogen At 1.9 Angstroms
Resolution
pdb|1TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TNG|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNH|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNI|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNJ|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNK|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNL|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|2TGA|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|2TGD|A Chain A, Lack Of The Transition State Stabilization Site Is A
Factor In The Inactivity Of Trypsinogen, A Serine
Protease Zymogen. Structure Of Dfp Inhibited Bovine
Trypsinogen At 2.1 Angstroms Resolution
pdb|2TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
Length = 229
Score = 62.8 bits (151), Expect = 7e-10, Method: Composition-based stats.
Identities = 41/135 (30%), Positives = 63/135 (46%), Gaps = 12/135 (8%)
Query: 390 RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRL 449
+IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RL
Sbjct: 6 KIVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRL 56
Query: 450 GEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPED 509
GE +++ E + IV HP ++ T D+ L++ + I +P
Sbjct: 57 GEDNINVVEGNEQFISASKSIV--HPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTS 114
Query: 510 DTNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 115 CAS-AGTQCLISGWG 128
Score = 40.0 bits (92), Expect = 0.004, Method: Composition-based stats.
Identities = 21/47 (44%), Positives = 26/47 (55%), Gaps = 5/47 (10%)
Query: 562 RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
+IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 6 KIVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 47
Score = 32.3 bits (72), Expect = 0.87, Method: Composition-based stats.
Identities = 15/48 (31%), Positives = 26/48 (54%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
P VL+ + P++++S C++ Y I CAG+ +G DSC+
Sbjct: 138 PDVLKCLKAPILSDSSCKSAYPG-----QITSNMFCAGYLEGGKDSCQ 180
>pdb|3V0X|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 62.8 bits (151), Expect = 7e-10, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T+ D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSETYNNDIMLIKLKSAASLXSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.007, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
>pdb|1Y59|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5A|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5B|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5U|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
Length = 223
Score = 62.8 bits (151), Expect = 7e-10, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T+ D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.008, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
Score = 32.3 bits (72), Expect = 0.95, Method: Composition-based stats.
Identities = 15/48 (31%), Positives = 26/48 (54%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
P VL+ + P++++S C++ Y I CAG+ +G DSC+
Sbjct: 132 PDVLKCLKAPILSDSSCKSAYPG-----QITSNMFCAGYLEGGKDSCQ 174
>pdb|1G3B|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Magnesium(Ii) Chelate
pdb|1G3C|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff Base
Iron(Iii) Chelate
pdb|1G3D|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Copper (Ii) Chelate
pdb|1G3E|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff-Base
Copper (Ii) Chelate
Length = 228
Score = 62.4 bits (150), Expect = 7e-10, Method: Composition-based stats.
Identities = 41/135 (30%), Positives = 63/135 (46%), Gaps = 12/135 (8%)
Query: 390 RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRL 449
+IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RL
Sbjct: 5 KIVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRL 55
Query: 450 GEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPED 509
GE +++ E + IV HP ++ T D+ L++ + I +P
Sbjct: 56 GEDNINVVEGNEQFISASKSIV--HPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTS 113
Query: 510 DTNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 114 CAS-AGTQCLISGWG 127
Score = 40.0 bits (92), Expect = 0.004, Method: Composition-based stats.
Identities = 21/47 (44%), Positives = 26/47 (55%), Gaps = 5/47 (10%)
Query: 562 RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
+IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 5 KIVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 46
Score = 32.3 bits (72), Expect = 0.89, Method: Composition-based stats.
Identities = 15/48 (31%), Positives = 26/48 (54%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
P VL+ + P++++S C++ Y I CAG+ +G DSC+
Sbjct: 137 PDVLKCLKAPILSDSSCKSAYPG-----QITSNMFCAGYLEGGKDSCQ 179
>pdb|1V2U|T Chain T, Benzamidine In Complex With Bovine Trypsin Varinat X(Ssai)
Bt.D1
pdb|1V2V|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssai)
Bt.C1
pdb|1V2W|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssai)bt.B4
Length = 223
Score = 62.0 bits (149), Expect = 1e-09, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 62/134 (46%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.007, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
>pdb|1V2O|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.B4
pdb|1V2P|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.A4
Length = 223
Score = 61.6 bits (148), Expect = 1e-09, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 62/134 (46%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.007, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
>pdb|1V2S|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Ssfi.Glu)bt.D1
pdb|1V2T|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(ssfi.glu)bt.b4
Length = 223
Score = 61.6 bits (148), Expect = 1e-09, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 62/134 (46%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.007, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
>pdb|1V2J|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssri)
Bt.C1
pdb|1V2R|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssri)bt.B4
Length = 223
Score = 61.6 bits (148), Expect = 1e-09, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 62/134 (46%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.007, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
>pdb|2D8W|A Chain A, Structure Of Hyper-Vil-Trypsin
Length = 223
Score = 61.6 bits (148), Expect = 1e-09, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 62/134 (46%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCXK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.008, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
Score = 30.4 bits (67), Expect = 3.1, Method: Composition-based stats.
Identities = 15/48 (31%), Positives = 25/48 (52%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
P VL+ + P++++S C++ Y I CAG +G DSC+
Sbjct: 132 PDVLKCLKAPILSDSSCKSAYPG-----QITSNMFCAGXLEGGKDSCQ 174
>pdb|5PTP|A Chain A, Structure Of Hydrolase (Serine Proteinase)
Length = 223
Score = 61.6 bits (148), Expect = 1e-09, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 62/134 (46%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.008, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
Score = 32.3 bits (72), Expect = 0.91, Method: Composition-based stats.
Identities = 15/48 (31%), Positives = 26/48 (54%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
P VL+ + P++++S C++ Y I CAG+ +G DSC+
Sbjct: 132 PDVLKCLKAPILSDSSCKSAYPG-----QITSNMFCAGYLEGGKDSCQ 174
>pdb|1HJ9|A Chain A, Atomic Resolution Structures Of Trypsin Provide Insight
Into Structural Radiation Damage
Length = 223
Score = 61.6 bits (148), Expect = 1e-09, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 62/134 (46%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.008, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
>pdb|1TAB|E Chain E, Structure Of The Trypsin-Binding Domain Of Bowman-Birk
Type Protease Inhibitor And Its Interaction With Trypsin
pdb|1TPA|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2PTC|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1PPC|E Chain E, Geometry Of Binding Of The Benzamidine-and Arginine-based
Inhibitors
N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-
amidinophenylalanyl- Piperidine (napap) And
(2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4-
Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine
Carboxylic Acid (mqpa) To Human Alpha-thrombin: X-ray
Crystallographic Determination Of The Napap-trypsin
Complex And Modeling Of Napap- Thrombin And
Mqpa-thrombin
pdb|1PPE|E Chain E, The Refined 2.0 Angstroms X-Ray Crystal Structure Of The
Complex Formed Between Bovine Beta-Trypsin And Cmti-I, A
Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima):
Topological Similarity Of The Squash Seed Inhibitors
With The Carboxypeptidase A Inhibitor From Potatoes
pdb|1PPH|E Chain E, Geometry Of Binding Of The Nalpha-Tosylated Piperidides Of
M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To
Thrombin And Trypsin: X- Ray Crystal Structures Of Their
Trypsin Complexes And Modeling Of Their Thrombin
Complexes
pdb|1SMF|E Chain E, Studies On An Artificial Trypsin Inhibitor Peptide Derived
From The Mung Bean Inhibitor
pdb|1JRT|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1JRS|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1CE5|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzamidine
pdb|2BZA|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzylamine
pdb|1QCP|A Chain A, Crystal Structure Of The Rwj-51084 Bovine Pancreatic Beta-
Trypsin At 1.8 A
pdb|1SBW|A Chain A, Crystal Structure Of Mung Bean Inhibitor Lysine Active
Fragment Complex With Bovine Beta-Trypsin At 1.8a
Resolution
pdb|1YYY|1 Chain 1, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1SFI|A Chain A, High Resolution Structure Of A Potent, Cyclic Protease
Inhibitor From Sunflower Seeds
pdb|1TIO|A Chain A, High Packing Density Form Of Bovine Beta-trypsin In
Cyclohexane
pdb|2TIO|A Chain A, Low Packing Density Form Of Bovine Beta-Trypsin In
Cyclohexane
pdb|2BTC|E Chain E, Bovine Trypsin In Complex With Squash Seed Inhibitor
(Cucurbita Pepo Trypsin Inhibitor Ii)
pdb|3BTE|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta-Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTD|E Chain E, The Crystal Structures Of The Complexes Between The Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTF|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTG|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTH|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTK|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTM|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTQ|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTT|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTW|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|1QBN|A Chain A, Bovine Trypsin 2-[amino(Imino)methyl]-2-Hydroxyphenoxy]-6-
[3-(4,5-Dihydro-1h-Imidazol-2-Yl)phenoxy]pyridine-4-
Carboxylic Acid (Zk-806688) Complex
pdb|1QBO|A Chain A, Bovine Trypsin
7-[[6-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
2-Methyl-Benzimidazol-1-Yl]methyl]naphthalene-2-
Carboximidamid Zk-806711 Inhibitor Complex
pdb|1QB9|A Chain A, Bovine Trypsin
7-[[2-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
9h-Carbozol-9-Yl] Methyl]naphthalene-2-Carboximidamide
(Zk- 806450) Complex
pdb|1QB1|A Chain A, Bovine Trypsin With 1-[2-[5-[amino(imino)methyl]-2-
Hydroxyphenoxy]-6-[3-(4,
5-dihydro-1-methyl-1h-imidazol-2-
Yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid
(zk- 806974)
pdb|1QB6|A Chain A, Bovine Trypsin 3,3'-[3,5-Difluoro-4-Methyl-2, 6-
Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) (Zk-
805623) Complex
pdb|1QA0|A Chain A, Bovine Trypsin 2-Aminobenzimidazole Complex
pdb|1F2S|E Chain E, Crystal Structure Of The Complex Formed Between Bovine
Beta- Trypsin And Mcti-A, A Trypsin Inhibitor Of Squash
Family At 1.8 A Resolution
pdb|1D6R|A Chain A, Crystal Structure Of Cancer Chemopreventive Bowman-Birk
Inhibitor In Ternary Complex With Bovine Trypsin At 2.3
A Resolution. Structural Basis Of Janus-Faced Serine
Protease Inhibitor Specificity
pdb|1C9T|A Chain A, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|B Chain B, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|C Chain C, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|D Chain D, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|E Chain E, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|F Chain F, Complex Of Bdellastasin With Bovine Trypsin
pdb|1QL7|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1QL8|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1G9I|E Chain E, Crystal Structure Of Beta-Trysin Complex In Cyclohexane
pdb|1EJM|A Chain A, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|C Chain C, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|E Chain E, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1JIR|A Chain A, Crystal Structure Of Trypsin Complex With Amylamine In
Cyclohexane
pdb|1J8A|A Chain A, Crystal Structure Of Benzamidine Inhibited Bovine
Pancreatic Trypsin At 105k To 1.21a Resolution From
Laboratory Source With High Number Of Waters Modelled
pdb|1G36|A Chain A, Trypsin Inhibitor Complex
pdb|1K1P|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1O|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1N|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1M|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1L|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1J|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1I|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1EB2|A Chain A, Trypsin Inhibitor Complex (Bpo)
pdb|1GJ6|A Chain A, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1N6X|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1N6Y|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1OYQ|A Chain A, Trypsin Inhibitor Complex
pdb|1O2H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O2O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2P|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Q|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2R|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2S|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2T|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2U|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2V|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2W|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2X|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Y|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Z|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O30|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O31|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O32|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O33|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O34|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O35|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O36|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O37|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O38|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O39|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3A|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3B|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3C|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3D|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3E|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3F|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3G|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O3N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1NC6|A Chain A, Potent, Small Molecule Inhibitors Of Human Mast Cell
Tryptase. Anti-Asthmatic Action Of A Dipeptide-Based
Transition State Analogue Containing Benzothiazole
Ketone
pdb|1P2I|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2J|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2K|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OX1|A Chain A, Crystal Structure Of The Bovine Trypsin Complex With A
Synthetic 11 Peptide Inhibitor
pdb|1RXP|A Chain A, Structure Of Trypsin (Orthorhombic) With 1-(4-Tert-
Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino-
Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid
pdb|1S0Q|A Chain A, Native Bovine Pancreatic Trypsin
pdb|1S0R|A Chain A, Bovine Pancreatic Trypsin Inhibited With Benzamidine At
Atomic Resolution
pdb|2A7H|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|1TX7|A Chain A, Bovine Trypsin Complexed With P-
Amidinophenylmethylphosphinic Acid (Ampa)
pdb|2BLV|A Chain A, Trypsin Before A High Dose X-Ray "burn"
pdb|2BLW|A Chain A, Trypsin After A High Dose X-Ray "burn"
pdb|1TX8|A Chain A, Bovine Trypsin Complexed With Amso
pdb|1Y3U|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3V|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3W|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3X|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3Y|A Chain A, Trypsin Inhibitor Complex
pdb|1YP9|A Chain A, Trypsin Inhibitor Complex
pdb|2AYW|A Chain A, Crystal Structure Of The Complex Formed Between Trypsin
And A Designed Synthetic Highly Potent Inhibitor In The
Presence Of Benzamidine At 0.97 A Resolution
pdb|2FI3|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser,
Cys38->ser) In Complex With Trypsin
pdb|2FX4|A Chain A, Bovine Trypsin Bound By 4-piperidinebutyrate To Make
Acylenzyme Complex
pdb|2FX6|A Chain A, Bovine Trypsin Complexed With 2-Aminobenzamidazole
pdb|2AGE|X Chain X, Succinyl-Aapr-Trypsin Acyl-Enzyme At 1.15 A Resolution
pdb|2AGG|X Chain X, Succinyl-Aapk-Trypsin Acyl-Enzyme At 1.28 A Resolution
pdb|2AGI|X Chain X, The Leupeptin-Trypsin Covalent Complex At 1.14 A
Resolution
pdb|2AH4|X Chain X, Guanidinobenzoyl-Trypsin Acyl-Enzyme At 1.13 A Resolution
pdb|2G5N|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G5V|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G8T|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2F3C|E Chain E, Crystal Structure Of Infestin 1, A Kazal-Type
Serineprotease Inhibitor, In Complex With Trypsin
pdb|2G81|E Chain E, Crystal Structure Of The Bowman-Birk Inhibitor From Vigna
Unguiculata Seeds In Complex With Beta-Trypsin At 1.55
Angstrons Resolution
pdb|2G55|A Chain A, Anomalous Substructure Of Trypsin (P3121)
pdb|2OTV|A Chain A, Crystal Structure Of The Complex Formed Between Bovine
Trypsin And Nicotinamide At 1.56 A Resolution
pdb|2J9N|A Chain A, Robotically Harvested Trypsin Complexed With Benzamidine
Containing Polypeptide Mediated Crystal Contacts
pdb|2OXS|A Chain A, Crytal Structure Of The Trypsin Complex With Benzamidine
At High Temperature (35 C)
pdb|2UUY|A Chain A, Structure Of A Tick Tryptase Inhibitor In Complex With
Bovine Trypsin
pdb|2ILN|A Chain A, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2ILN|B Chain B, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2CMY|A Chain A, Crystal Complex Between Bovine Trypsin And Veronica
Hederifolia Trypsin Inhibitor
pdb|1AQ7|A Chain A, Trypsin With Inhibitor Aeruginosin 98-b
pdb|1AUJ|A Chain A, Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor
pdb|1AZ8|A Chain A, Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor
pdb|1BJU|A Chain A, Beta-Trypsin Complexed With Acpu
pdb|1BJV|A Chain A, Beta-Trypsin Complexed With Appu
pdb|1GBT|A Chain A, Structure Of An Acyl-Enzyme Intermediate During Catalysis:
(Guanidinobenzoyl) Trypsin
pdb|1MAX|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MAY|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MTS|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTU|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTV|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTW|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1TLD|A Chain A, Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms
Resolution In A Crystal Form With Low Molecular Packing
Density. Active Site Geometry, Ion Pairs And Solvent
Structure
pdb|1TPO|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPP|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPS|A Chain A, Atomic Structure Of The Trypsin-A90720a Complex: A Unified
Approach To Structure And Function
pdb|1TYN|A Chain A, Atomic Structure Of The Trypsin-cyclotheonamide A Complex:
Lessons For The Design Of Serine Protease Inhibitors
pdb|1XUF|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUG|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUH|A Chain A, Trypsin-Keto-Babim-Co+2, Ph 8.2
pdb|1XUI|A Chain A, Trypsin-Keto-Babim, Zn+2-Free, Ph 8.2
pdb|1XUJ|A Chain A, Trypsin-Keto-Babim-Zn+2, Ph 8.2
pdb|1XUK|A Chain A, Trypsin-Babim-Sulfate, Ph 5.9
pdb|2PLX|A Chain A, Trypsin Complexed To A Synthetic Peptide From Veronica
Hederifolia
pdb|2PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3PTB|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|3PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1C1N|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1O|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1P|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1Q|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1R|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1T|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2D|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2E|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2F|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2G|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2H|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2I|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2J|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2K|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2L|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2M|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5P|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Q|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5R|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5S|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5T|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5U|A Chain A, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5V|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GHZ|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI0|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI1|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI2|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI3|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI4|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI5|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI6|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2O9Q|A Chain A, The Crystal Structure Of Bovine Trypsin Complexed With A
Small Inhibition Peptide Orb2k
pdb|2QN5|T Chain T, Crystal Structure And Functional Study Of The Bowman-Birk
Inhibitor From Rice Bran In Complex With Bovine Trypsin
pdb|2QYI|A Chain A, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2QYI|C Chain C, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2ZDK|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDL|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDM|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDN|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFS|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFT|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZHD|A Chain A, Exploring Trypsin S3 Pocket
pdb|3D65|E Chain E, Crystal Structure Of Textilinin-1, A Kunitz-Type Serine
Protease Inhibitor From The Australian Common Brown
Snake Venom, In Complex With Trypsin
pdb|3E8L|A Chain A, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|3E8L|B Chain B, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|2ZQ1|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZQ2|A Chain A, Exploring Trypsin S3 Pocket
pdb|3ITI|A Chain A, Structure Of Bovine Trypsin With The Mad Triangle B3c
pdb|3GY2|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY3|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY4|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY5|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY6|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Bis-Benzamidines Diminazene And Pentamidine
pdb|3GY7|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY8|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3AAS|A Chain A, Bovine Beta-Trypsin Bound To Meta-Guanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAU|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diguanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|B Chain B, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3M35|A Chain A, Trypsin In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3MFJ|A Chain A, Bovine Trypsin At 0.8 A Resolution, Restrained Refinement
pdb|3MI4|A Chain A, Bovine Trypsin At 0.8 A Resolution, Non-Restrained
Refinemen
pdb|3I29|A Chain A, Crystal Structure Of A Binary Complex Between An Mutant
Tryp Inhibitor With Bovine Trypsin
pdb|3A7T|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide
pdb|3A7V|A Chain A, Crystal Structure Of Trypsin Complexed With
3-Formylbenzimidamide
pdb|3A7W|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((Tetrahydro-2h-
Pyran-2-Yloxyimino)methyl)benzimidamide (Soaking 4hours)
pdb|3A7X|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
45seconds)
pdb|3A7Y|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
3-Yloxyimino)methyl)benzimidamide (Soaking 2hours)
pdb|3A7Z|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
4-Yloxyimino)methyl)benzimidamide (Soaking 3hours)
pdb|3A80|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic Acid
(Soaking 40seconds)
pdb|3A81|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 8
Hours)
pdb|3A82|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid
pdb|3A83|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide
pdb|3A84|A Chain A, Crystal Structure Of Trypsin Complexed With(E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 5
Seconds)
pdb|3A85|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 15
Seconds)
pdb|3A86|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 30
Seconds)
pdb|3A87|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 5
Minutes)
pdb|3A88|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 30
Minutes)
pdb|3A89|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 4
Hours)
pdb|3A8A|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide And Aniline
pdb|3A8B|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((4-
Bromophenylimino)methyl)benzimidamide
pdb|3A8C|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
With Mixture Of
[(E)-2-(4-Carbamimidoylbenzylideneaminooxy)acetic Acid]
And [(E)-2-
(4-Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic
Acid])
pdb|3A8D|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Under
Aniline-Free Condition)
pdb|3LJJ|A Chain A, Bovine Trypsin In Complex With Ub-Thr 10
pdb|3LJO|A Chain A, Bovine Trypsin In Complex With Ub-Thr 11
pdb|2XTT|B Chain B, Bovine Trypsin In Complex With Evolutionary Enhanced
Schistocerca Gregaria Protease Inhibitor 1 (Sgpi-1-P02)
pdb|3NK8|A Chain A, Trypsin In Complex With Fluorine-Containing Fragment
pdb|3NKK|A Chain A, Trypsin In Complex With Fluorine Containing Fragment
pdb|3M7Q|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Pancreatic Trypsin
pdb|3RDZ|A Chain A, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3RDZ|B Chain B, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3ATI|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3ATK|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3ATL|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamidine
pdb|3ATM|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXA|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3RXB|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobutanoic Acid
pdb|3RXC|A Chain A, Crystal Structure Of Trypsin Complexed With
2-Aminopyridine
pdb|3RXD|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3RXE|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide
pdb|3RXF|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminopyridine
pdb|3RXG|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminocyclohexanol
pdb|3RXH|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Imidazol-4-Yl) Ethanamine
pdb|3RXI|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXJ|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobenzoic Acid
pdb|3RXK|A Chain A, Crystal Structure Of Trypsin Complexed With Methyl
4-Amino-1-Methyl- Pyrrolidine-2-Carboxylate
pdb|3RXL|A Chain A, Crystal Structure Of Trypsin Complexed With
(2,5-Dimethyl-3-Furyl) Methanamine
pdb|3RXM|A Chain A, Crystal Structure Of Trypsin Complexed With
[2-(2-Thienyl)thiazol-4- Yl]methanamine
pdb|3RXO|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Pyrrol-1-Ylphenyl) Methanamine
pdb|3RXP|A Chain A, Crystal Structure Of Trypsin Complexed With
(1,5-Dimethylpyrazol-3- Yl)methanamine
pdb|3RXQ|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F01
And F05, Cocktail Experiment)
pdb|3RXR|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine (F01 And F03, Cocktail Experiment)
pdb|3RXS|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine (F04 And A06, Cocktail
Experiment)
pdb|3RXT|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamin (F04 And F03, Cocktail
Experiment)
pdb|3RXU|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And A06, Cocktail Experiment)
pdb|3RXV|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And F03, Cocktail Experiment)
pdb|3T25|A Chain A, Tmao-Grown Orthorhombic Trypsin (Bovine)
pdb|3T26|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Sarcosine
pdb|3T27|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Betaine
pdb|3T28|A Chain A, Tmao-Grown Trypsin (Bovine)-Previously Unreported
Tetragonal Crystal Form
pdb|3T29|A Chain A, Tmao-Grown Trigonal Trypsin (Bovine)
pdb|4AB8|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4AB9|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABA|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABB|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABD|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABE|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABF|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABG|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABH|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABI|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Pta)sfti-1(1,14), That Was 1,4-
Disubstituted With A 1,2,3-Trizol To Mimic A Trans Amide
Bond
pdb|4ABJ|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Ica)sfti-1(1,14), That Was 1,5-
Disubstituted With 1,2,3-Trizol To Mimic A Cis Amide
Bond
pdb|3VPK|A Chain A, Crystal Structure Of 6-guanidinohexanoyl Trypsin
pdb|3UNR|A Chain A, Bond Length Analysis Of Asp, Glu And His Residues In
Trypsin At 1.2a Resolution
pdb|3RU4|T Chain T, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
pdb|1C1S|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|4I8G|A Chain A, Bovine Trypsin At 0.8 Resolution
pdb|4I8H|A Chain A, Bovine Trypsin At 0.75 Resolution
pdb|4I8J|A Chain A, Bovine Trypsin At 0.87 A Resolution
pdb|4I8K|A Chain A, Bovine Trypsin At 0.85 Resolution
pdb|4I8L|A Chain A, Bovine Trypsin At 0.87 Resolution
pdb|4AOQ|A Chain A, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|B Chain B, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|C Chain C, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOR|A Chain A, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|B Chain B, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|C Chain C, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
Length = 223
Score = 61.6 bits (148), Expect = 1e-09, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 62/134 (46%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.008, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
Score = 32.3 bits (72), Expect = 0.91, Method: Composition-based stats.
Identities = 15/48 (31%), Positives = 26/48 (54%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
P VL+ + P++++S C++ Y I CAG+ +G DSC+
Sbjct: 132 PDVLKCLKAPILSDSSCKSAYPG-----QITSNMFCAGYLEGGKDSCQ 174
>pdb|1V2Q|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Sswi)bt.B4
Length = 223
Score = 61.6 bits (148), Expect = 1e-09, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 62/134 (46%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.008, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
>pdb|1TAW|A Chain A, Bovine Trypsin Complexed To Appi
pdb|1ZR0|A Chain A, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
pdb|1ZR0|C Chain C, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
Length = 223
Score = 61.6 bits (148), Expect = 1e-09, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 62/134 (46%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.008, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
Score = 32.0 bits (71), Expect = 1.3, Method: Composition-based stats.
Identities = 15/48 (31%), Positives = 25/48 (52%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
P VL+ + P+++ S C++ Y I CAG+ +G DSC+
Sbjct: 132 PDVLKCLKAPILSTSSCKSAYPG-----QITSNMFCAGYLEGGKDSCQ 174
>pdb|2TLD|E Chain E, Crystal Structure Of An Engineered Subtilisin Inhibitor
Complexed With Bovine Trypsin
Length = 220
Score = 61.6 bits (148), Expect = 1e-09, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 62/134 (46%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.008, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
>pdb|2FI4|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser) In
Complex With Trypsin
pdb|2FTL|E Chain E, Crystal Structure Of Trypsin Complexed With Bpti At 100k
Length = 223
Score = 61.2 bits (147), Expect = 2e-09, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 62/134 (46%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSNTLNNDIMLIKLKSAASLXSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.008, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
Score = 32.3 bits (72), Expect = 0.91, Method: Composition-based stats.
Identities = 15/48 (31%), Positives = 26/48 (54%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
P VL+ + P++++S C++ Y I CAG+ +G DSC+
Sbjct: 132 PDVLKCLKAPILSDSSCKSAYPG-----QITSNMFCAGYLEGGKDSCQ 174
>pdb|1AZZ|A Chain A, Fiddler Crab Collagenase Complexed To Ecotin
pdb|1AZZ|B Chain B, Fiddler Crab Collagenase Complexed To Ecotin
Length = 226
Score = 61.2 bits (147), Expect = 2e-09, Method: Composition-based stats.
Identities = 43/138 (31%), Positives = 66/138 (47%), Gaps = 17/138 (12%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG +A WP Q +L +I Y CG +L + W +TAAHC++ D++ LG
Sbjct: 1 IVGGVEAVPNSWPHQAAL--FIDDMYF--CGGSLISPEWILTAAHCMDGAGFVDVV--LG 54
Query: 451 EHDLSTEEEPYGYQERRVQIVAS----HPQFDPRTFEYDLALLRFYEPVKFQPNIIPICV 506
H++ +E +V I ++ H ++ D+A++R PV I + +
Sbjct: 55 AHNIREDEAT------QVTIQSTDFTVHENYNSFVISNDIAVIRLPVPVTLTAAIATVGL 108
Query: 507 PEDDTNFVGTSAHVTGWG 524
P D VGT TGWG
Sbjct: 109 PSTDVG-VGTVVTPTGWG 125
Score = 40.4 bits (93), Expect = 0.004, Method: Composition-based stats.
Identities = 20/48 (41%), Positives = 28/48 (58%), Gaps = 4/48 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVE 610
IVGG +A WP Q +L +I Y CG +L + W +TAAHC++
Sbjct: 1 IVGGVEAVPNSWPHQAAL--FIDDMYF--CGGSLISPEWILTAAHCMD 44
>pdb|3VEQ|B Chain B, A Binary Complex Betwwen Bovine Pancreatic Trypsin And A
Engineered Mutant Trypsin Inhibitor
Length = 223
Score = 60.8 bits (146), Expect = 2e-09, Method: Composition-based stats.
Identities = 40/134 (29%), Positives = 62/134 (46%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ T D+ L++ + + +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSNTLNNDIMLIKLKSAASLNSRVASVSLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.3 bits (90), Expect = 0.008, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
Score = 32.3 bits (72), Expect = 0.93, Method: Composition-based stats.
Identities = 15/48 (31%), Positives = 26/48 (54%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
P VL+ + P++++S C++ Y I CAG+ +G DSC+
Sbjct: 132 PDVLKCLKAPILSDSSCKSAYPG-----QITSNMFCAGYLEGGKDSCQ 174
>pdb|1YBW|A Chain A, Protease Domain Of Hgfa With No Inhibitor
pdb|1YBW|B Chain B, Protease Domain Of Hgfa With No Inhibitor
pdb|1YC0|A Chain A, Short Form Hgfa With First Kunitz Domain From Hai-1
pdb|2R0K|A Chain A, Protease Domain Of Hgfa With Inhibitor Fab58
Length = 283
Score = 60.8 bits (146), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 18/162 (11%)
Query: 378 KEVCGRR----LFPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTA 433
++ CGRR F RI+GG + G PW ++ +I ++ C +L + W V+A
Sbjct: 19 RQACGRRHKKRTFLRPRIIGGSSSLPGSHPWLAAI--YIGDSF---CAGSLVHTCWVVSA 73
Query: 434 AHCVEDVPPSD-LLLRLGEHDLS-TEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRF 491
AHC PP D + + LG+H + T + + + + F+P ++DL L+R
Sbjct: 74 AHCFSHSPPRDSVSVVLGQHFFNRTTDVTQTFGIEKYIPYTLYSVFNPS--DHDLVLIRL 131
Query: 492 YEP----VKFQPNIIPICVPEDDTNF-VGTSAHVTGWGRLYE 528
+ + PIC+PE + F G + GWG L E
Sbjct: 132 KKKGDRCATRSQFVQPICLPEPGSTFPAGHKCQIAGWGHLDE 173
Score = 33.9 bits (76), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 17/51 (33%), Positives = 27/51 (52%), Gaps = 5/51 (9%)
Query: 558 FPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
F RI+GG + G PW ++ +I ++ C +L + W V+AAHC
Sbjct: 31 FLRPRIIGGSSSLPGSHPWLAAI--YIGDSF---CAGSLVHTCWVVSAAHC 76
>pdb|4D8N|A Chain A, Human Kallikrein 6 Inhibitors With A
Para-Amidobenzylanmine P1 Group Carry A High Binding
Efficiency
pdb|3VFE|A Chain A, Virtual Screening And X-Ray Crystallography For Human
Kallikrein 6 Inhibitors With An Amidinothiophene P1
Group
Length = 223
Score = 60.5 bits (145), Expect = 3e-09, Method: Composition-based stats.
Identities = 40/128 (31%), Positives = 64/128 (50%), Gaps = 11/128 (8%)
Query: 420 CGAALFNENWAVTAAHCVEDVPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDP 479
CG L + W +TAAHC + +L + LG+H+L +E ++ HP +D
Sbjct: 26 CGGVLIHPLWVLTAAHCKK----PNLQVFLGKHNLGQQESSQEQSSVVRAVI--HPDYDA 79
Query: 480 RTFEYDLALLRFYEPVKFQPNIIPICVPEDDTNFVGTSAHVTGWGRLYEGRF----RRSY 535
+ + D+ LLR P K I P+ + E D + TS H+ GWG+ +G F + +Y
Sbjct: 80 ASHDQDIMLLRLARPAKLSELIQPLPL-ERDCSAQTTSCHILGWGKTADGDFPDTIQCAY 138
Query: 536 GHPATRQE 543
H +R+E
Sbjct: 139 IHLVSREE 146
Score = 29.6 bits (65), Expect = 5.2, Method: Composition-based stats.
Identities = 19/77 (24%), Positives = 35/77 (45%), Gaps = 8/77 (10%)
Query: 615 QIIPIIQNCRRRESNLWKMA---LADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIP 671
Q +P+ ++C + ++ + ADG P +Q + +++ CE Y I
Sbjct: 102 QPLPLERDCSAQTTSCHILGWGKTADGDFPDTIQCAYIHLVSREECEHAYPG-----QIT 156
Query: 672 EIFICAGWRKGSFDSCE 688
+ +CAG K DSC+
Sbjct: 157 QNMLCAGDEKYGKDSCQ 173
>pdb|1GVL|A Chain A, Human Prokallikrein 6 (Hk6) PROZYME PROPROTEASE M
Proneurosin
Length = 223
Score = 60.1 bits (144), Expect = 4e-09, Method: Composition-based stats.
Identities = 40/128 (31%), Positives = 64/128 (50%), Gaps = 11/128 (8%)
Query: 420 CGAALFNENWAVTAAHCVEDVPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDP 479
CG L + W +TAAHC + +L + LG+H+L +E ++ HP +D
Sbjct: 27 CGGVLIHPLWVLTAAHCKK----PNLQVFLGKHNLRQQESSQEQSSVVRAVI--HPDYDA 80
Query: 480 RTFEYDLALLRFYEPVKFQPNIIPICVPEDDTNFVGTSAHVTGWGRLYEGRF----RRSY 535
+ + D+ LLR P K I P+ + E D + TS H+ GWG+ +G F + +Y
Sbjct: 81 ASHDQDIMLLRLARPAKLSELIQPLPL-ERDCSAQTTSCHILGWGKTADGDFPDTIQCAY 139
Query: 536 GHPATRQE 543
H +R+E
Sbjct: 140 IHLVSREE 147
Score = 29.6 bits (65), Expect = 5.2, Method: Composition-based stats.
Identities = 19/77 (24%), Positives = 35/77 (45%), Gaps = 8/77 (10%)
Query: 615 QIIPIIQNCRRRESNLWKMA---LADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIP 671
Q +P+ ++C + ++ + ADG P +Q + +++ CE Y I
Sbjct: 103 QPLPLERDCSAQTTSCHILGWGKTADGDFPDTIQCAYIHLVSREECEHAYPG-----QIT 157
Query: 672 EIFICAGWRKGSFDSCE 688
+ +CAG K DSC+
Sbjct: 158 QNMLCAGDEKYGKDSCQ 174
>pdb|3QK1|A Chain A, Crystal Structure Of Enterokinase-Like Trypsin Variant
Length = 229
Score = 60.1 bits (144), Expect = 4e-09, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 62/134 (46%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
E +++ E + IV HP ++ R D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNKRRKNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 511 TNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 AS-AGTQCLISGWG 122
Score = 39.7 bits (91), Expect = 0.005, Method: Composition-based stats.
Identities = 44/184 (23%), Positives = 69/184 (37%), Gaps = 68/184 (36%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED-----LWSQII 617
IVGG P+Q+SL S Y H CG +L N W V+AAHC + L I
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNI 55
Query: 618 PIIQ-----------------NCRRRESNLWKMAL----------ADGPLPS-------- 642
+++ N RR+ +++ + L A LP+
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNKRRKNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQ 115
Query: 643 ------------------VLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSF 684
VL+ + P++++S C++ Y I CAG+ +G
Sbjct: 116 CLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG-----QITSNMFCAGYLEGGK 170
Query: 685 DSCE 688
DSC+
Sbjct: 171 DSCQ 174
>pdb|1NTP|A Chain A, Use Of The Neutron Diffraction HD EXCHANGE TECHNIQUE TO
Determine The Conformational Dynamics Of Trypsin
Length = 223
Score = 60.1 bits (144), Expect = 4e-09, Method: Composition-based stats.
Identities = 40/133 (30%), Positives = 61/133 (45%), Gaps = 12/133 (9%)
Query: 392 VGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLGE 451
VGG P+Q+SL S Y H CG +L + W V+AAHC + S + +RLGE
Sbjct: 2 VGGYTCGANTVPYQVSLN----SGY-HFCGGSLIDSQWVVSAAHCYK----SGIQVRLGE 52
Query: 452 HDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDDT 511
+++ E + IV HP +D T D+ L++ + I +P
Sbjct: 53 DNINVVEGNEQFISASKSIV--HPSYDSNTLNNDIMLIKLKSAASLDSRVASISLPTSCA 110
Query: 512 NFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 111 S-AGTQCLISGWG 122
Score = 35.8 bits (81), Expect = 0.079, Method: Composition-based stats.
Identities = 19/45 (42%), Positives = 24/45 (53%), Gaps = 5/45 (11%)
Query: 564 VGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
VGG P+Q+SL S Y H CG +L + W V+AAHC
Sbjct: 2 VGGYTCGANTVPYQVSLN----SGY-HFCGGSLIDSQWVVSAAHC 41
Score = 32.3 bits (72), Expect = 0.88, Method: Composition-based stats.
Identities = 15/48 (31%), Positives = 26/48 (54%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
P VL+ + P++++S C++ Y I CAG+ +G DSC+
Sbjct: 132 PDVLKCLKAPILSDSSCKSAYPG-----QITSNMFCAGYLEGGKDSCQ 174
>pdb|3OTJ|E Chain E, A Crystal Structure Of Trypsin Complexed With Bpti (Bovine
Pancreatic Trypsin Inhibitor) By X-RayNEUTRON JOINT
REFINEMENT
Length = 223
Score = 60.1 bits (144), Expect = 4e-09, Method: Composition-based stats.
Identities = 40/133 (30%), Positives = 61/133 (45%), Gaps = 12/133 (9%)
Query: 392 VGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLGE 451
VGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLGE
Sbjct: 2 VGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLGE 52
Query: 452 HDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDDT 511
+++ E + IV HP ++ T D+ L++ + I +P
Sbjct: 53 DNINVVEGNEQFISASKSIV--HPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA 110
Query: 512 NFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 111 S-AGTQCLISGWG 122
Score = 37.7 bits (86), Expect = 0.024, Method: Composition-based stats.
Identities = 20/45 (44%), Positives = 24/45 (53%), Gaps = 5/45 (11%)
Query: 564 VGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
VGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 2 VGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
Score = 32.3 bits (72), Expect = 0.91, Method: Composition-based stats.
Identities = 15/48 (31%), Positives = 26/48 (54%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
P VL+ + P++++S C++ Y I CAG+ +G DSC+
Sbjct: 132 PDVLKCLKAPILSDSSCKSAYPG-----QITSNMFCAGYLEGGKDSCQ 174
>pdb|2VNT|A Chain A, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|B Chain B, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|C Chain C, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|D Chain D, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|E Chain E, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|F Chain F, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
Length = 276
Score = 59.7 bits (143), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 49/156 (31%), Positives = 79/156 (50%), Gaps = 14/156 (8%)
Query: 381 CGRR-LFPSSRIVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVE 438
CG++ L P +I+GGE T PW ++ R+ + + CG +L + W ++A HC
Sbjct: 13 CGQKTLRPRFKIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFI 72
Query: 439 DVPPS-DLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEY--DLALL--RFYE 493
D P D ++ LG L++ + G + V+ + H + T + D+ALL R E
Sbjct: 73 DYPKKEDYIVYLGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKE 130
Query: 494 PVKFQPN--IIPICVPE--DDTNFVGTSAHVTGWGR 525
QP+ I IC+P +D F GTS +TG+G+
Sbjct: 131 GRCAQPSRTIQTICLPSMYNDPQF-GTSCEITGFGK 165
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 19/60 (31%), Positives = 31/60 (51%), Gaps = 1/60 (1%)
Query: 553 GNRILFPSSRIVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
G + L P +I+GGE T PW ++ R+ + + CG +L + W ++A HC D
Sbjct: 14 GQKTLRPRFKIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFID 73
>pdb|2ZGC|A Chain A, Crystal Structure Of Active Human Granzyme M
pdb|2ZGH|A Chain A, Crystal Structure Of Active Granzyme M Bound To Its
Product
pdb|2ZKS|A Chain A, Structural Insights Into The Proteolytic Machinery Of
Apoptosis- Inducing Granzyme M
Length = 240
Score = 59.7 bits (143), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 42/141 (29%), Positives = 64/141 (45%), Gaps = 12/141 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG + P+ SL++ H CG L + W +TAAHC+ + L L LG
Sbjct: 1 IIGGREVIPHSRPYMASLQR----NGSHLCGGVLVHPKWVLTAAHCLAQR-MAQLRLVLG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDP-RTFEYDLALLRFYEPVKFQPNIIPICVP-E 508
H L + + ++ HP++ P E DLALL+ VK I P+ +P +
Sbjct: 56 LHTLDSPGLTF-----HIKAAIQHPRYKPVPALENDLALLQLDGKVKPSRTIRPLALPSK 110
Query: 509 DDTNFVGTSAHVTGWGRLYEG 529
GT + GWG ++G
Sbjct: 111 RQVVAAGTRCSMAGWGLTHQG 131
Score = 35.4 bits (80), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 17/54 (31%), Positives = 27/54 (50%), Gaps = 4/54 (7%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWSQI 616
I+GG + P+ SL++ H CG L + W +TAAHC+ +Q+
Sbjct: 1 IIGGREVIPHSRPYMASLQR----NGSHLCGGVLVHPKWVLTAAHCLAQRMAQL 50
>pdb|1AO5|A Chain A, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
pdb|1AO5|B Chain B, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
Length = 237
Score = 59.7 bits (143), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 44/154 (28%), Positives = 64/154 (41%), Gaps = 22/154 (14%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
+VGG PWQ++ + H CG L + NW +TAAHC D + LG
Sbjct: 1 VVGGFNCEKNSQPWQVA----VYYQKEHICGGVLLDRNWVLTAAHCYVD----QYEVWLG 52
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRT-----------FEYDLALLRFYEPVKFQP 499
++ L EE Q R V HP F+ F DL LLR +P
Sbjct: 53 KNKLFQEEP--SAQHRLVSKSFPHPGFNMSLLMLQTIPPGADFSDDLMLLRLSKPADITD 110
Query: 500 NIIPICVPEDDTNFVGTSAHVTGWGRLYEGRFRR 533
+ PI +P + G+ +GWG + R+++
Sbjct: 111 VVKPIALPTKEPK-PGSKCLASGWGSITPTRWQK 143
Score = 38.9 bits (89), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 24/49 (48%), Gaps = 4/49 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
+VGG PWQ++ + H CG L + NW +TAAHC D
Sbjct: 1 VVGGFNCEKNSQPWQVA----VYYQKEHICGGVLLDRNWVLTAAHCYVD 45
>pdb|1FQ3|A Chain A, Crystal Structure Of Human Granzyme B
pdb|1FQ3|B Chain B, Crystal Structure Of Human Granzyme B
Length = 227
Score = 59.7 bits (143), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 8/136 (5%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG +A P+ L W + + L +CG L +++ +TAAHC S + + LG
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKS-LKRCGGFLIQDDFVLTAAHCWG----SSINVTLG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H++ E+EP Q V+ HP ++P+ F D+ LL+ K + P+ +P +
Sbjct: 56 AHNIK-EQEPT-QQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLPSNK 113
Query: 511 TNFV-GTSAHVTGWGR 525
G + V GWG+
Sbjct: 114 AQVKPGQTCSVAGWGQ 129
Score = 34.3 bits (77), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 16/46 (34%), Positives = 26/46 (56%), Gaps = 1/46 (2%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
I+GG +A P+ L W + + L +CG L +++ +TAAHC
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKS-LKRCGGFLIQDDFVLTAAHC 45
>pdb|1OP8|A Chain A, Crystal Structure Of Human Granzyme A
pdb|1OP8|B Chain B, Crystal Structure Of Human Granzyme A
pdb|1OP8|C Chain C, Crystal Structure Of Human Granzyme A
pdb|1OP8|D Chain D, Crystal Structure Of Human Granzyme A
pdb|1OP8|E Chain E, Crystal Structure Of Human Granzyme A
pdb|1OP8|F Chain F, Crystal Structure Of Human Granzyme A
Length = 234
Score = 59.7 bits (143), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 46/138 (33%), Positives = 65/138 (47%), Gaps = 10/138 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG + T P+ + L R T C AL ++W +TAAHC + + LG
Sbjct: 1 IIGGNEVTPHSRPYMV-LLSLDRKTI---CAGALIAKDWVLTAAHCNLNKRSQVI---LG 53
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPED- 509
H + T EEP Q V+ +P +DP T E DL LL+ E K + + +P+
Sbjct: 54 AHSI-TREEPT-KQIMLVKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKG 111
Query: 510 DTNFVGTSAHVTGWGRLY 527
D GT V GWGR +
Sbjct: 112 DDVKPGTMCQVAGWGRTH 129
Score = 35.0 bits (79), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 22/65 (33%), Positives = 32/65 (49%), Gaps = 4/65 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWSQIIPIIQN 622
I+GG + T P+ + L R T C AL ++W +TAAHC + SQ+I +
Sbjct: 1 IIGGNEVTPHSRPYMV-LLSLDRKTI---CAGALIAKDWVLTAAHCNLNKRSQVILGAHS 56
Query: 623 CRRRE 627
R E
Sbjct: 57 ITREE 61
>pdb|1IAU|A Chain A, Human Granzyme B In Complex With Ac-Iepd-Cho
Length = 227
Score = 59.3 bits (142), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 8/136 (5%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG +A P+ L W + + L +CG L +++ +TAAHC S + + LG
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKS-LKRCGGFLIRDDFVLTAAHCWG----SSINVTLG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H++ E+EP Q V+ HP ++P+ F D+ LL+ K + P+ +P +
Sbjct: 56 AHNIK-EQEPT-QQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLPSNK 113
Query: 511 TNFV-GTSAHVTGWGR 525
G + V GWG+
Sbjct: 114 AQVKPGQTCSVAGWGQ 129
Score = 33.9 bits (76), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 16/46 (34%), Positives = 26/46 (56%), Gaps = 1/46 (2%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
I+GG +A P+ L W + + L +CG L +++ +TAAHC
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKS-LKRCGGFLIRDDFVLTAAHC 45
>pdb|1ORF|A Chain A, The Oligomeric Structure Of Human Granzyme A Reveals The
Molecular Determinants Of Substrate Specificity
Length = 234
Score = 59.3 bits (142), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 46/138 (33%), Positives = 65/138 (47%), Gaps = 10/138 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG + T P+ + L R T C AL ++W +TAAHC + + LG
Sbjct: 1 IIGGNEVTPHSRPYMV-LLSLDRKTI---CAGALIAKDWVLTAAHCNLNKRSQVI---LG 53
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPED- 509
H + T EEP Q V+ +P +DP T E DL LL+ E K + + +P+
Sbjct: 54 AHSI-TREEPT-KQIMLVKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKG 111
Query: 510 DTNFVGTSAHVTGWGRLY 527
D GT V GWGR +
Sbjct: 112 DDVKPGTMCQVAGWGRTH 129
Score = 35.0 bits (79), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 22/65 (33%), Positives = 32/65 (49%), Gaps = 4/65 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWSQIIPIIQN 622
I+GG + T P+ + L R T C AL ++W +TAAHC + SQ+I +
Sbjct: 1 IIGGNEVTPHSRPYMV-LLSLDRKTI---CAGALIAKDWVLTAAHCNLNKRSQVILGAHS 56
Query: 623 CRRRE 627
R E
Sbjct: 57 ITREE 61
>pdb|1GVZ|A Chain A, Prostate Specific Antigen (Psa) From Stallion Seminal
Plasma
Length = 237
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 22/147 (14%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG + PWQ++ + +CG L + W +TAAHC+ D D + LG
Sbjct: 1 IIGGWECEKHSKPWQVA----VYHQGHFQCGGVLVHPQWVLTAAHCMSD----DYQIWLG 52
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFE-----------YDLALLRFYEPVKFQP 499
H+LS +E+ + + + PQFD + +DL LLR +P +
Sbjct: 53 RHNLSKDEDTAQFHQVSDSFL--DPQFDLSLLKKKYLRPYDDISHDLMLLRLAQPARITD 110
Query: 500 NIIPICVPEDDTNFVGTSAHVTGWGRL 526
+ + +P + +G++ + +GWG +
Sbjct: 111 AVKILDLPTQEPK-LGSTCYTSGWGLI 136
Score = 33.9 bits (76), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 16/49 (32%), Positives = 25/49 (51%), Gaps = 4/49 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GG + PWQ++ + +CG L + W +TAAHC+ D
Sbjct: 1 IIGGWECEKHSKPWQVA----VYHQGHFQCGGVLVHPQWVLTAAHCMSD 45
>pdb|1SPJ|A Chain A, Structure Of Mature Human Tissue Kallikrein (Human
Kallikrein 1 Or Klk1) At 1.70 Angstrom Resolution With
Vacant Active Site
Length = 238
Score = 58.5 bits (140), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 17/150 (11%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG + PWQ +L + ST+ +CG L + W +TAAHC+ D + L LG
Sbjct: 1 IVGGWECEQHSQPWQAALYHF--STF--QCGGILVHRQWVLTAAHCISD----NYQLWLG 52
Query: 451 EHDLSTEE---------EPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNI 501
H+L +E E + + + ++ +H + + +DL LLR EP +
Sbjct: 53 RHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDA 112
Query: 502 IPICVPEDDTNFVGTSAHVTGWGRLYEGRF 531
+ + + VG++ +GWG + F
Sbjct: 113 VKVVELPTEEPEVGSTCLASGWGSIEPENF 142
Score = 38.1 bits (87), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 20/49 (40%), Positives = 28/49 (57%), Gaps = 4/49 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
IVGG + PWQ +L + ST+ +CG L + W +TAAHC+ D
Sbjct: 1 IVGGWECEQHSQPWQAALYHF--STF--QCGGILVHRQWVLTAAHCISD 45
>pdb|2ZGJ|A Chain A, Crystal Structure Of D86n-gzmm Complexed With Its Optimal
Synthesized Substrate
Length = 240
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 41/141 (29%), Positives = 64/141 (45%), Gaps = 12/141 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG + P+ SL++ H CG L + W +TAAHC+ + L L LG
Sbjct: 1 IIGGREVIPHSRPYMASLQR----NGSHLCGGVLVHPKWVLTAAHCLAQR-MAQLRLVLG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDP-RTFEYDLALLRFYEPVKFQPNIIPICVP-E 508
H L + + ++ HP++ P E +LALL+ VK I P+ +P +
Sbjct: 56 LHTLDSPGLTF-----HIKAAIQHPRYKPVPALENNLALLQLDGKVKPSRTIRPLALPSK 110
Query: 509 DDTNFVGTSAHVTGWGRLYEG 529
GT + GWG ++G
Sbjct: 111 RQVVAAGTRCSMAGWGLTHQG 131
Score = 35.4 bits (80), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 17/54 (31%), Positives = 27/54 (50%), Gaps = 4/54 (7%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWSQI 616
I+GG + P+ SL++ H CG L + W +TAAHC+ +Q+
Sbjct: 1 IIGGREVIPHSRPYMASLQR----NGSHLCGGVLVHPKWVLTAAHCLAQRMAQL 50
>pdb|1Q3X|A Chain A, Crystal Structure Of The Catalytic Region Of Human Masp-2
pdb|1Q3X|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-2
Length = 328
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 74/165 (44%), Gaps = 23/165 (13%)
Query: 380 VCGRRLFPSS-RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV- 437
VCG + RI GG+KA G +PWQ+ + + AL +NW +TAAH V
Sbjct: 75 VCGLSARTTGGRIYGGQKAKPGDFPWQVLILGGTTAA------GALLYDNWVLTAAHAVY 128
Query: 438 -EDVPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFD-PRTFEYDLALLRFYEPV 495
+ S L +R+G + Y + + V H + F+ D+AL++ V
Sbjct: 129 EQKHDASALDIRMGTLKRLSPH----YTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKV 184
Query: 496 KFQPNIIPICVPEDD------TNFVGTSAHVTGWGRLYEGRFRRS 534
NI PIC+P + T+ +GT+ +GWG G R+
Sbjct: 185 VINSNITPICLPRKEAESFMRTDDIGTA---SGWGLTQRGFLARN 226
Score = 38.1 bits (87), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 19/50 (38%), Positives = 26/50 (52%), Gaps = 6/50 (12%)
Query: 560 SSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
RI GG+KA G +PWQ+ + + AL +NW +TAAH V
Sbjct: 84 GGRIYGGQKAKPGDFPWQVLILGGTTAA------GALLYDNWVLTAAHAV 127
>pdb|1SGF|A Chain A, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|X Chain X, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 240
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 39/141 (27%), Positives = 67/141 (47%), Gaps = 22/141 (15%)
Query: 403 PWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLGEHDLSTEEEPYG 462
PW +++ ++ + ++CG L + NW +TAAHC D + LG+++ E+EP
Sbjct: 16 PWHVAVYRFNK----YQCGGVLLDRNWVLTAAHCYND----KYQVWLGKNNF-LEDEPSD 66
Query: 463 YQERRVQIVASHPQFD--------PR---TFEYDLALLRFYEPVKFQPNIIPICVPEDDT 511
Q R V HP F+ P+ + DL LLR +P + PI +P ++
Sbjct: 67 -QHRLVSKAIPHPDFNMSLLNEHTPQPEDDYSNDLMLLRLSKPADITDVVKPITLPTEEP 125
Query: 512 NFVGTSAHVTGWGRLYEGRFR 532
G++ +GWG +F+
Sbjct: 126 KL-GSTCLASGWGSTTPIKFK 145
Score = 35.8 bits (81), Expect = 0.073, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 23/37 (62%), Gaps = 4/37 (10%)
Query: 575 PWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
PW +++ ++ + ++CG L + NW +TAAHC D
Sbjct: 16 PWHVAVYRFNK----YQCGGVLLDRNWVLTAAHCYND 48
>pdb|2BDG|A Chain A, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDG|B Chain B, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDH|A Chain A, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|B Chain B, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|C Chain C, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|D Chain D, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDI|A Chain A, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|B Chain B, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|C Chain C, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|D Chain D, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|E Chain E, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|F Chain F, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|G Chain G, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|H Chain H, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|I Chain I, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|J Chain J, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|K Chain K, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|L Chain L, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|M Chain M, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|N Chain N, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|O Chain O, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|P Chain P, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
Length = 223
Score = 57.8 bits (138), Expect = 2e-08, Method: Composition-based stats.
Identities = 41/140 (29%), Positives = 61/140 (43%), Gaps = 10/140 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+ GE + PWQ +L + L C L + W ++AAHC ++ + LG
Sbjct: 1 IINGEDCSPHSQPWQAAL---VMENELF-CSGVLVHPQWVLSAAHCFQN----SYTIGLG 52
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H L ++EP G Q + HP+++ DL L++ E V I I +
Sbjct: 53 LHSLEADQEP-GSQMVEASLSVRHPEYNRPLLANDLMLIKLDESVSESDTIRSISIASQC 111
Query: 511 TNFVGTSAHVTGWGRLYEGR 530
G S V+GWG L GR
Sbjct: 112 PT-AGNSCLVSGWGLLANGR 130
Score = 30.4 bits (67), Expect = 3.5, Method: Composition-based stats.
Identities = 15/52 (28%), Positives = 26/52 (50%), Gaps = 4/52 (7%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWS 614
I+ GE + PWQ +L + L C L + W ++AAHC ++ ++
Sbjct: 1 IINGEDCSPHSQPWQAAL---VMENELF-CSGVLVHPQWVLSAAHCFQNSYT 48
>pdb|1FI8|A Chain A, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
pdb|1FI8|B Chain B, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
Length = 228
Score = 57.8 bits (138), Expect = 2e-08, Method: Composition-based stats.
Identities = 38/137 (27%), Positives = 64/137 (46%), Gaps = 7/137 (5%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG +A P+ L+ + KCG L E++ +TAAHC S + + LG
Sbjct: 1 IIGGHEAKPHSRPYMAYLQIMDEYSGSKKCGGFLIREDFVLTAAHC----SGSKIQVTLG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H++ +E+ Q V + HP ++ +T D+ LL+ K + P+ +P +
Sbjct: 57 AHNIKEQEKM--QQIIPVVKIIPHPAYNSKTISNDIMLLKLKSKAKRSSAVKPLNLPRRN 114
Query: 511 TNFV-GTSAHVTGWGRL 526
G +V GWG+L
Sbjct: 115 VKVKPGDVCYVAGWGKL 131
Score = 32.7 bits (73), Expect = 0.68, Method: Composition-based stats.
Identities = 20/74 (27%), Positives = 33/74 (44%), Gaps = 15/74 (20%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------------- 609
I+GG +A P+ L+ + KCG L E++ +TAAHC
Sbjct: 1 IIGGHEAKPHSRPYMAYLQIMDEYSGSKKCGGFLIREDFVLTAAHCSGSKIQVTLGAHNI 60
Query: 610 --EDLWSQIIPIIQ 621
++ QIIP+++
Sbjct: 61 KEQEKMQQIIPVVK 74
>pdb|1BDA|A Chain A, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
pdb|1BDA|B Chain B, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 57.8 bits (138), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 24/212 (11%)
Query: 380 VCGRRLF--PSSRIVGGEKATFGKWPWQISLRQWIRSTYLHK--CGAALFNENWAVTAAH 435
CG R + P RI GG A PWQ ++ R + + CG L + W ++AAH
Sbjct: 1 TCGLRQYSQPQFRIKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAH 60
Query: 436 CVED-VPPSDLLLRLGE--HDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFY 492
C ++ PP L + LG + EEE Q+ V+ H +FD T++ D+ALL+
Sbjct: 61 CFQERFPPHHLTVILGRTYRVVPGEEE----QKFEVEKYIVHKEFDDDTYDNDIALLQLK 116
Query: 493 EP----VKFQPNIIPICVPEDDTNFVG-TSAHVTGWGR------LYEGRFRRSYG--HPA 539
+ + +C+P D T ++G+G+ Y R + ++ +P+
Sbjct: 117 SDSSRCAQESSVVRTVCLPPADLQLPDWTECELSGYGKHEALSPFYSERLKEAHVRLYPS 176
Query: 540 TRQEMATCWNHFLGNRILFPSSRIVGGEKATF 571
+R N + + +L GG +A
Sbjct: 177 SRCTSQHLLNRTVTDNMLCAGDTRSGGPQANL 208
Score = 34.3 bits (77), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 18/55 (32%), Positives = 27/55 (49%), Gaps = 2/55 (3%)
Query: 559 PSSRIVGGEKATFGKWPWQISLRQWIRSTYLHK--CGAALFNENWAVTAAHCVED 611
P RI GG A PWQ ++ R + + CG L + W ++AAHC ++
Sbjct: 10 PQFRIKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQE 64
>pdb|2EEK|A Chain A, Crystal Structure Of Atlantic Cod Trypsin Complexed With
Benzamidine
Length = 220
Score = 57.4 bits (137), Expect = 2e-08, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 61/134 (45%), Gaps = 12/134 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG + T Q+SL S Y H CG +L +++W V+AAHC + V L +RLG
Sbjct: 1 IVGGYECTKHSQAHQVSLN----SGY-HFCGGSLVSKDWVVSAAHCYKSV----LRVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
EH + E Y V HP + D+ L++ +P + + +P +
Sbjct: 52 EHHIRVNEGTEQYISSSS--VIRHPNYSSYNINNDIMLIKLTKPATLNQYVHAVALPT-E 108
Query: 511 TNFVGTSAHVTGWG 524
T V+GWG
Sbjct: 109 CAADATMCTVSGWG 122
Score = 35.4 bits (80), Expect = 0.11, Method: Composition-based stats.
Identities = 20/50 (40%), Positives = 29/50 (58%), Gaps = 5/50 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDL 612
IVGG + T Q+SL S Y H CG +L +++W V+AAHC + +
Sbjct: 1 IVGGYECTKHSQAHQVSLN----SGY-HFCGGSLVSKDWVVSAAHCYKSV 45
Score = 29.6 bits (65), Expect = 6.0, Method: Composition-based stats.
Identities = 17/55 (30%), Positives = 30/55 (54%), Gaps = 8/55 (14%)
Query: 634 ALADGPLPSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
++ADG LQ +S+P+++++ C Y I + CAG+ +G DSC+
Sbjct: 127 SVADG---DKLQCLSLPILSHADCANSYPGM-----ITQSMFCAGYLEGGKDSCQ 173
>pdb|1FY1|A Chain A, [r23s,F25e]hbp, A Mutant Of Human Heparin Binding Protein
(Cap37)
Length = 225
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 42/142 (29%), Positives = 67/142 (47%), Gaps = 11/142 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG KA ++P+ S I++ H+CG AL + + +TAA C + P + LG
Sbjct: 1 IVGGRKARPRQFPFLAS----IQNQGSHECGGALIHARFVMTAASCFQSQNPGVSTVVLG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQ--FDPRTFEYDLALLRFYEPVKFQPNIIPICVP- 507
+DL E Q R+ ++S + +DP+ DL LL+ ++ + +P
Sbjct: 57 AYDLRRRER----QSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPLPL 112
Query: 508 EDDTNFVGTSAHVTGWGRLYEG 529
++ T GT V GWG G
Sbjct: 113 QNATVEAGTRCQVAGWGSQRSG 134
Score = 35.4 bits (80), Expect = 0.098, Method: Compositional matrix adjust.
Identities = 23/68 (33%), Positives = 36/68 (52%), Gaps = 7/68 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDL---WSQIIPI 619
IVGG KA ++P+ S I++ H+CG AL + + +TAA C + S ++
Sbjct: 1 IVGGRKARPRQFPFLAS----IQNQGSHECGGALIHARFVMTAASCFQSQNPGVSTVVLG 56
Query: 620 IQNCRRRE 627
+ RRRE
Sbjct: 57 AYDLRRRE 64
>pdb|1FUJ|A Chain A, Pr3 (Myeloblastin)
pdb|1FUJ|B Chain B, Pr3 (Myeloblastin)
pdb|1FUJ|C Chain C, Pr3 (Myeloblastin)
pdb|1FUJ|D Chain D, Pr3 (Myeloblastin)
Length = 221
Score = 57.4 bits (137), Expect = 3e-08, Method: Composition-based stats.
Identities = 39/137 (28%), Positives = 66/137 (48%), Gaps = 5/137 (3%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG +A P+ SL Q + H CG L + ++ +TAAHC+ D+P + + LG
Sbjct: 1 IVGGHEAQPHSRPYMASL-QMRGNPGSHFCGGTLIHPSFVLTAAHCLRDIPQRLVNVVLG 59
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H++ T +EP Q+ ++ +D D+ L++ P ++ + +P+ D
Sbjct: 60 AHNVRT-QEPTQQHFSVAQVFLNN--YDAENKLNDILLIQLSSPANLSASVATVQLPQQD 116
Query: 511 TNFV-GTSAHVTGWGRL 526
GT GWGR+
Sbjct: 117 QPVPHGTQCLAMGWGRV 133
Score = 37.0 bits (84), Expect = 0.037, Method: Composition-based stats.
Identities = 23/77 (29%), Positives = 40/77 (51%), Gaps = 4/77 (5%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWSQIIPII-- 620
IVGG +A P+ SL Q + H CG L + ++ +TAAHC+ D+ +++ ++
Sbjct: 1 IVGGHEAQPHSRPYMASL-QMRGNPGSHFCGGTLIHPSFVLTAAHCLRDIPQRLVNVVLG 59
Query: 621 -QNCRRRESNLWKMALA 636
N R +E ++A
Sbjct: 60 AHNVRTQEPTQQHFSVA 76
>pdb|1FON|A Chain A, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
pdb|1FON|B Chain B, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
Length = 240
Score = 57.0 bits (136), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 41/143 (28%), Positives = 63/143 (44%), Gaps = 13/143 (9%)
Query: 394 GEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLGEHD 453
GE A W WQ+SL+ + H CG +L +W VTA HC+ ++ LGE+D
Sbjct: 2 GEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCISTSRTYQVV--LGEYD 59
Query: 454 LSTEEEPYGYQERRVQIVAS----HPQFDPRTFE--YDLALLRFYEPVKFQPNI-IPICV 506
S E E+ + I A HP ++ D+AL++ + + +
Sbjct: 60 RSVLEG----SEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQLANLP 115
Query: 507 PEDDTNFVGTSAHVTGWGRLYEG 529
P D +++GWGRLY G
Sbjct: 116 PAGDILPNEAPCYISGWGRLYTG 138
Score = 43.5 bits (101), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 18/45 (40%), Positives = 24/45 (53%)
Query: 566 GEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVE 610
GE A W WQ+SL+ + H CG +L +W VTA HC+
Sbjct: 2 GEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCIS 46
>pdb|2FI5|E Chain E, Crystal Structure Of A Bpti Variant (Cys38->ser) In
Complex With Trypsin
pdb|2FTM|A Chain A, Crystal Structure Of Trypsin Complexed With The Bpti
Variant (Tyr35- >gly)
Length = 224
Score = 57.0 bits (136), Expect = 4e-08, Method: Composition-based stats.
Identities = 41/135 (30%), Positives = 62/135 (45%), Gaps = 13/135 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG P+Q+SL S Y H CG +L N W V+AAHC + S + +RLG
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHCYK----SGIQVRLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKF-QPNIIPICVPED 509
E +++ E + IV HP ++ T D+ L++ + I +P
Sbjct: 52 EDNINVVEGNEQFISASKSIV--HPSYNSNTLNNDIMLIKLKSAASLXDSRVASISLPTS 109
Query: 510 DTNFVGTSAHVTGWG 524
+ GT ++GWG
Sbjct: 110 CAS-AGTQCLISGWG 123
Score = 39.3 bits (90), Expect = 0.008, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL S Y H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCGANTVPYQVSLN----SGY-HFCGGSLINSQWVVSAAHC 41
Score = 32.3 bits (72), Expect = 0.93, Method: Composition-based stats.
Identities = 15/48 (31%), Positives = 26/48 (54%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
P VL+ + P++++S C++ Y I CAG+ +G DSC+
Sbjct: 133 PDVLKCLKAPILSDSSCKSAYPG-----QITSNMFCAGYLEGGKDSCQ 175
>pdb|4GAW|A Chain A, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|B Chain B, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|C Chain C, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|D Chain D, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|E Chain E, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|F Chain F, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|G Chain G, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|H Chain H, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|I Chain I, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|J Chain J, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|K Chain K, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|L Chain L, Crystal Structure Of Active Human Granzyme H
Length = 226
Score = 56.2 bits (134), Expect = 6e-08, Method: Composition-based stats.
Identities = 35/135 (25%), Positives = 64/135 (47%), Gaps = 8/135 (5%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG +A P+ ++ Q+++ +CG L +++ +TAAHC S + + LG
Sbjct: 1 IIGGHEAKPHSRPY-MAFVQFLQEKSRKRCGGILVRKDFVLTAAHC----QGSSINVTLG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H++ +E + + I HP ++P+ F D+ LL+ K+ + P+ +P
Sbjct: 56 AHNIKEQERTQQFIPVKRPI--PHPAYNPKNFSNDIMLLQLERKAKWTTAVRPLRLPSSK 113
Query: 511 TNFV-GTSAHVTGWG 524
G V GWG
Sbjct: 114 AQVKPGQLCSVAGWG 128
Score = 31.2 bits (69), Expect = 1.8, Method: Composition-based stats.
Identities = 14/46 (30%), Positives = 27/46 (58%), Gaps = 1/46 (2%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
I+GG +A P+ ++ Q+++ +CG L +++ +TAAHC
Sbjct: 1 IIGGHEAKPHSRPY-MAFVQFLQEKSRKRCGGILVRKDFVLTAAHC 45
>pdb|1SC8|U Chain U, Urokinase Plasminogen Activator B-Chain-J435 Complex
pdb|1VJ9|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt464 Complex
pdb|1VJA|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt463 Complex
Length = 262
Score = 56.2 bits (134), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 381 CGRR-LFPSSRIVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVE 438
CG++ L P +I+GGE T PW ++ R+ + + CG +L + W ++A HC
Sbjct: 5 CGQKTLRPRFKIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFI 64
Query: 439 DVPPS-DLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEY--DLALL--RFYE 493
D P D ++ LG L++ + G + V+ + H + T + D+ALL R E
Sbjct: 65 DYPKKEDYIVYLGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKE 122
Query: 494 PVKFQPN--IIPICVPE--DDTNFVGTSAHVTGWGR 525
QP+ I I +P +D F GTS +TG+G+
Sbjct: 123 GRCAQPSRTIQTISLPSMYNDPQF-GTSCEITGFGK 157
Score = 40.0 bits (92), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 19/60 (31%), Positives = 31/60 (51%), Gaps = 1/60 (1%)
Query: 553 GNRILFPSSRIVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
G + L P +I+GGE T PW ++ R+ + + CG +L + W ++A HC D
Sbjct: 6 GQKTLRPRFKIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFID 65
>pdb|1TON|A Chain A, Rat Submaxillary Gland Serine Protease, Tonin. Structure
Solution And Refinement At 1.8 Angstroms Resolution
Length = 235
Score = 55.8 bits (133), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 43/145 (29%), Positives = 66/145 (45%), Gaps = 24/145 (16%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG K PWQ++ + + YL CG L + +W +TAAHC + + + LG
Sbjct: 1 IVGGYKCEKNSQPWQVA----VINEYL--CGGVLIDPSWVITAAHCYSN----NYQVLLG 50
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTF-----------EYDLALLRFYEPVKFQP 499
++L ++EP+ Q R V+ HP + P DL LL EP
Sbjct: 51 RNNL-FKDEPFA-QRRLVRQSFRHPDYIPLIVTNDTEQPVHDHSNDLMLLHLSEPADITG 108
Query: 500 NIIPICVPEDDTNFVGTSAHVTGWG 524
+ I +P + VG++ +GWG
Sbjct: 109 GVKVIDLPTKEPK-VGSTCLASGWG 132
Score = 38.9 bits (89), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 19/55 (34%), Positives = 30/55 (54%), Gaps = 6/55 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWSQII 617
IVGG K PWQ++ + + YL CG L + +W +TAAHC + + ++
Sbjct: 1 IVGGYKCEKNSQPWQVA----VINEYL--CGGVLIDPSWVITAAHCYSNNYQVLL 49
>pdb|1ZJK|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-2
Length = 403
Score = 55.8 bits (133), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 47/165 (28%), Positives = 74/165 (44%), Gaps = 23/165 (13%)
Query: 380 VCGRRLFPSS-RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV- 437
VCG + +I GG+KA G +PWQ+ + + AL +NW +TAAH V
Sbjct: 150 VCGLSARTTGGQIYGGQKAKPGDFPWQVLILGGTTAA------GALLYDNWVLTAAHAVY 203
Query: 438 -EDVPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRT-FEYDLALLRFYEPV 495
+ S L +R+G + Y + + V H + F+ D+AL++ V
Sbjct: 204 EQKHDASALDIRMGTLKRLSPH----YTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKV 259
Query: 496 KFQPNIIPICVPEDD------TNFVGTSAHVTGWGRLYEGRFRRS 534
NI PIC+P + T+ +GT+ +GWG G R+
Sbjct: 260 VINSNITPICLPRKEAESFMRTDDIGTA---SGWGLTQRGFLARN 301
Score = 36.2 bits (82), Expect = 0.057, Method: Compositional matrix adjust.
Identities = 18/48 (37%), Positives = 26/48 (54%), Gaps = 6/48 (12%)
Query: 562 RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+I GG+KA G +PWQ+ + + AL +NW +TAAH V
Sbjct: 161 QIYGGQKAKPGDFPWQVLILGGTTAA------GALLYDNWVLTAAHAV 202
>pdb|4FXG|H Chain H, Complement C4 In Complex With Masp-2
pdb|4FXG|J Chain J, Complement C4 In Complex With Masp-2
Length = 242
Score = 55.8 bits (133), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 22/153 (14%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV--EDVPPSDLLLR 448
I GG+KA G +PWQ+ + + AL +NW +TAAH V + S L +R
Sbjct: 1 IYGGQKAKPGDFPWQVLILGGTTAA------GALLYDNWVLTAAHAVYEQKHDASALDIR 54
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFD-PRTFEYDLALLRFYEPVKFQPNIIPICVP 507
+G + + Y + + V H + F+ D+AL++ V NI PIC+P
Sbjct: 55 MG----TLKRLSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLP 110
Query: 508 EDD------TNFVGTSAHVTGWGRLYEGRFRRS 534
+ T+ +GT+ +GWG G R+
Sbjct: 111 RKEAESFMRTDDIGTA---SGWGLTQRGFLARN 140
Score = 35.4 bits (80), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 25/47 (53%), Gaps = 6/47 (12%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
I GG+KA G +PWQ+ + + AL +NW +TAAH V
Sbjct: 1 IYGGQKAKPGDFPWQVLILGGTTAA------GALLYDNWVLTAAHAV 41
>pdb|3TVJ|B Chain B, Catalytic Fragment Of Masp-2 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 242
Score = 55.8 bits (133), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 22/153 (14%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV--EDVPPSDLLLR 448
I GG+KA G +PWQ+ + + AL +NW +TAAH V + S L +R
Sbjct: 1 IYGGQKAKPGDFPWQVLILGGTTAA------GALLYDNWVLTAAHAVYEQKHDASALDIR 54
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFD-PRTFEYDLALLRFYEPVKFQPNIIPICVP 507
+G + + Y + + V H + F+ D+AL++ V NI PIC+P
Sbjct: 55 MG----TLKRLSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLP 110
Query: 508 EDD------TNFVGTSAHVTGWGRLYEGRFRRS 534
+ T+ +GT+ +GWG G R+
Sbjct: 111 RKEAESFMRTDDIGTA---SGWGLTQRGFLARN 140
Score = 35.4 bits (80), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 25/47 (53%), Gaps = 6/47 (12%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
I GG+KA G +PWQ+ + + AL +NW +TAAH V
Sbjct: 1 IYGGQKAKPGDFPWQVLILGGTTAA------GALLYDNWVLTAAHAV 41
>pdb|1EUF|A Chain A, Bovine Duodenase(New Serine Protease), Crystal Structure
Length = 227
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 39/137 (28%), Positives = 59/137 (43%), Gaps = 8/137 (5%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG +A P+ ++ + S H CG L E++ +TAAHC+ S + + LG
Sbjct: 1 IIGGHEAKPHSRPY-MAFLLFKTSGKSHICGGFLVREDFVLTAAHCLG----SSINVTLG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H++ E R I HP ++ T D+ LL+ + PI +P
Sbjct: 56 AHNIMERERTQQVIPVRRPI--PHPDYNDETLANDIMLLKLTRKADITDKVSPINLPRSL 113
Query: 511 TNFV-GTSAHVTGWGRL 526
G V GWGRL
Sbjct: 114 AEVKPGMMCSVAGWGRL 130
Score = 32.3 bits (72), Expect = 0.96, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 1/47 (2%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
I+GG +A P+ ++ + S H CG L E++ +TAAHC+
Sbjct: 1 IIGGHEAKPHSRPY-MAFLLFKTSGKSHICGGFLVREDFVLTAAHCL 46
>pdb|1LMW|B Chain B, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
pdb|1LMW|D Chain D, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
Length = 253
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 45/145 (31%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 391 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPS-DLLLR 448
I+GGE T PW ++ R+ + + CG +L + W ++A HC D P D ++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEY--DLALL--RFYEPVKFQPN--II 502
LG L++ + G + V+ + H + T + D+ALL R E QP+ I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 503 PICVPE--DDTNFVGTSAHVTGWGR 525
IC+P +D F GTS +TG+G+
Sbjct: 119 TICLPSMYNDPQF-GTSCEITGFGK 142
Score = 33.9 bits (76), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 26/50 (52%), Gaps = 1/50 (2%)
Query: 563 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GGE T PW ++ R+ + + CG +L + W ++A HC D
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFID 50
>pdb|1OWD|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWI|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWJ|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWK|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQT|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1U6Q|A Chain A, Substituted 2-naphthamadine Inhibitors Of Urokinase
Length = 245
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 45/145 (31%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 391 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPS-DLLLR 448
I+GGE T PW ++ R+ + + CG +L + W ++A HC D P D ++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEY--DLALL--RFYEPVKFQPN--II 502
LG L++ + G + V+ + H + T + D+ALL R E QP+ I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 503 PICVPE--DDTNFVGTSAHVTGWGR 525
IC+P +D F GTS +TG+G+
Sbjct: 119 TICLPSMYNDPQF-GTSCEITGFGK 142
Score = 33.9 bits (76), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 26/50 (52%), Gaps = 1/50 (2%)
Query: 563 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GGE T PW ++ R+ + + CG +L + W ++A HC D
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFID 50
>pdb|1GJ7|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJ8|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJA|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJB|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1O3P|B Chain B, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1C5W|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5X|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Y|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Z|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GJ9|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJD|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJC|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
Length = 253
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 45/145 (31%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 391 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPS-DLLLR 448
I+GGE T PW ++ R+ + + CG +L + W ++A HC D P D ++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEY--DLALL--RFYEPVKFQPN--II 502
LG L++ + G + V+ + H + T + D+ALL R E QP+ I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 503 PICVPE--DDTNFVGTSAHVTGWGR 525
IC+P +D F GTS +TG+G+
Sbjct: 119 TICLPSMYNDPQF-GTSCEITGFGK 142
Score = 33.9 bits (76), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 26/50 (52%), Gaps = 1/50 (2%)
Query: 563 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GGE T PW ++ R+ + + CG +L + W ++A HC D
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFID 50
>pdb|3IG6|B Chain B, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
pdb|3IG6|D Chain D, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
Length = 253
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 45/145 (31%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 391 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPS-DLLLR 448
I+GGE T PW ++ R+ + + CG +L + W ++A HC D P D ++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEY--DLALL--RFYEPVKFQPN--II 502
LG L++ + G + V+ + H + T + D+ALL R E QP+ I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 503 PICVPE--DDTNFVGTSAHVTGWGR 525
IC+P +D F GTS +TG+G+
Sbjct: 119 TICLPSMYNDPQF-GTSCEITGFGK 142
Score = 33.9 bits (76), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 26/50 (52%), Gaps = 1/50 (2%)
Query: 563 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GGE T PW ++ R+ + + CG +L + W ++A HC D
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFID 50
>pdb|1GI8|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI7|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI9|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
Length = 245
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 45/145 (31%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 391 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPS-DLLLR 448
I+GGE T PW ++ R+ + + CG +L + W ++A HC D P D ++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEY--DLALL--RFYEPVKFQPN--II 502
LG L++ + G + V+ + H + T + D+ALL R E QP+ I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 503 PICVPE--DDTNFVGTSAHVTGWGR 525
IC+P +D F GTS +TG+G+
Sbjct: 119 TICLPSMYNDPQF-GTSCEITGFGK 142
Score = 33.9 bits (76), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 26/50 (52%), Gaps = 1/50 (2%)
Query: 563 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GGE T PW ++ R+ + + CG +L + W ++A HC D
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFID 50
>pdb|1O5A|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1O5B|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5C|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
Length = 253
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 45/145 (31%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 391 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPS-DLLLR 448
I+GGE T PW ++ R+ + + CG +L + W ++A HC D P D ++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEY--DLALL--RFYEPVKFQPN--II 502
LG L++ + G + V+ + H + T + D+ALL R E QP+ I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 503 PICVPE--DDTNFVGTSAHVTGWGR 525
IC+P +D F GTS +TG+G+
Sbjct: 119 TICLPSMYNDPQF-GTSCEITGFGK 142
Score = 33.9 bits (76), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 26/50 (52%), Gaps = 1/50 (2%)
Query: 563 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GGE T PW ++ R+ + + CG +L + W ++A HC D
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFID 50
>pdb|1OWE|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWH|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQA|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQO|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
Length = 245
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 45/145 (31%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 391 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPS-DLLLR 448
I+GGE T PW ++ R+ + + CG +L + W ++A HC D P D ++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEY--DLALL--RFYEPVKFQPN--II 502
LG L++ + G + V+ + H + T + D+ALL R E QP+ I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 503 PICVPE--DDTNFVGTSAHVTGWGR 525
IC+P +D F GTS +TG+G+
Sbjct: 119 TICLPSMYNDPQF-GTSCEITGFGK 142
Score = 33.9 bits (76), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 26/50 (52%), Gaps = 1/50 (2%)
Query: 563 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GGE T PW ++ R+ + + CG +L + W ++A HC D
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFID 50
>pdb|1A7S|A Chain A, Atomic Resolution Structure Of Hbp
pdb|1AE5|A Chain A, Human Heparin Binding Protein
Length = 225
Score = 54.7 bits (130), Expect = 2e-07, Method: Composition-based stats.
Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 15/150 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG KA ++P+ S++ R H CG AL + + +TAA C + P + LG
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGR----HFCGGALIHARFVMTAASCFQSQNPGVSTVVLG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQ--FDPRTFEYDLALLRFYEPVKFQPNIIPICVP- 507
+DL E Q R+ ++S + +DP+ DL LL+ ++ + +P
Sbjct: 57 AYDLRRRER----QSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPLPL 112
Query: 508 EDDTNFVGTSAHVTGWGRLYEG----RFRR 533
++ T GT V GWG G RF R
Sbjct: 113 QNATVEAGTRCQVAGWGSQRSGGRLSRFPR 142
Score = 33.1 bits (74), Expect = 0.52, Method: Composition-based stats.
Identities = 22/68 (32%), Positives = 35/68 (51%), Gaps = 7/68 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWSQIIPII-- 620
IVGG KA ++P+ S++ R H CG AL + + +TAA C + + ++
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGR----HFCGGALIHARFVMTAASCFQSQNPGVSTVVLG 56
Query: 621 -QNCRRRE 627
+ RRRE
Sbjct: 57 AYDLRRRE 64
>pdb|1H9H|E Chain E, Complex Of Eeti-Ii With Porcine Trypsin
Length = 231
Score = 54.7 bits (130), Expect = 2e-07, Method: Composition-based stats.
Identities = 38/136 (27%), Positives = 62/136 (45%), Gaps = 12/136 (8%)
Query: 391 IVGGEKATFGK-WPWQISLRQWIRSTYLHKC-GAALFNENWAVTAAHCVEDVPPSDLLLR 448
IVGG + P+Q+SL ++ H C G +L N W V+AAHC S + +R
Sbjct: 1 IVGGYTCSAANSIPYQVSL-----NSGSHFCSGGSLINSQWVVSAAHCSYK---SRIQVR 52
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
LGEH++ E Q + +HP F+ T + D+ L++ P + + +P
Sbjct: 53 LGEHNIDVLEG--NEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR 110
Query: 509 DDTNFVGTSAHVTGWG 524
+ ++GWG
Sbjct: 111 SCAAAGTECSLISGWG 126
Score = 30.8 bits (68), Expect = 2.7, Method: Composition-based stats.
Identities = 19/48 (39%), Positives = 26/48 (54%), Gaps = 7/48 (14%)
Query: 563 IVGGEKATFGK-WPWQISLRQWIRSTYLHKC-GAALFNENWAVTAAHC 608
IVGG + P+Q+SL ++ H C G +L N W V+AAHC
Sbjct: 1 IVGGYTCSAANSIPYQVSL-----NSGSHFCSGGSLINSQWVVSAAHC 43
Score = 30.0 bits (66), Expect = 4.8, Method: Composition-based stats.
Identities = 17/50 (34%), Positives = 27/50 (54%), Gaps = 6/50 (12%)
Query: 641 PSVLQ-EVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCEE 689
PS+LQ + PV+++S C++ Y I IC G+ +G DSC +
Sbjct: 136 PSLLQCSLKAPVLSDSSCKSSYPG-----QITGNMICVGFLEGGKDSCSQ 180
>pdb|1FY3|A Chain A, [g175q]hbp, A Mutant Of Human Heparin Binding Protein
(cap37)
Length = 225
Score = 54.7 bits (130), Expect = 2e-07, Method: Composition-based stats.
Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 15/150 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG KA ++P+ S++ R H CG AL + + +TAA C + P + LG
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGR----HFCGGALIHARFVMTAASCFQSQNPGVSTVVLG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQ--FDPRTFEYDLALLRFYEPVKFQPNIIPICVP- 507
+DL E Q R+ ++S + +DP+ DL LL+ ++ + +P
Sbjct: 57 AYDLRRRER----QSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPLPL 112
Query: 508 EDDTNFVGTSAHVTGWGRLYEG----RFRR 533
++ T GT V GWG G RF R
Sbjct: 113 QNATVEAGTRCQVAGWGSQRSGGRLSRFPR 142
Score = 33.1 bits (74), Expect = 0.53, Method: Composition-based stats.
Identities = 22/68 (32%), Positives = 35/68 (51%), Gaps = 7/68 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWSQIIPII-- 620
IVGG KA ++P+ S++ R H CG AL + + +TAA C + + ++
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGR----HFCGGALIHARFVMTAASCFQSQNPGVSTVVLG 56
Query: 621 -QNCRRRE 627
+ RRRE
Sbjct: 57 AYDLRRRE 64
>pdb|3TJU|A Chain A, Crystal Structure Of Human Granzyme H With An Inhibitor
pdb|3TJV|A Chain A, Crystal Structure Of Human Granzyme H With A Peptidyl
Substrate
pdb|3TK9|A Chain A, Crystal Structure Of Human Granzyme H
Length = 226
Score = 54.3 bits (129), Expect = 2e-07, Method: Composition-based stats.
Identities = 34/135 (25%), Positives = 64/135 (47%), Gaps = 8/135 (5%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG +A P+ ++ Q+++ +CG L +++ +TAAHC S + + LG
Sbjct: 1 IIGGHEAKPHSRPY-MAFVQFLQEKSRKRCGGILVRKDFVLTAAHC----QGSSINVTLG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H++ +E + + I HP ++P+ F ++ LL+ K+ + P+ +P
Sbjct: 56 AHNIKEQERTQQFIPVKRPI--PHPAYNPKNFSNNIMLLQLERKAKWTTAVRPLRLPSSK 113
Query: 511 TNFV-GTSAHVTGWG 524
G V GWG
Sbjct: 114 AQVKPGQLCSVAGWG 128
Score = 31.2 bits (69), Expect = 1.8, Method: Composition-based stats.
Identities = 14/46 (30%), Positives = 27/46 (58%), Gaps = 1/46 (2%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
I+GG +A P+ ++ Q+++ +CG L +++ +TAAHC
Sbjct: 1 IIGGHEAKPHSRPY-MAFVQFLQEKSRKRCGGILVRKDFVLTAAHC 45
>pdb|2ZCH|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|2ZCK|P Chain P, Crystal Structure Of A Ternary Complex Between Psa, A
Substrat-Acyl Intermediate And An Activating Antibody
pdb|2ZCL|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|3QUM|P Chain P, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
pdb|3QUM|Q Chain Q, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
Length = 237
Score = 53.9 bits (128), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 41/152 (26%), Positives = 65/152 (42%), Gaps = 22/152 (14%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG + PWQ+ + R+ CG L + W +TAAHC+ + ++ LG
Sbjct: 1 IVGGWECEKHSQPWQVLVASRGRAV----CGGVLVHPQWVLTAAHCIRN----KSVILLG 52
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFE-----------YDLALLRFYEPVKFQP 499
H L E+ Q +V HP +D + +DL LLR EP +
Sbjct: 53 RHSLFHPED--TGQVFQVSHSFPHPLYDMSLLKNRFLRPGDDSSHDLMLLRLSEPAELTD 110
Query: 500 NIIPICVPEDDTNFVGTSAHVTGWGRLYEGRF 531
+ + +P + GT+ + +GWG + F
Sbjct: 111 AVKVMDLPTQEPAL-GTTCYASGWGSIEPEEF 141
Score = 35.0 bits (79), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 17/49 (34%), Positives = 25/49 (51%), Gaps = 4/49 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
IVGG + PWQ+ + R+ CG L + W +TAAHC+ +
Sbjct: 1 IVGGWECEKHSQPWQVLVASRGRAV----CGGVLVHPQWVLTAAHCIRN 45
>pdb|1PJP|A Chain A, The 2.2 A Crystal Structure Of Human Chymase In Complex
With Succinyl- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|1T31|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|2HVX|A Chain A, Discovery Of Potent, Orally Active, Nonpeptide Inhibitors
Of Human Mast Cell Chymase By Using Structure-Based Drug
Design
pdb|3S0N|A Chain A, Crystal Structure Of Human Chymase With Benzimidazolone
Inhibitor
Length = 226
Score = 53.9 bits (128), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 9/137 (6%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG + P+ L + CG L N+ +TAAHC + + LG
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAG----RSITVTLG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H+++ EE+ +Q+ V HP+++ T +D+ LL+ E + + P
Sbjct: 57 AHNITEEEDT--WQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQK 114
Query: 511 TNFV--GTSAHVTGWGR 525
NFV G V GWGR
Sbjct: 115 -NFVPPGRMCRVAGWGR 130
>pdb|2QXG|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXG|B Chain B, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXH|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXI|A Chain A, High Resolution Structure Of Human Kallikrein 7 In Complex
With Suc-Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXJ|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-ala-pro-phe-chloromethylketone And Copper
Length = 224
Score = 53.9 bits (128), Expect = 3e-07, Method: Composition-based stats.
Identities = 38/139 (27%), Positives = 61/139 (43%), Gaps = 23/139 (16%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+ G G PWQ++L + LH CG L NE W +TAAHC ++
Sbjct: 1 IIDGAPCARGSHPWQVAL---LSGNQLH-CGGVLVNERWVLTAAHC-----------KMN 45
Query: 451 EHDLSTEEEPYGYQERRVQIVAS-----HPQFDPRTFEYDLALLRFYEPVKFQPNIIPIC 505
E+ + + G +RR Q + + HP + +T DL L++ + + +
Sbjct: 46 EYTVHLGSDTLG--DRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVR 103
Query: 506 VPEDDTNFVGTSAHVTGWG 524
+P GT+ V+GWG
Sbjct: 104 LPS-RCEPPGTTCTVSGWG 121
Score = 42.4 bits (98), Expect = 0.001, Method: Composition-based stats.
Identities = 20/46 (43%), Positives = 25/46 (54%), Gaps = 4/46 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
I+ G G PWQ++L + LH CG L NE W +TAAHC
Sbjct: 1 IIDGAPCARGSHPWQVAL---LSGNQLH-CGGVLVNERWVLTAAHC 42
>pdb|3BSQ|A Chain A, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|B Chain B, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|C Chain C, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
Length = 227
Score = 53.9 bits (128), Expect = 3e-07, Method: Composition-based stats.
Identities = 38/139 (27%), Positives = 61/139 (43%), Gaps = 23/139 (16%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+ G G PWQ++L + LH CG L NE W +TAAHC ++
Sbjct: 1 IIDGAPCARGSHPWQVAL---LSGNQLH-CGGVLVNERWVLTAAHC-----------KMN 45
Query: 451 EHDLSTEEEPYGYQERRVQIVAS-----HPQFDPRTFEYDLALLRFYEPVKFQPNIIPIC 505
E+ + + G +RR Q + + HP + +T DL L++ + + +
Sbjct: 46 EYTVHLGSDTLG--DRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVR 103
Query: 506 VPEDDTNFVGTSAHVTGWG 524
+P GT+ V+GWG
Sbjct: 104 LPS-RCEPPGTTCTVSGWG 121
Score = 42.4 bits (98), Expect = 0.001, Method: Composition-based stats.
Identities = 20/46 (43%), Positives = 25/46 (54%), Gaps = 4/46 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
I+ G G PWQ++L + LH CG L NE W +TAAHC
Sbjct: 1 IIDGAPCARGSHPWQVAL---LSGNQLH-CGGVLVNERWVLTAAHC 42
>pdb|1KLT|A Chain A, Crystal Structure Of Pmsf-Treated Human Chymase At 1.9
Angstroms Resolution
Length = 226
Score = 53.5 bits (127), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 38/137 (27%), Positives = 61/137 (44%), Gaps = 9/137 (6%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG ++ P+ L + CG L N+ +TAAHC + + LG
Sbjct: 1 IIGGTESKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAG----RSITVTLG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H+++ EE+ +Q+ V HP+++ T +D+ LL+ E + + P
Sbjct: 57 AHNITEEEDT--WQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFP-SQ 113
Query: 511 TNFV--GTSAHVTGWGR 525
NFV G V GWGR
Sbjct: 114 FNFVPPGRMCRVAGWGR 130
>pdb|2WUB|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUB|C Chain C, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUC|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non- Inhibitory Antibody Fab40.Deltatrp And
Ac-Kqlr-Chloromethylketone
pdb|3K2U|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Inhibitory Antibody Fab40
Length = 257
Score = 53.5 bits (127), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 40/145 (27%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSD-LLLRL 449
I+GG + G PW ++ +I ++ C +L + W V+AAHC PP D + + L
Sbjct: 1 IIGGSSSLPGSHPWLAAI--YIGDSF---CAGSLVHTCWVVSAAHCFSHSPPRDSVSVVL 55
Query: 450 GEHDLS-TEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEP----VKFQPNIIPI 504
G+H + T + + + + F+P ++DL L+R + + PI
Sbjct: 56 GQHFFNRTTDVTQTFGIEKYIPYTLYSVFNPS--DHDLVLIRLKKKGDRCATRSQFVQPI 113
Query: 505 CVPEDDTNF-VGTSAHVTGWGRLYE 528
C+PE + F G + GWG L E
Sbjct: 114 CLPEPGSTFPAGHKCQIAGWGHLDE 138
Score = 31.2 bits (69), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 15/46 (32%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
I+GG + G PW ++ +I ++ C +L + W V+AAHC
Sbjct: 1 IIGGSSSLPGSHPWLAAI--YIGDSF---CAGSLVHTCWVVSAAHC 41
>pdb|2R0L|A Chain A, Short Form Hgfa With Inhibitory Fab75
Length = 248
Score = 53.5 bits (127), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 40/145 (27%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSD-LLLRL 449
I+GG + G PW ++ +I ++ C +L + W V+AAHC PP D + + L
Sbjct: 1 IIGGSSSLPGSHPWLAAI--YIGDSF---CAGSLVHTCWVVSAAHCFSHSPPRDSVSVVL 55
Query: 450 GEHDLS-TEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEP----VKFQPNIIPI 504
G+H + T + + + + F+P ++DL L+R + + PI
Sbjct: 56 GQHFFNRTTDVTQTFGIEKYIPYTLYSVFNPS--DHDLVLIRLKKKGDRCATRSQFVQPI 113
Query: 505 CVPEDDTNF-VGTSAHVTGWGRLYE 528
C+PE + F G + GWG L E
Sbjct: 114 CLPEPGSTFPAGHKCQIAGWGHLDE 138
Score = 31.2 bits (69), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 15/46 (32%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
I+GG + G PW ++ +I ++ C +L + W V+AAHC
Sbjct: 1 IIGGSSSLPGSHPWLAAI--YIGDSF---CAGSLVHTCWVVSAAHC 41
>pdb|1NN6|A Chain A, Human Pro-Chymase
Length = 228
Score = 53.1 bits (126), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 9/137 (6%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG + P+ L + CG L N+ +TAAHC + + LG
Sbjct: 3 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAG----RSITVTLG 58
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H+++ EE+ +Q+ V HP+++ T +D+ LL+ E + + P
Sbjct: 59 AHNITEEEDT--WQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFP-SQ 115
Query: 511 TNFV--GTSAHVTGWGR 525
NFV G V GWGR
Sbjct: 116 FNFVPPGRMCRVAGWGR 132
>pdb|4AFQ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFQ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFS|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFZ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFZ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AG1|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|B Chain B, Human Chymase - Fynomer Complex
Length = 226
Score = 53.1 bits (126), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 9/137 (6%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG + P+ L + CG L N+ +TAAHC + + LG
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAG----RSITVTLG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H+++ EE+ +Q+ V HP+++ T +D+ LL+ E + + P
Sbjct: 57 AHNITEEEDT--WQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFP-SQ 113
Query: 511 TNFV--GTSAHVTGWGR 525
NFV G V GWGR
Sbjct: 114 FNFVPPGRMCRVAGWGR 130
>pdb|3N7O|A Chain A, X-Ray Structure Of Human Chymase In Complex With Small
Molecule Inhibitor
Length = 226
Score = 53.1 bits (126), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 9/137 (6%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG + P+ L + CG L N+ +TAAHC + + LG
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAG----RSITVTLG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H+++ EE+ +Q+ V HP+++ T +D+ LL+ E + + P
Sbjct: 57 AHNITEEEDT--WQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFP-SQ 113
Query: 511 TNFV--GTSAHVTGWGR 525
NFV G V GWGR
Sbjct: 114 FNFVPPGRMCRVAGWGR 130
>pdb|1NPM|A Chain A, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
pdb|1NPM|B Chain B, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
Length = 225
Score = 52.8 bits (125), Expect = 6e-07, Method: Composition-based stats.
Identities = 36/127 (28%), Positives = 59/127 (46%), Gaps = 18/127 (14%)
Query: 403 PWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLGEHDLSTEEEPYG 462
PWQ +L Q R CG L + W +TAAHC + +RLG+H L + ++P
Sbjct: 13 PWQAALFQGERLI----CGGVLVGDRWVLTAAHCKK----QKYSVRLGDHSLQSRDQP-- 62
Query: 463 YQERRVQIVAS--HPQF---DPRTFEYDLALLRFYEPVKFQPNIIPICVPEDDTNFVGTS 517
E+ +Q+ S HP + +P +D+ L+R + P+ + + VG
Sbjct: 63 --EQEIQVAQSIQHPCYNNSNPEDHSHDIMLIRLQNSANLGDKVKPVQLA-NLCPKVGQK 119
Query: 518 AHVTGWG 524
++GWG
Sbjct: 120 CIISGWG 126
Score = 33.1 bits (74), Expect = 0.52, Method: Composition-based stats.
Identities = 16/40 (40%), Positives = 21/40 (52%), Gaps = 4/40 (10%)
Query: 575 PWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWS 614
PWQ +L Q R CG L + W +TAAHC + +S
Sbjct: 13 PWQAALFQGERLI----CGGVLVGDRWVLTAAHCKKQKYS 48
>pdb|3H7T|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
pdb|3H7T|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
Length = 235
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 44/190 (23%), Positives = 77/190 (40%), Gaps = 28/190 (14%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG+K+ K PW + + + CG ++ N+ +TAA CV+ PSD+ + G
Sbjct: 1 IIGGKKSDITKEPWAVGVLVDEKPF----CGGSILTANFVITAAQCVDGTKPSDISIHYG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNI-----IPIC 505
+T+ +++ IV H P T + + A++ P+K +P
Sbjct: 57 SSYRTTKGT--SVMAKKIYIVRYH----PLTMQNNYAVIETEMPIKLDDKTTKKIELPSL 110
Query: 506 V--PEDDTNFVGTSAHVTGWGRL------YEGRFRRSYGHPATRQEMATCWNHFLGNRIL 557
+ PE D TS V+GWG Y G + R+ + ++ +
Sbjct: 111 LYDPEPD-----TSVLVSGWGSTNFKSLEYSGDLMEANFTVVDRKSCEEQYKQIEADKYI 165
Query: 558 FPSSRIVGGE 567
+ GGE
Sbjct: 166 YDGVFCAGGE 175
Score = 35.4 bits (80), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 15/48 (31%), Positives = 26/48 (54%), Gaps = 4/48 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVE 610
I+GG+K+ K PW + + + CG ++ N+ +TAA CV+
Sbjct: 1 IIGGKKSDITKEPWAVGVLVDEKPF----CGGSILTANFVITAAQCVD 44
>pdb|1RTF|B Chain B, Complex Of Benzamidine With The Catalytic Domain Of Human
Two Chain Tissue Plasminogen Activator [(Tc)-T-Pa]
pdb|1A5H|A Chain A, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
pdb|1A5H|B Chain B, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
Length = 252
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 22/199 (11%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHK--CGAALFNENWAVTAAHCVED-VPPSDLLL 447
I GG A PWQ ++ R + + CG L + W ++AAHC ++ PP L +
Sbjct: 1 IKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLTV 60
Query: 448 RLGE--HDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEP----VKFQPNI 501
LG + EEE Q+ V+ H +FD T++ D+ALL+ + +
Sbjct: 61 ILGRTYRVVPGEEE----QKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVV 116
Query: 502 IPICVPEDDTNFVG-TSAHVTGWGR------LYEGRFRRSYG--HPATRQEMATCWNHFL 552
+C+P D T ++G+G+ Y R + ++ +P++R N +
Sbjct: 117 RTVCLPPADLQLPDWTECELSGYGKHEALSPFYSERLKEAHVRLYPSSRCTSQHLLNRTV 176
Query: 553 GNRILFPSSRIVGGEKATF 571
+ +L GG +A
Sbjct: 177 TDNMLCAGDTRSGGPQANL 195
Score = 30.4 bits (67), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 16/51 (31%), Positives = 25/51 (49%), Gaps = 2/51 (3%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHK--CGAALFNENWAVTAAHCVED 611
I GG A PWQ ++ R + + CG L + W ++AAHC ++
Sbjct: 1 IKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQE 51
>pdb|1A5I|A Chain A, Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva
Plasminogen Activator In Complex With Egr-Cmk
(Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/200 (26%), Positives = 84/200 (42%), Gaps = 28/200 (14%)
Query: 380 VCGRRLF--PSSRIVGGEKATFGKWPWQISLRQWIRSTYLHK--CGAALFNENWAVTAAH 435
CG R + P GG PWQ ++ R + + CG L + W +TAAH
Sbjct: 1 TCGLRKYKEPQLHSTGGLFTDITSHPWQAAIFAQNRRSSGERFLCGGILISSCWVLTAAH 60
Query: 436 CV-EDVPPSDLLLRLGE-HDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFY- 492
C E P L + LG + + EE Q +V+ H +FD T+ D+ALL+
Sbjct: 61 CFQESYLPDQLKVVLGRTYRVKPGEEE---QTFKVKKYIVHKEFDDDTYNNDIALLQLKS 117
Query: 493 ---EPVKFQPNIIPICVPEDDTNFVG-TSAHVTGWGR-----------LYEGRFRRSYGH 537
+ + ++ IC+PE + T ++G+G+ L EG R +
Sbjct: 118 DSPQCAQESDSVRAICLPEANLQLPDWTECELSGYGKHKSSSPFYSEQLKEGHVRL---Y 174
Query: 538 PATRQEMATCWNHFLGNRIL 557
P++R +N + N +L
Sbjct: 175 PSSRCAPKFLFNKTVTNNML 194
Score = 30.4 bits (67), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 16/57 (28%), Positives = 25/57 (43%), Gaps = 2/57 (3%)
Query: 559 PSSRIVGGEKATFGKWPWQISLRQWIRSTYLHK--CGAALFNENWAVTAAHCVEDLW 613
P GG PWQ ++ R + + CG L + W +TAAHC ++ +
Sbjct: 10 PQLHSTGGLFTDITSHPWQAAIFAQNRRSSGERFLCGGILISSCWVLTAAHCFQESY 66
>pdb|1FV9|A Chain A, Crystal Structure Of Human Microurokinase In Complex With
2- Amino-5-Hydroxy-Benzimidazole
Length = 245
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 44/145 (30%), Positives = 71/145 (48%), Gaps = 13/145 (8%)
Query: 391 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPS-DLLLR 448
I+GGE T PW ++ R+ + + CG +L + W ++A HC D P D ++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEY--DLALL--RFYEPVKFQPN--II 502
LG L++ + G + V+ + H + T + D+ALL R E QP+ I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 503 PICVPE--DDTNFVGTSAHVTGWGR 525
I +P +D F GTS +TG+G+
Sbjct: 119 TIALPSMYNDPQF-GTSCEITGFGK 142
Score = 33.9 bits (76), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 26/50 (52%), Gaps = 1/50 (2%)
Query: 563 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GGE T PW ++ R+ + + CG +L + W ++A HC D
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFID 50
>pdb|3MWI|U Chain U, The Complex Crystal Structure Of Urokianse And
5-Nitro-1h-Indole-2- Amidine
Length = 246
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 44/145 (30%), Positives = 71/145 (48%), Gaps = 13/145 (8%)
Query: 391 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPS-DLLLR 448
I+GGE T PW ++ R+ + + CG +L + W ++A HC D P D ++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEY--DLALL--RFYEPVKFQPN--II 502
LG L++ + G + V+ + H + T + D+ALL R E QP+ I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 503 PICVPE--DDTNFVGTSAHVTGWGR 525
I +P +D F GTS +TG+G+
Sbjct: 119 TIALPSMYNDPQF-GTSCEITGFGK 142
Score = 33.9 bits (76), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 26/50 (52%), Gaps = 1/50 (2%)
Query: 563 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GGE T PW ++ R+ + + CG +L + W ++A HC D
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFID 50
>pdb|2NWN|A Chain A, New Pharmacophore For Serine Protease Inhibition Revealed
By Crystal Structure Of Human Urokinase-Type Plasminogen
Activator Complexed With A Cyclic Peptidyl Inhibitor,
Upain-1
pdb|2O8T|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145Q) IN COMPLEX WITH
Inhibitors
pdb|3KGP|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KHV|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KID|U Chain U, The Crystal Structures Of 2-Aminobenzothiazole-Based
Inhibitors In Complexes With Urokinase-Type Plasminogen
Activator
pdb|3M61|U Chain U, Crystal Structure Of Complex Of Urokinase And A Upain-1
Variant(W3a) In Ph4.6 Condition
pdb|3OX7|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph4.6
pdb|3OY5|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph7.4
pdb|3OY6|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh036 At Ph4.6
pdb|3QN7|A Chain A, Potent And Selective Bicyclic Peptide Inhibitor (Uk18) Of
Human Urokinase-Type Plasminogen Activator(Upa)
Length = 253
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 44/145 (30%), Positives = 71/145 (48%), Gaps = 13/145 (8%)
Query: 391 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPS-DLLLR 448
I+GGE T PW ++ R+ + + CG +L + W ++A HC D P D ++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEY--DLALL--RFYEPVKFQPN--II 502
LG L++ + G + V+ + H + T + D+ALL R E QP+ I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 503 PICVPE--DDTNFVGTSAHVTGWGR 525
I +P +D F GTS +TG+G+
Sbjct: 119 TIALPSMYNDPQF-GTSCEITGFGK 142
Score = 33.9 bits (76), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 26/50 (52%), Gaps = 1/50 (2%)
Query: 563 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GGE T PW ++ R+ + + CG +L + W ++A HC D
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFID 50
>pdb|2O8U|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|2O8W|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|3PB1|E Chain E, Crystal Structure Of A Michaelis Complex Between
Plasminogen Activator Inhibitor-1 And Urokinase-Type
Plasminogen Activator
Length = 253
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 44/145 (30%), Positives = 71/145 (48%), Gaps = 13/145 (8%)
Query: 391 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPS-DLLLR 448
I+GGE T PW ++ R+ + + CG +L + W ++A HC D P D ++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEY--DLALL--RFYEPVKFQPN--II 502
LG L++ + G + V+ + H + T + D+ALL R E QP+ I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 503 PICVPE--DDTNFVGTSAHVTGWGR 525
I +P +D F GTS +TG+G+
Sbjct: 119 TIALPSMYNDPQF-GTSCEITGFGK 142
Score = 33.9 bits (76), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 26/50 (52%), Gaps = 1/50 (2%)
Query: 563 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GGE T PW ++ R+ + + CG +L + W ++A HC D
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFID 50
>pdb|1EJN|A Chain A, Urokinase Plasminogen Activator B-Chain Inhibitor Complex
pdb|1F5K|U Chain U, Urokinase Plasminogen Activator B-Chain-Benzamidine
Complex
pdb|1F5L|A Chain A, Urokinase Plasminogen Activator B-Chain-Amiloride Complex
pdb|1F92|A Chain A, Urokinase Plasminogen Activator B Chain-Uki-1d Complex
pdb|2R2W|U Chain U, Urokinase Plasminogen Activator B-Chain-Gppe Complex
pdb|2VIN|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIO|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIP|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIQ|A Chain A, Fragment-based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-type
Plasminogen Activator
pdb|2VIV|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIW|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
Length = 253
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 44/145 (30%), Positives = 71/145 (48%), Gaps = 13/145 (8%)
Query: 391 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPS-DLLLR 448
I+GGE T PW ++ R+ + + CG +L + W ++A HC D P D ++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEY--DLALL--RFYEPVKFQPN--II 502
LG L++ + G + V+ + H + T + D+ALL R E QP+ I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 503 PICVPE--DDTNFVGTSAHVTGWGR 525
I +P +D F GTS +TG+G+
Sbjct: 119 TISLPSMYNDPQF-GTSCEITGFGK 142
Score = 33.9 bits (76), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 26/50 (52%), Gaps = 1/50 (2%)
Query: 563 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GGE T PW ++ R+ + + CG +L + W ++A HC D
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFID 50
>pdb|4FU7|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU8|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU9|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUB|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUC|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUD|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUE|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUF|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUG|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUH|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUI|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUJ|A Chain A, Crystal Structure Of The Urokinase
pdb|4DVA|U Chain U, The Crystal Structure Of Human Urokinase-type Plasminogen
Activator Catalytic Domain
pdb|4DW2|U Chain U, The Crystal Structure Of Upa In Complex With The Fab
Fragment Of Mab- 112
Length = 246
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 44/145 (30%), Positives = 71/145 (48%), Gaps = 13/145 (8%)
Query: 391 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPS-DLLLR 448
I+GGE T PW ++ R+ + + CG +L + W ++A HC D P D ++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEY--DLALL--RFYEPVKFQPN--II 502
LG L++ + G + V+ + H + T + D+ALL R E QP+ I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 503 PICVPE--DDTNFVGTSAHVTGWGR 525
I +P +D F GTS +TG+G+
Sbjct: 119 TIALPSMYNDPQF-GTSCEITGFGK 142
Score = 33.9 bits (76), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 26/50 (52%), Gaps = 1/50 (2%)
Query: 563 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GGE T PW ++ R+ + + CG +L + W ++A HC D
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFID 50
>pdb|1W0Z|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W10|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W11|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W12|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W13|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W14|U Chain U, Urokinase Type Plasminogen Activator
pdb|3MHW|U Chain U, The Complex Crystal Structure Of Urokianse And 2-
Aminobenzothiazole
Length = 247
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 44/145 (30%), Positives = 71/145 (48%), Gaps = 13/145 (8%)
Query: 391 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPS-DLLLR 448
I+GGE T PW ++ R+ + + CG +L + W ++A HC D P D ++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEY--DLALL--RFYEPVKFQPN--II 502
LG L++ + G + V+ + H + T + D+ALL R E QP+ I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 503 PICVPE--DDTNFVGTSAHVTGWGR 525
I +P +D F GTS +TG+G+
Sbjct: 119 TISLPSMYNDPQF-GTSCEITGFGK 142
Score = 33.9 bits (76), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 26/50 (52%), Gaps = 1/50 (2%)
Query: 563 IVGGEKATFGKWPWQISL-RQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GGE T PW ++ R+ + + CG +L + W ++A HC D
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFID 50
>pdb|1AU8|A Chain A, Human Cathepsin G
pdb|1T32|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|1CGH|A Chain A, Human Cathepsin G
Length = 224
Score = 50.4 bits (119), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 41/137 (29%), Positives = 65/137 (47%), Gaps = 8/137 (5%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG ++ P+ L Q +CG L E++ +TAAHC S++ + LG
Sbjct: 1 IIGGRESRPHSRPYMAYL-QIQSPAGQSRCGGFLVREDFVLTAAHCWG----SNINVTLG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H++ E + R I HPQ++ RT + D+ LL+ V+ N+ P+ +P
Sbjct: 56 AHNIQRRENTQQHITARRAI--RHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPRAQ 113
Query: 511 TNFV-GTSAHVTGWGRL 526
GT V GWGR+
Sbjct: 114 EGLRPGTLCTVAGWGRV 130
>pdb|1PPZ|A Chain A, Trypsin Complexes At Atomic And Ultra-High Resolution
pdb|1PQA|A Chain A, Trypsin With Pmsf At Atomic Resolution
Length = 224
Score = 50.4 bits (119), Expect = 3e-06, Method: Composition-based stats.
Identities = 43/144 (29%), Positives = 63/144 (43%), Gaps = 20/144 (13%)
Query: 391 IVGGEKATFGKWPWQISLRQ----WIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLL 446
IVGG A+ G +P+ +S+ + W CG +L N N +TAAHCV S
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGPW--------CGGSLLNANTVLTAAHCVSGYAQSGFQ 52
Query: 447 LRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICV 506
+R G ++ G + V HP + DLA+L+ + NI +
Sbjct: 53 IRAGSLSRTS-----GGITSSLSSVRVHPSYSGNN--NDLAILKLSTSIPSGGNIGYARL 105
Query: 507 PEDDTNFV-GTSAHVTGWGRLYEG 529
++ V G+SA V GWG EG
Sbjct: 106 AASGSDPVAGSSATVAGWGATSEG 129
Score = 37.4 bits (85), Expect = 0.028, Method: Composition-based stats.
Identities = 20/51 (39%), Positives = 28/51 (54%), Gaps = 12/51 (23%)
Query: 563 IVGGEKATFGKWPWQISLRQ----WIRSTYLHKCGAALFNENWAVTAAHCV 609
IVGG A+ G +P+ +S+ + W CG +L N N +TAAHCV
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGPW--------CGGSLLNANTVLTAAHCV 43
>pdb|2PSX|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin
pdb|2PSY|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin And Zinc
Length = 227
Score = 50.4 bits (119), Expect = 3e-06, Method: Composition-based stats.
Identities = 41/134 (30%), Positives = 60/134 (44%), Gaps = 9/134 (6%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+ G PWQ +L +R L+ CGA L + W +TAAHC + V +RLG
Sbjct: 1 IINGSDCDMHTQPWQAAL--LLRPNQLY-CGAVLVHPQWLLTAAHCRKKV----FRVRLG 53
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
+ LS E G Q + HP + DL L++ ++ ++ PI V
Sbjct: 54 HYSLSPVYES-GQQMFQGVKSIPHPGYSHPGHSNDLMLIKLNRRIRPTKDVRPINVSSHC 112
Query: 511 TNFVGTSAHVTGWG 524
+ GT V+GWG
Sbjct: 113 PS-AGTKCLVSGWG 125
Score = 35.0 bits (79), Expect = 0.15, Method: Composition-based stats.
Identities = 18/46 (39%), Positives = 24/46 (52%), Gaps = 3/46 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
I+ G PWQ +L +R L+ CGA L + W +TAAHC
Sbjct: 1 IINGSDCDMHTQPWQAAL--LLRPNQLY-CGAVLVHPQWLLTAAHC 43
>pdb|1GDU|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1PQ5|A Chain A, Trypsin At Ph 5, 0.85 A
pdb|1PQ7|A Chain A, Trypsin At 0.8 A, Ph5 BORAX
pdb|1PQ8|A Chain A, Trypsin At Ph 4 At Atomic Resolution
pdb|2G51|A Chain A, Anomalous Substructure Of Trypsin (P1)
pdb|2G52|A Chain A, Anomalous Substructure Of Trypsin (P21)
pdb|1TRY|A Chain A, Structure Of Inhibited Trypsin From Fusarium Oxysporum At
1.55 Angstroms
pdb|2VU8|E Chain E, Crystal Structure Of An Insect Inhibitor With A Fungal
Trypsin
Length = 224
Score = 50.4 bits (119), Expect = 3e-06, Method: Composition-based stats.
Identities = 43/144 (29%), Positives = 63/144 (43%), Gaps = 20/144 (13%)
Query: 391 IVGGEKATFGKWPWQISLRQ----WIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLL 446
IVGG A+ G +P+ +S+ + W CG +L N N +TAAHCV S
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGPW--------CGGSLLNANTVLTAAHCVSGYAQSGFQ 52
Query: 447 LRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICV 506
+R G ++ G + V HP + DLA+L+ + NI +
Sbjct: 53 IRAGSLSRTS-----GGITSSLSSVRVHPSYSGNN--NDLAILKLSTSIPSGGNIGYARL 105
Query: 507 PEDDTNFV-GTSAHVTGWGRLYEG 529
++ V G+SA V GWG EG
Sbjct: 106 AASGSDPVAGSSATVAGWGATSEG 129
Score = 37.4 bits (85), Expect = 0.028, Method: Composition-based stats.
Identities = 20/51 (39%), Positives = 28/51 (54%), Gaps = 12/51 (23%)
Query: 563 IVGGEKATFGKWPWQISLRQ----WIRSTYLHKCGAALFNENWAVTAAHCV 609
IVGG A+ G +P+ +S+ + W CG +L N N +TAAHCV
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGPW--------CGGSLLNANTVLTAAHCV 43
>pdb|4GSO|A Chain A, Structure Of Jararacussin-I
Length = 232
Score = 50.4 bits (119), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 30/136 (22%), Positives = 63/136 (46%), Gaps = 11/136 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
++GG++ + P+ L ++ + CG L N+ W VTAAHC ++ ++LG
Sbjct: 1 VLGGDECDINEHPFLAFLY-----SHGYFCGLTLINQEWVVTAAHCDS----TNFQMQLG 51
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H E + + + + + + D+ L++ +P+ +I P+ +P +
Sbjct: 52 VHSKKVLNEDEQTRNPKEKFICPNKNMS-EVLDKDIMLIKLDKPISNSKHIAPLSLPSNP 110
Query: 511 TNFVGTSAHVTGWGRL 526
+ VG+ + GWG +
Sbjct: 111 PS-VGSVCRIMGWGSI 125
Score = 32.3 bits (72), Expect = 0.98, Method: Compositional matrix adjust.
Identities = 15/46 (32%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
++GG++ + P+ L ++ + CG L N+ W VTAAHC
Sbjct: 1 VLGGDECDINEHPFLAFLY-----SHGYFCGLTLINQEWVVTAAHC 41
>pdb|2XRC|A Chain A, Human Complement Factor I
pdb|2XRC|B Chain B, Human Complement Factor I
pdb|2XRC|C Chain C, Human Complement Factor I
pdb|2XRC|D Chain D, Human Complement Factor I
Length = 565
Score = 50.4 bits (119), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 45/171 (26%), Positives = 72/171 (42%), Gaps = 12/171 (7%)
Query: 390 RIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRL 449
RIVGG++A G PWQ++++ T CG W +TAAHC+ +
Sbjct: 321 RIVGGKRAQLGDLPWQVAIKDASGIT----CGGIYIGGCWILTAAHCLRASKTHRYQIWT 376
Query: 450 GEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQ----PNIIPIC 505
D + E +I+ H ++ T++ D+AL+ + + P IP C
Sbjct: 377 TVVDWIHPDLKRIVIEYVDRIIF-HENYNAGTYQNDIALIEMKKDGNKKDCELPRSIPAC 435
Query: 506 VPEDDTNFV-GTSAHVTGWGRLYEGRFRRSYGHPATRQEMATCWNHFLGNR 555
VP F + V+GWGR E R + ++ + + F GNR
Sbjct: 436 VPWSPYLFQPNDTCIVSGWGR--EKDNERVFSLQWGEVKLISNCSKFYGNR 484
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 23/77 (29%), Positives = 37/77 (48%), Gaps = 11/77 (14%)
Query: 552 LGNRILFPSSRIVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVE- 610
+ NR+ RIVGG++A G PWQ++++ T CG W +TAAHC+
Sbjct: 311 VKNRMHIRRKRIVGGKRAQLGDLPWQVAIKDASGIT----CGGIYIGGCWILTAAHCLRA 366
Query: 611 ------DLWSQIIPIIQ 621
+W+ ++ I
Sbjct: 367 SKTHRYQIWTTVVDWIH 383
>pdb|1KYN|B Chain B, Cathepsin-G
pdb|1KYN|A Chain A, Cathepsin-G
Length = 235
Score = 50.4 bits (119), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 41/137 (29%), Positives = 65/137 (47%), Gaps = 8/137 (5%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG ++ P+ L Q +CG L E++ +TAAHC S++ + LG
Sbjct: 1 IIGGRESRPHSRPYMAYL-QIQSPAGQSRCGGFLVREDFVLTAAHCWG----SNINVTLG 55
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H++ E + R I HPQ++ RT + D+ LL+ V+ N+ P+ +P
Sbjct: 56 AHNIQRRENTQQHITARRAI--RHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPRAQ 113
Query: 511 TNFV-GTSAHVTGWGRL 526
GT V GWGR+
Sbjct: 114 EGLRPGTLCTVAGWGRV 130
>pdb|3FZZ|A Chain A, Structure Of Grc
pdb|3FZZ|B Chain B, Structure Of Grc
Length = 227
Score = 49.7 bits (117), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 66/155 (42%), Gaps = 14/155 (9%)
Query: 420 CGAALFNENWAVTAAHCVEDVPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDP 479
CG L + + +TAAHC + + LG H++ +EE Q V HP ++P
Sbjct: 30 CGGFLVRDKFVLTAAHC----KGRSMTVTLGAHNIKAKEET--QQIIPVAKAIPHPDYNP 83
Query: 480 RTFEYDLALLRFYEPVKFQPNIIPICVPEDDTNFV-GTSAHVTGWGRLY-EGRFRRSYGH 537
D+ LL+ K + P+ +P + + G +V GWG++ +G F ++
Sbjct: 84 DDRSNDIMLLKLVRNAKRTRAVRPLNLPRRNAHVKPGDECYVAGWGKVTPDGEFPKTLHE 143
Query: 538 -PATRQEMATCWNHF-----LGNRILFPSSRIVGG 566
T Q+ C + F N I S+I G
Sbjct: 144 VKLTVQKDQVCESQFQSSYNRANEICVGDSKIKGA 178
>pdb|3G01|A Chain A, Structure Of Grc Mutant E192rE193G
pdb|3G01|B Chain B, Structure Of Grc Mutant E192rE193G
Length = 227
Score = 49.7 bits (117), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 40/154 (25%), Positives = 66/154 (42%), Gaps = 14/154 (9%)
Query: 420 CGAALFNENWAVTAAHCVEDVPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDP 479
CG L + + +TAAHC + + LG H++ +EE Q V HP ++P
Sbjct: 30 CGGFLVRDKFVLTAAHC----KGRSMTVTLGAHNIKAKEET--QQIIPVAKAIPHPDYNP 83
Query: 480 RTFEYDLALLRFYEPVKFQPNIIPICVPEDDTNFV-GTSAHVTGWGRLY-EGRFRRSYGH 537
D+ LL+ K + P+ +P + + G +V GWG++ +G F ++
Sbjct: 84 DDRSNDIMLLKLVRNAKRTRAVRPLNLPRRNAHVKPGDECYVAGWGKVTPDGEFPKTLHE 143
Query: 538 -PATRQEMATCWNHF-----LGNRILFPSSRIVG 565
T Q+ C + F N I S+I G
Sbjct: 144 VKLTVQKDQVCESQFQSSYNRANEICVGDSKIKG 177
>pdb|2RDL|A Chain A, Hamster Chymase 2
pdb|2RDL|B Chain B, Hamster Chymase 2
Length = 226
Score = 49.3 bits (116), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 35/137 (25%), Positives = 58/137 (42%), Gaps = 9/137 (6%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG + P+ L +L C L N+ +TAAHC + + LG
Sbjct: 1 IIGGTECRPHARPYMAYLEIVTPENHLSACSGFLIRRNFVMTAAHCAG----RSITVLLG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNI--IPICVPE 508
H+ +E+ +Q+ V+ HP++D R D+ LL+ E + +PI +
Sbjct: 57 AHNKKVKED--TWQKLEVEKQFPHPKYDDRLVLNDIMLLKLKEKANLTLGVGTLPISA-K 113
Query: 509 DDTNFVGTSAHVTGWGR 525
++ G GWGR
Sbjct: 114 SNSIPPGRVCRAVGWGR 130
>pdb|3H7O|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
pdb|3H7O|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
Length = 228
Score = 49.3 bits (116), Expect = 7e-06, Method: Composition-based stats.
Identities = 38/140 (27%), Positives = 64/140 (45%), Gaps = 19/140 (13%)
Query: 393 GGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLGEH 452
GGEK + PW +++R + L CG A+ ++ + +TAAHCV D P ++++
Sbjct: 2 GGEKTDIKQVPWTVAVRTYPGEESL-TCGGAILSQWFVLTAAHCVFDQKPETIVIQYEST 60
Query: 453 DLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKF-----QPNIIPICVP 507
+L E+P + S + T E D+A+L P+K +P +P
Sbjct: 61 NLW--EDPGKSDPYVSHVYLSF--YRQETMENDIAILELSRPLKLDGLKSKPAKLP---- 112
Query: 508 EDDTNF---VGTSAHVTGWG 524
D F G+ V+G+G
Sbjct: 113 --DIEFRPKTGSDVLVSGYG 130
Score = 43.1 bits (100), Expect = 5e-04, Method: Composition-based stats.
Identities = 23/68 (33%), Positives = 37/68 (54%), Gaps = 5/68 (7%)
Query: 565 GGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDLWSQIIPIIQNCR 624
GGEK + PW +++R + L CG A+ ++ + +TAAHCV D + I I +
Sbjct: 2 GGEKTDIKQVPWTVAVRTYPGEESL-TCGGAILSQWFVLTAAHCVFDQKPETIVI----Q 56
Query: 625 RRESNLWK 632
+NLW+
Sbjct: 57 YESTNLWE 64
>pdb|1PPG|E Chain E, The Refined 2.3 Angstroms Crystal Structure Of Human
Leukocyte Elastase In A Complex With A Valine
Chloromethyl Ketone Inhibitor
pdb|1H1B|A Chain A, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|1H1B|B Chain B, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|2Z7F|E Chain E, Crystal Structure Of The Complex Of Human Neutrophil
Elastase With 12SLPI
pdb|3Q76|A Chain A, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q76|B Chain B, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q77|A Chain A, Structure Of Human Neutrophil Elastase In Complex With A
Dihydropyrimidone Inhibitor
Length = 218
Score = 49.3 bits (116), Expect = 8e-06, Method: Composition-based stats.
Identities = 43/141 (30%), Positives = 63/141 (44%), Gaps = 8/141 (5%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG +A WP+ +SL+ +R H CGA L N+ ++AAHCV +V + + LG
Sbjct: 1 IVGGRRARPHAWPFMVSLQ--LRGG--HFCGATLIAPNFVMSAAHCVANVNVRAVRVVLG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H+LS E Q VQ + + +DP D+ +L+ N+ +P
Sbjct: 57 AHNLSRREPT--RQVFAVQRIFEN-GYDPVNLLNDIVILQLNGSATINANVQVAQLPAQG 113
Query: 511 TNF-VGTSAHVTGWGRLYEGR 530
G GWG L R
Sbjct: 114 RRLGNGVQCLAMGWGLLGRNR 134
Score = 39.7 bits (91), Expect = 0.006, Method: Composition-based stats.
Identities = 20/46 (43%), Positives = 28/46 (60%), Gaps = 4/46 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG +A WP+ +SL+ +R H CGA L N+ ++AAHC
Sbjct: 1 IVGGRRARPHAWPFMVSLQ--LRGG--HFCGATLIAPNFVMSAAHC 42
>pdb|1PPF|E Chain E, X-Ray Crystal Structure Of The Complex Of Human Leukocyte
Elastase (Pmn Elastase) And The Third Domain Of The
Turkey Ovomucoid Inhibitor
Length = 218
Score = 49.3 bits (116), Expect = 8e-06, Method: Composition-based stats.
Identities = 43/141 (30%), Positives = 63/141 (44%), Gaps = 8/141 (5%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG +A WP+ +SL+ +R H CGA L N+ ++AAHCV +V + + LG
Sbjct: 1 IVGGRRARPHAWPFMVSLQ--LRGG--HFCGATLIAPNFVMSAAHCVANVNVRAVRVVLG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H+LS E Q VQ + + +DP D+ +L+ N+ +P
Sbjct: 57 AHNLSRREPT--RQVFAVQRIFEN-GYDPVNLLNDIVILQLNGSATINANVQVAQLPAQG 113
Query: 511 TNF-VGTSAHVTGWGRLYEGR 530
G GWG L R
Sbjct: 114 RRLGNGVQCLAMGWGLLGRNR 134
Score = 39.7 bits (91), Expect = 0.006, Method: Composition-based stats.
Identities = 20/46 (43%), Positives = 28/46 (60%), Gaps = 4/46 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG +A WP+ +SL+ +R H CGA L N+ ++AAHC
Sbjct: 1 IVGGRRARPHAWPFMVSLQ--LRGG--HFCGATLIAPNFVMSAAHC 42
>pdb|2RG3|A Chain A, Covalent Complex Structure Of Elastase
Length = 218
Score = 49.3 bits (116), Expect = 8e-06, Method: Composition-based stats.
Identities = 43/141 (30%), Positives = 63/141 (44%), Gaps = 8/141 (5%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG +A WP+ +SL+ +R H CGA L N+ ++AAHCV +V + + LG
Sbjct: 1 IVGGRRARPHAWPFMVSLQ--LRGG--HFCGATLIAPNFVMSAAHCVANVNVRAVRVVLG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H+LS E Q VQ + + +DP D+ +L+ N+ +P
Sbjct: 57 AHNLSRREPT--RQVFAVQRIFEN-GYDPVNLLNDIVILQLNGSATINANVQVAQLPAQG 113
Query: 511 TNF-VGTSAHVTGWGRLYEGR 530
G GWG L R
Sbjct: 114 RRLGNGVQCLAMGWGLLGRNR 134
Score = 39.7 bits (91), Expect = 0.006, Method: Composition-based stats.
Identities = 20/46 (43%), Positives = 28/46 (60%), Gaps = 4/46 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG +A WP+ +SL+ +R H CGA L N+ ++AAHC
Sbjct: 1 IVGGRRARPHAWPFMVSLQ--LRGG--HFCGATLIAPNFVMSAAHC 42
>pdb|1HNE|E Chain E, Structure Of Human Neutrophil Elastase In Complex With A
Peptide Chloromethyl Ketone Inhibitor At 1.84-Angstroms
Resolution
Length = 218
Score = 48.9 bits (115), Expect = 1e-05, Method: Composition-based stats.
Identities = 43/143 (30%), Positives = 62/143 (43%), Gaps = 12/143 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG +A WP+ +SL+ +R H CGA L N+ ++AAHCV +V + + LG
Sbjct: 1 IVGGRRARPHAWPFMVSLQ--LRGG--HFCGATLIAPNFVMSAAHCVANVNVRAVRVVLG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVAS--HPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
H+LS E R+V V +DP D+ +L+ N+ +P
Sbjct: 57 AHNLSRREP-----TRQVFAVQRIFEDGYDPVNLLNDIVILQLNGSATINANVQVAQLPA 111
Query: 509 DDTNF-VGTSAHVTGWGRLYEGR 530
G GWG L R
Sbjct: 112 QGRRLGNGVQCLAMGWGLLGRNR 134
Score = 39.7 bits (91), Expect = 0.006, Method: Composition-based stats.
Identities = 20/46 (43%), Positives = 28/46 (60%), Gaps = 4/46 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG +A WP+ +SL+ +R H CGA L N+ ++AAHC
Sbjct: 1 IVGGRRARPHAWPFMVSLQ--LRGG--HFCGATLIAPNFVMSAAHC 42
>pdb|1XVM|A Chain A, Trypsin From Fusarium Oxysporum- Room Temperature To
Atomic Resolution
pdb|1XVO|A Chain A, Trypsin From Fusarium Oxysporum At Ph 6
pdb|1FY5|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDN|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FY4|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FN8|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDQ|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
Length = 224
Score = 48.9 bits (115), Expect = 1e-05, Method: Composition-based stats.
Identities = 42/143 (29%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 392 VGGEKATFGKWPWQISLRQ----WIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLL 447
VGG A+ G +P+ +S+ + W CG +L N N +TAAHCV S +
Sbjct: 2 VGGTSASAGDFPFIVSISRNGGPW--------CGGSLLNANTVLTAAHCVSGYAQSGFQI 53
Query: 448 RLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP 507
R G ++ G + V HP + DLA+L+ + NI +
Sbjct: 54 RAGSLSRTS-----GGITSSLSSVRVHPSYSGNN--NDLAILKLSTSIPSGGNIGYARLA 106
Query: 508 EDDTNFV-GTSAHVTGWGRLYEG 529
++ V G+SA V GWG EG
Sbjct: 107 ASGSDPVAGSSATVAGWGATSEG 129
Score = 35.8 bits (81), Expect = 0.090, Method: Composition-based stats.
Identities = 19/50 (38%), Positives = 27/50 (54%), Gaps = 12/50 (24%)
Query: 564 VGGEKATFGKWPWQISLRQ----WIRSTYLHKCGAALFNENWAVTAAHCV 609
VGG A+ G +P+ +S+ + W CG +L N N +TAAHCV
Sbjct: 2 VGGTSASAGDFPFIVSISRNGGPW--------CGGSLLNANTVLTAAHCV 43
>pdb|2XWB|F Chain F, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|H Chain H, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 732
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 34/121 (28%), Positives = 59/121 (48%), Gaps = 24/121 (19%)
Query: 399 FGKWPWQISLRQWIRSTYLHK-CGAALFNENWAVTAAHC--VEDVPPSDLLLRLGEHDLS 455
+ K PWQ + IR + H+ C A+ +E + +TAAHC V+D S + GE
Sbjct: 456 YHKQPWQAKI-SVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEK--- 511
Query: 456 TEEEPYGYQERRVQIVASHPQFD---------PRTFEYDLALLRFYEPVKFQPNIIPICV 506
++ +++V HP ++ P ++YD+AL++ +K+ I PIC+
Sbjct: 512 --------RDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICL 563
Query: 507 P 507
P
Sbjct: 564 P 564
>pdb|2OK5|A Chain A, Human Complement Factor B
Length = 752
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 34/121 (28%), Positives = 59/121 (48%), Gaps = 24/121 (19%)
Query: 399 FGKWPWQISLRQWIRSTYLHK-CGAALFNENWAVTAAHC--VEDVPPSDLLLRLGEHDLS 455
+ K PWQ + IR + H+ C A+ +E + +TAAHC V+D S + GE
Sbjct: 475 YHKQPWQAKI-SVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEK--- 530
Query: 456 TEEEPYGYQERRVQIVASHPQFD---------PRTFEYDLALLRFYEPVKFQPNIIPICV 506
++ +++V HP ++ P ++YD+AL++ +K+ I PIC+
Sbjct: 531 --------RDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICL 582
Query: 507 P 507
P
Sbjct: 583 P 583
>pdb|3HRZ|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|I Chain I, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|2XWJ|I Chain I, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|J Chain J, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|K Chain K, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|L Chain L, Crystal Structure Of Complement C3b In Complex With Factor
B
Length = 741
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 34/121 (28%), Positives = 59/121 (48%), Gaps = 24/121 (19%)
Query: 399 FGKWPWQISLRQWIRSTYLHK-CGAALFNENWAVTAAHC--VEDVPPSDLLLRLGEHDLS 455
+ K PWQ + IR + H+ C A+ +E + +TAAHC V+D S + GE
Sbjct: 465 YHKQPWQAKI-SVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEK--- 520
Query: 456 TEEEPYGYQERRVQIVASHPQFD---------PRTFEYDLALLRFYEPVKFQPNIIPICV 506
++ +++V HP ++ P ++YD+AL++ +K+ I PIC+
Sbjct: 521 --------RDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICL 572
Query: 507 P 507
P
Sbjct: 573 P 573
>pdb|1RRK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
pdb|1RS0|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With Di-Isopropyl-Phosphate (Dip)
pdb|1RTK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With 4-Guanidinobenzoic Acid
Length = 497
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 35/123 (28%), Positives = 60/123 (48%), Gaps = 28/123 (22%)
Query: 399 FGKWPWQISLRQWIRSTYLHK-CGAALFNENWAVTAAHC--VEDVPPSDLLLRLGEHDLS 455
+ K PWQ + IR + H+ C A+ +E + +TAAHC V+D EH +
Sbjct: 223 YHKQPWQAKI-SVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDD----------KEHSIK 271
Query: 456 TEEEPYGYQER--RVQIVASHPQFD---------PRTFEYDLALLRFYEPVKFQPNIIPI 504
G ++R +++V HP ++ P ++YD+AL++ +K+ I PI
Sbjct: 272 VS---VGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPI 328
Query: 505 CVP 507
C+P
Sbjct: 329 CLP 331
>pdb|2WIN|I Chain I, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|J Chain J, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|K Chain K, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|L Chain L, C3 Convertase (C3bbb) Stabilized By Scin
Length = 507
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 35/123 (28%), Positives = 60/123 (48%), Gaps = 28/123 (22%)
Query: 399 FGKWPWQISLRQWIRSTYLHK-CGAALFNENWAVTAAHC--VEDVPPSDLLLRLGEHDLS 455
+ K PWQ + IR + H+ C A+ +E + +TAAHC V+D EH +
Sbjct: 231 YHKQPWQAKI-SVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDD----------KEHSIK 279
Query: 456 TEEEPYGYQER--RVQIVASHPQFD---------PRTFEYDLALLRFYEPVKFQPNIIPI 504
G ++R +++V HP ++ P ++YD+AL++ +K+ I PI
Sbjct: 280 VS---VGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPI 336
Query: 505 CVP 507
C+P
Sbjct: 337 CLP 339
>pdb|1MZA|A Chain A, Crystal Structure Of Human Pro-Granzyme K
pdb|1MZD|A Chain A, Crystal Structure Of Human Pro-Granzyme K
Length = 240
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 39/148 (26%), Positives = 62/148 (41%), Gaps = 13/148 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC----VEDVPPSDLL 446
I+GG++ + P+ S++ H CG L + W +TAAHC + P+
Sbjct: 3 IIGGKEVSPHSRPFMASIQYGGH----HVCGGVLIDPQWVLTAAHCQYRFTKGQSPT--- 55
Query: 447 LRLGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICV 506
+ LG H LS E E + I S DP++ D+ L++ K ++ + +
Sbjct: 56 VVLGAHSLSKNEASKQTLEIKKFIPFSRVTSDPQS--NDIMLVKLQTAAKLNKHVKMLHI 113
Query: 507 PEDDTNFVGTSAHVTGWGRLYEGRFRRS 534
+ GT VTGWG R S
Sbjct: 114 RSKTSLRSGTKCKVTGWGATDPDSLRPS 141
Score = 33.1 bits (74), Expect = 0.50, Method: Compositional matrix adjust.
Identities = 23/64 (35%), Positives = 32/64 (50%), Gaps = 6/64 (9%)
Query: 631 WKMALADGPLPS-VLQEVSVPVINNSLC--ETMYRAAGFIEHIPEIFICAGWRKGSFDSC 687
W D PS L+EV+V V++ LC ++ Y FI + +CAG KG DSC
Sbjct: 130 WGATDPDSLRPSDTLREVTVTVLSRKLCNSQSYYNGDPFIT---KDMVCAGDAKGQKDSC 186
Query: 688 EEHA 691
+ A
Sbjct: 187 KGDA 190
Score = 32.3 bits (72), Expect = 0.99, Method: Compositional matrix adjust.
Identities = 15/46 (32%), Positives = 24/46 (52%), Gaps = 4/46 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
I+GG++ + P+ S++ H CG L + W +TAAHC
Sbjct: 3 IIGGKEVSPHSRPFMASIQYGGH----HVCGGVLIDPQWVLTAAHC 44
>pdb|1DLE|A Chain A, Factor B Serine Protease Domain
pdb|1DLE|B Chain B, Factor B Serine Protease Domain
Length = 298
Score = 48.1 bits (113), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 35/123 (28%), Positives = 60/123 (48%), Gaps = 28/123 (22%)
Query: 399 FGKWPWQISLRQWIRSTYLHK-CGAALFNENWAVTAAHC--VEDVPPSDLLLRLGEHDLS 455
+ K PWQ + IR + H+ C A+ +E + +TAAHC V+D EH +
Sbjct: 24 YHKQPWQAKI-SVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDD----------KEHSIK 72
Query: 456 TEEEPYGYQER--RVQIVASHPQFD---------PRTFEYDLALLRFYEPVKFQPNIIPI 504
G ++R +++V HP ++ P ++YD+AL++ +K+ I PI
Sbjct: 73 VS---VGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPI 129
Query: 505 CVP 507
C+P
Sbjct: 130 CLP 132
>pdb|2HNT|C Chain C, Crystallographic Structure Of Human Gamma-Thrombin
Length = 70
Score = 47.8 bits (112), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 26/68 (38%), Positives = 40/68 (58%), Gaps = 8/68 (11%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV------EDVPPSD 444
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+ ++ +D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 445 LLLRLGEH 452
LL+R+G+H
Sbjct: 59 LLVRIGKH 66
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
IV G A G PWQ+ L + +S CGA+L ++ W +TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFR--KSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1B0F|A Chain A, Crystal Structure Of Human Neutrophil Elastase With Mdl
101, 146
Length = 218
Score = 47.4 bits (111), Expect = 3e-05, Method: Composition-based stats.
Identities = 42/143 (29%), Positives = 60/143 (41%), Gaps = 12/143 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
IVGG +A WP+ +SL+ H CGA L N+ ++AAHCV +V + + LG
Sbjct: 1 IVGGRRARPHAWPFMVSLQL----AGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVAS--HPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
H+LS E R+V V +DP D+ +L+ N+ +P
Sbjct: 57 AHNLSRREP-----TRQVFAVQRIFEDGYDPVNLLNDIVILQLNGSATINANVQVAQLPA 111
Query: 509 DDTNF-VGTSAHVTGWGRLYEGR 530
G GWG L R
Sbjct: 112 QGRRLGNGVQCLAMGWGLLGRNR 134
Score = 38.1 bits (87), Expect = 0.017, Method: Composition-based stats.
Identities = 19/46 (41%), Positives = 26/46 (56%), Gaps = 4/46 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG +A WP+ +SL+ H CGA L N+ ++AAHC
Sbjct: 1 IVGGRRARPHAWPFMVSLQL----AGGHFCGATLIAPNFVMSAAHC 42
>pdb|2AIP|A Chain A, Crystal Structure Of Native Protein C Activator From The
Venom Of Copperhead Snake Agkistrodon Contortrix
Contortrix
pdb|2AIQ|A Chain A, Crystal Structure Of Benzamidine-Inhibited Protein C
Activator From The Venom Of Copperhead Snake Agkistrodon
Contortrix Contortrix
Length = 231
Score = 46.6 bits (109), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 27/107 (25%), Positives = 52/107 (48%), Gaps = 6/107 (5%)
Query: 420 CGAALFNENWAVTAAHCVEDVPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDP 479
CG L N+ W +TA HC ++ + LG H+L + + + + + + D
Sbjct: 25 CGGTLINQEWVLTARHCDR----GNMRIYLGMHNLKVLNKDALRRFPKEKYFCLNTRND- 79
Query: 480 RTFEYDLALLRFYEPVKFQPNIIPICVPEDDTNFVGTSAHVTGWGRL 526
++ D+ L+R PV+ +I P+ +P + + VG+ + GWG +
Sbjct: 80 TIWDKDIMLIRLNRPVRNSAHIAPLSLPSNPPS-VGSVCRIMGWGTI 125
>pdb|1SI5|H Chain H, Protease-Like Domain From 2-Chain Hepatocyte Growth Factor
Length = 240
Score = 46.2 bits (108), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 45/174 (25%), Positives = 65/174 (37%), Gaps = 18/174 (10%)
Query: 404 WQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLGEHDLSTEEEPYGY 463
W +SLR + H CG +L E+W +TA C D LG HD+ +
Sbjct: 13 WMVSLRYRNK----HICGGSLIKESWVLTARQCFPSRDLKDYEAWLGIHDVHGRGDEKCK 68
Query: 464 QERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDDTNFV-GTSAHVTG 522
Q V + P+ DL L++ P + I +P + TS V G
Sbjct: 69 QVLNVSQLVYGPEGS------DLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKTSCSVYG 122
Query: 523 WGRL----YEGRFRRSYGHPATRQEMATCWNHFLGNRILFPSSRIVGGEKATFG 572
WG Y+G R ++ + ++ C H G L S G EK G
Sbjct: 123 WGYTGLINYDGLLRVAHLYIMGNEK---CSQHHRGKVTLNESEICAGAEKIGSG 173
Score = 29.6 bits (65), Expect = 5.8, Method: Compositional matrix adjust.
Identities = 13/33 (39%), Positives = 18/33 (54%), Gaps = 4/33 (12%)
Query: 576 WQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
W +SLR + H CG +L E+W +TA C
Sbjct: 13 WMVSLRYRNK----HICGGSLIKESWVLTARQC 41
>pdb|1SHY|A Chain A, The Crystal Structure Of Hgf Beta-Chain In Complex With
The Sema Domain Of The Met Receptor
Length = 234
Score = 46.2 bits (108), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 45/174 (25%), Positives = 65/174 (37%), Gaps = 18/174 (10%)
Query: 404 WQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLGEHDLSTEEEPYGY 463
W +SLR + H CG +L E+W +TA C D LG HD+ +
Sbjct: 13 WMVSLRYRNK----HICGGSLIKESWVLTARQCFPSRDLKDYEAWLGIHDVHGRGDEKCK 68
Query: 464 QERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDDTNFV-GTSAHVTG 522
Q V + P+ DL L++ P + I +P + TS V G
Sbjct: 69 QVLNVSQLVYGPEGS------DLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKTSCSVYG 122
Query: 523 WGRL----YEGRFRRSYGHPATRQEMATCWNHFLGNRILFPSSRIVGGEKATFG 572
WG Y+G R ++ + ++ C H G L S G EK G
Sbjct: 123 WGYTGLINYDGLLRVAHLYIMGNEK---CSQHHRGKVTLNESEICAGAEKIGSG 173
Score = 29.6 bits (65), Expect = 5.8, Method: Compositional matrix adjust.
Identities = 13/33 (39%), Positives = 18/33 (54%), Gaps = 4/33 (12%)
Query: 576 WQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
W +SLR + H CG +L E+W +TA C
Sbjct: 13 WMVSLRYRNK----HICGGSLIKESWVLTARQC 41
>pdb|3BEU|A Chain A, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
pdb|3BEU|B Chain B, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
Length = 224
Score = 46.2 bits (108), Expect = 6e-05, Method: Composition-based stats.
Identities = 39/147 (26%), Positives = 66/147 (44%), Gaps = 20/147 (13%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDV-PPSDLLLRL 449
+VGG +A G++P+ + L CG AL+ ++ +TAAHCV + +
Sbjct: 1 VVGGTRAAQGEFPFMVRLSM--------GCGGALYAQDIVLTAAHCVSGSGNNTSITATG 52
Query: 450 GEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNI-IPICVPE 508
G DL + + R +++ + P F T+ D AL++ +P+ QP + I
Sbjct: 53 GVVDLQSSS---AVKVRSTKVLQA-PGFTKETYGKDWALIKLAQPIN-QPTLKIATTTAY 107
Query: 509 DDTNFVGTSAHVTGWGRLYEGRFRRSY 535
+ F V GWG EG ++ Y
Sbjct: 108 NQGTFT-----VAGWGANREGGSQQRY 129
Score = 36.6 bits (83), Expect = 0.051, Method: Composition-based stats.
Identities = 17/47 (36%), Positives = 27/47 (57%), Gaps = 8/47 (17%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+VGG +A G++P+ + L CG AL+ ++ +TAAHCV
Sbjct: 1 VVGGTRAAQGEFPFMVRLSM--------GCGGALYAQDIVLTAAHCV 39
>pdb|3I78|A Chain A, 3599170186220-Loops Of Fxa In Sgt
Length = 229
Score = 45.8 bits (107), Expect = 9e-05, Method: Composition-based stats.
Identities = 40/147 (27%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDV-PPSDLLLRL 449
+VGG +A G++P+ + L I CG AL+ ++ +TAAHCV + +
Sbjct: 1 VVGGTRAAQGEFPFMVRL---INEENEGFCGGALYAQDIVLTAAHCVSGSGNNTSITATG 57
Query: 450 GEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNI-IPICVPE 508
G DL + + R +++ + P F T+ D AL++ +P+ QP + I
Sbjct: 58 GVVDLQSSS---AVKVRSTKVLQA-PGFTKETYGKDWALIKLAQPIN-QPTLKIATTTAY 112
Query: 509 DDTNFVGTSAHVTGWGRLYEGRFRRSY 535
+ F V GWG EG ++ Y
Sbjct: 113 NQGTFT-----VAGWGANREGGSQQRY 134
Score = 36.2 bits (82), Expect = 0.061, Method: Composition-based stats.
Identities = 18/47 (38%), Positives = 28/47 (59%), Gaps = 3/47 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+VGG +A G++P+ + L I CG AL+ ++ +TAAHCV
Sbjct: 1 VVGGTRAAQGEFPFMVRL---INEENEGFCGGALYAQDIVLTAAHCV 44
>pdb|3I77|A Chain A, 3599170-Loops Of Fxa In Sgt
Length = 230
Score = 45.4 bits (106), Expect = 1e-04, Method: Composition-based stats.
Identities = 40/147 (27%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDV-PPSDLLLRL 449
+VGG +A G++P+ + L I CG AL+ ++ +TAAHCV + +
Sbjct: 1 VVGGTRAAQGEFPFMVRL---INEENEGFCGGALYAQDIVLTAAHCVSGSGNNTSITATG 57
Query: 450 GEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNI-IPICVPE 508
G DL + + R +++ + P F T+ D AL++ +P+ QP + I
Sbjct: 58 GVVDLQSSS---AVKVRSTKVLQA-PGFTKETYGKDWALIKLAQPIN-QPTLKIATTTAY 112
Query: 509 DDTNFVGTSAHVTGWGRLYEGRFRRSY 535
+ F V GWG EG ++ Y
Sbjct: 113 NQGTFT-----VAGWGANREGGSQQRY 134
Score = 36.2 bits (82), Expect = 0.064, Method: Composition-based stats.
Identities = 18/47 (38%), Positives = 28/47 (59%), Gaps = 3/47 (6%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+VGG +A G++P+ + L I CG AL+ ++ +TAAHCV
Sbjct: 1 VVGGTRAAQGEFPFMVRL---INEENEGFCGGALYAQDIVLTAAHCV 44
>pdb|3RP2|A Chain A, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
pdb|3RP2|B Chain B, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
Length = 224
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 34/137 (24%), Positives = 60/137 (43%), Gaps = 9/137 (6%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG ++ P+ L CG L + + +TAAHC ++ + LG
Sbjct: 1 IIGGVESIPHSRPYMAHLDIVTEKGLRVICGGFLISRQFVLTAAHC----KGREITVILG 56
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQP--NIIPICVPE 508
HD+ E Q+ +V+ H ++ +D+ LL+ + V+ P N++P+ P
Sbjct: 57 AHDVRKRES--TQQKIKVEKQIIHESYNSVPNLHDIMLLKLEKKVELTPAVNVVPLPSPS 114
Query: 509 DDTNFVGTSAHVTGWGR 525
D + G GWG+
Sbjct: 115 DFIH-PGAMCWAAGWGK 130
>pdb|2HNT|E Chain E, Crystallographic Structure Of Human Gamma-Thrombin
Length = 81
Score = 44.7 bits (104), Expect = 2e-04, Method: Composition-based stats.
Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 5/60 (8%)
Query: 474 HPQFDPR-TFEYDLALLRFYEPVKFQPNIIPICVPEDDTNF----VGTSAHVTGWGRLYE 528
HP+++ R + D+AL++ +PV F I P+C+P+ +T G VTGWG L E
Sbjct: 14 HPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKE 73
>pdb|4E7N|A Chain A, Crystal Structure Of Ahv_tl-I, A Glycosylated Snake-Venom
Thrombin- Like Enzyme From Agkistrodon Halys
Length = 238
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 35/138 (25%), Positives = 62/138 (44%), Gaps = 12/138 (8%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG++ + + ++L T CG L N+ W +TAAHC + ++LG
Sbjct: 1 IIGGDECNINEHRFLVALYTSRSRTLF--CGGTLINQEWVLTAAHCDR----KNFRIKLG 54
Query: 451 EHD--LSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
H + E+E + + ++S + ++ D+ L+R PVK +I P
Sbjct: 55 MHSKKVPNEDEQTRVPKEKFFCLSSK---NYTLWDKDIMLIRLDSPVKNSKHIAPF-SLP 110
Query: 509 DDTNFVGTSAHVTGWGRL 526
VG+ + GWGR+
Sbjct: 111 SSPPSVGSVCRIMGWGRI 128
Score = 32.3 bits (72), Expect = 0.89, Method: Compositional matrix adjust.
Identities = 15/46 (32%), Positives = 24/46 (52%), Gaps = 2/46 (4%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
I+GG++ + + ++L T CG L N+ W +TAAHC
Sbjct: 1 IIGGDECNINEHRFLVALYTSRSRTLF--CGGTLINQEWVLTAAHC 44
>pdb|3H5C|B Chain B, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex
Length = 317
Score = 42.4 bits (98), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 34/130 (26%), Positives = 54/130 (41%), Gaps = 20/130 (15%)
Query: 403 PWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLR---LGEHDLSTEEE 459
PWQ+ L + CG + EN+ +T A C LL R + + T ++
Sbjct: 106 PWQVKLTNSEGKDF---CGGVIIRENFVLTTAKC-------SLLHRNITVKTYFNRTSQD 155
Query: 460 PYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDDTN----FVG 515
P + V + H ++D E DL+LL P++ +P+C PE D
Sbjct: 156 PLMIKITHVHV---HMRYDADAGENDLSLLELEWPIQCPGAGLPVCTPEKDFAEHLLIPR 212
Query: 516 TSAHVTGWGR 525
T ++GW R
Sbjct: 213 TRGLLSGWAR 222
>pdb|3F1S|B Chain B, Crystal Structure Of Protein Z Complexed With Protein
Z-Dependent Inhibitor
Length = 283
Score = 42.4 bits (98), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 34/130 (26%), Positives = 54/130 (41%), Gaps = 20/130 (15%)
Query: 403 PWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLR---LGEHDLSTEEE 459
PWQ+ L + CG + EN+ +T A C LL R + + T ++
Sbjct: 65 PWQVKLTNSEGKDF---CGGVIIRENFVLTTAKC-------SLLHRNITVKTYFNRTSQD 114
Query: 460 PYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD----TNFVG 515
P + V + H ++D E DL+LL P++ +P+C PE D
Sbjct: 115 PLMIKITHVHV---HMRYDADAGENDLSLLELEWPIQCPGAGLPVCTPEKDFAEHLLIPR 171
Query: 516 TSAHVTGWGR 525
T ++GW R
Sbjct: 172 TRGLLSGWAR 181
>pdb|2I6Q|A Chain A, Complement Component C2a
pdb|2I6S|A Chain A, Complement Component C2a
Length = 517
Score = 41.6 bits (96), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 49/110 (44%), Gaps = 10/110 (9%)
Query: 403 PWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLGEHDLSTEEEPYG 462
PW ++++ + T C AL ++ W +TAAHC D L R+ D ++
Sbjct: 244 PWHVTIKPKSQET----CRGALISDQWVLTAAHCFRDGNDHS-LWRVNVGDPKSQWGKEF 298
Query: 463 YQERRV-----QIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP 507
E+ V + A Q + D+ALL+ + VK + PIC+P
Sbjct: 299 LIEKAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLP 348
Score = 32.7 bits (73), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 21/37 (56%), Gaps = 4/37 (10%)
Query: 575 PWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
PW ++++ + T C AL ++ W +TAAHC D
Sbjct: 244 PWHVTIKPKSQET----CRGALISDQWVLTAAHCFRD 276
>pdb|3S69|A Chain A, Crystal Structure Of Saxthrombin
Length = 234
Score = 41.6 bits (96), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/136 (23%), Positives = 59/136 (43%), Gaps = 10/136 (7%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
++GG++ + SL + ST C L NE W +TAAHC ++ ++LG
Sbjct: 1 VIGGDECNINE---HRSLVAFFNSTGFF-CSGTLINEEWVLTAAHC----DNTNFQMKLG 52
Query: 451 EHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPEDD 510
H E + + + + + + D + D+ L++ V +I+P+
Sbjct: 53 VHSKKVLNEDEQTRNPKEKFICPNKKND-EVLDKDIMLIKLDSRVSNSEHIVPL-SLPSS 110
Query: 511 TNFVGTSAHVTGWGRL 526
VG+ H+ GWG +
Sbjct: 111 PPSVGSVCHIMGWGSI 126
Score = 29.6 bits (65), Expect = 5.9, Method: Compositional matrix adjust.
Identities = 16/46 (34%), Positives = 23/46 (50%), Gaps = 4/46 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
++GG++ + SL + ST C L NE W +TAAHC
Sbjct: 1 VIGGDECNINE---HRSLVAFFNSTGFF-CSGTLINEEWVLTAAHC 42
>pdb|2ODP|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
pdb|2ODQ|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
Length = 509
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 49/110 (44%), Gaps = 10/110 (9%)
Query: 403 PWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLGEHDLSTEEEPYG 462
PW ++++ + T C AL ++ W +TAAHC D L R+ D ++
Sbjct: 236 PWHVTIKPKSQET----CRGALISDQWVLTAAHCFRDGNDHS-LWRVNVGDPKSQWGKEF 290
Query: 463 YQERRV-----QIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVP 507
E+ V + A Q + D+ALL+ + VK + PIC+P
Sbjct: 291 LIEKAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLP 340
Score = 32.7 bits (73), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 21/37 (56%), Gaps = 4/37 (10%)
Query: 575 PWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
PW ++++ + T C AL ++ W +TAAHC D
Sbjct: 236 PWHVTIKPKSQET----CRGALISDQWVLTAAHCFRD 268
>pdb|2KAI|A Chain A, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|A Chain A, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|X Chain X, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|A Chain A, Kallikrein Complexed With Hirustasin
pdb|1HIA|X Chain X, Kallikrein Complexed With Hirustasin
Length = 80
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 23/68 (33%), Positives = 36/68 (52%), Gaps = 8/68 (11%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDVPPSDLLLRLG 450
I+GG + PWQ+++ + S++ +CG L N W +TAAHC D + + LG
Sbjct: 1 IIGGRECEKNSHPWQVAIYHY--SSF--QCGGVLVNPKWVLTAAHCKND----NYEVWLG 52
Query: 451 EHDLSTEE 458
H+L E
Sbjct: 53 RHNLFENE 60
Score = 38.5 bits (88), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 28/49 (57%), Gaps = 4/49 (8%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED 611
I+GG + PWQ+++ + S++ +CG L N W +TAAHC D
Sbjct: 1 IIGGRECEKNSHPWQVAIYHY--SSF--QCGGVLVNPKWVLTAAHCKND 45
>pdb|1OP0|A Chain A, Crystal Structure Of Aav-sp-i, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 39.7 bits (91), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 26/107 (24%), Positives = 47/107 (43%), Gaps = 6/107 (5%)
Query: 420 CGAALFNENWAVTAAHCVEDVPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDP 479
CG L N W VTAAHC +D ++LG H E + + + + + + +
Sbjct: 26 CGGTLINPEWVVTAAHCDS----TDFQMQLGVHSKKVLNEDEQTRNPKEKFICPN-KNNN 80
Query: 480 RTFEYDLALLRFYEPVKFQPNIIPICVPEDDTNFVGTSAHVTGWGRL 526
+ D+ L++ +P+ +I P+ VG+ + GWG +
Sbjct: 81 EVLDKDIMLIKLDKPISNSKHIAPL-SLPSSPPSVGSVCRIMGWGSI 126
Score = 29.6 bits (65), Expect = 5.4, Method: Compositional matrix adjust.
Identities = 11/17 (64%), Positives = 11/17 (64%)
Query: 592 CGAALFNENWAVTAAHC 608
CG L N W VTAAHC
Sbjct: 26 CGGTLINPEWVVTAAHC 42
>pdb|2ASU|B Chain B, Crystal Structure Of The Beta-Chain Of HgflMSP
Length = 234
Score = 39.3 bits (90), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 36/137 (26%), Positives = 51/137 (37%), Gaps = 15/137 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVED--VPPSDLLLR 448
+VGG G PW +SLR H CG +L E W +TA C +P + +
Sbjct: 1 VVGGHP---GNSPWTVSLRN---RQGQHFCGGSLVKEQWILTARQCFSSCHMPLTGYEVW 54
Query: 449 LGEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNIIPICVPE 508
LG + + Q V + P L LL+ V + IC+P
Sbjct: 55 LGTLFQNPQHGEPSLQRVPVAKMVCGPSGS------QLVLLKLERSVTLNQRVALICLPP 108
Query: 509 D-DTNFVGTSAHVTGWG 524
+ GT + GWG
Sbjct: 109 EWYVVPPGTKCEIAGWG 125
Score = 32.0 bits (71), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 18/46 (39%), Positives = 22/46 (47%), Gaps = 6/46 (13%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
+VGG G PW +SLR H CG +L E W +TA C
Sbjct: 1 VVGGHP---GNSPWTVSLRN---RQGQHFCGGSLVKEQWILTARQC 40
>pdb|1EPT|A Chain A, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 43
Score = 38.9 bits (89), Expect = 0.010, Method: Composition-based stats.
Identities = 19/46 (41%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 436
IVGG P+Q+SL ++ H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCAANSIPYQVSL-----NSGSHFCGGSLINSQWVVSAAHC 41
Score = 38.9 bits (89), Expect = 0.010, Method: Composition-based stats.
Identities = 19/46 (41%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHC 608
IVGG P+Q+SL ++ H CG +L N W V+AAHC
Sbjct: 1 IVGGYTCAANSIPYQVSL-----NSGSHFCGGSLINSQWVVSAAHC 41
>pdb|1OP2|A Chain A, Crystal Structure Of Aav-Sp-Ii, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 38.1 bits (87), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 25/107 (23%), Positives = 47/107 (43%), Gaps = 6/107 (5%)
Query: 420 CGAALFNENWAVTAAHCVEDVPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDP 479
CG L N W VTAAHC ++ ++LG H E + + + + + + +
Sbjct: 26 CGGTLINPEWVVTAAHCDS----TNFQMQLGVHSKKVLNEDEQTRNPKEKFICPN-KNNN 80
Query: 480 RTFEYDLALLRFYEPVKFQPNIIPICVPEDDTNFVGTSAHVTGWGRL 526
+ D+ L++ +P+ +I P+ VG+ + GWG +
Sbjct: 81 EVLDKDIMLIKLDKPISNSKHIAPL-SLPSSPPSVGSVCRIMGWGSI 126
Score = 29.6 bits (65), Expect = 5.5, Method: Compositional matrix adjust.
Identities = 11/17 (64%), Positives = 11/17 (64%)
Query: 592 CGAALFNENWAVTAAHC 608
CG L N W VTAAHC
Sbjct: 26 CGGTLINPEWVVTAAHC 42
>pdb|2FMJ|A Chain A, 220-Loop Mutant Of Streptomyces Griseus Trypsin
Length = 222
Score = 37.0 bits (84), Expect = 0.035, Method: Composition-based stats.
Identities = 37/147 (25%), Positives = 65/147 (44%), Gaps = 22/147 (14%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDV-PPSDLLLRL 449
+VGG +A G++P+ + L CG AL+ ++ +TAAHCV + +
Sbjct: 1 VVGGTRAAQGEFPFMVRLSM--------GCGGALYAQDIVLTAAHCVSGSGNNTSITATG 52
Query: 450 GEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNI-IPICVPE 508
G DL + + R +++ + P ++ D AL++ +P+ QP + I
Sbjct: 53 GVVDLQSSS---AVKVRSTKVLQA-PGYNGTG--KDWALIKLAQPIN-QPTLKIATTTAY 105
Query: 509 DDTNFVGTSAHVTGWGRLYEGRFRRSY 535
+ F V GWG EG ++ Y
Sbjct: 106 NQGTFT-----VAGWGANREGGSQQRY 127
Score = 36.6 bits (83), Expect = 0.051, Method: Composition-based stats.
Identities = 17/47 (36%), Positives = 27/47 (57%), Gaps = 8/47 (17%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+VGG +A G++P+ + L CG AL+ ++ +TAAHCV
Sbjct: 1 VVGGTRAAQGEFPFMVRLSM--------GCGGALYAQDIVLTAAHCV 39
>pdb|1OS8|A Chain A, Recombinant Streptomyces Griseus Trypsin
Length = 223
Score = 36.6 bits (83), Expect = 0.045, Method: Composition-based stats.
Identities = 37/147 (25%), Positives = 65/147 (44%), Gaps = 22/147 (14%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDV-PPSDLLLRL 449
+VGG +A G++P+ + L CG AL+ ++ +TAAHCV + +
Sbjct: 1 VVGGTRAAQGEFPFMVRLSM--------GCGGALYAQDIVLTAAHCVSGSGNNTSITATG 52
Query: 450 GEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNI-IPICVPE 508
G DL + + R +++ + P ++ D AL++ +P+ QP + I
Sbjct: 53 GVVDLQSSS---AVKVRSTKVLQA-PGYNGTG--KDWALIKLAQPIN-QPTLKIATTTAY 105
Query: 509 DDTNFVGTSAHVTGWGRLYEGRFRRSY 535
+ F V GWG EG ++ Y
Sbjct: 106 NQGTFT-----VAGWGANREGGSQQRY 127
Score = 36.2 bits (82), Expect = 0.057, Method: Composition-based stats.
Identities = 17/47 (36%), Positives = 27/47 (57%), Gaps = 8/47 (17%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+VGG +A G++P+ + L CG AL+ ++ +TAAHCV
Sbjct: 1 VVGGTRAAQGEFPFMVRLSM--------GCGGALYAQDIVLTAAHCV 39
>pdb|1OSS|A Chain A, T190p Streptomyces Griseus Trypsin In Complex With
Benzamidine
Length = 223
Score = 36.6 bits (83), Expect = 0.048, Method: Composition-based stats.
Identities = 37/147 (25%), Positives = 65/147 (44%), Gaps = 22/147 (14%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCVEDV-PPSDLLLRL 449
+VGG +A G++P+ + L CG AL+ ++ +TAAHCV + +
Sbjct: 1 VVGGTRAAQGEFPFMVRLSM--------GCGGALYAQDIVLTAAHCVSGSGNNTSITATG 52
Query: 450 GEHDLSTEEEPYGYQERRVQIVASHPQFDPRTFEYDLALLRFYEPVKFQPNI-IPICVPE 508
G DL + + R +++ + P ++ D AL++ +P+ QP + I
Sbjct: 53 GVVDLQSSS---AVKVRSTKVLQA-PGYNGTG--KDWALIKLAQPIN-QPTLKIATTTAY 105
Query: 509 DDTNFVGTSAHVTGWGRLYEGRFRRSY 535
+ F V GWG EG ++ Y
Sbjct: 106 NQGTFT-----VAGWGANREGGSQQRY 127
Score = 36.2 bits (82), Expect = 0.059, Method: Composition-based stats.
Identities = 17/47 (36%), Positives = 27/47 (57%), Gaps = 8/47 (17%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+VGG +A G++P+ + L CG AL+ ++ +TAAHCV
Sbjct: 1 VVGGTRAAQGEFPFMVRLSM--------GCGGALYAQDIVLTAAHCV 39
>pdb|1SGT|A Chain A, Refined Crystal Structure Of Streptomyces Griseus Trypsin
At 1.7 Angstroms Resolution
Length = 223
Score = 36.6 bits (83), Expect = 0.052, Method: Composition-based stats.
Identities = 17/47 (36%), Positives = 27/47 (57%), Gaps = 8/47 (17%)
Query: 391 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 437
+VGG +A G++P+ + L CG AL+ ++ +TAAHCV
Sbjct: 1 VVGGTRAAQGEFPFMVRLSM--------GCGGALYAQDIVLTAAHCV 39
Score = 36.6 bits (83), Expect = 0.052, Method: Composition-based stats.
Identities = 17/47 (36%), Positives = 27/47 (57%), Gaps = 8/47 (17%)
Query: 563 IVGGEKATFGKWPWQISLRQWIRSTYLHKCGAALFNENWAVTAAHCV 609
+VGG +A G++P+ + L CG AL+ ++ +TAAHCV
Sbjct: 1 VVGGTRAAQGEFPFMVRLSM--------GCGGALYAQDIVLTAAHCV 39
>pdb|1BQY|A Chain A, Plasminogen Activator (tsv-pa) From Snake Venom
pdb|1BQY|B Chain B, Plasminogen Activator (tsv-pa) From Snake Venom
Length = 234
Score = 35.8 bits (81), Expect = 0.088, Method: Compositional matrix adjust.
Identities = 26/106 (24%), Positives = 45/106 (42%), Gaps = 6/106 (5%)
Query: 420 CGAALFNENWAVTAAHCVEDVPPSDLLLRLGEHDLSTEEEPYGYQERRVQIVASHPQFDP 479
CG L N++W VTAAHC ++ L G H E ++ + + + + D
Sbjct: 26 CGGTLINQDWVVTAAHC----DSNNFQLLFGVHSKKILNEDEQTRDPKEKFFCPNRKKDD 81
Query: 480 RTFEYDLALLRFYEPVKFQPNIIPICVPEDDTNFVGTSAHVTGWGR 525
+ D+ L++ V +I P+ VG+ + GWG+
Sbjct: 82 EV-DKDIMLIKLDSSVSNSEHIAPL-SLPSSPPSVGSVCRIMGWGK 125
Score = 31.6 bits (70), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 11/17 (64%), Positives = 13/17 (76%)
Query: 592 CGAALFNENWAVTAAHC 608
CG L N++W VTAAHC
Sbjct: 26 CGGTLINQDWVVTAAHC 42
>pdb|1EPT|C Chain C, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
pdb|1AKS|B Chain B, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
Length = 98
Score = 35.4 bits (80), Expect = 0.12, Method: Composition-based stats.
Identities = 18/48 (37%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
PS+LQ + PV++NS C++ Y I IC G+ +G DSC+
Sbjct: 7 PSLLQCLKAPVLSNSSCKSSYPG-----QITGNMICVGFLQGGKDSCQ 49
>pdb|1UHB|B Chain B, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 98
Score = 33.1 bits (74), Expect = 0.47, Method: Composition-based stats.
Identities = 17/48 (35%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGSFDSCE 688
PS+LQ + PV+++S C++ Y I IC G+ +G DSC+
Sbjct: 7 PSLLQCLKAPVLSDSSCKSSYPG-----QITGNMICVGFLEGGKDSCQ 49
>pdb|1BBR|E Chain E, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|E Chain E, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|G Chain G, Thrombin:hirudin 51-65 Complex
pdb|1YCP|M Chain M, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 109
Score = 30.8 bits (68), Expect = 2.9, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 27/51 (52%), Gaps = 8/51 (15%)
Query: 641 PSVLQEVSVPVINNSLCETMYRAAGFIEHIPEIFICAGWRKGS---FDSCE 688
PSVLQ V++P++ +C+ R I + CAG++ G D+CE
Sbjct: 7 PSVLQVVNLPLVERPVCKASTRI-----RITDNMFCAGYKPGEGKRGDACE 52
>pdb|2KAI|B Chain B, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|B Chain B, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|Y Chain Y, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|B Chain B, Kallikrein Complexed With Hirustasin
pdb|1HIA|Y Chain Y, Kallikrein Complexed With Hirustasin
Length = 152
Score = 30.4 bits (67), Expect = 3.6, Method: Composition-based stats.
Identities = 14/52 (26%), Positives = 26/52 (50%), Gaps = 1/52 (1%)
Query: 478 DPRTFEYDLALLRFYEPVKFQPNIIPICVPEDDTNFVGTSAHVTGWGRLYEG 529
D + + +DL LLR P K + + +P + +G++ +GWG + G
Sbjct: 2 DGKDYSHDLMLLRLQSPAKITDAVKVLELPTQEPE-LGSTCEASGWGSIEPG 52
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.320 0.136 0.440
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 16,628,230
Number of Sequences: 62578
Number of extensions: 624311
Number of successful extensions: 2431
Number of sequences better than 100.0: 348
Number of HSP's better than 100.0 without gapping: 293
Number of HSP's successfully gapped in prelim test: 55
Number of HSP's that attempted gapping in prelim test: 1019
Number of HSP's gapped (non-prelim): 912
length of query: 697
length of database: 14,973,337
effective HSP length: 106
effective length of query: 591
effective length of database: 8,340,069
effective search space: 4928980779
effective search space used: 4928980779
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 55 (25.8 bits)